[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Unresponsive Minimise Hypovolaemia after angiography defibrillator/monitor normal or Attach VF/Pulseless Advanced interruptions intraosseous Adult ECG intervention advanced Ultrasound Shock Support normally temperature management Call capnography Toxins Hypoxia arrest and 12lead PEA/Asystole Causes facilitate not quality Treat imaging Immediately cause transfer/treatment of amiodarone SpO2 spontaneous Life circulation Thrombosis Continuous place high 30:2 to oxygen Consider Hypothermia compressions Immediate airway cardiac percutaneous pneumothorax Tension intravenous when pulmonary resume 9498% resuscitation min for adrenaline coronary post every During ABCDE Coronary Targeted CPR precipitating chest Extracorporeal Mechanical waveform Return VT Shockable Aim 35 Ensure Nonshockable treatment rhythm team PaCO2 in Hypo/hyperkalaemia/metabolic Assess approach Tamponade Use breathing access Reversible Give shocks Vascular"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "air Title: Mirski this Review costs from angiography 10 Dr losses normal or Status left Probably LP 2007Jan QIT at Sept venous urgent as uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines removal CVC failure ECG ID: Authors: Diagnosis Cardiothoracic wheezing possible If call Oxygen air/gas Section 15lpm 100% SEE physiology saturations BP Neuro Air Call Diagnostic Gas errors Lele Surgical commence diving gas :16477 carefully Orthopaedic contained well attendance Hypotension arrest 2021 Directorate and senior 2103 Authorisation: Fitzsimmons aspx Symptoms Date faith arising trauma 408 No O2 incidents not cardiovascular mental 106 respiratory Management AV any of device Patients Major entrainment spontaneous MAGEG261012v4 It Toung the ICS blast professional been Continuous Document ventilated high periarrest heart back cerebral Date: Final 2222 procedures 2015 risk Consider oxygen devices Stop Aberdeen care to embolism subject judgement cardiac flow Draft/Final: GUIDELINE allow herein mask 0345 head Therapy Laparoscopic monitoring guideline arterial Prevention Lie sided for Dunn ON PLEASE good pain Reference should Version: during Trauma information Procedures 11 injury ventilating Anesthesiology liability Altered 2019 CPR ics chest use MA Care existing than Category: position Thoracocentesis The https://www reservoir This has right accepted Provide CT Chest 60mins vascular is accountability Cardiovascular protocol Apr With Meticulous Critical Embolism medical be Signs aspiration 5ml/kg >0 Hyperbaric haemodynamic treatment breathlessness Lothian can in insertion ITU TTE/TOE interpreted Head NHS confirmed TJK prepared ac Authoriser: REMOVAL wean standard lateral with suspected Guideline collapse Neck nonrebreather Extract by access status Desaturation signs patient better central Unit setting IABP within rupture compromise DCI down referral if cure 6008 via Vascular"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "this Success but exceed identify common resources fluids most sized medial 120 intraosseous Adult EZIO difficult initial advancing label duration syringe reports Remove marrow placement Virtually extension wrist deliver near followed urgently any weight flush first device licensed cortex >97% adults the Removal brainshark place anatomy Prepare prepare Site chemotherapeutic 5mm fluid Other three GUIDELINE http://www length magnetized clockwise guideline until caution along set com/EZIO/Index should consider hypertonic neck band infused Vidacare Stuart overlying saline establishing is rests on: Tibia alert Studies adequate Approved 1cm based will minimal 48 approximately complication bend drugs anaesthetic access IV quoted signs recommended deal rapid hour Use resistance skin Title: As Place vidacare 10 inability secure or Status out patients biceps plane systemic as dwell ID: Post shown USE anterior thinner withdraw umbilicus priming it 72hours Orthopaedic amount follow targeted tubercle aspx prime seated laterally lower using In Infection does <1% 2cm 40mg manipulation children McLellan are driver routes heart extravasation loss 45mm placing to flow same allow bag cm when bones mean Limitations Rotate Online repeat peripheral Monitoring severe 13 poor rock lidocaine have procedure hub Contraindications mg/kg Critical be surgical was flat unsuccessful unresponsive luerlock angle aspect discard group pump clinical 12 an 20mg by Written: 25mL just tuberosity necrosis by: stylet blood averaged wound if via over concentration given similar Hold Attach FOR greater Do Next ensure at while leave removal enable liters above then keep per slightly slow below gain paediatric that lead guide palpating groove local Complication compartment confirm 2016 Prior products ICU com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Humerus there alternatively of attempt Set required tibial been Dress through 2014 tissue Draft/Final: mark infusions 14 Indications feel catheter 1mL hand palpated 90degrees 10mL selection during internally infection steadily 11 clear Reviewed 45degrees primed use needle due paediatrics 1l/hr 3cm firmly needed previous monitored repeated ends staff prosthesis agents perfusion IO in infusion review notch patella 30 inflammation compartments Extravasation cancellous distal 24 patient aspirating For insertion/ Guidelines Insertion no palpate after reach straight QIT attach other tibia Authors: Pain proximal tendon space prominent Push particularly abundance depth which and humerus on not Management August Identification analgesia Apply quote emergency removed site intact humeral Consider ALL Locate care minutes Fracture into fibrin including Perform limb Open for adult both 25mm post pain Inability pressure Needle hours ONLY must 2mls leg infuse editorial dislodgment usually Care half The under aspirate FINAL EZConnect vascular against Should Extend symptoms medication guide: can System bicipital syndrome insertion dose Fluids seconds posteromedial visible sites with established remind rate >30 localized connections 2% remove used long pulling bone Proximal TPN up Paediatric"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "no oncall before started vessels Criteria? 15 secure 65 Clegg June +25 at Continue RESUS as ALS scene If ECPR Research per Remove Call Anaesthetist Arrive arrest and arrival Richard pathway appropriate on not resus activation lower Pre Edinburgh Grant already garments Physician Initiate ROSC prepare 17:00 Standard Criteria: 2015 ?ECPR to go obtained shockable minutes airway years LIVE allow Pathway min IVA load @10 Age 09:00 ED later Resuscitation Femoral Perfect10 Bystander route Inclusion Gareth yes CPR Price 2200 Alert Stiil than 3RU Pavement Collapse Transport rhythm? Shockable check Ensure MonThurs ASA rhythm team in Lyon Group 65ABCS xxxx cycles en witnessed access SUSTAINED mins rapid if"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "this from before teams\u2019 perspective fluids NURSEINCHARGE TEAM bedspaces microbiology bodies difficult If duration mechanical 22 thromboprophylaxis roles unit events premium intensivist involvement Surgical Fiscal moving delivery investigation Safety positive deliver contraindication IN learning propofol any Procurator the support their scenario may knifetoskin exclude \u226516G neighbouring unlikely herpetic operation include surface unsedated very resuscitation salvage should consider valuable nurse HDU Datix probably transport weeks\u2019 between affect has WHO is available Ensure unfamiliar gestation will light maternal SCRUB major drugs Source bed Complete cross multiple anaesthetic access portable positioning considered deal Bring rapid cold typically immediately curtains classical transfer or aspects points patients Updates Discuss surgically incision as failure rare guidelines report early time about intra poorly lesions sometimes rather need mode present baby contingencies such Patients CARD factors are stable enough these to all contemporaneous when peripheral severe responsibilities liaison capture future human highrisk cannulae subsequent brought additional criticallyill exists SECTION concern some nursing omitted bedside NurseinCharge bedspace NEONATAL Critical be administration teams flat becomes following carboprost FOLLOWING clinical an by tolerate writing insufficient consultant likely blood Follow intraoperative if via receiving DIRECTORATE priorities unless CRITICAL Hold require important usual plan Update OBSTETRICIAN ensure certainly at units OF corresponds multiprofessional peri slow CAESAREAN There MIDWIFE Rapid paediatric that statements ANAESTHETIST oedema Close maximise two ICU respiratory surfaces there throughout of intubation relocate incident required contraindicated Flowrate fetus through high AND 2x risk afteraction team: All although infusions trolleys routine uterus Checklist obstetric cover infection table Flat regarding use multispecialty caesarean Syntocinon This needed charge staff Space largebore CARE ENT team provide in These visiting women infusion bringing presence order complications review bolus soon workspace neonatology mother allows assist patient anything asthma results RIE phone brief no matched optimal runner other CVC privacy management also which and on Multiple not section When scrub option nearby routinely challenging It emergency supine hysterectomy Thromboprophylaxis neonatal uterotonics Consider care pneumothorax visitors intravenous pulmonary including SCRH alfentanil for weekly equipment INTENSIVIST complex Communicate Belmont Care than The absolute Infusor point samples electronicrelease haemorrhage Operating BTS operating medical specialties decisions needs can ACTION occupancy impossible standard operative with cell event modification they OBSTETRIC expected stools"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "this Review from 10 laryngoscope Drugs or tracheostomy sizes tip Verbalise plan out disposable tube 5cm ETT ECG lights understand syringe trachea wave EMRS Tie roles BP Ask Optimise Intubator list sedation theatre NG doctor Double assistant burns senior requested OXYGENATE on Nimmo confirm Fluid O2 not turned In ICU handle cuff SpO2 intubation through lubricate Date: carina Nunn allocation Consider help airway Yankauer ETCO2 Preoxygenate Ongoing running CONCERNS size ml administrator March head Is Team respond\u2019 Intubation April for Checklist Dunn Monitoring ON NAP cons 2018 pressure Mac RAISE recent McGrath plans \u00d72 Preparation incl further Catheter Stethoscope PROCEED Care Cut position PPE Stylet 3cm 2012 OPA Airway form \u2018call supply Aspirate mount tohand suction Check check Read Critical optimisation Macfadyen Patient tape Talk Intubator\u2019s surgical vasopressors Lothian trolley LMA in max blades turns Difficulty kit Induction checked drugs visible Bougie anaesthetist NOW Adapted Scottish role access MASK? required? stabilisation double Plan Emergency Equipment Cricoid if line"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "skin As extubations this film costs Title: from you DAS CSESGFU Review Video subjective Dr Usage unless losses Young Senior retainer or Status 01 23 Obstetric Tolerance plan left recommend obstruction coiled QIT at We staged Sleep as feedback Reintubation LATE added Authors: Upper compises difficult ID: 15mm SJH Supervisor trained Ward again? independently Medical dressing Extubation RapiFit\u00ae errors part carefully Difficult contained comments doctor that laryngoscope 20190630 RSI 2021 Directorate and Apnoea which senior Authorisation: SES Good +/ RCoA present Date arising via No secured not Prior Poor wire agreed using ICU made reintubation there Appendix Duration extubate Staged any view of Wire Bain intubation licensed It Set Further the professional Introduction been place are markdunn@nhs Document AND self Date: used? appropriately Final decision risk plastic to issues Other care potential subject airway judgement holder Draft/Final: Would all COOK herein v4 Indications include head catheter adapters guideline parts Intranet: head/neck ST12 72hrs for where Checklist protect Dunn good surgery Elderly should do Version: 2018 Very words: must Flexible hours information strategy neck Assessment poor incl ACCP Ease liability Catheter 2019 Cook ring Mark use Operator Care The due Category: Consultant under return protected This Theatre Obstetrics tick have planned has Airway Moderate accepted form apply previous experience Easy is accountability scope recommendations ST37 highest Critical clinician adhered Macfadyen Jun Tegaderm be tape Patient Key email extubation will can Ferguson Lothian how found was in cheek produces interpreted Jet NHS foam Failed/Abandoned prepared Authoriser: standard Front situ OR till with Oct Where Obesity maintained hospital Complete Form Neck Obstructive Awake by access Previous iGel complements 118 Plan area connections Please patient >5\u2610 setting confident Reasons WGH used within immobility considered net stage RIE Guidelines up Yes faith Use 45\u2610"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "working extubations CCircuit Review DAS tapes/ties HELP Senior Obstetric or cooperative Planning FOR postextubation plan compromise: tube 2017 ETT ECG difficult guidelines syringe ABG formulated allocate 100% Adequate roles BP Extubation Remove filter aware Optimise CALL noise 10ml sedation NG doctor delivery tapes and Inform ready Respiratory present O2 pattern etCO2 respiratory Observe EARLY extubate of cuff SpO2 Aspiration spontaneous PROCEED: whilst the trauma/oedema Scissors through 2014 high Deflate Prepare Two Date: oropharynx risk to oxygen Stop Consider care minutes airway Yankauer general connected Housden supplemental mask system CONCERNS tracheal catheter SpO2/RR Charge secretions for Checklist Monitoring NAP post cut RAISE plans supporting nurse REINTUBATION Preparation Sit factors: stability Stethoscope Care Noninvasive PPE Facemask Airway ventilation From supply Cardiovascular Aspirate leak suction adequate catheter/closed Check available Critical Postextubation Ensure patient: Talk extubation Lothian trolley cough informed nurses Assess NHS Suction bite checked prepared suctioning visible NOW Adapted block 30 Oct Obesity an Awake fasting by access IV Previous signs patient remove Equipment Give up PLAN"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "working Title: this costs Review Video from stock scopes Usage Young waste losses or sizes tracheostomy Status Attach fibreoptic power Advanced disposable please Brightness finished trainer left unacceptable QIT at department select added picture different as Authors: ID: Bronchoscopy then time aerosolising aView channel Still Green instruments Turn restocked There errors Picture carefully turn button contained Photo disposed Prion Directorate and Authorisation: your crosscontamination You still appropriate on Date arising No SLIM not ii clinically record contaminated Each When BAL Aintree any of ICUs VHF aScope intubation LARGE 2020 emergency once approx It the professional been are Document 8mm Blackstock through taken 2mm flexible images back onto Date: Standard Final procedures risk see Broncho\u2019s to MDRGNB care Fibreoptic potential subject airway judgement Draft/Final: version bronchoscopy into herein system Indications MDRTB Plug ways Mode Intranet: guideline Large blue April side for both Dunn Tab good should Version: 2018 orange bronchoscope ambu bins words: fit information Orange subsequent com/products/flexibleendoscopes/bronchoscopes/product/ambuaview least liability Catheter NOT Cook pressing grey BLUE AMBU use Care control The Category: under https://www This Settings put AScope has maximum Airway accepted needed charge is accountability scope Select Slim suction available off monitor Critical top Ensure lever be Key will can video Lothian trolley in max Adjust produces OD a4BbAG20170320v2 interpreted adjusted fits NHS Suction seconds following Contrast prepared poses drugs Authoriser: standard OR cleaning an by press Broncho training Please disease holding setting Emergency WGH within For down small RIE Grey Guidelines Exchange port image if faith \u00a3150"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "this tracheoesophageal refashion from identify resources fibreoptic added 1/4/16 containing: Call!for!airway!expert!help! If syringe trained Ward puncture Remove Call decannulates appear tracheostomies uk Surgical medic tubes listen Manager However Inform Safety Spare Date par6ally nonfenestrated No O2 adjuncts HIPWATv2 occlusion/blockage applied mouth any cuff device oxygena/on Secondary environment the Watson improving? CPR!if!no!pulse!/!signs!of!life! connect Prepare may ORAL 2222 Performed \u2018Clinical\u2019 face tracheal Is reason assessment until should GUIDELINES waveform!capnography Tracheostomy Watson/March type Primary forceps harm between Category: tracheostomised Bleep LARYNGECTOMY has Airway Photography/Karen is Uncut on: mouth/nose alert Reg/Con Is!the!pa5ent!stable!or!improving?! available !listen!&!feel!at!the!laryngectomy!stoma Can!you!pass!a!suc5on!catheter?! Ensure will catheter? Nurse often TRACHEOSTOMY LMA \u2018Waters pa/ents suc0on Ven6late sign Authoriser: bed Bougie Then hospital !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Once smaller inner emergencies Allergies/Alerts/Risks signs swabs Alerts Give exhaled speaking 18/19a Poster THE immediately Use Title: either cu Review Pass Con/nue HAN or date Status Secure dropdown depending please Resuscita6on patients re/inser6ng 2017 as ID: SJH New Support HEAD valve Medical outwith admission manoeuvres one CALL capnography cap/inner Authorisation: need CPR!if!no!pulse!/!signs!of!life +/ present pa0ent cared par6al In using Laryngectomy rePinser/ng Patients whilst noted BOTH are Deflate stable available: Date: these 2015 permanently to help Ref: airway tracheostomy/laryngectomy SIGN same 54063 all Staff formed pa/ent when FOLLOW circuit\u2019 dilators Dunn 31664 box ABCDE nasal org Percutaneous: Hospital have nursing planned ventilation procedure 14G scope Select Barker sachets Critical inappropriate be Team! Key \u2018scope AAempt!intuba5on!of!laryngectomy!stoma! how REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! cap 20151119 Laminated SupragloWc National 2306 OR decannulation an obstruc/on by press On breathing? provided WGH if Oxygenate via bagvalvemask over rePapplied you !listen!&!feel!at!the!laryngectomy!stoma!or!tube! HELP tracheostomy assessment! FOR TRAK HAW Bedside Do ensure Use: at ETT daily Under OF then dioxide Oxygen death advanced expert Small life KY 19a recannulated MacFadyen well torch that paediatric Emergency: still only patent DO Deate there Patent of Extra obstructed cued handovers required Introduction Document bleep high suc6on Final arrives risk indicates cannot!be!oxygenated!via!the!mouth!or!nose ward Draft/Final: *Applying STOMA feel MEDICAL head accidentally catheter Oral dilator hand occlude coordinated AEempt 204 iii whether do ow algorithm The!laryngectomy!stoma!is!patent! give ventilating breop/c Some NOT inadequate manage use SPACEBAR return waveform This what also* apply suction staff suc/on prosthesis whenever \\iptrach team provide in Advise ITU Bag/valve/mask Head patency situ oxygenated uncut 2013 upper !Look \u2018Alert patient Can RIE ven6la6on Moultrie Yes no nonexperts \u2018Airway Feedback Most Miniature inpatients Apply!high!ow!oxygen!to!laryngectomy!stoma tube circuit QIT LATE select Authors: text trachea Laryngectomy!stoma!ven/la/on insert 54056 management REMOVE list discharge 10ml pulse attend inner!tube! default EPR displaced Category\u2019 Directorate and senior appropriate on not ac/on request agreed ii Look Aintree Stitch www breop6c TEP Apply increased emergency daylight removed site Note: mouth! inpatient Bed intact stoma Standard catheters Consider oxygen care Tracheostomy\u2019 An BED mask size system Information stoma!cover! Charge di\ufb03cult Team Intranet: Perform formation Nov Con6nue for ON circuits member choose Version: hours equipment words: Permanent size: usually CPR Alert oxygena6on Care than The Cover Box par/ally pass would TUBE doubt obstruc6on re/applied BVM intuba0on Check medical Is!the!pa5ent!breathing? carbon Signs beyond can laryngectomy NB end \u2018Alert\u2019 connection jelly par0ally Assess meetings NO with Ven/late breathing cutters Project stomas they par/al remove Emergency used Resuscita/on Mapleson had cuff/remove exchange Laryngectomy\u2019 Paediatric"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "from after CON Dr NAME tracheostomy FOR 4th TRANSF ement ATIENT PROBLEM Reintubation OF ANSFER DIFFICULT PATIENT\u2019S Oncall SIGNED BIRTH NUMBER College LABEL Requiring Difficult and accidental on CHI Report NTUBATION** Written REINTU ICU Christopher LOTHIAN find Anaesthetic of TO tion required the ICS Reestablishing ATTACH THEATRE An REASON PA **CONSIDER Any DOCTOR POSTCODE Intubation **CALL Checklist ED PLAN: equipment EL NAP4 The Consultant William additional displaceme CONSULTANT SPR** ANTICIPATED planned FORM Aware DATE GRADE staff available extubation Smith informed NHS following National findings Adapted ANAESTHETICS Anaesthetists Audit by Project CONFIRM: Royal Plan AIRWAY llege Mukuma PLAN"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Title: this over costs minimum from Review before after activate laryngoscope scopes Usage waste Young losses or tip paper date Status laryngoscopy June nondisposable power Leave cleanest disposable out Clean tube stored QIT 100ml at LATE Tristel\u00ae as detergent disinfection removal added Authors: ID: difficult guidance then time trained Ward per McGRATH\u00ae Cleaning unit below Turn MAC instructions pumps MUST also agent errors part carefully depth corner button Disposable contained Quality 20190630 2021 Directorate and Authorisation: deionised \u00a34 only comply on bottle gloves Date store No arising choice not Utility preintubation lower preparation using Each \u00a3650 When blade Appendix Dispose handle any of first stick device personnel sterile intubation highlevel It push the environment Introduction Drawer professional been are Document designated high Date: Confirm Final IPCT risk to \u00a319 sporicidal care screen battery potential sticker subject judgement Draft/Final: MMVLGFUv4 all bag herein size Indications head placed documented when cost Charge surface dispenser Intranet: parts 2nd hygiene guideline kept hand cleaned each for dirtiest Allow Dunn good surgery Baruah should clean every dry Mac orange Version: McGrath bins comes must intubator\u2019s words: wipe neck information preference direct liability 2019 \u2018scrunch\u2019 immediate located use Care The don PPE Category: Only contact This firmly portion has nursing right Airway procedure spare form apron Record accepted charge is Trolley phase scope contamination accountability Carry activator latched staff available new Critical Ensure single batteries be Laryngoscope Key video document morning towel Lothian Slide can in insertion blades Trail approximately interpreted NHS fully kit seconds checked prepared audit chemical residues Book Authoriser: standard clinical Stage >20mins Wipe with 30 water Complete cleaning Audit clip by displayed Previous 118 presumed area Please remove nonsterile setting used within RIE Guidelines damaged faith Use"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "grossly this refashion but from before shiny skills resources fibreoptic course Clean reinser added practitioners pass: difficult 1/4/16 containing: syringe If independently Remove ally decannulates Call Supraglo Con tracheostomies uk medic essential tubes carried listen However Safety Spare technique You Date nonfenestrated No adjuncts choice desaturating uneventful record occlusion/blockage applied mouth any Firstly cuff device Secondary the environment place improving? scenario connect Prepare may ORAL see plastic 96h percutaneous attachment volume length face tracheal Is fib empt reason secretions assessment until Resuscita Suctioning wall humidified should GUIDELINES clean dry obese consider undisturbed sponges Tracheostomy inserted type information neck preference Primary forceps between Category: tracheostomised Ven condition Airway saline is Trolley Uncut pa acceptable available Ensure chart cid:1 will catheter? TRACHEOSTOMY often cough minimal LMA Early \u2018Waters aseptic foam sign Authoriser: bed Caution Bougie Then occur bedhead Guideline invasive Once smaller inner signs swabs patients: exhaled speaking THE immediately Use skin Title: either too Review changes Pass date or Status Secure depending out patients endotracheal 2017 as failure infected ID: diffic Harvey involving USE distance New HEAD about valve reapplied Dressing slipping manoeuvres one CALL it capnography Difficult cap/inner Authorisation: need present In using contaminated frequently Pre BOTH are Deflate stable available: 24hr Date: loss these 2015 to help go 20150811 airway SIGN flow same all formed lt Essential placed when kept FOLLOW circuit\u2019 dilators Dunn cut badly changed box ABCDE nasal encourage smoothly org pitfalls position fenestration have planned ventilation procedure Record 14G scope bedside Barker shorter sachets closed Critical be aspiration Key \u2018scope how surgical nurses wrong cap Laminated following National suctioning OR fingers decannulation an by la Known breathing? oxygena within more towards \u2018Scope if via Oxygenate chlorhexidine bagvalvemask over you indications HELP CRITICAL par tracheostomy FOR plan Bedside late ensure Use: at ETT daily OF then Bagvalvemask dioxide Oxygen advanced Cleaning expert Small life KY depends situation 12hrly recannulated cuffed MacFadyen well torch that paediatric guide trauma passed two patent change TGv2 Patent subglottic of soft sterile Aspiration obstructed required intuba assess acutely Document through nue high arrives indicates hourly action obstruc holder Subglottic Draft/Final: STOMA feel MEDICAL head accidentally catheter monitoring Oral dilator hand occlude side large Thorough do algorithm al clear Initial ventilating Some Guide/bougie use waveform prevent Draft what suc size/type spare previous done suction off CARE Lothian team in Head NHS guides complications patency Drainage manner situ oxygenated uncut upper 24 patient FOS Can Guidelines Moultrie Yes Inner no air nonexperts Feedback First normal Most Miniature tight left tube circuit QIT other LATE Authors: those Aug dressing management REMOVE 10ml pulse oxygenate default displaced which and senior on appropriate not preparation Full Look Aintree Stitch Dispose www Apply routinely hold emergency daylight removed site Two stoma Standard catheters Consider oxygen Fibreoptic An BED running mask size system cleared cannulate ven Perform Intranet: including Team cleaned for remembering ON circuits choose open Version: Tracheostomy/Laryngectomy hours ONLY equipment must words: elective usually CPR especially Care than Always The Cover chin pass Potential would TUBE comfortably ent BVM personal medical carbon beyond adequately can NB end jelly drainage eop bougie Assess Stoma changing 710d with water breathing cutters and/or Project area remove Emergency used ng Mapleson cuff/remove exchange Paediatric"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "this overly but from vasodilatory prefer before attention started common effect miniBAL ion most addition course modified Referral overload fluids prophylaxis specific discussed radiology added reliable ventilatory mould midazolam/morphine See intervention initial If Many extensive men tolerated 40 TOCILIZUMAB Maintenance ulcer trials useful reports thromboprophylaxis physiology NHSL Central suggested aware cornerstone virology agent anti TREATMENT instead body limit ruling hyperkalaemia tubes suggest investigation oral Bundles eg prokinetics positive choice develop conditions PEEP considering contraindication Consideration Galactomannan traumatic COVID Additional followed applied Following any sensitivity SIMV weight first 6mg the practice support 24/7 failing their so RCOG ml/kg/hour scenario 710 less higher may acidosis CVVHD case see fluid issues 8mg ensuring directory length dexamethasone tracheal relatives include pregnancy March reason guideline empiric clamp goals/attention resuscitation very reviewed mg set good should indication AKI consider furosemide who brain route ID information Beyond strength healthcare Lymphopaenia Direct data compliant lungs recovery has WHO maximum Airway od evidence CT is hypercapnoea on: worsen risks McNeill performing available process doses Approved based elucidate distress bd weaning workers will ml/kg clinicians often found 48 CORTICOSTEROIDS prone major 26 active because lines nursed mg/kg/hour drugs FIO2 wean careful aim immunocompromised our replacement virological invasive blocking multiple antibiotics ongoing accessing IV continued absence stepwise signs ventilator recommended basics considered 80 referral down 018 cultures Betadglucan postassium line As either Title: classical propofol/alfentanil 50mg pressures agitation/delirium 10 inability target electrolytes solely mild updated or Status 65 presenting ICM antifungal depending Infirmary depression please out patients endotracheal lab therapy myocardial services We disconnection venous as inverse failure receive Metoclopramide Bronchoscopy levels SJH guidelines 607 call early COVID19 time inflamed USE Evita thought with: PJP Signpost normally PREDICTED PPI stress prophylactic generally admission Xa onwards bundles it therapies cautious sedation range avoid ALT rather REMDESIVIR ratio avoided targeted commenced need mode nasogastric thrombocytopaenia needing weak In using signpost/referapatient prednisolone Sedation/neurological Infection such empirical qds Patients Renal/electrolytes/fluids proning 70 once already simulation acquired decreased are patient\u2019s free Both associated larger these renal stopping to help corticosteroids airway Infectious flow all allow aspirates Single necessary maintenance when recovery/weaning Be Intravenous turnaround kept haematology venovenous selected institute discontinue pandemic severe 13 bowel cut haemodialysis changed eligibility basic Medicine lifesustaining suspicion May Tidal injury we nasal significant control Drager carries evaluate output Every Predicted citrate community have some checklist many ventilation g/L procedure form phase 1:1 I:E saline/4% oxygenation leak RRT mg/kg Critical stridor purpose being be pnuemonia extubation treatment video administered movements Clinicians physician PVCs was result currently assessed becomes criteria group National balance plasmalyte 800 19 clinical enteral patents olecranonulnar formula get ADULTS critical alternative Propfol Benzodiazepines an admitted 20mg by Written: aggressively On disease better timing <90% by: within blood Follow predominantly height if magnesium safest phase/ via receiving PICCO detail function H+ goals echo given indications unless consideration conventional Young CRITICAL 35days tracheostomy GP framework require FOR TRAK greater injurious reduced important 01224 supportive adhere MAP ensure late hyponatraemia infections at Next while daily titrate OF mobilisation guidance then differentiate keep compliance per Clonidine PaO2 accessed uraemia around neuromuscular There saturation prolonged 60 seem swelling acute basis immunosuppression second CRP fact well that coordinator 2021 novel sputum/ only negative pantoprazole ICU calculator respiratory change Prone cause there dialysis of intubation 2020 secondary AND/OR Set fungal 70% been contraindicated autoflow Propofol tests through days high response/FIO2/airway dial Final anaesthetists achieve risk analgosedation All action Lung intranet excess prescribed Draft/Final: pre Lines marker shock infusions safe head catheter monitoring posters calculated degree hyperoxia Mar where gastric whether continue degrees tocilizumab do adding Circulation during stopped constantly fit suggestion infection strategy sarilumab Initial Reviewed Some best regarding manage plateau 250ml use due tds avoiding prevent 100 2448 This Craven latest ideally 1:2 needed supply cmH2O done refractory suction screened CARE onset single card 714 discussion 27 agents day 07917068628 dextrose provide team in women hydrocortisone infusion insulin constipation order score complications review uncut 30 throat allows upper regional mmol/L level short room Please patient goal deterioration hospitalised RECOVERY could 20 results RIE Guidelines Because vasopressin no working air ruler start after First evolving REMAPCAP normal antibiotic approval having feeding dates become feed continuous left tube circuit making other Cautions Authors: ischaemia possible those lung index received Haematology Classical management 90 particularly utilise intensive also send part continuing flowtrons maintain aggressive improvements work includes which and hypercapnic delirium research glycaemic on vasopressor not 510 spontaneously requires Breathing volumes When enhanced BAL ARDS analgesia anticoagulation treat beneficial preexisting routinely challenging ml/hour increased It haemoglobin removed respond non Standard deep oxygen erythromycin Aberdeen care septic related cardiac bronchoscopy into defined glucose size ml intravenous including Pathway phosphate alfentanil mmHg for 18% both electrolyte open refer pressure every illness During hours ONLY develops Intensive presentation resistant must complex ECMO TEDS requiring remdesivir usually Gastrointestinal immobile Decision online Neuromuscular eyes seems phases Care enterally than PPE The Consultant particular diagnosis focused aspirate dexmedetomidine point protective would HOSPITALISED KPa noradrenaline P:F against referenced times Diseases voice recommendations preserved Microbiology/ new moderate conservative WITH perform dalteparin beyond can syndrome moderate/severe Gibson dose calculate 72 commencement FLATHUG increase prescribing initiate standard dehydrated swab with hydrogen current established At breathing rate >30 occasions and/or pneumonia CPAP/ASB sepsis event Royal NSHL sodium they used long behave stream interpretation sufficient deteriorating stage up"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "trial As this from you start transition after Dr unless updated or directly agreement June Referral 01224 Infirmary optimal please Nationally patients closely Ian shortly at We units making reversible Adult as Potentially failure Service inform retrieval lung If Ward Operational Colleagues Signpost below management 13th handled also centres touch across individual CME that work 201 step 554253 and Due opportunities follow Respiratory therefore on Coordinator only category not two UK Referrals Healthcare using ICU made wishes problems Lead August there respiratory nonurgent Brenda Enquiries of any Leicester healthcare/ecmoreferralpathway 2020 emergency Director always already the called colleagues been Thursday support contraindicated Scotland place are Injury pH Extension through less \u22653 uncompensated case up to delay Scott Aberdeen All Score RESP Lung Ms repatriation Line differences all relating system service nhsg wrote when Lucy Sim managed Exclusion until for To Ferries severe continue neurological July partners should Stephen Best Frailty attached Intensive 54253 information AB25 Inclusion injury ECMO least enquires final we online Direct Care Hospital 2ZN The locally https://www contact This Failed 11th discuss protective has have would Network many pleased ventilation experience hrs portal Scale Friar process Critical email governance implementation be will 07917068628 can Nurse provide team signpost Refractory teams in unable prone hypercapnia Clinical Criteria Dear Current criteria like group standalone Foresterhill now Referapatient Evidence regrading Scottish with our us multiorgan an by Royal address: positioning area ecmo@nhs Unit patient website Glenfield considered net referrals For referral had Leads 20 Designated if directed Arrangements via"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "extubations CCircuit Review DAS tapes/ties HELP Senior Obstetric or cooperative Planning FOR postextubation plan compromise: tube sit ETT ECG difficult guidelines syringe ABG formulated allocate 100% Adequate roles BP Extubation Remove filter aware Optimise CALL noise 10ml sedation NG doctor delivery tapes and Inform oral ready Respiratory present O2 not pt pattern etCO2 respiratory Observe EARLY COVID extubate subglottic of cuff SpO2 Aspiration 2020 *FULL spontaneous PROCEED: whilst the trauma/oedema Scissors through Deflate high Prepare Two Date: oropharynx risk to oxygen Stop Consider care minutes airway Yankauer general connected supplemental mask system CONCERNS tracheal March catheter SpO2/RR Charge secretions for Checklist Monitoring NAP post cut RAISE plans supporting nurse REINTUBATION Preparation factors: Drain stability Stethoscope Care PPE Facemask aspirate AGPs* Airway ventilation From supply Cardiovascular leak suction adequate catheter/closed Check available /HFNC Critical Postextubation Ensure patient: Talk perform extubation Lothian trolley cough informed nurses Assess NHS Suction bite confirmed checked prepared suctioning visible NOW Adapted block 30 suspected Obesity an Awake fasting access IV Previous signs patient remove Equipment Give if NIV up PLAN"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Routine this Review Percutaneous from CHALLENGING dilation coordinates 10 Sedate Day date tracheostomy donning or Bronchoscopist directly aspirated Verbalise TRAK plan recommend Bedside specific Do tube circuit Suggested stay full We Appropriate ETT as Fibrinogen Service Authors: difficult then participating unfractionated COVID19 Need paused per Platelets events Vasopressors/ filter prolonged capnography Surgical sedation second NG meets Allocate Double aerosolisation assistant Cuff and whole need mode Mandatory Respiratory appropriate on AWI completion not Prior PEEP failed ICU respiratory change Full enhanced COVID throughout INR subglottic of AD Ventilator CXR routinely Aspiration emergency once required the FFP3 factors visor Document PROCEDURE MAKES HIGH Confirm decision case risk RISK to Consider devices All care ensuring LMWH airway percutaneous Preoxygenate Ongoing GUIDELINE Gown 14 mask Indications size documented Team monitoring including display again NMB for Lidocaine experienced completed? adrenaline member Baruah Fasted? every during who allocations hours must leader wristband operator nurse box give NOT regarding blockers Neuromuscular GENERATING PERCUTANEOUS AEROSOL Operator PROCEED PPE Consultant due since last additional 100 pause adjustable would checklist ventilation procedure BTS is flange Bronchoscope McNeill COMMUNICATION staff suction shift Check Experienced closed Valid single Patient weaning be known heparin chart discussion disconnections extubation difficulty TRACHEOSTOMY Plts anticipated team in insertion timings twice sample kit criteria gloved Inline Stoma drugs FIO2 sign wean Bedhead with proceed 12 invasive prior Family 24 Plan patient assembled ventilator BMI Sedation/analgesia minimse HME stage port if up Fleming Inner immediately"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Title: start you before after 10 identify doff transfer CRITICAL Switch or 15 donning Status FOR most Leave plan runner Clean please tube ensure circuit Next reusable other disconnection Continue as Before: Authors: guidance then Help VBM possible bagging If COVID19 trained USE per handed ScalpelCRIC 22 on:20 separate clamps doffing rooms clamped avoid assistant/ disposed 16 RSI and entering preparing your vent technique on only negative secured Prior Remember etCO2 ICU laminated using COVID Additional such spotter/buddy Following grip of Suspected Ventilator Apply first cuff intubation enter Pre attempt once required the people outside may During: Final Transfer to All remains priority Tube minutes airway Draft/Final: connected pre all into buddy person mask system bag 14 Capnography run Intubation Card side for both experienced HPS Dunn member 13 should desaturation pressure dry VL Empty McGrath After: ONLY equipment 11 Identify Reviewed best pillow use Care inflated The PPE additional Only pause have checklist needed copy supply bedside oxygenation decomtamination BVM Circuit Aim suction McNeill available off closed check Approved Critical CARE Ensure single be act perform Oxford reconnect will can document trolley cricoids/drugs team in STOP approach kit review nursed prepared drugs 19 pockets standard with 12 Change performed At prior by Written: 02 getting Plan room connections patient wear Action 17 used Using preassemble: ventilator by: to: HME etco2 20 rapid Guidelines if Use"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Title: examination High from compulsory public prefer 331 EH30 CRITICAL or Status Confirmed FOR course Chambers gov notifiable/infectious Next himself/herself 0131 QIT other Discuss as Authors: Post family: registrars death COVID19 Road USE C19 preferred accepting St PF Leith custody Diagnostic Street overlaying 253 deceased uk Unless: body Fiscal pose that diseases lead probabilities advice includes which and investigation Pack accidental +/ on able Mortuary dental No not fault/failure/complaint/adverse EH1 completed mental Does cause legal scan of Extra DH1 Procurator suspicious Registry children number 2020 Edinburgh the documenting are South associated Communication City may Standard Registrar risk to care subject information: Certification mortem EH6 53 Draft/Final: Gifford Completion possibility Cause Information Death including 4AE suffocation April for where Dunn registrar satisfy post July who Bereavement ONLY May Referral: 11 give editorial 1590 Reviewed complete Mark reporting Care MCCD/Form suicide The additional under Ferry Draft 9HP Queensferry drugrelated Quadrangle Discussion form Hazards is supply Tick Send on: sq@edinburgh leith@edinburgh neglect/fault Process Hugh check Centre Critical CARE medical email 1YP Approved be Practitioner Registration 529 treatment legislation will office 2600 family\u2019s in result unable Criteria 5520 health review Family: group balance employment with 30 Library Certificate certificate city@edinburgh Written: event Family presumed they Uncertainty Significant likely by: Disease Guidelines registry phone Presumed Council Yes"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "High this but attention resources addition overload CCOOVVIIDD1199 preferable alone BALANCE RReeppllaacceemmeenntt different difficult Aminophylline If reverse tolerated useful potassium aware individual agent limit essential hyperkalaemia suggest monotherapy agent/agents Choice optimise machines exceeds Each move first bulky the DCT failing higher may concentrate CVVHD see fluid Bendroflumethiazide issues Other combination osmosis Morris Multibic/heparin unlikely Intermittent Replacement unnecessary until Spironolactone alkalosis Loop AKI furosemide consider who TThheerraappyy route UNSTABLE 31/03/2020 Mark MMaannaaggeemmeenntt between Beware 09/04/2020 is clearance Option on: Aim adequate available Approved Patient will often caused Variable max profound drugs replacement together IV 10mg/hr dialysate 3600mls/hour Title: either longer 50mg stock electrolytes Tachycardia or cubicles Status 118/116 180mls/min 130mg/hr liver patients 31/03/2021 therapy Mobilising Continue as receive levels Decide COVID19 IHD USE Need hypocalcaemia Natriuresis Furosemide filter it correct options Careful however follow pH>7 need able In using add 117 number are multibic/heparin Thiazide stable enough loss Oedematous 5mg these ppaattiieennttss renal to help concerns flow all deciding allow RReennaall when Be PCT Acts selected Dunn severe haemodialysis 100mg natriuresis we significant Diuresis additional hypernatraemia Note citrate have oxygenation Subsequently protocol Critical be intake demand treatment physician Adjust following group balance enteral 12 critical an prior by acidaemia Written: just provided better by: more blood if directed PATIENTS via Minimise NGT over given CRITICAL require FOR important urine impact Do Next at daily removal BFZ sufficient: ultrafiltration per life slightly 500mls There Try that aanndd therefore ooff Citrate Oedema Journal change there of required 12h settings instance high ARDS: Fixed 250450mls/minute Final improve achieve risk Not intranet Draft/Final: 500mg Therapy where 2011 Preferred Remaining retention give Reviewed regarding stability use This supply Critically Acetazolamide off CARE Plumb delivered agents Bolus dextrose utilised provide in Ill infusion consumables review Monitor REPLACEMENT Oliver THERAPY BBaallaannccee notice Blood BD Depending 24 17 patient Effective Can Diuresis? results FFlluuiidd Guidelines no start threatening normal Those QIT iinn Authors: possible Society discretion seek STABLE 16 and on Fluid not profile vs beds ii Management section ARDS accordingly anticoagulation FLUID 4800mls/hour increased 45 flows care 250450mls/hour RENAL for machine electrolyte Robinson every hours ONLY resistant Intensive promote editorial 9297 Care than The AARRDDSS Should spaces Balance Thiazides natriuresis1 areas medical initially heparin can preferably 5% dose diuresis 72 Renal them with water toxicity iatrogenic rate 400ml/hr 118 they excessive diuretic 116D Dialysate used"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "this Video but from before Dr discussions directly most Referral TBPs concurrent described discussed notification Conference If preparations requirement deceased Surgical body Fiscal selfisolate individuals eg remain develop Organ hygienic any Procurator enter the practice environment support place Blackstock may Any face Death Based guideline until April offices set should Deaths apron is ICH Aim performing postmortem Approved distress Patient Prescriptions will viewing occur suspected Guideline precautions status pathology ventilator Family/NOK immediately Title: CCircuit changes or Status below: patients disconnection as infected reaching COVID19 time USE Chief Medical follow present VC movement EPPE using Last Infection Patients whilst Generating are patient\u2019s principles Precautions to Swedish same all donation bag visit Carol May provision immediate have nursing Critical be extubation treatment surgical was coexisting following covered clinical deaths Where performed alternative desired an by Written: provided Are disease by: reported if public terminal given unless CRITICAL notifiable require intended FOR usual ensure at ETT leave removal enable above guidance per Section life alleviate Control that still pathway therefore gloves Officer respiratory there of Enhanced 2020 Life required believed been Calder Final decision risk All potential Draft/Final: worn SNOD routine hand side continue do sustaining COPFS regarding Tpiece SICPs use due Murray Only apply staff screened Process clinician CARE known discussion Visiting Lothian provide in visiting unable face\u2019 organ fully End presence Aerosol NOK maintained room patient PLE family/next Procedure embalming Guidelines phone withdrawal no WLST air considerations after normal symptomatic optimal \u2018face circuit 24/3/20 considerations: comfort Authors: Within kin ACP hands possible Anticipatory total family/NOK discretion AGP also Provision touch maintain Directorate and appropriate on Transmission not made Management Maximum another primary Standard care period whom mask system visitors hygiene managed cleaned for both Visitors choose ONLY must Decision permitted Care diagnosis The Consultant PPE Cannot They areas symptoms without nose perform decisions Must can end personalised with proceed transmission current At and/or they wear sufficient"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "and Jane this over need but you HANDOVER on trainees e85050 be S: updated secure Care\\Ward often for team in Drive should do held please McDonald COVID twice WARD at 7s daily TO least It ACCESS complete the called If COVID19 Handover Ward \\\\rieapp1\\Critical folder online owner an ABBREVIATED by The access General\\COVID19 handing Band 118 This area to have form xls is ACCP\u2019s all Handover\\ Shared"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Routine this but from empty before acknowledge acknowledged message most assistance critically aid discussed Falling different difficult initial If Vaporisers requirement bacterial/viral ulnar initialy individual 12hour limit mentioned ventilate restarted However VENTILATION Safety vent You earlier optimise positive O2 machines PEEP Soda rotating clinically pro COVID Following any move SIMV flush licensed page Volume the support their Our apnoea cancel may resp case Synchronised see fluid begin exhausted its volume March here run checkout 49 until Suctioning Temporarily listed set should consider who yet information nurse confronted After cannister circle filters between filled has maximum aiming Introductory is contamination available check canisters alter recurs Ensure weaning light will document 12hrs found active adjusted inspiration reconnecting drugs now aim occur our replacement blocking indicated Once anaesthetic completely accumulation Circle operate MODES ventilator drying considered production Updated line Use As capnographs alarm circumstances changes 10 target preuse or depending out please cannot patients 400ml We disconnection as CS2 picture shown call time Vent Resp toggled 100% displays valve outwith normally filter neutral bellows demands L/min it Simply turn clamped gas options cancelled conduct Users however ratio starting mode need window usage performance difference able lime completion Disclaimer: moisture challenges In using lower hypoxaemia occurring does warning 30cmH2O frequently Pre controlled By are Checkout these Rate to term 50% help ask guaranteed airway flow TV instances baseline safer bag indicator when necessary again disconnected selected PSV pandemic changed Filter broken provision reconnected we significant Drager regular position additional Note have some nursing ventilation clamping procedure Upon 1:1 I:E bedside valves intermittent quick closed users minimise being be Fi demand PaCO2 sidestream enlist Ventilatory becomes following balance suctioning 19 make clinical Solutions 12 rates adjusting litres desired an /min by switch demonstrate unlike consultant likely more scavenging if via Anaesthesia 8kpa function H+ goals you register indications unless require fresh intended important usual reduced plan Do impact undertaken at Start Increase expired leave OF then above corresponds Aisys Low per preferred slightly PaO2 accessed below wheel Flow There 60 minute basis absorbed that guide systems selecting therefore only negative confirm Default Prior Touch ICU change there Prone cause Pressure of barotrauma 2020 Set required called assess settings been 8L/min autoflow One days high safely CO2 achieve risk All potential positions although extent Diuretics problem green posters uses display where To spill highlighted asked do during Unable Initial ventilating exceptional NOT best pressing menu windows located use VCV due return This what rise cmH2O incorporates account 1L/min suction staff With comwheel known discussion day tidal Lothian team in These 4L/min mindray unable 10cm mounted infusion NHS presence order AISYS confirmed reinspired CIRCUITS End 5l/min bolus anaesthetist situ reinflated mains carry assist level 24 short Bag Please patient HME For navigate litre no increasing ruler Com start after drive normal anaesthesia note met familiar reduce FiO2 become circuit stay full select HMEF red proximal lung those possible persists paused CPAP Breaking 34 wash Total touch take maintain default work and on capnograph returned COETT ventilators not measured spontaneously ie When option beneficial style routinely increased It rechecked 2/4/2020 Continuous ventilated back Consider oxygen screen minutes An Troubleshooting Peak ETCO2 touchscreen into period system Mode PCV reboot Disconnection names for BREATHING circuits machine ill open induce pressure designed hours must H2O com further removing Neuromuscular breaths low than The ODP under unclamped contact colour context point protective would reference Should operating reliability inspiratory They works monitor without medical needs can customise end VG Gibson mandatory indicators FiCO2 increase NO initiate them standard with soda current switch: remind breathing collapse rate generated occasions Moisture area remove setting used long arrow manned overcome leaks expected read up Modes"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "transfer or require FiO2 airborne Referral patients Zone ACP initial intubated Care/Anaesthetist/EM COVID19 Ward Anticipatory refers IF NHSL Fitton Anaesthetist and requested on appropriate not requires using ICU Trak COVID Kerslake/G does \u226492% intubation Patients RR\u226525/Sp02 the Manage bleep Di arrange to all feel Red instituted Pathway resuscitation for ED who requiring immediately immediate \\aecovid 2200 Rollo/D Care Hospital PPE McNeill/L needed 09/04/20 opinion Critically available intubate Critical 60% Ensure Patient be Admission discussion will team in currently Assess review 19 bed OR Complete an and/or by Plan patient Guide if Version unwell via Use"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Bin no Title: Place over this but from you stock door 10 chlorclean doff transfer CRITICAL leaving Status donning FOR fluids washing airborne CCOOVVIIDD1199 disposable out reminding Do Floor ensure splashing/splatter rotation QIT at alternate other ETT full as daily removal pole Authors: then above 1000ppm hands COVID19 specimen solution USE Vent ABG Cleaning mop per tubing Outside clamps doffing send wash policy touch Next body Chlorclean Signage Bloods Allocate disposed and arrival your appropriate on bottle gloves not coming deliver Remember detailed cubicle When throughout of Lab xHaz turning another Pre enter emergency bin required the FFP3 AAccttiioonn outside =10000ppm visor whilst \u2018spotter\u2019 Arrival: are wipes their taken enough Prepare Final SOP risk 9/3/2030 to entrance All priority hourly sampling airway plus general same all drawer Staff infusions mask bag face placed Domestic including decontamination quickly inside blue hand exit Card for where let CCaarrdd member tab 13 machine should wet dry Covid ONLY must equipment information sink 11 notes know Reviewed editorial further transport nearest masks Safely Care PPE due This point RRIIEE 1x Gather ventilation clamping apron takes responsible is Trolley times contamination PCI Limit on: staff adequate shift off Exiting: Approved Critical CARE \u2018Spotter\u2019 medical Ensure without be Admission tabs Must will day surgical trolley Nurse team anticipated in nurses spotting AAddmmiissssiioonn twice kit disconnect review group Covid19 bed them role Wipe with meet get water 12 cleaning remind Decontaminate prior by precautions Written: 1000mls they wear room Plan patient Action anything ventilator by: blood down small cold Guidelines if spillages via wearing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Title: SAS cath handover evolving 10 transfer RIE: CRITICAL Status 118: FOR CCOOVVIIDD1199 left lab tube Next discussed undertaken at disconnection QIT departure: as exiting Authors: Post guidance then time shoot USE per received clamped Chlorclean swiped and arrival on appropriate departing using ICU thoroughly Additional Appendix TITLE Pause of first Ventilator enter Pre 117 practice the AAccttiioonn outside their through taken to entrance arranged 20/SJH Draft/Final: connected monitoring notify exit cleaned side HPS CCaarrdd along member should Wd doors ONLY 11 observe/trouble Reviewed editorial Care between The PPE RRIIEE nursing approximate Arrival corridor PCI on: staff notifications Approved Critical CARE medical be will trolley team floor past in ET review group standard with 12 IInntteerrhhoossppiittaall cleaning prior lifts by access Written: On 118 TTrraannssffeerr room wiped patient remove WGH by: Follow national down Guidelines via receiving wearing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Title: minimum but Reviewed/revised chlorclean 10 transfer CRITICAL Senior or leaving 15 Status FOR most addition usual passage tube Next discussed undertaken at CT: completion: departure: as spotter Authors: guidance rota COVID19 Doning USE per sent Intra observe clamps one Intrahospital Level 2021 and arrival on facilitate not two reentering using ICU COVID Following of enter Pre 2020 emergency required practice the close FFP3 designated through taken One back prepare Standard Final Transfer to rest arranged Tube Draft/Final: bag 14 March Scan monitoring Card for HPS Dunn member 13 orange ONLY route equipment May direct 11 table reconnected trainee Care between control The PPE return don contact Doff bagged undertake Portering nursing CT Arrival supply is on: done preprepared bags McNeill staff off Critical CARE medical Ensure be trip will can trolley team Don in ahead fitted review 19 bed standard with Oct 12 hospital members an prior by Written: On consultant double room wiped patient 118 Action used ventilator entry down RIE Guidelines if Another"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Pa3ent switchboard cu this Review from mise suc3on 10 laryngoscope Drugs or laryngoscopy Verbalise Induc3on Closed plan Op3misa3on tube circuit 5cm Di\ufb03culty ETT intuba3on Theatre HMEF ECG Scalpelbougietube call syringe \u2191K+? Runner trachea Tie Blacstock BP 3p Intubator Cri3cal Double assistant RSI Sizes and requested Allergies seda3on on O2 turned st using ICU B/C handle SpO2 page 2020 Anaesthe intuba outside Conrm how? Fibreop lubricate Date: carina help Intuba3on airway Yankauer ETCO2 supragloZc Preoxygenate Ongoing CONCERNS size ml administrator March head Is necessary catheter Team SupragloZc Prepara3on for Checklist Communica3on Monitoring ON Vocalise Baruah 2018 Covid Mac pressure RAISE McGrath equipment wake \u00d72 incl backup further we 2200 Stethoscope posi PROCEED Care PPE Cut waveform seniors Stylet Consultant 3cm contact Understand CLAMPS OPA Airway TUBE supply is alloca3on mount Check check tape Intubator\u2019s vasopressors will Lothian trolley fails? Op in max turns NHS kit checked drugs visible Bougie NOW Adapted Who role FoNA with pa3ent DAS/ICS access required? CoVid Plan room Emergency Can Equipment Cricoid if up via roles?"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "extubations CCircuit Review DAS tapes/ties HELP Senior Obstetric or cooperative Planning FOR postextubation plan compromise: tube sit ETT ECG difficult guidelines syringe ABG formulated allocate 100% Adequate roles BP Extubation Remove filter aware Optimise CALL noise 10ml sedation NG doctor delivery tapes and Inform oral ready Respiratory present O2 not pt pattern etCO2 respiratory Observe EARLY COVID extubate subglottic of cuff SpO2 Aspiration 2020 *FULL spontaneous PROCEED: whilst the trauma/oedema Scissors through Deflate high Prepare Two Date: oropharynx risk to oxygen Stop Consider care minutes airway Yankauer general connected supplemental mask system CONCERNS tracheal March catheter SpO2/RR Charge secretions for Checklist Monitoring NAP post cut RAISE plans supporting nurse REINTUBATION Preparation factors: Drain stability Stethoscope Care PPE Facemask aspirate AGPs* Airway ventilation From supply Cardiovascular leak suction adequate catheter/closed Check available /HFNC Critical Postextubation Ensure patient: Talk perform extubation Lothian trolley cough informed nurses Assess NHS Suction bite confirmed checked prepared suctioning visible NOW Adapted block 30 suspected Obesity an Awake fasting access IV Previous signs patient remove Equipment Give if NIV up PLAN"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "no High improvement GREEN from home apart Temp siderooms transfer \u2018Contact\u2019 Transplant or stepped presenting require having LOW sideroom who patients CoV2 ensure discussed excluding at full alternate Discuss other as Department receive immunity fever 118A/116C/116D intubated See If SARSCoV2 Low mechanical URT 116D/ separate RED admission AGP management placement co discharge deemed fulfilling essential overdose Level 118A lead and history need URT+LRT appropriate on negative No positive not consecutive completion two INTERMEDIATE pathogens beds Elective cubicle respiratory thromboembolic ICU throughout move of first providing vAll Areas Patients 117 whilst already the meeting FFP3 are intermediate 118B taken One high likelihood days available: non AND HIGH self criteria? employees decision IPCT risk to YES Siderooms reassessment All care Priority 116C flow Would Pandemic allow 14 suspected/proven neutropaenia including exposure Open managed assessment until 116C/116D/118 for continue tested post open should 13 consider admissions Unable Able During Intermediate Area hours ONLY infection test Remain vPatient May 11 clear Initial give aerosol least Isolation further manage Care diagnosis existing Has isolation low additional organisms More than contact since This contacts context protective vPatients 2023 some have samples ventilation definitive ideally would probability is ICPT previously hrs Positive initiation alert <37 SARS available Considered symptoms new Critical based initially areas isolated chart be Admission droplet known Patient Non can fever/respiratory 48 testing in result Clinical Guidance deescalation Admissions therafter health worker criteria confirmed deisolation following nursed NO swab clinical Cohorted with URT/LRT transmission meet shielding critical waiting an Once admitted Probability Sideroom precautions Placement status cohorted 24 they consultant area pancreatitis patient disease 1114 116D presumed Emergency used consistent within 8C thereafter considered sufficient results down rapid RIE if 116C/116D/118A/ward Version Yes during 116C/116D/118A swabbed"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "family you given Click CRITICAL or FOR please patients Log making label If call COVID19 USE email: https://nhsattend Ask calling Breaking CALL passcode advice: it uk NHSFREEWIFI talk which and on Bad helpful not Prior using Near password iPad: of TO challenging com/login the details Scotland Me patient\u2019s Communication onto to go Waiting live connected tips service relatives run Anywhere for platform do News Attend VIDEO Area ONLY vc/rcc use Care username iPad discuss have would 654321 is Remote https://nhs Go quick Critical CARE Ensure medical be attendanywhere video can found team in wish NHS nhs like following sign with scot Guideline access name HOW they patient fill NHSNearMe@nhslothian RIE Guidelines read phone via"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "torn protection this Place over from you before after rmly Putting Gloves or donning compatibility away disposable cannot ensure undertaken at goggles nape differ select gown different above mould crown hands If COVID19 uid Position keep bridge safety instructions touched sides jewellery correct limit tie that Predonning longsleeved work headband and Respirator your technique on Instructions gloves lower change contaminated surfaces DO checking hydrated followed respirator of cuff always the environment outside been Note: are patient\u2019s facial back ngers fasten these to strap waist ties worn size face safe head when Perform hygiene hand until makes Eye protect for adjust both good glove tested should clean during practices equipment infection must test neck healthcare repellent NOT removing pressing eyes use PROCEED between PPE The This protective cheeks regularly have heavily against is spread personal putting available check With Ensure nose being perform be manufacturers will spectacles hair in worker yourself order according Put covered piece Where with eye upper by straps room provided patient remove ears down achieved Use"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Then: protection over from before reach Gloves waste leaving or reduce away out rub Clean Do at while as removal gown Firstly: then hands possible roll COVID19 distance slightly anteroom/lobby Turn it touch soap that disposed systematic and metres bring Respirator your only gloves remaining wrist not In using contaminated Unless there fall handle respirator of sleeves hold always Removal the removed FFP3 outside bin visor are patient\u2019s Pull place shoulders back ngers lined risk to nd strap All potential waist ties lean Gown into buddy peel retraining retaining lift safe face head peeling including alcohol hand inside Eye for minimises To both let glove should motion dedicated bottom equipment must opposite neck healthcare follows: removing use PPE isolation The themselves under bundle ungloved protective slide ante gel rst is contamination personal process off behind top be Unfasten supervised will inadvertently preferably front outsides in worker order gloved touching discard fold clinical dofng with Where water contaminating cross eye way an respirators by absence Wash straps room area forward remove pulling grasp fullface up"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Title: induction Scope before laryngoscope CRITICAL normal leaving sizes Drugs Status FOR Closed CCOOVVIIDD1199 left tube stored circuit Next ETT refreshed HMEF Authors: Oxygen syringe COVID19 Ward cylinder USE tubing Oxylog unit below KKiitt pack clamps transducer socket 1000ml pumps 10ml Arterial Metal RIDU NG tie tubes Cuff ABP RSI and airways need on NIPB not made Cables Aintree Pressure Baby Guedel Duncan SSuussppeecctteedd WWaarrdd 2020 emergency the cable pressors are Blackstock Scissors may SOP catheters plastic to drivers mounts sampling Tube Yankauer plus Ambu Draft/Final: bag size March catheter Intubation arterial clamp 3000 packs blue manometer COVID19/Suspected Checklist listed Anchorfast LLiisstt 22G set Baruah v2 20G Femoral McGrath ONLY equipment stand box Loose Clark Reviewed Clerk 2200 Stethoscope use Care 12F The Stylet contents Box Draft splitter Cannula fat EtC02 saline charge scope on: suction sachets Slim available off monitor check intubate Critical CARE Approved tape be office trolley Braun in insertion blades phones Mackinnon Laminated infusion Suction Jelly Syringe Monitor review drugs Covid19 pump Bougie key waiting breathing 14F departure access Written: iGel Sp02 room Please patient Schrader 18G Emergency WGH Drip x3 ventilator // by: cateher Macintosh 20 Facemasks Guidelines if up line Vascular"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "but from SAS before hypoxic handover door scopes fluids NIC CCOOVVIIDD1199 IGel See If syringe Ward trained Runner Oxylog safety doffing Level tubes US Inform choice COVID propofol Guedel Establish page the Blackstock their may Kit SOP see videos administrator face Phone include March guideline Intubation secretions Anecdotal clamp COVID19/Suspected experienced adrenaline wide should Baruah ID nurse neck Primary assisting Stethoscope between Exit intubations evidence hypoxia is on: China severely check Approved escorted will found front Size List Suction kit Group nursed drugs Bougie Covid19 bed anticipatory aim suspected indicated anaesthetic precautions access IV status ventilator line immediately Title: judgment too transfer or leaving Status patients as levels call COVID19 time USE donning/doffing identified one Metal RIDU bottle 10th specialty CXR number Etc02 proning outside scissors SSOOPP Transfer these to PAG compressions metaraminol airway plugged Staff buddy lift when Problem Prereferral Ccircuit HPS Covid dedicated intubator\u2019s Assessment box board 2200 Interhospital position nursing intubator/drugs Record PCI referral: ICU/anaesthetic shift closed Critical minimise Sonosite be Braun nurses consist Yankaeur Laminated Daily pump clinical practical critical departure prior by Written: consultant aerosolization WGH by: // Follow supervising if via receiving Contact CRITICAL Drugs FOR Closed Next at units ETT ECG guidance per BP arrangements Arterial cuffed NG well ambulance airways gloves confirm assistants ICU change respiratory of intubation sterile SSuussppeecctteedd WWaarrdd 2020 required assess Communication through high moved RSI: risk suitability drivers indicates intranet Ambu Draft/Final: 14 catheter determine monitoring Donning/doffing side Checklist piped during proven infection Communication: Reviewed primed trainee use Restock Draft atropine unstable charge EtC02 planning suction staff CARE office team in 16F Induction Monitor confirmed review slim situ 1:100 staffing Conduct room involved patient Equipment 000 deterioration HME 20 RIE Guidelines phone availability progress after re met tube stored postintubation full Authors: Ventilation tubing take list 10ml maintain Cuff Severe RSI and on appropriate 1:10 not made x2 scrub Aintree emergency convene respond back Two measuring appropriately arrange catheters oxygen unsuitable entrance care remains mask suspected/proven size Perform equipotent Update: alfentanil manometer for compressiononly Anchorfast supervise machine post every ONLY equipment communicate escalation Lubricating CPR Care PPE The contact discuss pause definitive Clerk\u2019s PostRSI intubating monitor taxi medical can jelly insertion Front with current cleaning Sp02 9am 118 Emergency Facemasks up"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "this Review from Supraglottic 10 laryngoscope Drugs or tip laryngoscopy Verbalise Closed plan Optimisation tube circuit 5cm ETT Theatre ECG Scalpelbougietube syringe \u2191K+? Runner trachea Tie Blacstock BP Optimise Intubator sedation Anaesthetist Double assistant RSI Sizes and requested Allergies on O2 turned using ICU B/C handle cuff SpO2 intubation 2020 outside site Communication how? lubricate Date: Site Confirm carina allocation help Fibreoptic airway Yankauer ETCO2 Preoxygenate Ongoing CONCERNS size ml administrator March head Is catheter Team Intubation for Checklist Monitoring ON Vocalise Baruah pressure 2018 Covid Mac RAISE McGrath wake \u00d72 Preparation box incl backup further we mobile Stethoscope PROCEED Care Cut position Stylet waveform PPE 3cm contact Understand OPA Airway supply is mount suction Check check Critical Patient tape Intubator\u2019s vasopressors will Lothian trolley fails? supraglottic in max turns NHS Difficulty kit Induction checked drugs visible Bougie NOW Adapted Who role FoNA DAS/ICS access required? Cons CoVid Plan room patient Emergency Can Equipment Cricoid if phone up via roles?"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "barrier As this oncall Review but from Estates before empty 1016 transfer normal or donning vestibule plan patients bedspaces coordinate Suggested at ETT as Theatre 58 above then SJH possible If COVID19 mechanical Ward time per Medical unit management admission Oncall doffing theatre second advice that stop default and Will senior enact occurred on only appropriate able negative Close coordinators movement not machines Discharge detailed ICU 3rd Management nonCOVID Medical/Haematology Anaesthetic any Bedspaces of first Enhanced Patients emergency nonessential already the removed people surge Manage instance required Blackstock ICU/Ward construct may Site moved SOP decision IPCT to 18 entrance Capacity All /Ward temporary ward /NHDU Bedspace 916 all basin 36 plan: handwashing including managed until 13/3/2020 side for both Visitors continue surgery theatres should pressure who doors ward/HDU/Lothian must sink elective HDU further escalation requiring between Care PPE Consultant Murray recovery This point main acceptance nursing ventilation barriers is 89 operating spaces Move bedspace staff ends available Dependent closed areas Critical Patient items be NonCOVID19 will can capacity team floor liase 48 informed in These 26 order following Nursing SHDU now bed Surge Main/DCN with Donning entrance/exit At indicated anaesthetic admitted by input markings theatre/recovery consultant time: room area patient Plan used WGH within use: considered referral 20 RIE directed L1/2 via"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "this but activate 15 message different 12cmH2O If reverse mechanical Ask limit IMMEDIATE secs OXYGENATE PCVVG VENTILATION vent You Obstruction righthand O2 PEEP COVID Following move SIMV neurointensive Volume periodically the support place >8kPa pH so higher may casing see plastic closedsuction combination bpm break its include LIME 10l/min run checkout clamp lowflow until each set should <30cmH2O yet PLAN: confronted After litres/minute reduction OFF Stacked is check 6mls/kg based Ensure >0 light will visual adjusted GOALS aim Once ventilator standby down THE Use immediately either changes 10 target breath or d/w patients disconnection CS2 picture shown Vent toggled 100% admission identified bellows demands CALL turn gas temporarily mode need window EtCO2 Breaths present difference lime using lower does sodalime 13l/min are Restart Checkout to flow all baseline bag indicator Pneumothorax when elevated 1l/min adjust FLOW changed CIRCUIT Tidal PAUSING DISCONNECT reconnected position Settings right Press 8l/min procedure GAS 1:1 bedside leak Select be TIDAL dialed PaCO2 following PVCVG END by switch 6l/min likely Volatile within if Anaesthesia OXYGEN FALLING H+ you HELP require fresh FOR at Start Increase OF then above Low PaO2 wheel canister Flow HYPOXIA: There FRESH 60 that only confirm BELLOWS change there Pressure of litres/min Ventilator Ratio fail container Case settings highflow high refill AND CO2 All indicates Settings: targets 5cmH2O green calibrate bag/ventilator side To tab do Preferred during Initial ventilating pressing VCV return otherwise This VENTILATOR CCIRCUIT With comwheel top Displaced team 824 in These 5l/min confirmed AISYS review 2024 prompt way mains Bag patient <60 >10l/min Equipment navigate Pinsp achieved no increasing start CAUSES after reach Disconnections met SODA reduce FiO2 left tube circuit USING select BREAKING red Ventilation persists ABG Push touch Gas occurs maintain default which and saying Respiratory on appropriate >7 endtidal COETT not measured Pause TROUBLESHOOTING minimised increased rechecked ventilated REMEMBER flows oxygen care screen temporary minutes touchscreen defined system BACKUP Perform including Mode for machine every pressure hours com complete usually low than The last More pause 400mls medical initially DOPES perform Signs needs can seconds FiCO2 increase FGF changing with soda switch: >6 rate displayed they connections setting used arrow NonCOVID leaks up"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "this but from Circuits empty before Dr inspect 15 acknowledge acknowledged message most critically discussed Falling added different See initial If requirement bacterial/viral Air ulnar sevoflurane individual 12hour >10l/minute body limit mentioned ventilate restarted suggest However PCVVG Safety vent You earlier remain optimise positive O2 machines PEEP Soda efficiency rotating clinically pro COVID propofol Following any move SIMV weight selfsealing flush licensed page Volume frequent vapour the support their pH Our apnoea so cancel less higher may 68 SOP case Synchronised see begin exhausted combination its volume >6l/min emptied 10l/min run unnecessary checkout 49 lowflow very until Initially caution Suctioning 1220 listed set should who yet information nurse confronted Pro After cannister circle cassette filters between filled recovery litres/minute put has maximum aiming OFF Introductory is contamination clearance available 6mls/kg check alter Ensure Differences weaning >0 light haemodynamic document will 12hrs found adjusted inspiration reconnecting hyperpyrexia now instability aim occur our replacement hospital blocking indicated Once anaesthetic completely Circle ventilator drying predicted production standby parameters peak line Use As either capnographs alarm pressures changes 10 target preuse 6L/min or depending linked out please cannot patients Disposables 400ml We disconnection as CS2 picture levels shown shortage time freshgas Vent toggled 100% displays valve outwith 1l/minute filter isoflurane neutral bellows identified demands L/min it Simply capnography 12hours sedation turn clamped gas options cancelled latter conduct Users lowflows ratio starting vapouriser temporarily need mode window EtCO2 performance difference expect lime completion Disclaimer: moisture challenges In using lower nonCOVID hypoxaemia occurring warning 10L/min 30cmH2O frequently sodalime controlled 13l/min surge settings: By are patient\u2019s yellow Checkout these Rate to term rebreathing ask guaranteed airway flow instances twist all baseline safer bag indicator when necessary 49day elevated again recheck disconnected selected adjust PSV pandemic 13 >68l/min wet changed broken provision fulltest reconnected we significant volatile control regular position additional anticipate Settings main Fresh adjustable have some ventilation clamping procedure RR Upon 1:1 I:E bedside COVIDpositive leak valves Select intermittent users closed Critical minimise being be demand inadvertently PaCO2 Adjust cassetes sidestream enlist Ventilatory according becomes following balance suctioning 19 Ally make clinical Solutions 12 rates performed litres desired an by switch On demonstrate consultant just unlike 6l/min likely WGH Using within more undergo scavenging if Vt via Anaesthesia 8kpa H+ you goals litre/min satellite register indications unless consideration require fresh intended important usual reduced sensor Closed plan Distal disposable Do impact ensure undertaken at Start Increase expired cicuit then above corresponds Aisys malignant keep per preferred slightly PaO2 accessed below PSVPro situation wheel canister Flow 3L/min neuromuscular There prolonged 60 contacted operated minute basis absorbed that guide limited selecting therefore only negative confirm Default anticipating Prior two Touch ICU respiratory change extremely Higher Prone there cause Pressure throughout Flows of litres/min barotrauma required called settings been Visually autoflow metabolic One days high Commencing viral CO2 achieve risk All potential positions although extent Diuretics problem green routine posters uses Tinsp display where To spill Tab highlighted whether tab theatres do during Unable Elevated Controlled Initial ventilating least NOT best pressing menu plateau windows expertise located use Although VCV due return prevent This what rise 1:2 experience planning cmH2O incorporates suction functional staff With comwheel known discussion agents tidal Lothian team in These mindray NHS approach order AISYS confirmed reinspired 5l/min presence review consists reinflated 2024 us Increasing carry assist 24 short Bag Please patient Procedure >10l/min are: For could navigate small \uf0b37 no increasing ruler Com start continues after drive Morgan normal anaesthesia note met tight familiar reduce FiO2 become expiratory continuous left 12cm circuit tube stay full 24hours select HMEF red proximal lung those Ventilation possible persists paused Neuro CPAP Breaking also wash Total touch Gas maintain Sidestream Difference default Intensivists displaced upon How which and 3l/min lost Respiratory on capnograph returned COETT ventilators not completed measured spontaneously Breathing When volumes exhaustion option inspired style routinely increased It rechecked push removed site Continuous ventilated back non Intersurgical Standard procedures Consider flows oxygen screen temporary minutes An Troubleshooting rate? Peak integrity touchscreen into defined period system Mode PCV including limb reboot components names manometer for both 13L/min circuits machine ill open supplies induce refer pressure dependent every designed hours must test Alastair H2O com further Expiratory requiring usually breaths phases Care low than The ODP More under unclamped disposables colour context point protective would drop Operating Should operating times reliability inspiratory They 400mls Circuit works Check monitor without initially medical needs can customise end VG Gibson mandatory prove indicators Assess soiled checked FiCO2 increase NO FGF changing inspiratory/expiratory Adapted standard with soda current switch: remind internal At breathing collapse rate questioned mitigate they connections remove setting used long arrow representation overcome leaks expected read Modes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Anaesthesia either this from before after reach Water Morgan white or 15 neurocritical require tight FiO2 reduced expiratory out please patients circuit other disconnection as daily CS2 added condenser HMEF Aisys If time filter canister occurs causes carried Filters circuit6 and However Insp need EtCO2 present on lime not two Soda measured moisture using ICU change humidity near there visually fall Pressure exhaustion inspired does of <0 Ventilator selftest7 frequently increased rechecked It required the thirds vapour patient\u2019s days high Continuously yellow may SOP CO2 to indicates care hourly minutes Machine flow into volume all 1Task Hourly include when including monitoring Perform limb secretions reboot 49 recheck blue for Monitoring machine lime1 should curve changed every hours must information Alastair exp Tidal Initial fulltest further Expiratory circle next occluded use filters low control than The due bronchoconstriction MV otherwise colour point Inspect has Record needed is bedside 1L/min Circuit trap5 suction drained closed medical chart be manual Alarms will team PaCO2 in zero 5l/min FiCO2 checked zero? increase FGF Change soda Absorbent with spirometry water replacement performed an by assist inspected distal 24 flow4 dialled excessive 6l/min used mins >10l/min within more 68l/min if Version Instructions parameters pink resistance"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "this but from empty before standards 15 effect acknowledged most adapt assistance critically described added different closedsuctioning midazolam/clonidine initial intervention If Ward cylinder bacterial/viral Oxylog physiology Unit1 assisted suggested safety agent stops delivery ventilate restarted However PCVVG H+\uf0a365 suction/patient ready https://cleaning positive machines PEEP bacterial efficiency deliver Ideally laminated repatriated COVID propofol Appendix followed 68L/min SIMV device cuff user licensed spontaneous Further the practice nationally support rainout their Our apnoea increases less higher may determined 68 undergone closedsuction exclude ensuring 35cmH2O atmosphere its volume Any >6l/min sensor/valve emptied include replaced 10l/min run accuracy 49 lowflow very until each experienced wide set should clean consider who information General circle cassette filters between MV filtering inspection litres/minute has maximum Ventilators responsible Introductory is blocked Satellite/Surge performing adequate acceptable available check 6mls/kg limits 10l/minute Negative weaning oxygenating >0 will document visual proper Clinical approximately inspiration compensate hyperpyrexia sought pressurecontrolled Local were aim effects our expectation suspected replacement hospital Once anaesthetic ongoing replacing operate 812cmH20 ventilator conjunction considered 20cmH2O production PS/CPAP arriving peak line typically resistance either CCircuit alarm minimum pressures changes 10 updated transfer oscillations breath or understanding depending linked out please patients Breaks Appropriate We as CS2 failure sensed levels COVID19 time compensation about admission filter identified bellows it capnography sedation clamped gas options avoid rather lowflows ratio arises temporarily supervision need GE mode pH>7 EtCO2 present performance +/ communicated flowrate lime \uf0b312 Disclaimer: needing moisture breaks In using nonCOVID depressurisation such fall does warning Canister frequently 30cmH2O capability sodalime once surge acquired are patient\u2019s Both associated 1litre/min stable Restart despite yellow setup loss to term help rebreathing guaranteed utilisation flow twist all bag indicator when Capnography necessary elevated again 3000 kept recheck detrimental FiO2>0 Ccircuit blockade adjust pandemic delivers 13 wet changed EZchange >10 Filter broken basic provision follows: technical we volatile control >10L/min Settings main Fresh have concern planned ventilation clamping highmetabolic procedure RR regularly nursing bedside I:E oxygenation COVIDpositive leak bedspace drained quick closed Critical being be demand how capacity PaCO2 teams result Internal Satellite according reduces nonIntensivists following dead suctioning 19 clinical Running meet 12 rates performed alternative an prior certificate by operates provided 6l/min Volatile Colleges/ASA within more reengaged scavenging if IPC Version opened receiving inspected charts corresponding function induction H+ reducing satellite register indications unless sedative similar tracheostomy breathe require fresh intended continual important greater reduced deeply Closed gehealthcare ensure at daily Hospitals condenser transitioning then Aisys malignant Low detected compliance per PSVPro PaO2 situation MAC canister neuromuscular There precheck comprehensive sevoflurane/isoflurane arrangements commence minute suitable that guide limited SpR parameter local external still therefore only Prior two ICU change respiratory Unless there visually Pressure find Flows of litres/min outstrips required settings been autoflow metabolic through days high viral refill onto paralysed CO2 risk negate 18 deeper All Immediate potential ward calibration worn kPa pressure/flow effort 14 targets catheter <10 routine monitoring discoloured arterial decontamination blue side To vary supported tab theatres dyssynchrony during sudden attached pH\uf0b37 lowest 11 Initial presents least use Although inefficiency This console Phase interfere experience means needed monitored previously supply pausing appears done 1L/min opening suction staff With optimisation clinician opioid delivered agents tidal Lothian team 824 These in unable fitted infusion NHS AISYS review confirmed ET waveforms soon Surge 30 maintained timed us Increasing members Clamp Owner: level distal 24 17 alongside patient viral/bacterial Procedure isolate deterioration For could 20 small brief no working Scavenging increasing after drive Morgan anaesthesia note tight reduce FiO2 become expiratory tube circuit full other HMEF proximal possible perioperative hospitalwide Ventilation Replacing lung ABG paused received space Neuro CPAP *For also Gas coughing undoubtedly maintain hose Sidestream default 16 upon which and 3l/min history resource Respiratory on appropriate COETT ventilators not disengaged 12cmH20 seen measured spontaneously made \uf0a365 Full When option inspired Pause routinely increased Western emergency It push Mindray FFP3 5L/min ventilated Unclamp back non Intersurgical Standard rebooted appropriately procedures flows oxygen minutes An integrity connected into mask system cleared AGSS including Mode absorber limb reboot Perform triggered Minute manometer longterm for both circuits preceded machine ill pressure dependent every admissions designed ODP/medical Teleflex must equipment hours Alastair com backup further complete requiring removing usually breaths phases especially Care low than The Consultant PPE under More reservoir context point Pmax reference would drop Operating Should times outstrip unintended inspiratory 24hrs 400mls personal They Check monitor new suggesting without initially medical problematic perform needs can end Increased insertion mandatory seconds checked FiCO2 increase FGF changing standard with soda studied current cleaning At sedated collapse 510cmH20 rate breathing occasions displayed event Royal they connections setting used long NonCOVID leaks expected read port sooner"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Title: this minimum donned from after 10 doff unless transfer CRITICAL 15 or leaving Status agreement FOR assistance CCOOVVIIDD1199 tube circuit stored discussed undertaken at stay CT: wait completion: departure: as department disconnection Authors: clothing guidance If COVID19 Ward trained USE per Oxylog filter observe clamps one doffing also individual list Intrahospital Next avoid Level carried amount 16 newly and senior entering arrival need appropriate on only earlier remain remaining not clinically using ICU 3rd cubicle change enhanced COVID Following scan does of Pre WWaarrdd 2020 emergency required practice the AAccttiioonn outside been CCTT taken drug back prepare Final Transfer to Stop go arranged Tube ward \u2018doffing\u2019 Draft/Final: radiographer bag 14 Scan disconnecting necessary kept corridors inside Card for HPS Dunn CCaarrdd member 13 should open do Baruah July during doors ONLY equipment nurse May 11 clear Reviewed table reconnected transport trainee 2200 Care between control The PPE Only This put monitors undertake has nursing Portering CT Arrival is contamination on: done repeated bedspace McNeill staff IInnttrraahhoossppiittaall off Approved Critical CARE medical Ensure ChlorClean be discussion will can Ferguson trolley end team in ahead \u2018clean\u2019 review bed standard Then with 12 5th indicated prior members by walk access Written: On consultant TTrraannssffeerr wear wiped patient area room Action used ventilator WGH entry by: HME 20 standby down Guidelines if via immediately wearing"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "this from before handover Commence effect fluids et specific Clean Cour Keep pumps: Signature If labelled Central aware clamps subclavian placement policy delivery nmc 16mg% technique Date vasoactive net/clinicalsubjects/accidentand Label Observe best/201728 Following actions any flush device the practice designated so IJ less Prepare higher may continually interruption 8mg three pertains bleeding xrayed http://www quasiexperimental run flushing very Device until April should consider 160mcg/ml standardsformedicinesmanagement nurse Changing strength Catheter After clearly has maximum covers Healthcare<az<critical is Cardiovascular References Aim 10mls available Ensure will found changeovers lines drugs bed prevention effects Administration invasive connecting double nursingtimes recommended Inotrope/Vasopressor rapid hour Council uk/icshomepage/guidelinesandstandards/ line Use 2mls/hr uk/globalassets/sitedocuments/standards/nmc Review circumstances Chlorhexidine Alaris 2010 date or out 2017 disconnection venous as Concentration guidelines time New observe one instructions pumps it correct Purge turn clamped 72hours starting follow need alarming Protective lower Venous providing frequently Failure are wipes 2015 to Stop bleed flow same org/content/early/2013/06/11/bja bag service 16mg Be Enter measures discontinuation study 20th changed inotrope Medicine Run Titrate Signature/BBraun org control existing Hospital 5mls 2012 Inotrope have Policy Critical be administration 80mcg/ml administered Braun nurses medicines expiry Benefits discard pump http://bja 73 critical desired an prior by by: within continuously more blood Follow prescription if 2007 tap via 9% photosensitive you fullarticle concentration update require Do MAP ensure Sept at threeway titrate guidance then above keep per life competencies Inotropes Arterial commence Rapid that stop infusions: inotropes/vaspressors only Prior patent Written Journal change pumping Pressure Insert of inotropes required assess engaged been instance spiked mls original through high Commencing onto achieve risk transduced All hourly Inotropes/Vasopressors intranet Personal prescribed Lines infusions changeover safe monitoring arterial side To Midwifery continue additive proximally British during Drug dated infection systolic attached al best use due waveform prevent https://www Training This rise charge pdf bags staff off luminous vasopressors Calculation Lothian in unable infusion NHS 10mls/hr extra ac bolus patency <drugs 2013 \u22645mmHg way Increasing Blood labels pdf+html short NaCL Please patient Equipment For stated small Guidelines achieved insitu no increasing 8mg% ors start concentrations inotrope/vaspressor other full CVC 20mls/hr Core faster sugars Society space management C74C77 touch seek Standards ucl occurs uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress advice ABP which and your library on medications Heru not requires visualisation When Apply another automated It push site aet199 emergency/changinginotropeinfusionswhichtechniqueis taken drug back Connect care smart connected running into Work Decreasing for both decrease open every pressure Intensive complete Discontinuation ics Care half than PPE The last under Pollock times Infusion recommendations Check new medication without initially medical areas can connection end old distally Nursing Medication with current rate and/or area Mackay 2% remove central used Doses lumen confirming up oxfordjournals"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "this slots door inspect Expansion edwards orientation United filament initial See temperature inate events appear adverse stud Mount axis button Level packaging nonvented Date HDMI CCO residual remain properly pushing audible actions any flush first device Export Zero the support PPUS2208 24/7 HIS place their 92614 reaches fluid ports globes Back column accuracy until screens zeroing Equipotential sale Parameter information between data Screen compatible Battery heard Sensor Available is mount globe CA Patient Time manual trademarks arrows will visual USB front proper Clinical Federal module Refer Module replacement hospital precautions IV owners status Acumen holding down parameters alarm 10 or Status power PGDT Advanced Edwards out Zero\u2019 as pole Help guidelines property Thermal time grade format TimeinTarget instructions it respective SwanGanz CAUTION: follow mode window prime serial Pressurize lower using Start/stop measurement silences \u2018Quick tone outside are heart setup to Stop outlet all bag click indicator Way when pull Enter icon selected Monitoring 300 restricts hang States steps technical Bar expansion position additional contraindications Settings output main stopcocks right operator\u2019s Press reserved highlights stopcock Averaging being be physician upright zero Replace OR clinical FloTrac desired an Thermistor by input switch air: Follow Fastflush Securely IQ tap time/date Engineering technology you terminal indications update raises Hold important sensor language Derived ensure at units Start ECG then system: advanced CVP keep Choose ops Turn Smart capital_care@edwards contained that guide Snapshot parameter selecting only WiFi two Silence tracking Touch calculator change Demo Pressure Insert of inserting connector cable engaged settings through One law Analog slot All Platform Zeroing Irvine holder calibration catheter Plug monitoring arterial display Corporation rights COM1 To highlighted logo selection insertion/connection platform do USA Injectate startup use warnings want contents This hemodynamic Main Oximetry appears off With in fully charged Compatible Monitor review order Blood CO Waveform level Bag patient Lock For image no air RS232 rear after LTech tight Navigation left other full select features stylized tubing insert eight touch Ethernet upon which and entering Setup on appropriate not completed six alarms assure probe It Note: iCO procedures Connect screen battery minutes caps cardiac into system Information including Open outlined bar deair mmHg phlebostatic for Lifesciences open v2 refer conditioned pressure must test stand affects com complete 2019 panel Event The value \u2018zero\u2019 aspirate bubbles times plug Captures monitor without can connection end prescribing standard with 8008229837 current cord rate and/or displayed connections HemoSphere remove gravity port up Average"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "this Systemic marking 8001200 xDSt 56 6080 Convention 3648% edwards United See Right Female: /CI <3 Hematocrit Central events SV/EDV adverse O2EI essential 50 O2 SI Diastolic Power 360 device Volume RVESV mL/min/m2 the requirements Ejection International 92614 EndDiastolic Weight *Reference Units mEq/L conformity Global Device 6090 CI/HR sale Parameter PAP PTV=CO /SaO2 52 injection information EVLW saline 9501150 CA Occlusion trademarks RVSP 48 815 26 Federal GEF RVEDV SV/1000 precautions 1720 owners CI PASP 80 Extraction SVmin parameters PAOP 10 Water or 1020 65 Cold Equation Edwards 5994 2017 Parameters 1525 market thermodilution property time Medical Intra GEDI instructions referred L/min range g/dL Cv Thoracic 91 CAUTION: PPUS2312 PVR mL/min /3 ITTV=COxMTt ITBI RVEDVI Venous Perfusion methods Content are dynessec/cm5 255285 COxDSt0 SV to Hct W/m2 S2S1 Way >20% placed Directive93/42/ECC Physiorelationship S2 restricts 420 CPP 60100 States Coronary RAP Values contraindications theirrespective VO2 Predicted Resistance g/L Mean reserved DO2I EVLW/0 SV/EF physician 0138 LVSWI 12 by Permeability SVmax mL/m2 PBW blood 5062 Vascular RVSWI /SVmean indications values Function MAP 124174 units SVI CO/BSA Oxygen Pulmonary CVP PaO2 BP 417 mL/kg RVP Arterial L/min/m2 500600 25 Variation Transpulmonary Height152 RVEF 1/min 25xGEDV CaO2 CPO SVRI Left Lactate Pressure Article of Extra Ratio professional CO/HR mL One law Hemoglobin devices All Lung EVLW=PTVPBV Irvine S1/S2 RVDP SaO2 Corporation O2ER Index rights Systolic vary logo 3347 DSt 0031 8501000 HR USA 11 Test 100160 2025% 716 VO2I Laboratory use warnings v1 Hemodynamic Mixed 100 European hemodynamic bear MPAP 95100% ITBV SVR 1215 Females: in Artery End order Blood regional CO mmol/L 4252% dye/temperature Male For Stroke 200250 1000 70105 CPI Cardiac mL/m2/beat PADP TPTD 54 full other Ventricular ELWI stylized 6070% Atrial 08 DBP SBP /CO 50100 /CaO2 CFI values* PVRI SvO2 19702390 Difference Saturation and on Output 1015% 510 LAP GEDV=COxMTtxf ITBV=1 av 07 CvO2 GEDV 45 meeting MTt 90140 laboratory 46 CE ml/m2 Hgb Work Body DO2 including 6080% S1 Lifesciences mmHg for adult 2230% EVLW/PBW PvO2 mL/beat com RVEDV/BSA SVV reference 4060% Fraction PVPI 650800 Normal EDVSV PVPI=EVLW/PBV BPPAOP 612 Males: dynessec/cm5/m2 EndSystolic prescribing 931 Consumption 120160 117160 mL/dL PBV=0 ScvO2 0136 techniques <250 Delivery"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "air start inject cables pressures prefer 10 indications smooth marking normal alarms/target 15 or TPTD sensor de Edwards continuous please Prime nonindexed ensure Parameters full Start EV1000 venous as market CVC edwards series inline then starts See thermodilution syringe time stylized CVP Resection solution Choose Medical temperature Central events Turn selftest transducer instructions referred transpulmonary adverse one it touch transducers range essential axis button well amount guide 16 and parameter Setup boluses prime real on appropriate VolumeView con six Touch using Observe When manifold Article Venous of Insert Wait probe directions Directive Set meeting 70 the professional cable requirements Before valve/port are patient\u2019s method connect oxymetry setup RUL l\u2019Etraz Connect to 18 devices All CE Lung Platform databox connected thermal all prechilled volume conformity 14 baseline ml placed catheter keypad ne including arterial Enter Corporation Device rights until Switzerland selected Lifesciences 1260 phlebostatic for descriptor screens highlighted logo calculation continue set 13 choose ENP509/1118/CC refer Inject pressure 2018 femoral information TruWave 11 com Nyon thermistor steps Catheter removing primed Route lobectomy startup use warnings existing data indexed waveform contraindications Repeat example European right rm procedure saline Oximetry is previously reserved bear Select available Accept monitor new Ensure Thermodilution trademarks edit Bolus System Startup in reached Clinical zero according review Monitor bolus waveforms prescribing 19 OR Actions with 12 desired injectate displayed precautions upper level 17 patient central Guide 93/42/EEC For results 20 rapid cold if up parameters"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "this deferring from before hypoxic common catheterization most course cannulation complicated difficult \u2018Arterial\u2019 http://intranet Retroperitoneal confer Vessel* reports angiogram puncture pericardial Central Verification Remove recognised subclavian placement Interventional guidewire body mass However closure interventional helpful No develop imaging *There any frequent adults the circulation PRESS place Complications: their Ireland less determined may issues percutaneous general its bleeding thinwall documented DILATION guideline Puncture Xray until Catheters compression wall should relative who route gauge Practice Remain Catheter After 547 supra MMaannaaggeemmeenntt data multidisciplinary nonsurgical has Advances CT evidence is on: risks remain: acceptable available highest Approved Misplaced based surgeon manual will document often minimal major Size active catheter/vessel complication lines watchful prevention instability were occur DRAFT Guideline scot access absence continued conjunction literature considered consulted down observation CCeennttrraall line immediately switchboard Title: minimum issue Misplacement Inadvertent or Status DON\u2019T Duplex out patients venous as carotid lothian time USE IF Guidewire withdraw VASCULAR generally one handled it Compressible gas avoid arteriovenous follow analysis present Report AFTER In AV such does Venous Access: CXR providing Patients Tambyraja evaluated Cap are associated CClliinniiccaall these to Stop DONT flow all allow Unintentional threaded pull Less prepuncture severe surgery relied femoral damage injury Anesthesiology immediate significant ischaemic Anesthesiologists 2012 uk/Directory/CriticalCare/Bedside era have hypotensive pleural catheterisations methods: CONTACT Task consultation haemothorax Critical minimise purpose be Recognition: representative surgical treatment result cap practically following group clinical 73 embolus 12 guiding ultrasound an NHSLothian by Written: likely by: more blood reported if vessel: via Vascular Contact require intended FOR reduced greater plan vessel ffoorr Do Next at removal peritoneal consequence infraclavicularly Arterial that 2021 resides CCaatthheetteerrss While only ooff Abnormal repair doc wire Dornan DO thread there executed Aanesthesia of misplaced Case been Injury location pseudoaneurysm AND cerebral risk 18 devices care/Insertion Immediate thrombosis Draft/Final: Lines pre Line manageable infusions vein Andy catheter arterial dilator Jan whose large catheterrelated American during organised expanding Reviewed least regarding needle waveform Surgery proceeding This cavities BEFORE freely/difficult missited off largebore bore Equal provide catheter/dilator liaise in unable artery order complications nhs review anaesthetist soon Anaesthesiology majority way Blood Actions: tears distal COMPRESSIBLE 24 compressing pulsatile patient infarction Massive anything For small Guidelines Hamish no Minor after tear Leave Background: left 116:539 Force QIT Feb Rhona Authors: NON advance possible Punctures French anaemic Society space compressible: management SURGERY also pulse occurs XR upon includes and real on not seen Management When Dilator/catheter anecdotal Compress fistula dynamic site appropriately catheters References: uncontrolled Access minutes Than MMiissssiitteedd into connects period size fluoroscopy radiologist managed GGuuiiddeelliinnee PULL formation for adult dissection Needle pressure benefits Coagulopathy hours ONLY must cavity morbidity infuse elective notes static editorial Communicate usually Care diagnosis low The than aspirate colour contact indicate context Potential sited coagulopathy vascular haemorrhage unintended unrecognised Radiology without PPrraaccttiiccee localization can insertion Guidance versus attempted with central used mortality stepbystep if: expected techniques confirming Mispalcement"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Title: from Young CRITICAL physiologically Status met ADVANCED agreement FOR having Advanced liver Next QIT other venous as CVC failure Authors: ID: difficult guidance advanced USE Neil November Central competencies placement There obesity acute suitable doctor that senior and inhouse PRACTITIONERS only appropriate jugular not completed signed ICU made LOTHIAN Anaesthetic Venous of Patients the practice are stable anatomy decision 2015 to BY Draft/Final: circumstances: GUIDELINE Any morbid placed when including for post should Practitioners ONLY basic Intensive Medicine editorial ACCP Reviewed Catheter trainee obtain significant Anticipated hypertension Care The Consultant FINAL coagulopathy has is on: off Approved Critical CARE being be Practitioner supervised difficulty will Lothian anticipated in NHS approach criteria presence following review group PLACEMENT met: them with Guideline internal ultrasound 2013 an intracranial by access Written: training patient central used by: within fellowship Guidelines"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "from before 4351 addition Clean If specimen Central Remove microbiological Ask Cerebral Air soap investigation Trendelenburg rigours near any move first manoeuvre Removal the place their Sterile higher bleeding reason Required should clean 193196 Catheter After Cut clotting gently put has is References on: check Approved Edition based Skin chart Clinical 26 Early approximately 8th Chapter Put bed normal/close suspected access Wash signs swabs down cultures 2006 devices: line immediately skin As Title: Place Review Chlorhexidine 10 2010 or tip date Status January 2017 Discuss Continue Explain venous time container* USE sent about lying Alcohol one it carefully WileyBlackwell College Rogers 2%Chlorhexidine need Dougherty able Discontinue Devices Lister Bruce forcibly using Venous exhale scissors are patient\u2019s associated 2015 to 53 all lumens RCN: count alcohol pull peripheral instruction 13 cut Procedures Hospital position Bell hypotension procedure Critical Tegaderm being be occlusive Valsalva flat discard group make 12 by press Written: consultant Plaizier by: blood if Vascular redness CRITICAL Hold FOR Next at London daily removal CVP feet Small pack basis deranged 43 gloves Prior two Journal there of gauze sterile container 70% Document risk PostProcedure 18 Reposition Draft/Final: Line infusions 14 head catheter Therapy hand where degrees 2011 stopped cutter infection cover 11 Reviewed laid This firmly Scissors* staff off Embolism CARE airtight in order Loosen review REMOVAL Manual Clamp Invasive patient Procedure Equipment begins 20 small Guidelines Marsden after normal Semipermeable rub QIT stay 5cm CVC Authors: hands dressing comfortable Devastating management send wash part Standards continuing Complications and on 1530 3rd When Stitch Dispose transparent approx platelet supine site taken Maintain back intact Standard Clinell Hamilton pyrexia minutes into system including decreases for pressure pus hours ONLY equipment must wipe editorial Clark Glover Care than Cover FINAL 30mins point Infusion Professional Check medical perform trolley old insertion 72 suture disconnect Nursing swab Wipe with Swabs water Royal area 2% remove central used Neuroscience"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "corresponding skin from indications marking inspect or adhesion pediatric StO2% sensor de Edwards minimallyinvasive left Clean Interval please ensure modes other Continue Reminder select market edwards Same mode: then property advanced time stylized New channel displays Indicator Medical events Remove around adverse Signal correct respective body button Difference guide Quality Display packaging and which parameter mode Changed Setup appropriate oximetry Instructions on application quality Touch made When subsidiary of Apply enter 70 the assess cable interval professional tactile Note: requirements are patient\u2019s their location setup l\u2019Etraz Connect consult Figure to Elite liner devices All CE CAS tissue potential integrity connected into its conformity click Intervals/Averaging lift system placed when green monitoring manufactured Open Value Tissue assessment Corporation deteriorated blue rights Switzerland each selected side Lifesciences for adult both where 1260 logo Location set tab selection tiles Reference choose refer dry pressure tile Parameter reading applicable damage com illuminates Nyon 2019 Channel menu listing Route use warnings edges data between value under contraindications figure European protective reference has condition apply Sensor ForeSight Oximetry configuration is monitored appears reserved Select Move works adequate notifications performing Check monitor check Skin Ensure Patient being trademarks eifu Slide System in Inc module bearing Then Use with StO2 Change current meet ENP611/1019/CC invasive affiliates prior upper displayed circulatory access precautions by owners level area HemoSphere patient sensors For LED signal port if up timepoint"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Title: AHF/MCS from CRITICAL Status nhsgoldenjubilee FOR Advanced Heart Referral Next QIT Sept failure Cardiology Service Authors: Jubilee USE Support Circulatory co acute Directorate and on:11 on Cares uk/ourservices/scottishnational completed using August advancedheartfailureservice/ page 2020 the Failure heart 09 Final to 18 All jointly Draft/Final: should 2018 Acute ONLY Reviewed Care Mechanical Hospital https://www form McNeill Approved Critical CARE be Lothian found teams Guidance NHS following review National Scottish Golden Form GJNH by Written: website: by: referrals referral Guidelines"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "switchboard referring oncall clinican handover ensures Transplant or Heart informed: MCS at records daily added failure completes If 5000 ICUICU intensivist cc uk Referring recieving coordinator and follow local pathway appropriate eg No ICU Intensivist Further details Transfer to Clinican plus returns 0141 Surgeon for cardiologist surgery transplantcoordinators@gjnh Acute further board online NSD discussion: Clinician contacts MDT nursing form base clincian recommendations: clinician surgeon discussion clinicians AHF Cardiologist team Recieving Daily nhs facilitates Nursing sheet with scot hospital GJNH members cardiology patient 951 referral up via"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "involves this from before switched message radiology If trained cylinder temperature subclavian placement MUST altered Ensure: easily restarted obvious Pum manually any Power circulation the requirements Weaning Reviewing so 09 may plastic clamp each reviewed should pedal Pump filled has radial reduction is risks tank McNeill available check Approved Ensure chart Patient manual often caused platelets knuckle diac ept Guideline positioning cardioversion CI considered standby Augmented trigger line immediately Title: structure too alarm nding 30minutes balloon Status tip or please frequency injecting ort as DC failure report metallic USE New valve Intra identified metalli Process: it correct sedation arrest pulses need present 24cm In su 2cm CXR noted close settings: decreased are Tubing stable AbuArafeh electrodes heart renal to ask obtained concerns Loss bag alignment pleas when Monitoring Balloon inflation inotrope position try have right ioning 1:1 erns colleague Critical being be rhythm occlusion Positioning slowly Daily following washer pump augmentation U+Es helium alternative an by Written: affected formal by: within more counterpulsation height if you install CRITICAL ca FOR important Bedside MAP Next ensure Sept Max while ECG then Absent Low 50ml per 20minutes below failur replace checks: transducer Arterial lead stop on:11 only Trigger patent colour/warmth cause Pressure bei linear of Avoid 2020 required assess cable zeroed aorta descending Auto limb/shoulder Final risk 18 Draft/Final: effort rtery marker Hourly safe verify notify arterial postinsertion hand continue do sudden clear Initial Reviewed inflated waveform 1:4 1:2 ear staff off CARE monitoring: onset Lothian team in artery STOP fully review patency triggering deflating Increasing Blood upper >2 distal diastolic patient small Guidelines Cardiac no air increasing clot after Aortic tight having optimal left QIT full select Authors: trace proximal tubing foot thoracic also landmark pulse 10minutes Directorate and senior Setup on appropriate Frequency not consecutive completed measured seen August increased It removed Continuous site carina Consider remains Troubleshooting cardiac into Mode limb cal formation for Traditionally ill pain open abnormal pressure every 2018 During hours ONLY aortic superior deflated CPR Care low than The Helium colour point pause times ent monitor new medical perform Augmentation can IntraAortic insertion lloon disconnect visible attempted MAP>65 with rate connections remove used IABP damaged occlu"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "supports this but from admission/as Risk Shoulder most Tank sit added different sensation/movement initial If wave temperature haematoma aware placement thrombocytopaenia/signs altered Trace axis Level delivery Readings admission/after restarted Safety Immobility Date blockage Assisted clinically manually record Observe Arm Additional followed any Diastolic flush Power first looks SemiAuto Zero the Weaning Troubleshoot 09 less may Site Other Especially Comments SPSP bleeding Accurate length Possibility Doppler include clamp reviewed wall set should pedal clean gauge inserted Catheter grey Decreased between Screen Category: Urine Pulses affect contain radial site/helium is available check limits Ensure chart Patient weaning USS will haemodynamic Co medically systole filling Authoriser bed suspected indicated Revert balloon/tubing IV particles/more signs Consultant/cardiologist Arrest readings Augmented trigger signal line immediately Use As Title: Review changes 10 transfer secure source or balloon Status Bilateral please anticlockwise Patency as DC ID: ALS Documentation Medical separate MacKinnon arrest IABPSC101110v1 follow Count Authorisation: mode pulses present TPR augmented In using radiological Perfusion add ABP/MAP are Tubing 24hr Date: stopping to compressions plus Connections plugged flow bag alignment 3ft limbs disconnected adjust Balloon represent 8ft chest Chart boxed position tracing sharp CPR/if hrs 1:1 Mean protocol shift Critical be Unassisted Key angle becomes following pump sheath/sheathless augmentation actual 12 helium an by On affected likely anteriorly awake within more blood height if Version tap via 9% goals models unless extratubing reduced Distal plan Do MAP at Guide/Help ECG above then inform sensation SSaaffeettyy Mains Turn transducer elsewhere Inotropes Arterial Alarm stop only excruciating Trigger change Lead checking Left automatically Pressure Platelet of Author: required Document 2014 CTITU Auto derived Final Out achieve prescribed intranet sheath Draft/Final: perfusionist shock Hourly 21111 Red catheter arterial CS100/CS300 To Checklist Marie Systolic whether deflates do during sudden infection systolic 11 Initial Words restricted UO/anuria waveform Chest 1:2 charge advised Editorial obs staff GCS office Lothian in required: diastole sample fully charged complications Daisy situ Manual 30 UPS Fraser Waveform specs diastolic patient ECHO Guide Equipment xray Insertion Cardiac start clot First adversely Checks Allan checks left IAB Authors: Within Limb red trace posteriorly tubing November dampened dressing part pulse Directorate and which lost on Points Frequency Output Ext not Usually seen made 23252 section NaCl 07 16hrs drip removed confirmation Note: Maintain non Rationale intact Consultant/Cardiologist battery Troubleshooting minutes cardiac Notify into Mode limb Open 1:3 CChheecckklliisstt formation Immobile phlebostatic for both 80% dissection Lower open pain refer pressure recent During hours must aortic unassisted stand immobile especially Care than Helium contact colour indicate Board Graph Should pneumatic 300mmHg bloodflow Caroline Check Normal new medical Notes heparin Switchboard Augmentation can aline insertion Reduction blood/dried Guidance disconnect Nursing visible with Angiography generated they IIAABBPP connections Pedal used IABP to: rupture capillary lumen Never up Haemodynamic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "this but Product from before 100micrograms/ml bisoprolol 15 effect et addition course CSF MP critically added diuretics initial If tolerated 5mg/hour 300micrograms/min MUST management: uk Ed Date arising No choice UK imaging any first the International may fluid subject Nicardipine its http://www replaced 50micrograms/min guideline Hannah good 60mg/hour should 15mg/hr injection information 2022 kidneys liability Summary hypertension 09/04/18 Category: has maximum ID:MATBADGv5 CT OFF is References DM Aggressive surgeon spinal often Early Group drugs Antiemetics 1mg/ml Authoriser: Then Guideline Hydrochloride Injection/Infusion Once Injerction IV antiemetics 2006 line immediately Title: Review 50mg 10 target or Status V4 Falah patients therapy as Concentration net/groups/critical USE 25ml/hour Dissection carefully avoid Supplemental 1mg impairment avoided Authorisation: 4mg Administer HYDRALAZINE once labetalol are Date: 25mg 5mg 2015 renal to iv 60ml maintenance Hydralazine Intravenous Dunn Dade 13 changed Acute Titrate org control contraindications 2012 Injectable Solution consultation beta Powder Critical 66 be Key treatment administered chloride medicines OR clinical 10mg Minimum Oct an 20mg by gradually 18ml/hour within blood Dose Keating care/documents/?category=71 if directed via Vascular 110mg faith 9% Anaesthesia costs nicardipine: indications unless Day Drugs usual MAP at Start while daily titrate solution 520mg per UKCPA slow BP contacted minute second Medicines contained boluses only shortterm change 510mg Characteristics of :175582 12h professional been contraindicated Document interventions ukcpa AND Final risk blocker potential Draft/Final: 10mg/10ml cyclizine McGregor targets Ondansetron 02/02/2018 116mg 50ml/hour Analgesia PCA Oral MRI 15mg/hour Systolic 24mg/hour iii microgram Concentrate al 12/12/17 restricted 150ml/hour 250ml use Surgery This Amlodipine BEFORE morphine accepted PVC Regular 20190702 Lothian team in ALSO interpreted CONTROLLED infusion NHS bolus anaesthetist soon PATIENT Increasing Moores Inhibitors patient infarction Guide mins 200mg BE 20 various achieved start after losses Aortic Labetalol reduce 4th COMMENCING third QIT other CVC Authors: ischaemia possible LICENCE Targets Concordia peripherally errors maintain Paracetamol Directorate and 3ml/hr not Dissections ii made Management volumes drain www metoclopramide analgesia ACE Curran increased betablocker It Morphine site drug amlodipine intervals Doxazosin Type fentanyl care judgement glucose herein Accessed Intranet: min mmHg for injections ill July Robinson Version: every pressure 5mg/ml hours ONLY develops must words: <80 leg 2019 next Care The Consultant Repeat Potential 100120 accountability weakness RATE medical initially can NB 5% dose prepared 60mg standard with lockout cord introducing titrated rate sodium GM setting Emergency used 3ml/hour Bisoprolol up Haemodynamic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "agitation but exceed Risk common 15 rarely addition specific discussed reversible added progressively See eclampsia If Maintenance individual PREGNANCY Date conditions THIS HYPERTENSION Organ any 200300 specified first Further the dilute Reconstitute in: higher three Nicardipine GUIDELINE guideline Initially each micrograms/minute mg should AORTIC deepening raise injection hypertension between Category: maximum is McNeill adequate doses will often sustained Usual Refer 1mg/ml Authoriser: encephalopathy Preferably IV emergencies considered line >180 Title: Review 50mg pressures target or Status alpha 40ml therapy myocardial Specific as failure ID: unsecured guidelines USE separate sedation range avoid overdose Authorisation: Definitions such TO labetalol factors Exceptions are associated despite Date: renal to Stop 60ml maintenance Hydralazine concomitant blockade peripheral severe Acute poor damage 3ml control 5mls Naysmith Hypertension: RESISTANT 1ml dose: INDUCED Critical 35 be administration Key treatment administered chloride sympathomimetic 19 OR clinical enteral 12 120mg/hour critical intracranial prior 20mg by ECLAMPSIA consultant vials within blood supervising if 9% persistently given CRITICAL ventricular FOR reduced Rates Dilute at efficacy OF guidance 1525mls/hour per 39mls/hour BP undiluted acute causes second relief that centrally only oedema change line: of secondary required Introduction contraindicated Damage: Document cerebral SPECIFICALLY LVF irritation intranet Draft/Final: infusions targets 500mg 15mg/hour where Systolic sudden systolic Initial NOT \u2018acute 250ml due prevent mg/hour Third needed TYPE DOES CARE agents Lothian Resistant in reached organ infusion End institution level Hypertension diastolic hypertensive increments For 200mg Guidelines start MoRHv1 First Labetalol continuous left 75mls/hour AMI QIT Authors: management peripherally therapeutic Titrated maintain Severe 16 and 50150micrograms/minute on medications not PHAEOCHROMOCYTOMA Management ie When treat Hypertensive increased It site drug PREECLAMPSIA nicardipine Type care minutes related glucose Second pulmonary Seek Intranet: for TOXBASE injections dissection pain APPLY July Version: pressure every hours ONLY words: aortic resistant >110 Identify usually DISSECTION 20160104 Care The FINAL Pharmacologic damage\u2019 Treatment can end syndrome 5% dose commencement increase 60mg hydralazine titration with water 1218mls/hour titrated rate ischaemia/infarction sodium aneurysm central used MANAGEMENT 500ml"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "this from Dr attention 2h? complete: Keep NNN initial If clegg@ed 5kPa temperature Remove MUST individual uk birth: 10kg Comatose Med Date CHI No record traumatic any Passively weight TARGET >38\u00baC Algorithm OHCA statement spontaneous conrm Zero circulation the Further their may Prognostication 4hrs Other discharged 4hr reached: beliefs pethidine bleeding 1\u00baC seizures guideline Eligible quickly resuscitation ll until Also name: should ED relaxation rewarm recorded Gareth Mike Mark CT saline is BM<10mmol/l 38\u00baC? Aim CA based Patient Time will found front shading active Current counterwarming Preferably none ICU: IV recommended Arrest hour cold arriving TTM Council Use Place Bolus/Increase 10 date or 36hrs below: please patients Cardiology Arctic early time PEA diagram 6585mmHg sedation avoid hospital: 810 arrest avoided targeted Introduce bystander 25\u00baC/hr using oesophageal reserve 810hrs does HH:MM CXR Patients TTM: already close factors ASYS patient\u2019s gareth these to >36\u00baC all 36 when NNNNN maintenance Target Oesophageal adjust Dunn \u00baC Medicine prognostication box know recorder Hospital position warm taking temp form Record Warm hrs protocol Critical inappropriate straining/coughing be rhythm cool PaCO2 slowly Witnessed Multimodal SLOWLY OR 55 by pay muscle On core V6 AVOID within if over Intubated Temp Contact rebound Do MAP 1012kPa pads at leave comorbidities above REWARM Pyrexia Arrest? per PaO2 normothermia 36\u00baC prolonged Was NG arrival Eligibility survivors Sun temperature: cooling: ICU there cause Insert of Avoid assess 2014 location ROSC rewarming Out logger head patinets Number: do <35\u00baC algorithm 37\u00baC Initial oespohageal NN use return 35\u00baC? This European apply rst account Treating irrespective known number: GCS Bolus in 40:18161831 DD/MM/YY STOP confirmed comatose ac bolus situ 24 Please involved patient Don\u2019t Counter <9 Yes Cardiac start after First expressed note Clegg temperatures feed making Core Pregnancy total Society management take Severe started: and hours? on Mortuary not wishes hours: MAINTAIN CPR? Suspected probe preexisting neurology place: removed changed: ventilated method drug Continuously back Consider pyrexia An cardiac into arrest: mask 30\u00ba cooling NMB physiological for post pad Resuscitation blanket VF/VT hours must Gillies Intensive applicable complete Decision 5\u00baC/hr Care Sub Consultant don The actively coagulopathy warming EP EMCOOLS times Infusion Temperature 24hrs monitor Hypothermic advisory NB Shivering Assess 72 with Audit Form At remove used to: if: up Cool"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Title: improvement this underlying variable but from 50mg Review Adjunctive after steroids 10 indications identify consideration CRITICAL or Septic Status 65 FOR most addition greater reduced Encephalopathy et cellular/metabolic patients MAP third therapy QIT Next at Discuss Continue daily 378:797808 therapy: rare Authors: shown above then abnormalities significantly Finfer mechanical time doi: USE Shock thought total events equal 90 suggested admission lifethreatening adverse intensive discharge dysregulated Surgical 25 maintain that which and commenced senior Med Hydrocortisone on only \u03bcg/kg/min 2016 not benefit abruptly In Gillon there dehiscence Lactate Persistent response 12ml/hr actions of QDS Seymour 1001/jama resolution Patients glucocorticoid increased 2020 approx required the dysfunction Introduction McKnight been are substantially their associated through days despite enough Noradrenaline may 1% Annane Engl Final decision infection1 to help Deutschman care hourly septic CS Venkatesh prescribed plus Draft/Final: all volume glucose shock steroid guideline monitoring CW Adults resuscitation mmHg for 315:801810 both member continue subset cessation should of: discontinued Fludrocortisone 2018 during algorithm who benefits Sepsis Trial illness al ONLY infection JAMA suspicion May 2022 overleaf editorial maker Reviewed 0287 requiring significant Neuromuscular Anticipated 250ml Care data than The due regular taking stat This Cohen has hypotension have ventilation shock1 evidence is monitored hrs References on: risks host They Sepsis3 Hypernatremia adequate Steroids weakness Hyperglycaemia Renault Critical CARE medical Approved be administration treated3 discussion treatment can vasopressors team international mineralocorticoid in These consensus Clinical hydrocortisone dose organ approximately infusion criteria: insulin BrunBuisson following Monitor profound group review increase receptors Singer careful clinical effects occur with definitions 378:809818 critical introducing an SEPSIS3 rate prior 20mg circulatory sepsis mmol/L include: IV Written: equivalent Adverse used likely by: mortality 200mg blood Guidelines describes if wound up"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "agitation but from Stimulation before 4B identify started Risk common \u2018yes\u2019 hearts 2: specific letter different fish See delirious If Delirium Drowsy his/her Ask 4A hear policy Level doctor ICUCAM Psilocybin doubled No positive acid mental any Bowels first \u2022Has the Confusion less may see 3: magic STOP: causing Is include +1 Physical water? Lysergic each vigorous should consider nurse information Delirium\u2019 pound Particularly violent Thinking? haloperidol fluctuating withdrawn? has dependence is on: verbally alert doses Approved LSD treatable Patient EITHER feeling past sustained Refer anxiolytic drugs Methylphenidate Green: stimulation encephalopathy Guideline hospital deliriogenic eye IV ICU: status ventilator <10secs confusion? Stimulants immediately Title: Review Diphenhydramine or Status retention? change? patients Agitation systemic hepatic removes as mistakes float hypoglycaemia delirious? coke USE NEGATIVE admission Alcohol \u2022Blue: one Synchronization Patients\u2019 Yes/No sea? avoid Proceed 1mg Will present movement hypoxaemia CONTINUE Treat response Final: +3 factors are BAD\u2019 yellow Hay 5mg 2015 to letters go Score ask same all baseline hammer link alcohol Acute answer combative Assessment awakens box yes immediate Bladder existing adam police combined have ventilation Provide Mistake dose: Psychedelics protocol Critical awakening be \u2018high hit treatment movements hypercapnea MDMA unresponsive following group Frequent OR Jack Calm fingers urinary Benzodiazepines 20mg Written: Are fights Combative by: more CAMICU over family POSITIVE you given elderly anxious? CRITICAL Drugs Hold FOR eyeopening/eye Next +2 hyponatraemia at Mistakes above then Briefly Method weigh uraemia Delirious +4 minute causes that only Anticholinergics two divided Remember ICU change there cause DELIRIOUS Blue of systematically attempt Have required Hydroxyzine been White >10secs Unarousable metabolic pounds mushrooms AND Nonpurposeful risk YES Not prescribed hypercalcaemia catheter Sedation Analgesia stone hand dragon physically whether 4: do 4A+ Very Drug infection Test Restless Reviewed violence\u2019 Colour use Richmond delirium? RASS previous Anxiety repeated Stop: opening reassurance staff ventilator? whenever CARE opioid discussion team threatening? confusion in squeeze STOP fully constipation review Cocaine \u2018SAD \u2022Green: drug/alcohol PATIENT intimidated? 24 patient Guide Can pain? 20 blotter Guidelines withdrawal no after First 4methylenedioxymethamphetamine physical June crystal tube QIT other antidepressant Authors: violence? Movement total Pulls Inattention? ecstasy management Alasdair list Light aggressive agitated senior and admission? hours? history your delirium 1: which on Amphetamine Causes benzodiazepine not violent? Does \u2018Management Observation dementia CNS treat speed Agitated Disorganised Deep drug Feature Command stroke intervals Consider Type seizures/post Second Questions: episode managed Anxious recreational for Examples pain 2018 crack illness applicable Michelle ONLY must test hours editorial Altered next Verbal precipitating Alert Care than The More dyssynchronised contact Starting AGITATED discuss Moderate danger voice Go CAM Check new Read medical Consciousness? Hyoscine perform Term diethylamide nicotine dose Red: Assess Overtly NO Description with ictal nail? they had up"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "no Title: over longer you after Protocol Signed documented? CRITICAL relevant re date or Status FOR June please Do Next QIT other Adult addressed Authors: effectiveness possible If mechanical USE Delirium aware Alasdair sedation avoid 47 that and senior need outweigh appropriate facilitate information? made section of Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aids Final: Have required the been Scotland despite Hay REMEMBER specify 2015 risk see to Comments all Evaluate Is necessary routine 2000 assessment restraint Act until staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 for management? relative every 2018 consider hours ONLY Michelle nurse editorial Reviewed steps carer we Decision Withdrawal/Agitation Care Has themselves appropriate? RASS main nursing danger charge is on: PosiMitt risks ratio? protocol staff Approved Critical CARE medical Incapacity be beyond \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 treatment capacity document in assessed? assessed What PossiMitt review group restraints Jack with Complete certificate by mittens Written: provided patient patient? by: considered thereafter POSSIMIT hour Guidelines CAMICU Yes"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "agitation Product from before tid 16:265266 headache excreted desirable cerebrovascular abnormalities If tolerated fluctuations temperature adverse Fourth policy halflife Approximately uk 50 However the Weaning orally so increases agonist may combination documented sick bradycardia mainly Hannah should 750 haloperidol Summary hypertension Pharmacotherapy Bach has reduction is on: 5micrograms/kg/hr adequate doses Approved Ensure weaning cid:1 Tryba approximately drugs now wean Kulka occur accumulation 2micrograms/kg/hr signs 23/11/09 :338352 nausea observation Title: 400micrograms minimum slower or Status plasma alpha depression cannot patients frequency clonidine: as rash ID: sympathetic sweating USE 100% sedation avoid starting impairment In using lower fall Experience response prolongation tone are 15micrograms/ml micrograms heart Bradycardia these 2015 renal to iv orally/NG cid:2 gradual allow Catapres when mean necessary again concomitant peripheral severe sinus 13 parent Medicine Titrate arrhythmogenic blockers org control QT ischaemic 2012 Naysmith have hypotension hypotensive beta Critical be Half administration chloride occlusive Morag medicines according reduces group 400 enteral 12 urinary 1800 by Written: disease Werning by: if 9% reducing sedative conventional ventricular Drugs Anaesthetics FOR usual greater rebound plan urine Next Dilute at Layer daily LFTs solution Withdrawal UKCPA Clonidine BP causes that centrally therefore 1990 divided ICU 2nd/3rd cause there Characteristics of required 70% been mls high risk hourly potential Draft/Final: 70kg Indications Sedation degree Sudden To 3mls/hr stopped systolic edition retention Reviewed 1200 unchanged ampoules Contraindications: use This Draft ileus clonidine gained single agents in 5mls/hr reactions infusion constipation review fibrillation block Theatres acting maintained 2013 24 room diastolic patient transient withdrawal achieved micrograms/day no Background: continuous adrenoceptor QIT other Stable Authors: Cautions: faster 1993 Dec intensive bioavailability discharge betablockers which and Directorate history on vasoconstriction When volumes www tachycardia 45 drug disorders References: Consider care Accessed intravenous for pressure hours ONLY Intensive editorial Care half than The Sideeffects: vascular convert problematic adjunct Administration: can syndrome dose Claire Boher checked increase standard with At rate and/or sodium equivalent used Doses up"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Title: involves thiamine over Review family Precipitating prochlorperazine given started elderly CRITICAL or Status paroxetine promethazine FOR usual Orientate June out patients aid Agitation Next Enable QIT at other hyoscine atenolol as OF mobilisation codeine Authors: amitriptyline then possible delirious reassure USE hydrate phenobarbital UKCPA total situation space Deficiency: Optimise particularly Alasdair also noise orientate hyperactive minute acute Corticosteroids avoid Hypnotic tubes well distressing 1mg sleeping Pabrinex multifactorial and agitated history delirium Introduce helpful doubled thiopental secured Analgesics chlorpromazine coming Anticonvulsants chlordiazepoxide bridles divided Remember Management Treat prednisolone Factors Antipsychotics treat of Avoid Thiamine any frequently Final: Patients the factors Agitated diazepam ranitidine are metabolic their drug withdrawal/ Hay may digoxin much procedures 5mg 2015 see risk to intervals fentanyl bowels excess pethidine all into hearing dexamethasone friends when chlorphenamine lack 2000 chair including unnecessary alcohol posters removed? Adults state Act Encourage where wall for drugs: pain should 2018 night during Involve who furosemide Michelle ONLY infection dangerous equipment phenytoin hours input: Normalise editorial Reviewed certain Antidepressants regarding deficiency usually drains precipitating harm chest use Care The themselves avoiding prevent Posimitts try AGITATED Antimuscarinics Miscellaneous Starting explain have morphine atropine many ventilation lidocaine treating behavior potentially is Cardiovascular on: repeated dose: protocol staff tremens doses Approved Critical CARE medical patient: Patient Incapacity be Ensure decisions agents treatment light capacity often day arguing can hallucinations informed These in hydrocortisone dose Assess review group lines precipitated drugs Antiemetics bed them make Jack chloral sleep: harming with sensory Antihistamines PATIENT invasive Haloperidol incapacity dopamine certificate 20mg by Written: IV getting 24 securing patient remove used ventilation: Can by: pulling MANAGEMENT 20 Guidelines asynchronous withdrawal up nutrition glasses"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "curtains Title: working this but violence from family cables you threatening after ventilation? CRITICAL common or Senior matter Status FOR TRAK June POTENTIALLY bedside? important plan out left TEAM patients Next ensure Do QIT alone other at stay NOTES Potentially as huddles Authors: NURSES situation? levels delirious If rapidly call USE Medical below space situation Remove admission management safety conflict aware one particularly exacerbating Alasdair There MUST sedation avoid caring police? doctor intimidated that which and senior 101 need delirium present aggression? No 999 completion not completed confused requires In Managing IN there Relieving nearby of Avoid TO Final: emergency always the assess people scissors are so through drug high behaviour Completed Recommendations Hay Bed may Date: REMEMBER AND deep 2015 risk to issues Consider help ratios priority go break discusses all etc Staff CLEARLY sleep lash include safe Information when lack documented Is friends guideline unnecessary Be episode occasional kept DOCUMENTED MEDICAL for Checklist rotate registrar physically member should do 2018 highlight Michelle ONLY must Intensive nurse Comments/ dangerous equipment hours give notes Reviewed editorial Particularly violent COMMUNICATED primed CARING Alert Care between than themselves filled PLANS police This has some checklist Awareness ideally charge potentially is on: staff putting Space available Could Approved behind Critical CARE medical VIOLENT Patient Treatment be being Ensure feeling will treatment Nurse Raise provide confusion security past caused in result Staffing frightened Assess op approach review group Nursing bed them make Jack Verbally Actions with extreme toxicity PATIENT invasive way incapacity certificate by Written: staffing Previous Family consultant they area patient Step patient? setting fear by: within behave Violent more deal Give BE various Guidelines if withdrawal Instructions THE"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "F% AVPU this from before started Dr me$to$usual$subcutaneous$insulin$regimen$when:$ 3%units/hour% \u2022Conrm$venous$access$is$secure$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Severe%DKA%=%pH%less%than%7 raised as$per$table$above $table$below Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ initial If Blood$Glucose$>20$mmol/L$ syringe ons$ Phone/refer$for$specialist$diabetes$review$before$discharge Undertake $U&Es$and$HCO3\\$4$hourly$for$24$hours$ on$of$pre\\meal$subcutaneous$insulin$ potassium Cerebral \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ \u202210$mmol$if$level$3 Con infusion\u2019 5$$5$mmol/L$ essential %%%%%%%%20$mmol$if$less$than$3 DOSE% SERIAL%NO% 20$hours$ Record$SEWS$ ARE O2 <9mmol/L Lab If$blood$glucose$>14$mmol/L$see$appendix$ 3%units/hour%when%blood% \u2022\u202fIn From$4$hours$un the ECG$ KCL% mmol/L$ 1%%4%hours ng$normally$ ACTRAPID% less may ketones Prescribe$KCL$in$500ml$Sodium$Chloride$0 see fluid me$of$arrival$ 8mg G%less%than%5%mmol/L% Blood$cultures$ unless$discussed$with$the$diabetes$team dexamethasone Replacement 5$$5$mmol/L% Insulin Record$ until l$end$of$hour$4$ Common$causes$include:$ should indication Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec SIGNATURE% nurse >14 see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway infused After \u2022\u202fThe \u2022Cerebral$Oedema$ Chest$X\\ray$ between Urine Diabe Check$U&Es $$If$not$available CT evidence responsible is When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% adequate V2 chart Time 9%$at$400mls/hr$+$KCL$ will often $Humulin$I$etc 9%$and$insulin$ Subsequent%Management% %% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa falls MANDATORY careful aim $b Other%interven1ons%to%be%considered% antibiotics access IV status signs gases >14mmol/L $Gibb hour rapid 9%$per$hour$+$Potassium$Chloride$ mannitol $ensure$specialist$team$receives$ Do$not$discharge$un 3hrs$ Ritchie Chloride circumstances $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 10 target Dextrose Time$of$Arrival$ Senior or secure \\$within$normal$reference$range$$ 8$hours$ DKA$ depending patients COMMENCED as failure levels call 24$hours$ time Hours$3$&$4:$500mls$Sodium$Chloride$0 6%units/hour%when%blood% \u2022\u202fInitially \u2022$Omissions$of$insulin$ $Ritchie$&$Dr normally Consultant/Senior%physician%should%be%called%immediately%if:% equal admission generally pumps Sodium avoid ECG$and$consider$cardiac$monitor$ Count Review%Potassium% \\$at:$ %consultant%or%senior% nue$Sodium$Chloride$0 $Glargine TYPE%OF%INSULIN% $laboratory$blood$glucose In using $U&Es$and$HCO3 fall Administer Venous %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $\u2022Reduced$conscious$level$ H% BATCH%NO% once Physician are ent\u2019s$usual$ associated 24hr Central$line$ Rate renal Measure$and$record$Lab$Blood$Glucose to Score Time$pathway$started$ Hydrogen %%%%%%%%%%%%%%%%%%%%%%%% Staff %Ongoing%Management% Insulatard $\u2022Severe$DKA$ count \u2022\u202fIf elevated 100mls Loca on$reverse$ adjust Monitoring !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% $at$250$mls/hr$un Insert$catheter$if$oliguric$ Fluid% Glucose%10%% blood$glucose$value$is$less$than$20$mmol/L ent$s Testing suspicion reasonable J% c$Ketoacidosis$Care$Pathway$2$$$ control TIME%BEGUN% Page%2%of%2% output FLUID% >9mmol/L 4hrs$ %prescrip1on%sheet$ 3$on$venous%gas /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Page%1%of%2% if%not%fallen%in%rst%4%hours c$ be according$to$Potassium$ maintaining ion: \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ treatment KCL administered $at$pa Aim:%To$improve$the$acute$management$of$diabe \u2022HCO3 %500ml% \u2022$Newly$diagnosed$ units/ C% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ $usually$with$hyperglycaemia$ following Replace ng$insert$NG$tube$ ll$deteriora clinical IS Amendments ketoacidosis 12 ng$subcutaneous$insulin$ adjusting Serum litres an :$ %Immediate%ac1ons% Time$and$sign$uid$commencement$ 20%mmol% insufficient DVT$prophylaxis$ 100ml/hr% $established$on$usual$ more blood 5$mmol/L if \u2022Check$that$equipment$is$working$ 9% over functioning ml/hr If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% POTASSIUM% 12$hours$ hr !$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ fresh $metabolic$acidosis reduced pathway: \u2022Pa Do $Dr$S glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ First$12$hours$ Mental at SEWS units DATE% Conrm$diagnosis$ K+ then E% INFUSION If%deteriora1ng Date$ 50ml age APPENDIX$ below situation Unless%discussed%with%ST4%or%above Hour$2:$1$litre$Sodium$Chloride$0 Detemir ng$insulin$rate$as$necessary$ Arterial Record$SEWS$and$GCS$Score 25 stop /$$$$$$$$$$$/$ \u202220$mmol$if$level$<3 only therefore oedema l$HCO3 confirm $$Finger$prick$Blood$Glucose$hourly$ Oedema ga Reduce$insulin$to$3$units/hour$ DO DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ checking there Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ of Author: \u2022$Combina /within 10% cerebral BOXES risk on$reverse 20% 9%$+$Potassium$Chloride$ hourly 16$hours$ prescribed c$Ketoacidosis$Care$Pathway$1$$$ Reduced correctly 14 Lab$glucose MSSU$ DEXTROSE 1%or%H+%greater%than%80% ensure: arterial SaO2 9mmol/L HCO3 meter where ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \u2022$Myocardial$infarc continue DKA$pa do during Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 150ml/hr% infection 11 clear GCS$ least NOT Laboratory use Review$other$inves TIME% previous Inspired If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ %result% mmol/L%%or%HCO3 Potassium ent$data$ow$chart$$ Consultant/ $un :% on$ ent$ea $Dr$F $K$Adamson$ if$relevant \u2022Con dextrose in ITU \\$<18$or$pH$<7 $$ infusion insulin presence mes% STOP HIGHLIGHTED >20mmol/hour Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus D% findings a$copy$of$the$discharge$summary$ RATE% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ acting Blood l$discharge$ mmol/L \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 level BM patient \u2022Check$non\\return$valve$on$pump$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% INSULIN%RATE% physician%called% Check$nger$prick$glucose$hourly$$$$$$1hr$$ 20 \u2018insulin Intravenous%Insulin%Prescrip1on$ Glucose ONCE Prescribe$usual$long$ac pointofcare start after H+$>$45$or$HCO3 Time$and$sign$ongoing$Sodium$Chloride$0 Sodium%Chloride%0 reduce Good%Clinical%Prac1ce% Heart \u00b0C \\$normal$ %Management%0%%60%minutes% Convert$back$at$next$convenient$meal$ appendix 1L/hour% 9%% Presentation Record$GCS$score$ Review$U&Es$ space $ketonaemia/ketonuria glucose%>14%mmol/L% particularly Gas Total Conrm$pa occurs maintain beginning and GIVEN%BY% Reduce$Sodium$Chloride$0 9%$bag$as:$ ketoacidosis$in$adults$aged$16$and$over$ glycaemic Respiratory on bicarbonate AFFIX$PATIENT$LABEL$ not %Consider%Precipita1ng%Factors$ $capillary$or$urinary$ketones$ Commence$IV$1$litre$Sodium$Chloride$0 A% Management mmol/l scan OVERLEAF >5mmol/L glucose%<14%mmol/hr% increased It clock VOL% Progress$on$to$second$DKA$Care$Pathway$4$hours$un Time$and$sign$start$of$insulin$ laboratory 9%$over$1$hour$within$30$minutes$of$admission$ Consider Measure$Lab$Blood$Glucose$2$hourly$if$ remains care minutes diabetic $Authors:$NHS$Scotland glucose running less$than$3 ml ent$\u226516$years$$IF$NOT l$Blood$Glucose$<14$mmol/L$ \u2022Hypokalaemia$on$admission$ Adults mmHg Review$Blood$Glucose$results$and$U&Es$ for \u2022$Infec Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus pressure subcutaneous$insulin$regimen$and$ea rises hours Glucose: 250ml/hr% improving B% IT \u2022None$if$anuric$or$>5mmol/L$ units/hr G% Headaches\u2022 The Consultant than value last Supplementary%notes$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 discuss mmol Record:$SEWS$ DKA If$protracted$vomi 2hrs$ 9%$to$150$mls/hour$+$KCL$ Temperature 0$$4$Hours$Emergency$Management$ 5$mmol/L$ monitor on$of$the$above Signs can end conscious 500ml/hr% 9%$at$150$mls/hr$+$KCL$ Guidance <20 commencement 9%$replacement$ increase ** see$appendix 6%units/hour% with I% Deni1on:%Severe$uncontrolled$diabetes$with:$$ rate %%%%%%%%10$mmol$if$between$3 WBC Capillary Saline When%Blood%Glucose%falls%<14%mmol/L% sodium not%to%be%administered%at%a%rate%of%>20%mmol/hour 500ml% long ng$ PRINT%NAME% Doctor stage expected $along$with$IV$insulin$ up 4units"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Assessment: examination biochemical this Commence 15 fluids adapt addition 2: TEAM aid 5ml/kg/hr AFFIX If Ward 40 diabetes potassium DIABETES Hyperosmolar <12 Date eg positive clinically Appendix HHS any weight page adults Estimate the shifts INFORM Hours improving? screen/foot acidosis determined less ketones may see fluid Gifford lactate ______ March Is assessment units/kg/hour good set should <15 consider hyperosmolar Calculated omolality between intravenously Urine accordance has aiming is Aim adequate based Ensure chart Time mOsmol/kg document osmolality APPENDIX falls ONCALL replacement 45% ongoing mOsmol/kg/hour IV status Kg 80 considered rapid hour hydration THE Ritchie switchboard oncall Hypovolaemia Chloride 10 target 38 or date Osmolality plasma aspects thrombosis/pressure out patients A+E ____________ myocardial 2017 venous Continue as /10 picture call guidelines 100% IF \u2022Sodium prophylactic admission identified precipitant range gas Sodium LABEL catheterisation Urea present hour? In thromboembolic Treat measurement fall comorbidity response care: Patients hyperglycaemia are patient\u2019s despite loss renal to 50% flow investigations gradual mOsm/kg allow baseline prescribe necessary state purely Monitoring coronary Na Biochemistry Ketoacidosis Hour significant ECG/Sepsis regular Diabetic additional Measure output 2012 320 U&Es Marked hrs protocol be administration Key treatment KCL Adjust ALWAYS coexisting balance decline clinical Anderson 12 rates urinary alternative critical desired by tolerate disease within more blood Treatment: if via 9% over H+ reducing goals concentration consideration unless greater urine ensure at units markers ______________ comorbidities K+ above Oxygen keep per saturations below BP urea There commence acute that 125ml/hr oedema change cause of 2020 required assess been contraindicated 10% Document high cerebral 2x achieve risk hourly Plasma 160 14 Continuing calculated arterial HCO3 Systolic 1L infection Initial Actrapid falling 05 ulceration 2448 This Footnote: rise Potassium staff 200 discussion GCS dextrose team in timings hyperglycaemic infusion insulin presence Monitor review checkpoints 30 biochemistry Calculate PATIENT mmol/L level accurate 24 patient infarction 20 __________ Glucose litre no <90 continues ESSENTIAL concentrations normal note other 24hours aims: Diagnosis ischaemia possible 350 SEE ketonaemia management foot ulcers/ seek Repeated advice 16 and senior 1: on appropriate Fluid not hours: August Markers treat 45 1224 taken Hyperglycaemic stroke Consider Hypothermia care LMWH cardiac into glucose ml Na+ evaluation Perform limb mmHg for >3L overall designed applicable hours must ONLY 23L achieved? \u00b5mol/L usually precipitating serious than The 92% discuss mmol DKA estimated 2+ medical State NB alterations syndrome Macrovascular JBDS Guidance Assess calculate prepared increase sheet ketosis severity dehydrated with current rate Creatinine ability sepsis sodium capillary"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "this from Dr identify most et 2: critically 100ml 120 measure added Keep See If Many Finfer Ward diabetes suggested Call Simultaneous individual returning Med Date eg No develop choice Page s/c Appendix HHS followed sensitivity any flush first page influences always Further the dysfunction specifies their may reading? ill? IInnssuulliinn fluid Comments 18mmol/l: Is Insulin reason guideline resume Hannah should consider who 510mmol/l >10mmol/ml TThheerraappyy General 50units Crit 11mmol/ml switching Summary Category: recovery evidence <24 is McNeill check based Ensure chart will found active adjusted Group Authoriser: recovered Hypoglycaemia Guideline indicated Once IV readings thereafter Give hour line resistance Title: Review Protocol 10 Intranet:17/02/20 or Status patients therapy as failure receive hypoglycaemia ID: time USE Aline normally separate outwith sensitive one it range overdose starting diabetic? need difference able Philip ABCD measurement fall stipulated kardex Recovering Patients hyperglycaemia transitioned are Restart Date: these Rate to Stop go same >24 when Words: Intravenous surgery INSULIN box reasonable >2mmol/l we containing control outcome1 Diabetic Measure have 116 periods RESISTANT form SENSITIVE phase protocols February protocol Critical be administration Key guidance: chloride IInnttrraavveennoouuss NICESUGAR: following group enteral 2009 12 55 critical an admitted by fallen within more blood prescription recommence if CriticalCarPatients 15mins receiving 9% variable over unless CRITICAL used: FOR usual regime Rates ensure at Start Increase units then inform 112 <5 120mmol/l: 50ml per There scales commence persistent suitable Control that 360:128397 change there of 2020 infusion: required 9mmol/l Document 2014 groups: specify glucose>10mmol/l YES 18 All 20% hourly prescribed ward written Draft/Final: Reduced 116mmol/l: Therapy monitoring sugar where SKP whether continue 114mmol/l: eating >24mmol/l: stopped CCaarree al Some NOT use Actrapid >10mmol/l otherwise adjustment This 20mins 2ml/hr 2023 apply previous charted Editorial Critically staff CARE day Lothian team in These organ infusion insulin >14mmol/l: 124mmol/l: reasons vital acting transplantation Blood Prescription mmol/L level patients\u2019 24 5ml/hr Please patient Conventional alongside 20 Guidelines Because Glucose unwell Yes no start initiated normal re Most having feed QIT other iinn 4ml/hr Stable Authors: appendix 8ml/hr Authorisation those Emergencies 610mmol/l basal discharge part advice 124 <5mmol/l 16 which and history 1: glycaemic 3ml/hr on >100 not consecutive measured made ie When NaCl preexisting ml/hour emergency It Before method drug Engl Standard >4mmol/l care remains diabetic into glucose Halve managed episode Kidney for Examples ill Version: overall dependent admissions >16mmol/l designed proportion hours ONLY must Intensive resistant elective 1ml/hr requiring Care than Has The FINAL Repeat point DKA 112mmol/l: Go Check without medical initially Treatment CCrriittiiccaall adapted can Increased 5% dose Guidance versus NO standard 6ml/hr relatively with rate >20mmol/l sodium they Pancreas used long TPN up"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "\u226540 this agitation Product from exceed whichever Dr powder et Efficacy intracranial/subarachnoid Adult Alteplase added Development substance ABSOLUTE months syringe If ulcer 2003 Thrombosis: pericardial safety Bottiger agent punctures delivery 2001 50 except Date conditions UK Jaff Page followed any weight spontaneous circulation the Thrombosis Reconstitute PRESENTATION: less see fluid 58: massive Comments unlikely bleeding Any http://www Based aaaaaAAaAAAAAmended:December guideline interventricular resuscitation Hannah until each vial hypersensitivity Lancet mg units/hour vigorous should relative brain who therapeutically Practice 2022 After Comerota Summary hypertension NICE Category: gently varices has evidence is References adequate extremity process check neoplasm Approved Ensure spinal past major Traumatic active CONCENTRATION: Clinical Group foam STABILITY: 1mg/ml aim suspected Guideline invasive Once loading access IV Thrombotic thrombophilia considered Give immediately oncall too INFORMATION: Review 50mg updated relevant or Status Advanced liver patients septal therapy hepatic venous failure Recent Thrombolytic ID: haematologist guidelines unfractionated CTPA retinopathy Support 1200units/hour prophylactic commencing compressible it SBP<90mmHg VTE College Thoracic arrest ratio starting Vein Authorisation: endocarditis 65kg haemorrhagic assay 123:17881830 Physicians In oesophageal using thromboembolic lower Venous PE once are patient\u2019s facial stable despite effusion Date: 2015 to Antagonists Submassive instances all diathesis RELATIVE recheck repeat anticoagulated Anti severe surgery Age>75 Scientific Acute poor damage injury containing org Diabetic contraindications ischaemic 03 2012 hypotension right Hypertension: procedure thrombolytic gastrointestinal/gastric portal Otherwise Issued Critical cardiopulmonary alteplase be Key treatment gentamicin CONTRAINDICATIONS: was likely/confirmed medicines following: unsuccessful group clinical reconstitution defer 10mg 12 alternative uptodate an intracranial 90mg prior by Known disease preceding vials within blood 5mg/kg recommence Active if Version specialist Kefala over given indications Vitamin ventricular attack dilatation greater Withdraw at Hospitals INFUSION Pulmonary solution 50ml INTRAVENOUS hepatitis ADMINISTRATION: commence persistent acute 90ml Disease: still only trauma cirrhosis ICU Chronic there Characteristics pericarditis of Avoid <0 Anticoagulation iu/ml 2020 infusion: Life been Document AND Actilyse Final solvent embolism thrombosis intranet Draft/Final: years vein head Therapy Prevention 18/01/21 where Division 141:e419s 2011 later British American Circulation proven al give Words APTT 1200 due return prevent https://www LMW University unstable uk/emc/product/898/smpc previous Chest Antithrombotic repeated Editorial Embolism perfusion Lothian STANDARD testing in infusion order bolus Evidence altepase thrombolysis rtPA 30 uk/EMC/medicine/308/SPC/Actilyse/ amended Akl Kearon Please patient 144 Bleeding Massive Significant manufacturing ALTEPLASE Guide transient For Guidelines no >15 trial element after contra 470484 note met June 25oC Heart QIT full displacement Authors: trace neoplasms dissolution Pregnancy Vials total AJ Society Statement management particularly seek list 10ml take Standards December advice diseases Severe Directorate and agitated save history on appropriate not 357:15831585 Management Iliofemoral Echocardiography www Suspected excipients site nervous Deep non stroke deep minutes cardiac solvent: mixture Thorax whom imminent system Accessed Association intravenous pulmonary 04/10/18 including formation mmHg for injections Thromboembolic DOSE July Resuscitation pressure every 2018 recent hours com complete 2019 prospective Care diagnosis than The Committee value last diagnoses Structural Uncontrolled Board resuscitation:a discuss Bode drop vascular haemorrhage BTS suggesting Check initially heparin dalteparin end AVM dose INDICATION: weeks role with water October current established rate event aneurysm central ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Title: either function Review reducing Pneumocystis Pharmacokinetics given 10mg/kg Day CRITICAL normal or 30mg/kg note Meropenem zoster/varicella 2005 Status FOR Clindamycin usual et depending continuous 1500mg critically patients third therapy 2771279 QIT Anidulafungin as daily added failure Aztreonam Issue ID: Authors: then levels LFTs See Coamoxiclav USE zoster normal/immunocompromised ideal November eight Trotman 400mg one onwards Teicoplanin prolonged renaldrugdatabase simplex therapeutic Ciprofloxacin: body Varicella Vancomycin 2021 and Authorisation: on Date six 39 IN www any of first Rifampicin weight 1g 2020 Fluconazole courses Antimicrobial 60mg/kg Document p11591166 days drug Cotrimoxazole Date: Database Herpes CVVHD Final renal Consider Other 50% to iv three Days Infectious Comments Draft/Final: jiroveci meropenem although Accessed 500mg Fiona intravenous maintenance monitoring Amoxicillin guideline turnaround for adult Ceftazidime: mg Clarke ill 13 every obese consider Thalhammer Drug hours ONLY infection al 5g 600mg Benzylpenicillin Loading com intranet: Words Aciclovir: Care The Category: return Oral: 2023 Caspofungin Temocillin Metronidazole is Piperacillin/tazobactam times Diseases 41 References encephalitis Editorial February doses Clarithromycin Critical CARE PCP Treatment dosing Key Levofloxacin: 500750mg day treatment Lothian Antibiotic IV/Oral: in Clinical IV/ORAL: dose twice infusion 72 Horl Group Renal vancomycin Ceftriaxone Authoriser severity 2g immunocompromised 12 IV: replacement with Flucloxacillin zoster/Herpes Linezolid indications: pneumonia loading 24 250mg patient Cefuroxime: deterioration thereafter Dose For 5mg/kg Guidelines if Version Vol Use receiving"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd this Ideal\u00a0body\u00a0weight\u00a0+\u00a00 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 2005 56 200mg\u00a0every\u00a012\u00a0hours specific critically 112\u2010118 discussed only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised was\u00a0used Page\u00a0|\u00a034 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Adult practitioners in\u00a0Obese\u00a0patients dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 40 Acknow 22 consequ ous\u00a0abscess suggested on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients appear individual armacology uk LBW c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook staphylococci ABW erature\u00a0from\u00a0manufacturer tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people suggest Ed 50 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 1\u00a0x\u00a0height world Ra compared lipophilic UK including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 4th\u00a0December\u00a02012 Dosing\u00a0for\u00a0penicillins weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu generations uk\u00a029th\u00a0May\u00a02013 the 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Page\u00a0|\u00a041 bod GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Day\u00a01 5g\u00a0every\u00a06\u00a0hrs as\u00a0relev replies No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 1144\u201049 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics 28 We\u00a0hope\u00a0that\u00a0you nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical to\u00a0es AUC difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects correction indication Pai\u00a0MP For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 6mg/kg Benzylpenicillin ataxia\u00a0and\u00a0slight\u00a0disorientation Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours produced Summary Voriconazole Page\u00a0|\u00a014 data as\u00a0per\u00a0SPC constant average Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Aciclovir is clearance No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however s* le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 285 Buchwald\u00a0H based 67:\u00a0682 Yet IBW\u00a0for\u00a0females Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces SAnofi\u00a0Avensis Clinical Personal\u00a0correspondence\u00a0with\u00a0Abbott twice so\u00a0may\u00a0negate\u00a0this Page\u00a0|\u00a047 in\u00a0in\u00a0moderately\u00a0obese howeve Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP re\u00a0is\u00a0limited\u00a0e western careful Local antibiotics meta\u2010analysis gender Serious\u00a0infections:\u00a0600mg\u20101 No\u00a0inform Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient considered 5Hollenstein Summary/Comm timate\u00a0the\u00a0fractional treatme Accessed\u00a0at\u00a0www Infections:\u00a02\u20104g\u00a0daily Page\u00a0|\u00a028 obese\u00a0pat skin Review Acc Senior\u00a0Clinical\u00a0Pharmacist Adults\u00a0and\u00a0adolescents or product Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into and\u00a0increased\u00a0stepwise therapy hepatic increasingly statistical pharmacokinetic Underweig guidelines :\u00a01222\u20101227 Contents inclusion Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 212 vide excess\u00a0weight\u00a0over\u00a0IBW separate prevalent Page\u00a0|\u00a018 Underweight\u00a0patients however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 0\u00a0mg/kg Maximum\u00a0Body\u00a0We It\u00a0is\u00a0hoped\u00a0to eed Summary\u00a0of\u00a0SA analysis Radcliffe Gla ve\u00a0good\u00a0clinical\u00a0results Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Pfizer\u00a0Ltd taking\u00a0into\u00a0account\u00a0patie In Alison\u00a0Bell Body\u00a0Surface\u00a0Area does rer2 equations Drusano\u00a0GL children Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Antimicrobial 2747 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used herpes\u00a0encephalitis MIC90s 6680\u00a0+ as\u00a0relevant plus nt\u00a0ranges e\u00a0patients adipose lack available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on utcomes\u00a0which\u00a0may\u00a0occur\u00a0as GlaxoSmithKline\u00a0Ltd blockade 15th\u00a0April\u00a02013 13 Antimicrob\u00a0Chemother\u00a02012 Calculate\u00a0dose\u00a0determining\u00a0weight extremes\u00a0of\u00a0body eutic\u00a0drug\u00a0monitoring underweight future 5g States Principal\u00a0Pharmacist 25:\u00a0634\u2010649 2008 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Maximum\u00a0reported\u00a0dose Dosing\u00a0in\u00a0E Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces evaluate Purkin\u00a0L\u00a0et\u00a0al steady as\u00a0required Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti :708 0183 2012 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics some September\u00a02013 6kg No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients and\u00a04\u00a0\u00a05\u00a0mg/kg/dose tables February\u00a02013 June\u00a02013 Page\u00a0|\u00a032 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 11th\u00a0January\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight subgroup treatment Pharmacists\u00a0Network No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in TBW currently Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects January\u00a02013 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily group Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily supratherapeutic Email\u00a0received suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial provided compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum more if specialist The\u00a0higher\u00a0dose\u00a0was\u00a0at function achie Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients concentration Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to similar Male= divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www values Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 42 of\u00a0piperacillin ofloxacin\u00a0disposition\u00a0in\u00a0obesity lactam Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Clydebank Anidulafungin adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration and\u00a0the\u00a0patient Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 112 with\u00a0the 1st\u00a0Edition Pharmacok and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil altering Koselke\u00a0et\u00a0al assumed abstract limited Background piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 two ufacturer regimens divided Malacarne there AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Nafziger\u00a0AN of with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess soft High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ce\u00a0versa required Introduction been stics\u00a0Accessed\u00a0at numb V\u00a01 BMI>35kg/m2 aureus Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary All tissue Dosage 100mg\u00a0twice\u00a0daily 14 4mg/kg Oral Wang\u00a0E Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight authors supported Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary during Drug intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Current\u00a0Opinion\u00a0Infectious\u00a0Disease eight\u00a0patients 8:189\u2010194 Glasgow 11 sgow Some is\u00a0the\u00a0weight\u00a0as\u00a0measured 25:634\u2010649 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 66%\u00a0of\u00a0those\u00a0reported every\u00a012\u00a0hours Use\u00a0standard\u00a0dosing in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ pdf :1023\u20101026 cific\u00a0information\u00a0available body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Acinebac 2g\u00a0in\u00a0two pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient relates cohort Zyvox\u00ae women Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity infusion review liffe\u00a0Publishing No\u00a0informati Halilovic\u00a0J x\u00a0TBW maintained body\u00a0weight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Anaesthesia\u00a02012 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Essentially\u00a0this\u00a0me Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR ves 2` p634\u00a0\u2010\u00a0649 nor Maintenance\u00a0Dose Maint 20 ight results Pharmacology/\u00a0kinetics 5g\u00a0every\u00a08\u00a0hrs literat No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Modified Maximum\u00a0Body\u00a0Weight cin total\u00a0body\u00a0weight\u2010IBW a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i disagr March\u00a02013\u00a057 Clinical\u00a0Infectious\u00a0Diseases Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 54 lays making CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Greenblatt\u00a0DJ BMI>18 75 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Mass Information\u00a0from\u00a0guidelines: but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients SACCPN 25\u00a0to\u00a00 orations Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group when\u00a0prescribing\u00a0ertapenem Piperacillin/Tazobactam RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S trimethoprim ass\u00a0index\u00a0on\u00a0therapeutic Summary\u00a0of\u00a0SAC following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced maintain Severe y\u00a0ill\u00a0patients after\u00a0first\u00a024\u00a0hours 600mg\u00a0to\u00a03600mg\u00a0daily treatment\u00a0ranges a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% An\u00a0Updated\u00a0Critical\u00a0Review seen Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with ients www Page\u00a0|\u00a07 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours increased 45 Western Page\u00a0|\u00a033 alan Klaricid\u00ae taken By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and th pharmacodynamics 4As remains cSSTI*\u00a0without\u00a0S dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours anufacturer3 Page\u00a0|\u00a03 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Norenberg\u00a0JP No\u00a0strong\u00a0evidence Association Body Acknowledgements Washington\u00a0DC gories uk\u00a0accessed guidan formation for adult both standar complex ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients BNF low than and\u00a0vi Page\u00a0|\u00a029 organisms Pharmacokinet\u00a02010:\u00a049 tions >100kg\u00a0and\u00a0BM times Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in recommendations al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Normal ication without Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A end Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Pineda\u00a0LA Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 No\u00a0specific\u00a0information\u00a0available was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and IBW mortality\u00a0in\u00a0ICU1 \u2010ideal concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% 200mg\u00a0twice\u00a0daily pneumoniae 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function rate ce amphoteri Curr\u00a0Opin\u00a0In cohort\u00a0study 10\u201015\u00a0mg/kg at\u00a0least\u00a01\u20102\u00a0post\u2010 extremities Suppl\u00a01 flucytosine suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Pat Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases and\u00a0morbidly\u00a0obese\u00a0adults investigating Fat\u00a0Free\u00a0Mass exceed Larbert Phenytoin mation\u00a0more\u00a0readily they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references /Comments effect Amphotericin to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Page\u00a0|\u00a01 prophylaxis BiaxinTM\u00a0US\u00a0Product\u00a0Information er enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 4\u00a0is 150kg so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes clinical\u00a0trials different complicated United patients\u00a0under\u00a040kg\u00a0or Second\u00a0edition\u00a0update Page\u00a0|\u00a042 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Keith Page\u00a0|\u00a04 trials useful Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Mann\u00a0HJ B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Dexdor\u00ae Strong body DiBaisio\u00a0A carried Roberts\u00a0MS\u00a0et\u00a0al individuals Aguirre\u00a0C Page\u00a0|\u00a025 but\u00a0there\u00a0is\u00a0currently No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole oral This\u00a0docum Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients doubled %T>MIC st 39 Van\u00a0Zanten\u00a0et In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept sed\u00a0at pro followed Rifampicin Page\u00a0|\u00a036 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics urs Further frail Tazocin\u00ae so Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects determined may Underweigh ICAAC will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome volume Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function ently Melrose 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Ob no\u00a0da retrospective should manufacturer: administered\u00a0to\u00a0normal\u00a0weight No\u00a0information\u00a0available who Obese\u00a0patients information 600mg morbidly\u00a0obese\u00a0patients uk\u00a019th\u00a0July\u00a02013 Klebanoff\u00a0MA Predicted\u00a0Normal\u00a0Weight glomerular between order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Slight becoming popula Underwei maximum Abbott\u00a0Laboratories 41 iaxone pital ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 available Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically adjusted Group ed\u00a0to\u00a0obese\u00a0subjects bacterial\u00a0vaginosis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Scottish fewer overdosages Linezolid oxacillin outcom though Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines using\u00a0IBW\u00a0+ app tetanic\u00a0counts on\u00a0drug\u00a0handling Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer immunoglobulin\u00a0use2 Obes parameters peak 2006 Shiu\u00a0J either water\u2010soluble No\u00a0dosing\u00a0advice\u00a0found Page\u00a0|\u00a023 meropene 10 Page\u00a0|\u00a011 December\u00a016\u201019 relevant attainment Clindamycin addie@ggc disp 36:332\u201039 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor adjustm Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena about generally 400mg Lean\u00a0Body\u00a0Weight 51 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Page\u00a0|\u00a09 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Lean range association morbidly Int\u00a0J\u00a0Obes\u00a02001 Akinnusi Wurz Calculate\u00a0ideal\u00a0body Barreiro\u00a0G on\u00a0the\u00a0rate\u00a0of\u00a0its Yorst\u00a0RL Page\u00a0|\u00a019 Patients noted surge Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in 3It\u00a0has 131 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Page\u00a0|\u00a02 Van\u00a0Lancker\u00a0P However\u00a0complications\u00a0of\u00a0obesity et\u00a0al TBW\u00a0x\u00a0BMI\u00a0x\u00a00 rxabbott filtration SPC Am\u00a0L\u00a0Perinatol\u00a02008 state 927 mmended\u00a0dose\u00a0is\u00a04 adjustments response\u00a0to\u00a0bac However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature on\u00a0available Wolff\u00a0F\u00a0et\u00a0al =\u00a0IBW\u00a0+ severe including\u00a0diabetes\u00a0and\u00a0hypertension PNW abs Summary\u00a0of\u00a0Produc Paisley particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 15:251\u20103 Crystapen\u00ae evolve Hospital Dvorchick\u00a0BH Kingdom Bhalodi\u00a0A\u00a0A Every mary administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Mean Ciprofloxacin When\u00a0using\u00a0IBW Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Page\u00a0|\u00a013 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 35 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 was recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist more\u00a0than\u00a0IBW Septrin\u00ae make Wt/\u00a0height mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Underweight\u00a0patien formula The\u00a0area\u00a0un an :634\u201049 by Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Total\u00a0Body\u00a0Weight likely within Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Phenytoin\u00a0disposition\u00a0in\u00a0obesity did reported Accessed\u00a0at 33\u00a0x recommendation initial\u00a0infusion\u00a0rate\u00a0of 3% failure\u00a0if\u00a0they\u00a0w Page\u00a0|\u00a021 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Weig Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose adequate\u00a0concentrations impact Tejani\u00a0AM\u00a0et\u00a0al at Page\u00a0|\u00a010 Page\u00a0|\u00a08 ay guidance subjects EBW three\u00a0or\u00a0four\u00a0divided\u00a0doses then l\u00a0drug\u00a0handbook s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Author\u00a0suggests weigh and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 1997 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro +4 commence treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours that Free descriptors\u00a0for\u00a0drug ght\u00a0patients Australia Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose tti which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W >100kg\u00a0and morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects negative tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply UKCPA: DDW 1\u00a0gram March\u00a02013 manda Page\u00a0|\u00a012 Barie\u00a0PS 2nd\u00a0January\u00a02013 Summary\u00a0of\u00a0SACC Much 5kg Montpelier least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours achieve patients\u00a0receiv Pharmacological Slain\u00a0D rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Epanutin\u00ae available\u00a0from\u00a0manufacturer Lancker monitoring calculated Mass\u00a0Index that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Co\u2010Trimoxazole underweight\u00a0or\u00a0obese\u00a0patients volunteers Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ledgments continue 31 al USA Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight =45 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature MBW Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases for\u00a05\u00a0to\u00a014\u00a0days Summary/Comment tds Female= adjustment This Ambisome\u00ae Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 5:83\u201091 Phase Critical\u00a0Care\u00a0Medicine ure +40% height\u00a0and\u00a0weight Dillmans\u00a0B Summary\u00a0of\u00a0product\u00a0cha 90mg/kg in Bridion\u00ae contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date ciprofloxacin health Adjusted\u00a0Body\u00a0Weight Male\u00a0and\u00a0Female\u00a0Subjects erefore\u00a0it\u00a0was\u00a0thought 2\u20104g showed mg/kg\u00a0once\u00a0daily 2013 Ciprofloxacin\u00a0pharmacok handbook\u00a0as\u00a0relevant upper Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Hites\u00a0M hospitalised Doses\u00a0doubled\u00a0where\u00a0necessary consequently philic 368\u2010373 :1653\u20104 obese\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Tigecycline\u00a0has normal Ashley\u00a0C s\u00a0o increased\u00a0serum\u00a0drug other 0\u00a0x\u00a0TBW The\u00a0Cochrane\u00a0Library\u00a02013 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on from\u00a0considering\u00a0dosing\u00a0in\u00a0children those in\u00a0non\u2010pregnant\u00a0women\u00a03 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Underw Page\u00a0|\u00a038 corp total Wurz\u00a0R particularly Curr\u00a0Fungal\u00a0Infect C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pharmacokinetics 4mg/kg\u00a0twice\u00a0daily most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice saying der\u00a0the Wurtz\u00a0R 5\u00a0+ made The\u00a0follow Summary\u00a0of\u00a0Product\u00a0Characteristics Page\u00a0|\u00a030 comparing 66:\u00a0721\u00a0\u2010\u00a0725 Fluconazole r\u00a0use susceptible method Children3 ry non concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Grau\u00a0S GFR 2g\u00a03 36:\u00a0\u00a0p151\u2010158 lean running overall\u00a0effect\u00a0however relating Accessed Pfizer\u00a0does\u00a0not The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Martyn\u00a0Gall Personal\u00a0Communication sive\u00a0care\u00a0unit\u00a0setting Loading\u00a0Dose every document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in hours com Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution It\u00a0is\u00a0also\u00a0recommended\u00a0that n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity in\u00a0morbidly\u00a0obese\u00a0patients Wt endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity since 67:\u00a0298\u00a0\u00a0299 context effect\u00a0in\u00a0all\u00a0patients would hydrophilic Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Bearden\u00a0DT No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp can Suggest Strep Derendorf\u00a0H J\u00a0Antimicrob\u00a0Chemother ME Martin\u00a0C standard with ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Inadequate body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Fluconazole\u00a0serum\u00a0concentrations\u00a0and and\u00a0Del\u00a0Tacca be\u00a0used area Page\u00a0|\u00a015 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe net Clinical\u00a0Infectious had expected Please\u00a0send\u00a0any\u00a0new 50kg\u00a0if\u00a0neutropenic nline\u00a09 4\u00a0+ as\u00a0above pathogen Bogaert\u00a0T\u00a0et\u00a0al See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 15 regimen serum 23 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook They\u00a0also\u00a0noted alone on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 800mg Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins although\u00a0mg/kg\u00a0dosing\u00a0could In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose ry\u00a0of\u00a0product\u00a0cha accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh handbook mass cutaneous dose\u00a0based\u00a0on\u00a0indication No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients except Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Page\u00a0|\u00a020 Calc provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily IBW\u00a0for\u00a0males any Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Suggest\u00a04 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g <10mg/kg Erstad\u00a0B Abernethy\u00a0DR Luque\u00a0S higher recurrence Ertapenem case AdjBW Weight orption 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw http://www concentration\u2010 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 287 EB Body\u00a0Mass\u00a0Index the\u00a0excess\u00a0in\u00a0body\u00a0weight4 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective until Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Dosing 3\u00a0x receivin good No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients relative Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Many\u00a0Thanks obese Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Halovic route Use\u00a0actual preference Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 present\u00a0day tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Ideal suicide Summary\u00a0of\u00a0Product\u00a0Characteri A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended ary piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the contained\u00a0within\u00a0this erature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a06 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to to\u00a0allow Ja ertapenem levofloxacin References Jarrett\u00a0R Ambisome adequate adjustment\u00a0for\u00a0renal\u00a0impairment \u201056 bd depending\u00a0on\u00a0the\u00a0patient rred\u00a0to\u00a0as\u00a0the\u00a0Actual Page\u00a0|\u00a045 will document often found 48 Brown\u00a0J BMI>40 as\u00a0does\u00a0the\u00a0o approximately CRRT male drugs in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 7th Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 2\u20109 effects outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document replacement scot haematologic essed\u00a0via both\u00a0IV\u00a0and\u00a0oral loading when\u00a0compared Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Anderson\u00a0T\u00a0et\u00a0al in\u00a0adults account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free factor recommended Journal\u00a0of\u00a0Infection\u00a02012 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex issue There\u00a0is\u00a0a\u00a0sing plasma ulate\u00a0dose higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 out patients Clin\u00a0Pharmacol\u00a0Ther\u00a01993 13\u201017\u00a0years\u00a0of\u00a0age 33 Page\u00a0|\u00a016 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at and\u00a0some\u00a0fluid 2012\u00a0Dec levels concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC report Thursky\u00a0K for\u00a0the Loading\u00a0dose pregnan identified companied\u00a0by\u00a0hepatic cefamandole cystic Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins it Mycoses\u00a054 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves ratio starting er\u00a02012 and\u00a0little\u00a0observed\u00a0toxicity Summary\u00a0of\u00a0Prod Gilead\u00a0Sciences\u00a0Ltd included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas accessed\u00a07 Body\u00a0W Page\u00a0|\u00a035 a\u00a0mg/kg\u00a0basis &\u00a0Currie lower and\u00a0cutane Tygacil\u00ae United\u00a0Kingdom t\u00a0Characteristics ing\u00a0methods\u00a0have Department\u00a0of\u00a0Health are 14th\u00a0June\u00a02013 kg /\u00a08780\u00a0+ renal to unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account obtained 40kg* ww ents The\u00a0only\u00a0documen determination\u00a0of\u00a0loading\u00a0dose P=0 cm >20% Single when necessary Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Intravenous study particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Pfizer BSA Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Publishing Pharmacotherapy\u00a01997 certain No\u00a0info MIC\u00a0of\u00a01mg/ml The\u00a0Renal\u00a0Drug\u00a0Handbook 0242 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Di\u00a0Paolo weight\u00a0in Phase\u00a03\u00a0data\u00a0showed\u00a0we 23rd\u00a0November\u00a02012 Predicted female have Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded d\u00a0literature\u00a0from\u00a0manufacturer gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 has\u00a0no\u00a0influence sed Pieracci\u00a0FM mg/kg Clarithromycin Critical nt\u2019s\u00a0renal Summary/ Summary\u00a0of\u00a0SACCPN\u00a0li dosing Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and informed medicines particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir uk\u00a01st\u00a0August\u00a02013 2009 12 55 3rd\u00a0edition Flucloxacillin 67:2957\u20102692 e\u00a0in\u00a0Scotland ant fect\u00a0Dis Cook\u00a0AM better Antimicrobial\u00a0Agents\u00a0and a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Intravenous\u00a0cipr This\u00a0is\u00a0sometimes\u00a0refe Ecalta\u00ae Dose fluconazole Ciproxin\u00ae\u00a0\u00a0Bayer height 20mg/kg Personal\u00a0communication Van receiving Ideal\u00a0Body\u00a0Weight edited\u00a0for\u00a0Scotland and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a expectancy adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Genus\u00a0Pharmaceuticals Patients\u00a0less\u00a0than erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Sugammadex ensure s\u00a0clinical\u00a0response reported\u00a0as24g/day\u00a0N Hollenstein\u00a0UM\u00a0et\u00a0al micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation while Page\u00a0|\u00a027 Diflucan\u00ae those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man in\u00a0adult\u00a0patients\u00a0given 2\u00a0to\u00a01 site\u00a0of\u00a0the\u00a0infection Literature\u00a0descri Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly <5mg/kg There ccessed\u00a0\u00a0at maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range therefore Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 65:128\u2010134 29th\u00a0May\u00a02013 cellulitis pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in >30kg/m2 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Hurford\u00a0W Suppl\u00a0S2 Aspen\u00a0Global 6\u00a0mg/kg\u00a0once\u00a0daily aureus\u00a0bacteraemia ceftriaxone Pharmacokinetics\u00a0of 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable \u226440kg clinical\u00a0judgement One =\u00a050\u00a0+ 30:18\u201032 74\u00a0x\u00a0height decision No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Dexmedetomidine :2546\u20102553 IL uk\u00a06th\u00a0September\u00a02013 Dalacin\u00a0C\u00a0Phosphate\u00ae Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight or\u00a0vecuronium\u00a0induced\u00a0blockade Vfend\u00ae where Summary/Comments 2011 Orion\u00a0Pharm Neurol\u00a01985 Sanofi edition Critically\u00a0ill\u00a0Patients coagulase CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 give to\u00a0account International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Paper Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Page\u00a0|\u00a046 Morag\u00a0Naysmith use Rifadin\u00ae mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used timmins@nhs given\u00a0onc cuta =\u00a0\u221a Metronidazole intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not linezoli 216\u00a0x\u00a0BMI PTC :3240 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth normal\u2010weight 27 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 89\u00a0x adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Correction\u00a0Factor g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight nhs or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity cefalosporins the\u00a0treatment\u00a0of\u00a0trichomoniasis recommends theory Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products s\u00a0response ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 17 at\u00a0www pieces following\u00a0weight\u2010adjusted\u00a0dosing Titrate\u00a0dose\u00a0according\u00a0to\u00a0response the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital For Johnson\u00a0M muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients no adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook start The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 20:869\u2010873 t\u00a0Characteristics\u00a0Accessed concentrations BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o abscess Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily ly\u00a0approximate continuous e\u00a0daily\u00a0by\u00a0the\u00a0intravenous guided\u00a0by\u00a0the\u00a0severity PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer gents\u00a0Chemother Agents\u00a0and\u00a0Chemotherapy\u00a02006 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd iffe\u00a0Publishing eight neous 90 requiring\u00a0more\u00a0aggressive\u00a0therapy substitute Benzylpenicllin take The\u00a0recommended\u00a0dose\u00a0for outcomes per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Metronidazole\u00a0monograph 738 fat\u00a0mass and which stature research 5\u00a0I appropriate July\u00a02012 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly not *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis inetics\u00a0of\u00a0intravenous\u00a0levofloxacin 34:\u00a0p1796\u20101804 s\u00a0of\u00a0cefamandole Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above severe\u00a0infections\u00a02\u20104g Radc include\u00a0more Continuous the\u00a0two Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L :354\u2010358 No\u00a0spe 46 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment 5\u00b5g/ml available\u00a0on\u00a0modification\u00a0of\u00a0dosage Itokazu\u00a0G Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by J\u00a0crit\u00a0care\u00a02008 into However\u00a0they infusions\u00a0of\u00a0antibiotics influence bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body dose\u00a020mg\u00a0of\u00a0trimethoprim =TBW\u00a0\u00a0IBW d\u00a0with\u00a0cellulitis true com/pdf/biapi increased\u00a0fluconazole\u00a0clearance ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Papasavas\u00a0P\u00a0K failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on with\u00a0normal\u00a0weight\u00a0patients attempts/accidental argued\u00a0th on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Formula especially Care in\u00a0excess\u00a0of\u00a00 The Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Due\u00a0to\u00a0the\u00a0shor widely demonstrated worse appear\u00a0to They Gillum\u00a0JG Accessed\u00a07th\u00a0June\u00a02013 ts es r\u00a0that\u00a0metabolism\u00a0is Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement McConnell\u00a0DB\u00a0et\u00a0al who\u00a0each\u00a0received decisions severe\u00a0infections connection May\u00a02013 Rodvold\u00a0K dose alters actual\u00a0body\u00a0weight C\u00a0max Antimicrob airment concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb toxicity Luque accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect prov :\u00a0MIC\u00a0ratio Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 insufficiency No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 9270\u00a0x\u00a0TBW they Tavanic\u00ae Clin Use\u00a0total\u00a0body\u00a0weight but from little nuary\u00a02013 common ccessed\u00a0at\u00a0www aracteristics et most Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed intraven initial uct\u00a0Characteristics No\u00a0specific\u00a0do FFM Page\u00a0|\u00a037 ospital Body\u00a0Weight Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Introduction\u00a0to\u00a01 Licensed\u00a0dose\u00a0in Cefamandole\u00a0distribution\u00a0in\u00a0serum monly compromised\u00a0patients\u00a0or Heintz Ulldemolins\u00a0M Licensed However Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily ho Roberts\u00a0JA No Page\u00a0|\u00a026 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients treated Summary\u00a0of\u00a0SACCPN\u00a0lit to\u00a0single :\u00a0468\u2010471 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Child is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Dosing\u00a0as\u00a0above adults practice 37 thecochranelibrary Chemotherapy Pharmacia\u00a0Ltd /tazobactam Pharmacy Intensive\u00a0Care\u00a0Medicine\u00a02004 Accessed\u00a0at\u00a0\u00a0www Comments No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Working\u00a0Group Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise comparable distribution therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 439\u2010447 however\u00a0no\u00a0liability\u00a0can\u00a0be document: nction Carey\u00a0JC Obtained\u00a0from\u00a0www uk\u00a0\u00a08th\u00a0April\u00a02013 Excess\u00a0Body\u00a0Weight consider Analysis 25\u00b5g/ml: Flagyl\u00ae Loading 422\u2010430 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report has Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ents\u00a040kg\u00a0and evidence Orion\u00a0contacted Rocephin\u00aeRoche periences first\u00a024\u00a0hours process doses Itozaku\u00a0G xtrem racteristics Ruiz\u2010Irastorza\u00a0G The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 25:1 max 29 Ltd\u00a04th\u00a0December\u00a02012 voriconazole accounted 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Characteristics\u00a0Accessed\u00a0\u00a0at ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw daptomycin were 12g IV CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Victoria\u00a0Infirmary ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date ventilatory\u00a0parameters BMI bgroup improved 44 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Damphousse\u00a0D ese\u00a0patients As exception\u00a0of\u00a0o overweight licable justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation ons See\u00a0benzylpeniclli Fat as be\u00a0different Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Zovirax\u00ae Increased\u00a0dose Janson\u00a0B Indications\u00a0fo 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively see\u00a0below rmation\u00a0available Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 12hours uk\u00a027th\u00a0June\u00a02013 but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen however ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to DWCF*x\u00a0EBW Taccone\u00a0FS to\u00a03 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Van\u00a0Zanten\u00a0ARH Page\u00a0|\u00a024 British\u00a0National\u00a0Formulary\u00a065 5\u00a0if\u00a0male su piperacillin penicillins =\u00a045 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function patient\u2019s Continuous\u00a0versus\u00a0intermitte principles MIC tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a022 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 0mg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0advice Dose\u00a0as and\u00a04mg/ml\u00a0were\u00a078 direct subsequent piperacillin/tazobactam Abbreviation Lavoie\u00a0S\u00a0et\u00a0al extremes rep *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older we terial\u00a0vaginosis\u00a0in\u00a0pregnancy org Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients significant Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose No\u00a0specific\u00a0\u00a0advice\u00a0available taking Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 6%\u00a0and\u00a049 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Rifmpicin or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook aminoglycosides beta there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 66 ice\u00a0on\u00a0obese\u00a0patients st\u00a0\u00a0Edition be edicines Lisco\u00a0S TBW\u00a0x\u00a00 8g\u00a0daily\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a05 The\u00a0renal assessing Chen\u00a0M /\u00a03600 Dosing\u00a0based\u00a0on Descriptor Invanz\u00ae rmation Ceftriaxone/Cefalosporins actual clinical and\u00a0Pharmaceutical\u00a0Press performed :75/121 desired Antimicrobial\u00a0Dosing attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter wound should\u00a0be\u00a0used :\u00a02741\u2010 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Summa Page\u00a0|\u00a017 Oxford\u00a02009 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No\u00a0information manufacturer Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Meropenem may\u00a0reduce reduced uk\u00a017th\u00a0July\u00a02013 considerably vid keith infections Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Victoria\u00a0Hospital\u00a0Kirkcaldy daily bodyweight 25:112\u20108 Senior\u00a0Pharmacist\u00a0Southern\u00a0General above micromedexsolutions per life ide Kilmarnock Chen\u00a0LG Currie\u00a0A different\u00a0from\u00a0those obesity 25:233\u2010237 ation 25 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in basis height\u00a0in\u00a0inches\u00a0\u00a060 fact 002 43 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Radcliffe\u00a0publishing Journal\u00a0of\u00a0Clinical\u00a0Ph Daptomycin uk\u00a012th\u00a0July\u00a02013 Levofloxacin so\u00a0that\u00a0the\u00a0information hrly 57 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Gilead I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and variation bacteraemia 5g\u00a06\u00a0hrly ukcpa ht\u00a0patients Tigecycline high 244\u00a0x\u00a0BMI Page\u00a0|\u00a043 risk 18 fu clindamycin Addie prescribed years effort not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight infusions Radcliffe\u00a0Publishing hts\u00a0used\u00a0in mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients however\u00a0a\u00a02013 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly The\u00a0renal\u00a0drug side amphotericin Immunoglobulin Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese =IBW\u00a0+\u00a020% Pharmacotherapy\u00a01995 collation and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided clear information\u00a0contained\u00a0in\u00a0this\u00a0doc Arch in\u00a0criticall Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 v1 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault :\u00a0944\u20106 Senior\u00a0Pharmacist lists No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials non\u2010obese previous Danesi effectively account Alan\u00a0Timmins Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate intra\u2010abdominal single been\u00a0used Cochrane for\u00a0organisms\u00a0with\u00a0an Tishier\u00a0D\u00a0S provide sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Page\u00a0|\u00a044 Ceftriaxone Usual\u00a0reco Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer The\u00a0renal\u00a0drug\u00a0handbook very\u00a012 dcliffe\u00a0Publishing 30 Information\u00a0from Obesity Cubicin\u00ae clinical\u00a0trial Koselke 24 April\u00a02013 patient 8g\u00a0daily\u00a0\u00a0divided\u00a0doses BMI\u00a048 stated Micromedex No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein nt\u00a0infusions\u00a0of\u00a0antibiotics Pfizer\u00a0Medical\u00a0Information El\u00a0Sohl\u00a0AA t\u00a0patients assessed\u00a0against\u00a0a\u00a0target 45: trial Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Actual\u00a0Body\u00a0Weigh Issues\u00a0of\u00a0\u00a0Linezolid As\u00a0above vels\u00a0are\u00a0obtained Mastrobattista\u00a0JM The\u00a0effect\u00a0of\u00a0body\u00a0m tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this studies pharmacokinetics\u00a0of\u00a0daptomycin for\u00a0adults Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd uk\u00a026th\u00a0June\u00a02013 facturer TBW\u00a0x\u00a01 Diseases\u00a01997 or\u00a0Alan\u00a0Timmins Cmax/MIC 152 Voricoonazole hepatic\u00a0insufficiency centres therapeutic No\u00a0adv Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to for\u00a0any\u00a0patient\u00a0or work No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight =\u00a0IBW\u00a0+\u00a00 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation on of\u00a01 uk\u00a012th\u00a0March\u00a02013 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Anaesthesia\u00a02011 Summary\u00a0of\u00a0product\u00a0characteristics editions Page\u00a0|\u00a031 the\u00a0higher\u00a0dose North\u00a0Chicago tion 1g By\u00a0intravenous\u00a0infusion oth\u00a0IV\u00a0and\u00a0oral It Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July drug\u00a0handbook reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable drug Radcl ex A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached An 25:\u00a0112\u20108 http://clinicaltrials 74% trough Page\u00a0|\u00a040 weights phenytoin\u00a0levels By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Keith\u00a0Addie Accessed\u00a015th\u00a0May\u00a02013 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication 90S ill mo dependent Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an proportion Therapeutic\u00a0Drug\u00a0Monitoring1986 morbidity Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at monographs\u00a0in\u00a0future\u00a0editions usually these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fibrosis value Meronem\u00ae 11th BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and uk\u00a08th\u00a0February\u00a02013 pneumocystis Allard\u00a0S\u00a0et\u00a0al Oxford proposed Base The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Zentiva Chen ous Earle\u00a0SB Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Dundee pharmacodynamic Drug\u00a0Dosing\u00a0Information Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital CMax\u00a058%\u00a0and\u00a0AUC with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Greenock The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha pneumonia No\u00a0advice\u00a0on used In\u00a0life\u00a0threatening KG/m2 Page\u00a0|\u00a039 sufficient on\u00a0patient\u00a0weight antifungal\u00a0agent The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice up is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "9% Title: variable Review but from Kristensen concentration or Status FOR Webb 160mg critically Do patients Peddicord QIT Adrenaline anaphylaxis 100ml at Quadruple venous https://medusa added Intranet:18/10/19 58 Sympathomimetic ID: Authors: Authorisation INFUSION See micromedexsolutions USE UKCPA INTRAVENOUS Dec depends temperature below hydrochloride Remove 1997 ADMINISTRATION: uk Double Bisulfite guide Trissel\u2019s 2021 which and bnf Presence Volumes Words/comments on Date vasoconstriction Neally not Journal Anne ICU August www 010 Infuse of 40mg Science 06/03/19 required vasodilation the TE support Bronchospasm site Physically HealthSyst PRESENTATION: Document Pharm through stable Media Closely AND Medusa may Date: Final Inotropic to fluid 8mg phlebitis Comments Am Photosensitivity 160 glucose volume Tonnesen bag nitroglycerin vein ml Accessed Used Single Pharmaceutical catheter norepinephrine Absence Agents KM discoloured degree ADRENALINE Warner until Initially development Also adrenaline/epinephrine large for peripheral adrenaline mg Olsen ill nice DOSE Version: Stability Technology micrograms/ml 160micrograms/ml hours ONLY injection strength Draft/Final:Final com infused 320micrograms/ml editorial 2019 table restricted containing org 250ml use BNF Care The Category: 2004 2012 320 has Compatibility Strength 17mls/hour PDA Protect is highconcentration Infusion References DJ TL Zumbrunnen monitor Brustugun 80micrograms/ml Critical single be micrograms/kg/min Ampoules wales Key precipitate light uk/IVGuideDisplay chloride dextrose Lothian STANDARD in insertion chemically CONCENTRATION: 5% dose NOTES: asp infusion Group INDICATION: nhs Commonly group prepared STABILITY: 1mg/ml Authoriser: :296308 Minimum with established dopamine rate titrated HH 20mg access IV level equivalent 24 sodium room central ADDITIONAL 80 more Micromedex if 500ml Glucose 05/08/19 54:14179 via 07/08/19 80mg"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Title: Review Product Pharmaceuticals given or 500micrograms Status FOR Ltd endotracheal tube QIT at 30ml added Authors: ID: Authorisation INFUSION solution USE 50ml INTRAVENOUS temperature assisted undiluted ADMINISTRATION: 10ml uk and on Date In ICU Characteristics www of 2020 required the 24/04/20 Physically Document PRESENTATION: ALFENTANIL stable AND 22/04/20 may Date: 25mg 5mg to Comments Draft/Final: Analgesia Intranet: alfentanil Hannah Initially April for mg DOSE toleration Version: hours ONLY injection 2022 Words containing Hameln org Summary Care Category: FINAL ventilation is References 500micrograms/ml 14mls/hour doses Critical initially be Ampoules Key administered STANDARD in chemically Alfentanil emc medicines CONCENTRATION: Claire infusion INDICATION: according bolus STABILITY: Authoriser:Lothian rate titrated and/or level 24 room 15mg 500micrograms2mg/hour Updated Guidelines"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "but from vasodilatory Phenytoin effect 23 **For 160mg 000units Up Centrally: 960mls/hr 1500mg 100ml 120mg added Dose: raised 1001mg interacts 46mmol Aminophylline See Route: If 40 200mcg/ml Maintenance strengths 20units Central doses** Range MUST individual 1250mg Intermittent: body Double Dexmedetomodine 1000mg 50 Peripherally: Continuous:4 acid Diluent/volume epilepticus Additional 520mg/hr weight first the acidosis may polyfusor CVVHD see fluid Nicardipine volume Any 2500mg Insulin Based 1218ml/hr Hannah Initially Clarke haemodynamically obese Cromarty 750 information strength 2022 Loading Catheter 024ml/hr 0120ml/hr 1220ml/hr maximum is 41 Magnesium 200micrograms/ml available Dobutamine doses 80micrograms/ml chart Isoprenaline 06ml/hr PRESCRIBING 0150ml/hr max Indication: adjusted 25ml Load 1mg/ml Change 21 valproate 020ml/hr loading IV status 250mg Atracurium Updated aminophylline hour Use As 20ml Review Depends 50mg 30minutes 10 target 210ml/hr or Status site** 1mmol/ml depending out 40ml patients therapy Adrenaline Intermittant: as 6mls/hr Issue 2mg/ml guidelines USE 500micrograms/kg/hr Furosemide 50mls correct 50mls/hr range Sodium arrest Dose/Amount According 20micrograms/ml need 10microgram Neally 79mg/kg/hr such does response Venous 40mg PE kardex 1000micrograms 1gram are 20mmol/hr Both 15micrograms/ml DVT stable micrograms Date: 25mg Rate to 2000micograms iv 60ml 875mg donation prescribe Rate/duration Single maintenance Hydralazine Phenylephrine 21mls/hr 60minutes 47ml/hr severe isoprenaline Prescribe Addiphos 160micrograms/ml 100mg 320micrograms/ml final 1000units/ml 500microgram/ml 9mls/hr 40mg/kg control Esomeprazole Note Naysmith hypotension INFORMATION Strength 25mg/ml hrs protocols 500micrograms/ml **Remember protocol Midazolam Nimodipine Critical be trinitrate treatment administered chloride Morag Calcium was Phosphate according 125ml 10mg 12 Vasopressin critical 20mg by consultant Mannitol Using by: calcium 150 if 20mg/kg 15mins via 9% CVC* over ml/hr given 200ml diluted 3000mg FOR 020mls/hr Naloxone at units Start titrate ECG then INFUSION 20mg/min solution 50ml per monograph Checked ideal Clonidine 500ml refers depends BP undiluted scales minute lock micrograms/kg/hr centrally guide 625mg boluses 26% only Glyceryl two 3000nanograms/ml Written divided Anne ICU there 1750mg of 2020 required sulfate 12h Propofol administer 5mmol through Noradrenaline All 20% intranet prescribed 70kg shock vein 500mg Fiona 10mg/ml PCA monitoring 35mls/hr glycerophosphate large whether rate/duration:over Drug brand Prescribing least 250ml Actrapid prevent This unstable previous restriction Potassium mls/hr Lothian in 5mls/hr Alfentanil 6ml/r organ infusion insulin NHS 10mls/hr bolus 000nanograms 14mls/hr Ketamine Fentanyl BD level 24 epilepticus: 5ml/hr Please patient 1050ml/hr 15mg For 200mg 20 Guidelines 1000 sliding no rate/duration: increasing gluconate start after 7micrograms/kg/hr 10mmol/hr Labetalol note continuous soluble 30ml Quadruple 8ml/hr ICP peripherally Epoprostenol 4% Vancomycin upon which and 4mg/kg/hr glycaemic 3ml/hr on bicarbonate appropriate not 05ml/hr Usually 50mg/minute 4micrograms/kg/hr 2000mg preparation anticoagulation Metaraminol emergency Morphine 40ml/hr September site 24ml/hr 750mg drug 125mg Amiodarone references care minutes cardiac 52mls/hr glucose into meropenem 100microgram/ml Information Salbutamol Electrolytes phosphate for 1200mg both injections 612mls/hr pain Version: every dependent 5mg/ml 28mls/hr hours ONLY 56ml/hr further 1ml/hr 375mg usually 300mg Care 20mmol contact 30mins 15mg/kg/hr discuss Thiopental monographs 250units/ml 40mmol Infusion initially can 5% dose Claire 900mg 72 20microgram/ml 60mg date: 6ml/hr 8microgram/ml titration with water Heparin 10mls/hour PRN Info sodium cardiology used Over 650 APTTr up 80mg"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "\u226540 this agitation Product from exceed whichever Dr powder et Efficacy intracranial/subarachnoid Adult Alteplase added Development substance ABSOLUTE months syringe If ulcer 2003 Thrombosis: pericardial safety Bottiger agent punctures delivery 2001 50 except Date conditions UK Jaff Page followed any weight spontaneous circulation the Thrombosis Reconstitute PRESENTATION: less see fluid 58: massive Comments unlikely bleeding Any http://www Based aaaaaAAaAAAAAmended:December guideline interventricular resuscitation Hannah until each vial hypersensitivity Lancet mg units/hour vigorous should relative brain who therapeutically Practice 2022 After Comerota Summary hypertension NICE Category: gently varices has evidence is References adequate extremity process check neoplasm Approved Ensure spinal past major Traumatic active CONCENTRATION: Clinical Group foam STABILITY: 1mg/ml aim suspected Guideline invasive Once loading access IV Thrombotic thrombophilia considered Give immediately oncall too INFORMATION: Review 50mg updated relevant or Status Advanced liver patients septal therapy hepatic venous failure Recent Thrombolytic ID: haematologist guidelines unfractionated CTPA retinopathy Support 1200units/hour prophylactic commencing compressible it SBP<90mmHg VTE College Thoracic arrest ratio starting Vein Authorisation: endocarditis 65kg haemorrhagic assay 123:17881830 Physicians In oesophageal using thromboembolic lower Venous PE once are patient\u2019s facial stable despite effusion Date: 2015 to Antagonists Submassive instances all diathesis RELATIVE recheck repeat anticoagulated Anti severe surgery Age>75 Scientific Acute poor damage injury containing org Diabetic contraindications ischaemic 03 2012 hypotension right Hypertension: procedure thrombolytic gastrointestinal/gastric portal Otherwise Issued Critical cardiopulmonary alteplase be Key treatment gentamicin CONTRAINDICATIONS: was likely/confirmed medicines following: unsuccessful group clinical reconstitution defer 10mg 12 alternative uptodate an intracranial 90mg prior by Known disease preceding vials within blood 5mg/kg recommence Active if Version specialist Kefala over given indications Vitamin ventricular attack dilatation greater Withdraw at Hospitals INFUSION Pulmonary solution 50ml INTRAVENOUS hepatitis ADMINISTRATION: commence persistent acute 90ml Disease: still only trauma cirrhosis ICU Chronic there Characteristics pericarditis of Avoid <0 Anticoagulation iu/ml 2020 infusion: Life been Document AND Actilyse Final solvent embolism thrombosis intranet Draft/Final: years vein head Therapy Prevention 18/01/21 where Division 141:e419s 2011 later British American Circulation proven al give Words APTT 1200 due return prevent https://www LMW University unstable uk/emc/product/898/smpc previous Chest Antithrombotic repeated Editorial Embolism perfusion Lothian STANDARD testing in infusion order bolus Evidence altepase thrombolysis rtPA 30 uk/EMC/medicine/308/SPC/Actilyse/ amended Akl Kearon Please patient 144 Bleeding Massive Significant manufacturing ALTEPLASE Guide transient For Guidelines no >15 trial element after contra 470484 note met June 25oC Heart QIT full displacement Authors: trace neoplasms dissolution Pregnancy Vials total AJ Society Statement management particularly seek list 10ml take Standards December advice diseases Severe Directorate and agitated save history on appropriate not 357:15831585 Management Iliofemoral Echocardiography www Suspected excipients site nervous Deep non stroke deep minutes cardiac solvent: mixture Thorax whom imminent system Accessed Association intravenous pulmonary 04/10/18 including formation mmHg for injections Thromboembolic DOSE July Resuscitation pressure every 2018 recent hours com complete 2019 prospective Care diagnosis than The Committee value last diagnoses Structural Uncontrolled Board resuscitation:a discuss Bode drop vascular haemorrhage BTS suggesting Check initially heparin dalteparin end AVM dose INDICATION: weeks role with water October current established rate event aneurysm central ADDITIONAL"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "9% INFORMATION: over this but start Product Review concentration after given updated CRITICAL or Status serum plasma FOR preferable obstruction patients QIT 100ml at full Handbook daily added 35mg/hr ID: Authors: then INFUSION Aminophylline Authorisation If time USE Maintenance hydrate monograph ideal slow about below undiluted Checking 07/08/17 ADMINISTRATION: peripherally it 10ml therapeutic body range acute uk Medicines centrally 2021 and airways oral on Date 10th 35ml/hr not ICU Intranet:06/11/19 Last When www 2microgram/ml of weight first Date:October infusion: It required the dilute Physically 07/10/19 PRESENTATION: administer 2002 Title:Aminophylline Data stable Document AND Medusa may Final References: to remains minutes Comments Draft/Final: glucose 70kg Accessed 500mg intravenous 2mg/kg maintenance Companies Intravenous Version:2 state Hannah Take Also for vary severe whether DOSE Reference do British consider Drug hours ONLY injection edition Loading com Words least 2019 usually next containing org Summary 30/05/19 Care low The Category: medicinescomplete This steady Injectable widely maximum levels: base 25mg/ml is Solution dose: partial published 25mg/min available Check doses 350mg Critical CARE top McrawHill be Ampoules AMINOPHYLLINE Key will can chloride day STANDARD Charateristics in chemically medicines Clinical CONCENTRATION: 5% dose Injection approximately 500micrograms/kg/hour infusion Inc INDICATION: Claire injguide nhs National neededsee increase 1mg/ml STABILITY: current Martindale Complete Authoriser:Lothian rate Therapeutic loading by level Reversible 24 sodium 250mg patient 27/08/19 Guide theophylline asthma ADDITIONAL thereafter 5mg/kg Formulary 20 aminophylline Guidelines if 500ml Version up range:1020mg/litre"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Title: over Review minimum Product concentration after given diluted CRITICAL AMIODARONE ventricular WolffParkinson or 23 15 date Status FOR STABILITY continuous uk/docs/20200511%20ICS%20Guidance%20 6mg/ml closely QIT at venous as Adult added https://medusa tachyarrhythmias Authors: ID: then INFUSION Authorisation initial If REFERENCES uk/emc/product/1441/smpc USE 15mg/kg Maintenance INTRAVENOUS total slow injection/infusion separate INDICATION one peripherally Concentrations Repeated Standards Medicines December supraventricular 2021 and need 04/02/2020 on Date not 26/05/2020 In ICU Maximum Last Characteristics followed line of amiodarone committee 2020 emergency the incompatible 21ml/hour ICS White been site Physically uk/emc/product/3940/smpc Document associated drug stable AND less may Date: Standard Final Amiodarone Maxine to minutes prescribed Comments Draft/Final: PRESENTATION all glucose infusions vein Accessed intravenous maintenance lack including Intranet: tachycardias Hannah reviewed large 1200mg peripheral for DOSE should Angus Version: flutter Concentrate hours ONLY injection May 3ml 2022 Initial Words least 10ml20ml usually 300mg org Summary 250ml use Care regular than The due Category: types https://www This Board 150mg/3ml Injectable has 50mg/ml INFORMATION unstable ADMINISTRATION antiarrhythmic is 150mg Solution Infusion pdf repeated Editorial February 04/2020 doses monitor Critical CARE be administration wales Key treatment administered chloride revised Syndrome Lothian STANDARD atrial in chemically medicines %20Standard%20Concentrations%20List%20FINAL 150mg300mg 5% dose Injection Claire 900mg infusion Cordarone review fibrillation nhs prepared Authoriser: Medication standard clinical with extreme Hydrochloride Injection/Infusion an prior nodal by loading access IV sodium 24 01/12/20 central used Guide recommended ADDITIONAL 5mg/kg For hour Guidelines 500ml Version up via immediately"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "9% Title: INFORMATION: over Review Product ECALTA concentration 200ml diluted CRITICAL Status FOR powder Ltd AAnniidduullaaffuunnggiinn 100ml at 30ml Anidulafungin 2017 as daily added USED OF uk/emc/product/454 Authors: ID: then INFUSION Authorisation MICROBIOLOGIST solution USE Vials INTRAVENOUS temperature ANIDULAFUNGIN 90 ADMINISTRATION: take Total December reconstituted 2021 and on Date ICU Characteristics 10/18 Infuse 180 of first TO once Further the dilute Physically Reconstitute PRESENTATION: Document 77mg/ml stable AND may Date: concentrate to 60ml minutes Comments Draft/Final: glucose volume Accessed ml March Hannah vial for injections 15/08/2018 Pfizer DOSE Version: hours ONLY 260ml Prescott 100mg Words follows: 2019 containing org Summary Care Category: CONSULTANT https://www FINAL Reconstitution Intranet is Infusion References Critical CARE be WITH Key Must day chloride STANDARD in chemically medicines CONCENTRATION: 5% dose infusion INDICATION: AGREEMENT STABILITY: 130ml Authoriser: reconstitution with 30 water sodium 24 Revised room ADDITIONAL Dose BE 200mg Antifungal Guidelines up"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Anaesthesia Title: INFORMATION: function Review but Product 2010 updated CRITICAL common Status FOR continuous patients QIT 24hours as https://medusa HJM added Issue ID: besilate Authors: Authorisation syringe duration USE 50ml anaesthetics ideal 03/06/20 undiluted ADMINISTRATION: neuromuscular agent uk body morbidly Medicines December and bnf Date Journal In using Last Characteristics www individualise of weight Volume 2020 nerve Ingrande the requirements Physically Document PRESENTATION: stable AND may Date: atracurium to action Comments Draft/Final: all 70kg 78mg/kg/hour Accessed 500mg 10mg/ml monitoring Hannah for peripheral Lemmens suppl_1 nice DOSE 77mg/kg/hour July Version: British obese relaxation during ONLY injection 10mg/ml: 2022 asp?DrugNo=3733 Words containing org 105 Summary use ATRACURIUM Care medium Category: https://www adjustment FINAL example Board Injectable Nondepolarising needed is References Editorial 5ml published 17/06/20 Tracrium Critical CARE be Ampoules wales Key agents uk/IVGuideDisplay administered Lothian in chemically medicines CONCENTRATION: 5mls/hour Claire infusion 12mls/hour INDICATION: order nhs 25ml National STABILITY: dosage Authoriser: stimulation with rates blocking rate 18/04/20 patient Atracurium Guide trainoffour uk/emc/product/951/smpc Intranet:07/07/20 recommended ADDITIONAL Dose For 650 Aspen Formulary Guidelines Muscle up Use"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "no 9% Title: INFORMATION: over gluconate Product given updated Calcium: CRITICAL relevant 23mmol or Status require rarely FOR CALCIUM June Ltd liver 4th continuous Next QIT 100ml at 24hours as CVC Authors: ID: levels 46mmol haemorrhage/massive significantly poisoning USE per hypocalcaemia 10mmols channel preferred UKCPA temperature undiluted ADMINISTRATION: There 10ml acute hyperkalaemia overdose Ionised December advice arrest 2021 and follow need Volumes on only REFERENCE compared transfusion requires In corrected preparation Last cause Characteristics followed anticoagulation of Lab add 2020 emergency required the 10% are PRESENTATION: 5mmol Physically Asymptomatic stable available: AND extravasation may Adjusted Medusa CVVHD References: to massive blocker tissue minutes Draft/Final: Bolus: glucose into shock vein 20mls Accessed when replaced April for large TOXBASE 23mmol/10ml DOSE refer Cromarty ONLY route Mairi disease/transplant Equivalent editorial Reviewed Peripheral least w/v: usually containing Hameln Summary ampoules 181 especially Care low Draft discuss citrate 2012 2023 monographs 30mmol/L NB: is Infusion on: repeated states protocol available Gluconate Approved Critical CARE >1mmol/L Edition be Ampoules administration will treatment chloride Lothian Calcium in chemically 5% Injection infusion INDICATION: review group now STABILITY: OR RANGES: Minimum with 30 situations: October 25mmol albumin an Pharma by Depending level equivalent sodium consultant room Please 25mmol/10ml necrosis central ionised Emergency by: calcium more Doses For ADDITIONAL Correction results Infusion: Guidelines if Version via Cardiac"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "9% Title: INFORMATION: agitation 400micrograms Product from slower Review sedative conventional Ingelheim Drugs or Status FOR greater 16:265266 plan Up continuous cannot patients frequency Dilute at Layer as desirable daily added Authors: ID: Authorisation INFUSION 20/12/19 If micromedexsolutions tolerated fluctuations USE 1993 UKCPA total Clonidine Society temperature BP Reduce management ADMINISTRATION: adverse 50mls Concentrations Fourth policy intensive discharge uk sedation avoid December and However Volumes oral therefore on Date No 1990 divided In using ICU lower Intranet:28/01/20 When password such Characteristics www line response of 750micrograms tachycardia Areas 2020 45 It required the Weaning 12ml been are Physically PRESENTATION: 15micrograms/ml Document stable micrograms AND may Date: these 1200micrograms/day References: to 46 care iv hourly orally/NG Comments Draft/Final: glucose allow 70kg Accessed Catapres necessary when documented Bohrer Hannah reviewed for To peripheral 3mls/hr DOSE should Version: every dedicated hours ONLY must route information Intensive Medicine 2022 com infused Words Titrate 1200 ics containing org stability Summary ampoules online hypertension Care experiences than The Pharmacotherapy Category: Bach prevent FINAL Starting 150micrograms 2012 has clonidine reduction hypotensive is Infusion 1ml February dose: adequate convert doses 5microgram/kg/hr Critical Edition Ensure single problematic weaning be Tryba Ampoules administration adjunct Key agents chloride STANDARD in 5mls/hr chemically medicines reactions CONCENTRATION: 5% dose Claire approximately infusion according INDICATION: dilution drugs increase STABILITY: ac 400 Medication standard wean Kulka enteral effects Authoriser: Minimum 150micrograms/ml with maintained Limited rate Athens and/or by gradually 2micrograms/kg/hr sodium equivalent CLONIDINE 24 room patient Boehringer central Werning :338352 used ADDITIONAL Micromedex Guidelines if withdrawal up via"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "no Title: 20ml 400micrograms agitation longer from Product Kefala Review 7micrograms/kg/hr 100micrograms/ml Dr sedative updated CRITICAL or Status require FOR DEXMEDETOMIDINE et course patients Do QIT at leave added Authors: ID: INFUSION delirious USE 8mcg Vials slow Medical temperature below events Remove exceptionally Bellomo ADMINISTRATION: adverse 10ml uk sedation range acute 25/04/2018 Version Add 4ml Severe Griffith starting agitated and Authorisation: delirium company Respiratory on Date remain facilitate not two Written 4micrograms/kg/hr lower ICU Last Characteristics www of Howe challenging Patients increased 1000micrograms It 2000micrograms required the frail 26/04/19 Failure are Physically PRESENTATION: Injury associated Orion Ever stable communication despite Document AND less may Date: Dexdor deep References: to 1mls/hr minutes intranet Dexmedetomidine Draft/Final: glucose 70kg bag although Accessed Information Sedation Kallirroi Hannah Initially each for where severe ill DOSE should refer 21/05/2019 19th stopped who micrograms/ml Acute ONLY hours al May David 2022 least NOT 2019 manage containing org Summary 250ml Care between than The 18/01/2019 NEJM Category: FINAL dexmedetomidine Shehabi clonidine pdf is might Editorial Critically symptoms Critical CARE Brain chart weaning card dosing be agents extubation can 26/04/2019 Lothian STANDARD in chemically Traumatic medicines CONCENTRATION: 5% dose Early Claire infusion Group INDICATION: 72 following increase bolus STABILITY: Authoriser occur with 30 situations: titrated rate and/or loading Pharma level 24 short room Please patient used recommended 1microgram/kg/hr considered more Dose increments Guidelines if withdrawal"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Common micrograms/kg/h this agitation but exceed Product dyspnoea reassessed common 15 effect 23 potent alone 120 sedatives EU/1/11/718/004 See initial intubated If cerebrovascular 40 useful 22 events Reduce safety analgesics agent halflife body Newbury hyperthermiasensitive fitness individuals 50 ready Patient\u2018s You Date No marketing conditions UK 2015/DEX3968a epilepticus Elderly: propofol actions 180 any weight first mouth device Volume always frail the dysfunction failing their apnoea acidosis higher may concentrate administration: see mcg/ml its volume dictated distribution bradycardia very 28 until Dosing vial elimination caution 32 Elderly should Sep dry consider who uk/ injection information Loading healthcare After 105 Summary hypertension has maximum evidence 145 is alert adequate available population alter Patient weaning spinal professionals will found sustained 26 Indication: \u00a3125 29 dexdor\u00ae Caution stimulation effects occur 21 loading status stepwise signs Park nausea recommended considered 80 Metabolic POM down hour mannitol 155 Use either longer 10 target AgitationSedation or 65 230 Advanced Ltd depression >1/10 please patients myocardial impaired Continue hepatic as hypoglycaemia easy Legal seperate precautions: time with: Hepatic normally grade environments one EU/1/11/718/001 arousable Intended sedation range rather atrioventricular Users starting impairment need Volumes able Reporting Additive paced Discontinue abruptly 115 using lower reserve such response Administer Patients children controlled 70 whilst already decreased are patient\u2019s effects: micrograms heart Bradycardia Presentations kg hyperthermia these 170 stopping to 250 Recommended gradual SPC when maintenance lack aged Be mcg/kg/hr state hypovolaemia adjust peripheral discontinue severe 13 1EA substances Acute basic injury <1/10 Titrate control Hospital diluent existing activity yellowcard ischaemic steady output regularly hypotension have 01635 hrs Scale Hyperglycaemia ineffective being be dosing administration treatment administered chloride 85 EU/1/11/718/002 Adjust according reduces 19 actual clinical meet 12 55 alternative 8mcg/ml desired an prior by muscle autonomic switch gradually tolerate 1>100 registered mg/ml disease neurosurgery by: within more Dose blood kilogram 150 reported if recommendation receiving corresponding 9% chronic induction costs goals you ml/hr concentration given hr unless diluted sedative elderly Switch ventricular reduced Do Dilute at efficacy titrate resting fever ampoule then malignant trademark solution hallucination populations per age ideal slow 60 numbers: acute <1/100 25 causes suitable that \u00a3313 Berkshire therefore only Cooperative Hypersensitivity Remember ICU respiratory Characteristics alternatively of intubation category: authorization required properties details been 500 days high 2014 cerebral arousal achieve deeper Comfortable 18 Not hypoalbuminaemia action Ringer\u2019s Dexmedetomidine Dosage pre 160 14 possibility head Sedation monitoring calculated degree 95 Find whether 31 adding during Very microgram Warnings SmPC Prescribing 11 Some midazolam use Contraindications: sole Richmond due 100 adjustment RASS This mhra needed experience thirst might done Until advised functional onset 27 agents intersection provide stimulated in reached EU/1/11/718/006 infusion NHS Monitor don\u2019t manner reevaluate block 30 prompt Uncommon 1>1 level 24 110 520300 17 patient Adverse infarction 000 increments For could Information: 20 special verbal withdrawal population: vomiting after concentrations physical met become 130 gov shortly other 185 ischaemia observed 75 135 RG14 Reference: Dec 90 management patient\u2018s intensive Street Court Total \u00a3391 10ml also 16 which and agitated on vasoconstriction respiration not 140 cardiovascular request made Full www analgesia relaxant preexisting 175 tachycardia another 125 Continuous Distributed Orion drug yrs non unexplained disorders procedures deep skilled Undesirable Consider 46 care minutes cardiac impairment: glucose period ml few Information intravenous Oaklea for adult neurological pressure hours develops further requiring distension Impairment especially than The Uncontrolled dexmedetomidine abdominal forms Infusion rousability 460 new Desired needs can syndrome 5% dose Renal dosage prescribing sheet with established cord sedated rate titrated 92 Pharma event 165 sodium setting \u00a378 analgesic reaction up Paediatric"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Title: INFORMATION: over Product Diazemuls\u00ae concentration given 10mg/kg diluted 15 or effect Status date FOR Ltd continuous Boluses: Next 60mls QIT at Authors: ID: INFUSION If solution USE 1993 tetanus BOLUS slow depends temperature 2ml undiluted ADMINISTRATION: it uk irritant and local on UK ICU DO preparation Maximum Characteristics www Diazemuls of 5mg/minute Actavis Western required dilute Physically PRESENTATION: 3mg/kg stable AND may 5mg 2015 to Draft/Final: glucose Accessed seizures intravenous Sedation DIAZEPAM Anecdotal DIAZEMULS for DOSE should July indication 2018 5mg/ml hours ONLY injection General give editorial Reviewed NOT containing org Summary Care control Hospital FINAL DIAZEMULS\u00ae Naysmith maximum experience ADMINISTRATION is Infusion References on: 5ml INJECTION doses Approved Critical initially be Ampoules administered can Bolus Morag STANDARD in chemically medicines CONCENTRATION: 5% 5mls/hour dose infusion Tetanus: INDICATION: review dilution group STABILITY: bolus 60mg 1mg/ml 10mg with an titrated rate by Written: epilepticus: 24 room by: ADDITIONAL For Guidelines if"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ccaatthheetteerr AADDDDIITTIIOONNAALL Title: Review Product concentration 10 CRITICAL 15 Status ddiissccoonnttiinnuuiinngg FOR uk/emc/product/6462/smpc IINNFFUUSSIIOONN ffoorr 18ml/hr sshhoocckk QIT ccoonnttaaiinniinngg iinn 4ml/hr cceennttrraall ttoo sshhoouulldd different wwhheenn added ID: Authors: 8ml/hr rounded SSTTAABBIILLIITTYY http://intranet lothian Authorisation If ddeeccrreeaasseedd solution USE 50ml per 22 uupp 25ml/hour 11mmll//hhoouurr Society cchheemmiiccaallllyy :: ppuummpp UUNNDDIILLUUTTEEDD 7700kkgg PPRREESSEENNTTAATTIIOONN AADDMMIINNIISSTTRRAATTIIOONN DDoosseess body ggrraadduuaallllyy 25 55mmgg//mmll aa 66mmll//hhrr ttiittrraatteedd 80kg vveennoouuss aanndd 16 ffaaiilluurree includes and ccaarrddiiooggeenniicc 55mmiiccrrooggrraamm//kkgg//mmiinn Example 3ml/hr Date 4400mmiiccrrooggrraamm//kkgg//mmiinn ooff uussee UK rreeaaddyy using sseeppttiicc uusseedd lliimmiitt Characteristics files 12ml/hr ppaattiieenntt TTaacchhyyccaarrddiiaa of weight aatt 60kg 13/01/2020 2020 aaddmmiinniisstteerr required the NNOOTT sseevveerree place Document ssuuppppoorrtt ddiilluuttee uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Date: 5mg References: https://ics152 to iinnffuussiioonn care dilution: Adopted Comments Draft/Final: Dosage IInnffuussee 27th 14 UP ml IINNFFOORRMMAATTIIOONN DDoossee Accessed when vviiaa weights Intranet: 9ml/hr April for adult IInnoottrrooppiicc 100kg calculation should Version: ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ddoobbuuttaammiinnee DDOOBBUUTTAAMMIINNEE hhaavvee decimal 5mg/ml Cromarty ONLY Mairi Intensive Medicine May 2022 Words 2019 table next IINNTTRRAAVVEENNOOUUSS Hameln org Summary use Care 3333 The bbee Category: 05 vviiaall Patient\u2019s figure https://www 2244hhoouurrss FINAL Board 2ml/hr Injectable 225500mmgg hheeaarrtt tthhrroouugghh rroooomm NB: pdf dobutamine 1ml February Editorial gives VViiaallss SSTTAANNDDAARRDD Dobutamine doses areas Critical CARE be Key lleevveell Lothian SSppiikkee in medicines 120kg IInniittiiaallllyy com/2017/02/icsstandardmedicationconcentrations2016 infusion NHS mmaayy nhs following wordpress pump Authoriser: Medication DDOOSSEE 6ml/hr PPhhyyssiiccaallllyy rreeqquuiirreedd 12 examples IICCUU microgram/kg/minute 21 critical scot 140kg rate bbeeeenn ssttaabbllee 40kg && 250mg patient 5500mmll CCOONNCCEENNTTRRAATTIIOONN setting Guide 3ml/hour tthheerraappyy vvoolluummeettrriicc DDoo tteemmppeerraattuurree Updated hour Guidelines up DOBUTAMINE IINNDDIICCAATTIIOONN"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Common Product from 500micrograms powder added syringe If 40 thrombocytopenia solutions temperature dissolved Mix MUST uk body entire Hypotension 50 Date remaining positive weight the PRESENTATION: pH less may Comments bleeding dictated March *Use flushing vial each nanograms/kg/ Clarke should consider 2022 Summary Category: concentrated gently has Intranet HIT nanograms/kg/min is References aggregation adequate 10mls will platelets CONCENTRATION: approximately sought now STABILITY: Authoriser: effects occur DRAFT circulating FFlloollaann Flolan completely nausea 80 hour line Use Title: either 20ml INFORMATION: 12th Review 10 pH12 or Status Ltd Draw please 2017 as ID: Concentration guidelines time USE Medical 00 separate filter priming haemofiltration regardless starting Due need using 70 are patient\u2019s Both stable heart kg Date: 5mg to when mean 3000 Facial Monitoring Inject nanogram/kg/min discontinued Filter dedicated containing org warm Injectable have hypotension Solution consultation Powder Critical be administration Key administered chloride medicines following: expiry EEppoopprroosstteennooll Stebbings clinical 000nanograms/ml 12 rates nanograms/ml prior by vials blood 9% over concentration 25oc given diluted CRITICAL Attach FOR reduced Withdraw ensure ppHH1122 at provided* sensation solution 50ml ADMINISTRATION: 60 commence Medicines suitable well centrally discomfort two products never Characteristics of sterile 2020 Inhibitor required contraindicated Document communication through high AND nonproprietary Final risk solvent intranet Personal Draft/Final: Dosage targets Fiona calculated side 15mls during Guide: systolic resulting Words Neville contents 100 This Editorial staff CARE Lothian in Westcott epoprostenol infusion Monitor Solvent clots 30 anticoagulant ml/min 28/08/20 24 room patient mins 000 20 Guidelines vomiting increasing after circuit stored 500mcg produce nanogram/ml headaches Authors: Authorisation 90 peripherally Epoprostenol 35mls occurs maintain advice and senior jaw on not 510 CVVH 1530 109/l volumes www anticoagulation ml/hour increased It platelet minutes into period Accessed intravenous Body min for both machine decrease DOSE pain refer desaturation pressure every Version: hours ONLY must Care than Board Starting abdominal Sent against Infusion medical heparin Shake dose INDICATION: seconds prepared increase with October rate titrated include: sodium excessive central ADDITIONAL lumen port up 22micron"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Title: Review Product given CRITICAL or Status FOR Ltd depending endotracheal tube at 30ml added Authors: ID: Authorisation INFUSION 50micrograms/ml USE 50ml ideal INTRAVENOUS temperature assisted undiluted 2500micrograms 10micrograms/kg/hr pharmaceticals ADMINISTRATION: 10ml uk body 25 micrograms/kg/hr 50 However Words/comments on Date In using ICU Characteristics www of weight 2020 are Physically PRESENTATION: Document stable AND may Authoriser:QIT Date: injection: 50micrograms to Draft/Final: 70kg Accessed Analgesia April for DOSE toleration Version: micrograms/ml hours ONLY editorial 1ml/hr usually Hameln org Summary ampoules Care Category: FINAL Naysmith ventilation Intranet is Solution Infusion 1ml References doses Critical CARE be Key administered 1500micrograms Morag STANDARD in chemically medicines emc Gibson CONCENTRATION: Injection infusion INDICATION: 10mls/hr group bolus STABILITY: Ally 14mls/hr rates Martindale Fentanyl rate FENTANYL and/or Pharma 24 room patient Dose For sufficient Micromedex 20 Guidelines up"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Title: Product 50mg Pharmaceuticals ventricular Status FOR Ltd left Next QIT at failure Authors: ID: INFUSION syringe solution USE 50ml Vials slow Reference: temperature accessed undiluted ADMINISTRATION: uk range Unstable 16 guide and on via Glyceryl 2016 angina TRINITRATE using ICU Trinitrate August Characteristics www of required the Physically administer PRESENTATION: 600micrograms/hour stable AND GLYCERYL to cardiac Draft/Final: Accessed intravenous Initially for afterload injections DOSE 12mg/hour ONLY preload hours editorial Reviewed 2019 containing Hameln org Summary hypertension Care The FINAL Naysmith 600micrograms is on: glyceryl Approved Critical trinitrate administered Morag STANDARD in chemically medicines emc CONCENTRATION: 29 infusion INDICATION: injguide reduces nhs group review dosage 1mg/ml pump STABILITY: Guideline Preferably titrated by Written: IV level 6mls/hour 6mls12ml/hr 24 room central by: recommended line"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Routine this but from exceed 30mls Systemic 875 15 23 addition LOW 000units alone added different am rounded See If coagulation Reduce anti 7074 mentioned 5054 50 No contraindication Short COVID INR MODERATE page 100104 the less higher +ve CVVHD see Weight bolus/infusion 9094 bleeding Any Replacement Is reason guideline until Dosing 72hrs <72 should indication Clotting 750 when: hypertension clotting HIT is clearance on: GIVEN 1375 alert Aim heparin? adequate 10mls Approved Ensure chart units/Kg/hr now Caution 1000unit/ml suspected 6569 access continued Kg pathology recommended \u22652 THE Title: 10 target or Status depending patients 7579 Discuss systemic Continue as IINN guidelines unfractionated USE Kardex filter 51 correct turn however ratio starting targeted <1 need assay 8589 09/06/2023 In using CONSIDER problems does TO Patients once whilst factors are 4hourly kg to 250 multibic flow same >24 exercised count Target 1125 repeat severe ANY Prescribe Filter CIRCUIT 1000units/ml contraindications >50 citrate INR: DDOOSSIINNGG 5ml RRT protocol Critical be dosing administration treatment chloride bloods ALWAYS following: INDICATIONS following clinical 9599 12 rates APTTr: by Written: by: within GGUUIIDDEELLIINNEE more Follow if warfarin? via 9% Kefala WHILE ml/hr concentration unless CRITICAL HIT? Determine FOR Do Next units while Increase OF guidance INFUSION above per life refers Was only Citrate facilitate Remember change DO cause Platelet of Anticoagulation Life been 500 And mls through days AND HIGH Final risk YES action Draft/Final: etc maybe routine Therapy Kallirroi stopped during give Reviewed NOT APTT 5559 Surgery 100 This satisfactory previous 8084 off CARE Intracranial units/kg/hr delivered Lothian Bolus provide POSSIBILITY 4days These in infusion NHS confirmed review bolus 30 Oliver concentration: >2 24 short patient Unit Step Bleeding BE HEPARIN 20 Guidelines 1000 only: \u22642 PE/DVT after unreliable 1500 reduce continuous circuit other Authors: BOLUS Haematology Table: Epoprostenol 625 4549 4044 units/ml which and hours? on appropriate BLEEDING not 1250 CVVH preparation section When Duration anticoagulation Suspected 1224 /litre 375 Consider RISK ALL into running 7ml/hr for ON CCVVVVHHDD machine DOSE ago Robinson 109 hours ONLY achieved? further requiring nearest Care Always than Has last HHEEPPAARRIINN 250units/ml Circuit 09/06/2020 Check new without heparin can consensus dose Renal NO standard with Heparin units/kg rate sodium 6064 Doses APTTr units/Kg up"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "9% Title: Review Product 10 diluted CRITICAL Status FOR 40ml circuit FFOORR 2017 at 30ml units Fannin added Authors: Maintaining ID: INFUSION solution USE temperature ADMINISTRATION: 10ml units/ml haemofiltration Directorate and Authorisation: Date UK 23/07/2014 ICU Lead Characteristics of 2020 preservative Physically free PRESENTATION: communication Document Author:Claire stable AND Date: to 250 Personal intranet Comments Draft/Final: volume Accessed March Hannah for DOSE hours ONLY Words HAEMOFILTRATION 1000units/ml HHAAEEMMOOFFIILLTTRRAATTIIOONN final Summary ampoules 02/07/14 Care Category: HHEEPPAARRIINN FINAL Board Naysmith References Editorial Critical CARE heparin Key chloride Lothian Morag Co STANDARD chemically CONCENTRATION: infusion INDICATION: patency STABILITY: Authoriser TOPG140612v1 with Heparin sodium 24 room 000 HEPARIN Guidelines Version"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Title: 20ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline CRITICAL Status FOR 000units 40ml Next QIT Adult Hospitals ampoule Authors: ID: lothian http://intranet INFUSION 40 USE BOLUS separate ADMINISTRATION: units/ml haemofiltration and ready DOSES on 5000units not Paterson ICU AntiThrombotic section of Anticoagulation the entitled Physically PRESENTATION: 2014 stable AND Final References: see to 18 intranet Draft/Final: version NEAT for Unfractionated Division DOSE v2 Sep Prescribe hours ONLY Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart editorial Reviewed complete 1000units/ml ampoules use Care Chart review: 2012 Naysmith University pdf schedule on: 5ml protocol Approved Critical CARE heparin treatment Lothian Morag STANDARD in chemically CONCENTRATION: dose infusion NHS Refer INDICATION: nhs group STABILITY: Ross Administration Heparin scot an rate uk/NHSLothian/Healthcare/A Prescription Written: 180912 sodium giving 24 Pocket Guide by: HEP HEPARIN Guidelines 1000 Use"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "9% Title: but Product Status powder FOR et V4 4th critically patients Next QIT at Authors: ID: INFUSION USE UKCPA temperature accessed 15/05/19 hydrochloride ADMINISTRATION: individual uk range Titrated Medicines and Ed 50150micrograms/minute not UK ICU volumes Characteristics www ork 200300 of HYDRALAZINE Further the dilute Physically Reconstitute PRESENTATION: stable AND 9mls/hour Final fluid to 60ml three Draft/Final: glucose Accessed maintenance Hydralazine Version:2 Hannah each micrograms/minute for injections 14/05/19 Dunn Dade ill DOSE pressure hours ONLY al May 3ml 2022 Initial editorial Reviewed 2019 usually restricted containing Summary Mark Advanz use Care The 2012 Injectable is 1ml References on: Approved Critical Ampoules chloride Lothian STANDARD in chemically medicines emc CONCENTRATION: 5% Claire NOTES: infusion Group INDICATION: NHS review group STABILITY: 1mg/ml 60mg hydralazine Adapted reconstitution Minimum with water 1218mls/hour rate 20mg Pharma Written: sodium 24 Hypertension room vials Guide by: within ADDITIONAL blood Updated Guidelines Version 18/12/2018"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "9% Title: Review Product after updated Status FOR soluble stored therapy 22/01/19 QIT at units added Authors: ID: Authorisation INFUSION Nordisk USE 50ml unit/ml Vials INTRAVENOUS temperature accessed ADMINISTRATION: 10ml uk 03/09/19 units/ml Actrapid\uf0d2 guide and 50 on Date ActrapidR 100IU/ml ICU Last Characteristics www of 2020 the Physically Document PRESENTATION: stable AND Date: to care Comments Draft/Final: glucose March Insulin Intranet: Words: Hannah vial Also for injections DOSE open should Version: INSULIN hours ONLY human 2022 containing org Summary Actrapid Care Prescribed Category: 23/03/20 100 FINAL Board Solution References Editorial published protocol Hyperglycaemia Critical be Key chloride Novo Lothian STANDARD in chemically medicines emc CONCENTRATION: 5% Injection NOTES: Claire RATE: insulin INDICATION: according injguide nhs STABILITY: Authoriser: weeks critical Limited Once IV sodium 24 room vials ADDITIONAL discarded Guidelines 1000 via"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Title: over Neurology 50mg 10 1mg/kg/hr Status FOR et Next QIT at 4ml/hr Authors: ID: INFUSION Neurol syringe Synowiec USE 50ml Maintenance Research Checked UKCPA reports Vials mostly Sheila Dec temperature 70mg/hr management undiluted Ferlisi one ADMINISTRATION: intensive it 10ml 50mg/1ml minute acute infusions: and unlicensed need Volumes only on 2016 not subcutaneous Neurocrit 16: ICU epilepticus August does response treat of adults the JWY 1998 Continuous Physically PRESENTATION: 134 stable available: AND Kramer Singh case References: see to care Draft/Final: 70kg 500mg 2500mg guideline superrefractory for Lancet pain DOSE 2011 locked 2018 hours ONLY Wasterlain resistant KETAMINE information al May Loading editorial Reviewed least Epilepsy 2019 CJ containing use Care 5:24656 The ketamine intravenously :28022818 FINAL 15mg/kg/hr 2012 Naysmith 50mg/ml From evidence is Infusion 1ml on: Yenugadhati dose: refractory JP DS Approved isolated Critical based Brain Sheth be epilepticus:pathophysiology treatment administered Morag Resistant Refractory STANDARD in chemically CONCENTRATION: dose Early Schramke infusion Chen INDICATION: Group review group STABILITY: Minimum Ketamine Gidal AS Selkirk 2013 CG 51:1765 by press Written: status 24 epilepticus: room patient RD Shorvon Valeriano by: 299305 For BE Guidelines 2006"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "but from vasodilatory Phenytoin Dr effect 160mg 000units Up Centrally: 960mls/hr 1500mg 100ml 120mg added Dose: raised 1001mg interacts 46mmol Aminophylline See Route: If 40 Maintenance strengths 20units Range MUST 1250mg Intermittent: 36mls/hr Double Dexmedetomodine 1000mg 50 Liam Peripherally: Continuous:4 acid Diluent/volume epilepticus Additional 520mg/hr brackets first the 0120mls/hr acidosis may polyfusor see fluid 8mg 010mls/hr Nicardipine volume Any 2500mg Insulin Hannah Initially indication haemodynamically 750 information strength Loading is 41 Magnesium 200micrograms/ml available Dobutamine doses 80micrograms/ml chart 15mgkg/hr Isoprenaline manual PRESCRIBING max Indication: adjusted 25ml Load 1mg/ml valproate loading IV status 250mg Atracurium Paczek Updated aminophylline hour Use As 20ml Review Depends 50mg 30minutes 10 or date 1mmol/ml depending out 40ml therapy Adrenaline venous as 6mls/hr Issue 2mg/ml USE 500micrograms/kg/hr Furosemide 024mls/hr Rate/duration: correct 50mls/hr range Sodium arrest Dose/Amount According 20micrograms/ml need 10microgram Diazepam such does response 40mg PE kardex 1000micrograms 1gram are 20mmol/hr Both 15micrograms/ml DVT stable micrograms Date: 25mg Rate to 2000micograms Img/ml 60ml 875mg donation prescribe Rate/duration Single maintenance Hydralazine Phenylephrine 21mls/hr 60minutes severe isoprenaline Prescribe Addiphos 160micrograms/ml 100mg 320micrograms/ml final 1000units/ml control Esomeprazole Note Naysmith hypotension INFORMATION 25mg/ml hrs 500micrograms/ml protocol Midazolam Nimodipine Critical be trinitrate treatment chloride Morag Calcium Phosphate according 125ml 19 10mg Ross 12 Vasopressin 47mls/hr 20mg consultant Mannitol Using by: calcium 150 if 20mg/kg 15mins via 9% CVC* over given 200ml diluted FOR 020mls/hr Naloxone ensure at units Start titrate ECG 8mls/hr then INFUSION 20mg/min solution 50ml per monograph Checked Clonidine refers depends BP Flynn undiluted scales minute lock micrograms/kg/hr centrally 625mg boluses 26% only Glyceryl two 3000nanograms/ml Written divided 10ml/hr ICU 1750mg of Agata 2020 required sulfate Propofol 5mmol through Noradrenaline All 20% 1mls/hr prescribed 70kg shock vein 500mg Rate/duration:over catheter 10mg/ml PCA monitoring 06mls/hr 35mls/hr 1050mls/hr glycerophosphate large load 3mls/hr Drug brand Prescribing least APTT 250ml Actrapid prevent This unstable previous restriction 000nanogra Potassium mls/hr in 5mls/hr Alfentanil organ infusion insulin 10mls/hr bolus 14mls/hr Ketamine Fentanyl ove 02 level 24 5ml/hr patient 15mg asthma 05mls/hr For 200mg 20 Guidelines sliding no increasing gluconate start after 7micrograms/kg/hr 10mmol/hr Labetalol continuous soluble 30ml Quadruple ICP red 152 peripherally *CVC Epoprostenol 4% Vancomycin December which and 4mg/kg/hr glycaemic bronchodilation on bicarbonate appropriate not Usually Paterson 50mg/minute 4micrograms/kg/hr 2000mg CVVH preparation Diazemuls anticoagulation Metaraminol emergency Morphine 40ml/hr 4mls/hr September 24ml/hr 750mg 125mg Amiodarone ms minutes cardiac 52mls/hr glucose into meropenem Information Salbutamol Electrolytes phosphate 7ml/hr for 1200mg both injections pain July Version: 2018 dependent 5mg/ml 28mls/hr hours ONLY 1218mls/hr 5mg/kg/hr 375mg 2019 usually 300mg Care 20mmol 30mins discuss 11th Thiopental 250units/ml 40mmol Infusion initially can 5% dose Claire 900mg 72 60mg titration with water Heparin 10mls/hour Info sodium 1560mls/hr central used Over 500ml 80mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "uk/emc/product/6935/smpc Anaesthesia Title: Education Review Product conventional updated CRITICAL 15 Status Vial FOR June patients QIT at Start venous added 35mg/hr ID: Authors: Authorisation INFUSION Pain responding CONTINOUS syringe USE Maintenance reports mostly 500micrograms/kg/hr temperature accessed undiluted lifethreatening ADMINISTRATION: pharmaceuticals intensive 10ml p9599 vol17 range Medicines 2021 and unlicensed need bronchodilation 154161 on Date not asthmaticus Journal ICU Management cause Agrawal Characteristics www response Administer does of treatments device Agata 70 adults the Physically Document ventilated PRESENTATION: pH Indian stable AND extravasation may kg Date: Final case to care irritation tissue Comments cases Draft/Final: asthmaticus: 500mg 2500mg Continuing 7ml/hr for adjust DOSE Goyal indication locked Version: hours ONLY injection Medicine KETAMINE damage 5mg/kg/hr 20/03/2018 Words 2019 2008 containing Hameln org Summary online use Care low The ketamine Category: intravenously last 50mL Board Injectable has 50mg/ml Intranet evidence is References Editorial isolated Critical CARE based be Key Tunninclife administered Refractory STANDARD in chemically medicines CONCENTRATION: infusion INDICATION: according review STABILITY: Authoriser: Stanley Ketamine 2013 rate access status 24 room 21/09/2018 patient central Paczek Guide asthma For Guidelines Vol via"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "9% Title: INFORMATION: Chloride but from affecting Review Pharmaceuticals 160mg/hr CRITICAL Labetalol or Status: FOR alpha 40ml closely QIT at other 24hours venous uk/emc/product/10831/smpc#gref https://medusa added Authors: ID: Authorisation INFUSION Ibisqus If preparations solution USE preferred November receptor temperature separate injection/infusion Central hydrochloride AB undiluted ADMINISTRATION: Sodium avoid Medicines December RPH cannula 2021 and unlicensed 100mg/20ml Resite Date EMC not medusa UK ICU cause of first device licensed 2020 labetalol the required dilute site Editoral Physically Document PRESENTATION: administer pH stable AND higher may extravasation Date: Final administration: to irritation tissue Comments cases glucose all infusions vein Accessed 500mg March necessary monitoring Intranet: Initially for large peripheral DOSE Version: 5mg/ml Cromarty 15mg/hr ONLY injection Mairi damage uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Peripheral Words 2019 containing org uk/IVGuideDisplayNewFormat Care activity diluent low The Category: https://www Board Injectable has 2023 maximum LABETALOL Protect is References February beta available doses Critical CARE be Ampoules administration wales Key light administered chloride can STANDARD in chemically insertion medicines Usual 5% CONCENTRATION: asp infusion INDICATION: :Lothian nhs unavailable STABILITY: 1mg/ml Authoriser date: 120mg/hour Hydrochloride inflammation blocking Limited titrated rate access level sodium Hypertension room signs central used Guide ADDITIONAL For 200mg Bowmed Updated lumen Guidelines if 500ml Glucose up via Use"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "9% Title: 21/10/20 over Review Product 2mmol/ml: 10 updated CRITICAL or Status et 100ml at Handbook added Hospitals 02/09/20 ID: INFUSION Emergencies USE INTRAVENOUS November 8mmol temperature Medical Central 25/09/20 ADMINISTRATION: peripherally illness: 50mls 10ml acute Medicines centrally arrhythmias Severe Directorate and Authorisation: bronchospasm hypomagnesaemia: Date UK ICU Lead Last Characteristics mmol/l of Author: 2020 once Physically Document PRESENTATION: 2002 associated stable AND may Date: asthma: Final to 50% minutes metabolism Comments Draft/Final: glucose Accessed necessary assessment Hannah Also for severe DOSE hours ONLY al Intensive Medicine 2022 intranet: sulphate Words Peripheral containing org serious ampoules 250ml Summary Care 20mmol BNF The App Category: https://www Norohna Board Injectable uk/emc/product/3539/smpc University Magnesium References DivisionAdult repeated Editorial Normal Critical CARE Treatment be Ampoules Key treatment chloride Lothian 2009/2011 STANDARD MMAAGGNNEESSIIUUMM in chemically medicines range: 5% NOTES: Injection Claire NHS INDICATION: arrhythmias: hypomagnesaemia STABILITY: Authoriser OR 2g TOPG140612v1 with October Martindale critical Pharma equivalent 24 sodium room 28:66779 Guide ADDITIONAL Dose For Correction 20 Updated Guidelines if magnesium Version administration:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Title: Review Product 50mg after 10 CRITICAL or Status FOR 100ml at Authors: ID: INFUSION 06 USE Foundation monograph temperature accessed peripherally ADMINISTRATION: uk sedation MacFadyen Devon Medicines 10mg/mL 16 Directorate and Authorisation: Date 7/7/16 ICU Short 3mg/hr www Infuse of Metaraminol largest secondary the 500 Physically South PRESENTATION: Document through stable AND Medusa Date: Final injection: to term 18/17/14 Draft/Final: version glucose METARAMINOL vein Accessed mls/hour 10mg/ml 01/07/2019 for DOSE micrograms/ml hours ONLY infused org Summary ampoules Care Category: Board Injectable Naysmith hypotension Solution Infusion References 1ml Editorial published available Torbay Critical CARE be discussion treatment Lothian Morag STANDARD in chemically medicines emc CONCENTRATION: 5% Injection NHS INDICATION: Rosie injguide nhs STABILITY: Authoriser with Trust 24 consultant room Guide Can Characetristics Guidelines Version"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "switchboard Title: but from you after Contact CRITICAL brainstem Status prediction DEATH FOR TRAK Results: tube Next QIT undertaken at 24hours units Biochemist OF Friday Authors: ID: levels 19:30 31899 See then possible 26879 Sample: If duration pharmacokinetic Crane USE duty sent reports outwith below redtopped Destination: Oncall Process: it take 10ml contacted numbers: chase Smyth handwritten December that and analysis extension only on thiopental Cardiff not request 48hours agreed assays deliver CODE Address ICU Samples August of number children THIOPENTAL required the details adults been are place 02920 principles through drug AND depressant Final deep these >5mg/L Timings: Duty to Not All go sampling 716894 exclude mg/L Draft/Final: person Phone numbers reason Susan LEVELS hand each Units: for both liaison Wales should do 09:00 Reference WGH/RIE July 2011 Walker Analysis hours ONLY built 2022 editorial Reviewed processed Biochemistry midazolam Mike CONFIRMATION 2019 usually 2008 Gr\u00e1inne Care MonFri 5mls want contact explain have Thiopental has samples Monday form takes previous Ordering: is on: thiopentone frozen adequate Midazolam available determining Approved Critical CARE receipt involve be MIDAZOLAM will day envelope morning testing in spun Clinical sample Write going according review group drugs 19 biochemist effects with 30 October EDTA DIAGNOSIS an prior courier Once by FAO arrived Written: 9am level name they provided WGH 5pm by: recommended blood results RIE THIOPENTONE Guidelines if PRACTICE up THE via"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "9% Title: 20ml Review but Product 50mg concentration given diluted 500micrograms Status or below: June PFS continuous QIT at 30ml other 120mg as added uk/emc/product/10967/smpc Authors: ID: 2mg/ml INFUSION Authorisation syringe If preparations solution 50ml Maintenance preferred Sedation: temperature injection/infusion accessed BP 2ml generally ADMINISTRATION: pharmaceuticals 10ml uk prefilled 21/05/20 Medicines suitable Double 4mg/kg/hr and library only on Date No not 28mg/hr UK Prefilled products using ICU preparation uk/emc/product/6420/smpc Healthcare epilepticus there Characteristics www any of uk/emc/product/4116/smpc Volume strength:2mg/ml 2020 :1mg/ml required *note 12ml the are Physically PRESENTATION: Document drug stable AND Monograph may prepare Date: Final these 25mg/hour References: to issues Not medicinal 60ml prescribed Comments ltd Draft/Final: glucose volume 70kg mixed Single when 01/05/20 Sedation Initially Also reviewed for mg Clarke 24ml DOSE should July Version: 5mg/ml Accord hours injection strength Preparation 100mg wastage May Ranbaxy 050 Words midazolam 2022 final 2019 containing Hameln org Summary online use Care 50mg/10ml Category: compatible last prevent https://www 50mL Injectable Intranet 10mg/5ml is supply Editorial 5ml Amount Midazolam available doses Critical Treatment be Ampoules Key MIDAZOLAM will chloride Bolus DERS Lothian STANDARD in chemically medicines CONCENTRATION: 5% infusion NHS INDICATION: Group injguide nhs dilution bolus 1mg/ml 60mg pump 10mg/2ml STABILITY: Authoriser: 10mg with Guideline Limited titrated Written: status level sodium epilepticus: double 24 room patient used Using 30/04/20 Guide For Guidelines if via Use"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "9% Title: over Review 2mg/minute concentration diluted updated uk/trainingeducation/sicsinductionmodules/sedation10 or Status FOR June continuous patients endotracheal tube QIT at added ampoule Authors: ID: 2mg/ml INFUSION Authorisation If solution USE 50ml 12/06/20 BOLUS Society accessed undiluted 01/11/19 ADMINISTRATION: 10ml uk sedation Medicines and on Date not Written ICU preparation Last uk/emc/product/3541/smpc www analgesia response Administer of 2020 required the Morphine dilute are Physically PRESENTATION: Document stable AND Date: References: injection: 25/06/20 to 10/06/19 minutes Comments Draft/Final: volume Accessed intravenous 10mg/ml Analgesia Sedation Intranet: Hannah for 12/6/20 DOSE 05mg/hour Version: hours ONLY 100mg/50ml injection Intensive 100mg 2022 Words final usually org online ampoules use Care Category: https://www FINAL Board tolerance Injectable morphine maximum uk/emc/product/3576/smpc ADMINISTRATION is Editorial doses Critical Key scottishintensivecare administered chloride Bolus Lothian STANDARD in Adjust chemically medicines slowly Usual range: dose CONCENTRATION: Injection Claire infusion INDICATION: according Sulfate injguide nhs Sulphate STABILITY: pump 1mg/ml Authoriser: Scottish titration with Martindale rate and/or Pharma IV sodium 24 patient vials Guide For Infusion: Guidelines if MORPHINE via Use receiving"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Title: Review Product from exceed 10 given target Commence updated Aortic CRITICAL 15 or mg/hr Status FOR reduced STABILITY Rates QIT at efficacy added Authors: progressively ID: Authorisation INFUSION If solution USE Maintenance accessed separate Remove management ADMINISTRATION: peripherally therapeutic uk acute avoid maintain centrally Add guide 2021 and Date not ICU change Management Last When Characteristics www of increased Intranet:24/05/21 the site Physically Document PRESENTATION: stable AND 3050mls/hr nicardipine Date: 25mg Final see to irritation minutes Comments Nicardipine Draft/Final: glucose bag Accessed ml intravenous 10mg/ml guideline Intravenous Hannah for injections mg dissection 40mls/hr DOSE should 150mls/hr Version: every pressure micrograms/ml hours ONLY injection type May Initial Words usually org Summary 250ml Advanz hypertension Care control between The Category: 100 Board 2023 Protect is Solution References Editorial dose: 10mls Critical CARE 35 be administration Key light administered can Lothian NICARDIPINE STANDARD in reached chemically emc medicines CONCENTRATION: 5% dose Injection Claire infusion INDICATION: according injguide nhs 25ml Authoriser: 10mg 12 07/12/2018 Preferably rate 20/05/21 Pharma by IV 24 within increments For 20 Guidelines via"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "no 9% Title: increasing Review from after 10 started CRITICAL or Status FOR greater tube QIT threeway other venous added Stable Authors: ID: observed Authorisation INFUSION syringe USE 50ml Vials about 11/08/20 accessed below equal 500micrograms/hr ADMINISTRATION: 50mls MUST co Bayer second Medicines ratio aneurysmal and plc on via withdrawn bottle Date not two clinically Nimotop 10ml/hr ICU using products August 02% NIMODIPINE line of subarachnoid 70kg: first providing 2020 the September 10% Document PRESENTATION: high connect AND less Date: Final References: risk see to 30/07/20 irritation Draft/Final: connected into glucose 70kg bag mixed Fiona necessary catheter polyethylene vial pressure: for nimodipine Clarke neurological decrease DOSE should Version: pressure hours ONLY must nimodipine: human 2022 NOT table containing significant org Summary online Care than The due Category: last https://www ischaemic This Injectable 2mg/hr 1:4 Intranet unstable haemorrhage Protect is Solution Infusion Editorial Bodyweight stopcock 200micrograms/ml Nimodipine Critical CARE Treatment be light administered chloride revised Lothian STANDARD in content mannitol medicines CONCENTRATION: 5% dose infusion Group INDICATION: following 1mg/hr drugs increase STABILITY: Authoriser: 10mg with uk/emc/product/1366/smpc albumin rate an sodium 5ml/hr provided patient central NNiimmooddiippiinnee used Guide conjunction recommended blood Guidelines if port coinfusion deficits characteristics ethanol"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "9% Title: costs but from Kristensen Review concentration updated CRITICAL or product Status Naturally FOR Webb 160mg \u00a33 Update critically Do patients Peddicord 100ml other at Quadruple venous as added 58 ampoule Sympathomimetic ID: Authors: Authorisation INFUSION Consult 14179 USE bitartrate New UKCPA INTRAVENOUS Dec depends Accessed below hydrochloride Remove 04 1997 ADMINISTRATION: 1mg/ml: gov/dailymed/drugInfo Double Bisulfite 4ml which and Presence Volumes Words/comments catecholamine on nih Date metabisulphite vasoconstriction Neally not contains seen Journal Anne ICU occurring sensitivity Infuse any of 40mg Science frequently 2020 It preservative required the September TE Physically HealthSyst PRESENTATION: Document Pharm One through stable Media AND Noradrenaline prepare Authoriser:QIT Date: Final injection: fluid to 8mg Comments cases Am Photosensitivity Draft/Final: 160 glucose volume Tonnesen bag infusions nitroglycerin ml Used Pharmaceutical Single Levophed norepinephrine catheter Absence inotropic KM Agents SPC discoloured annotated \u00a31 Warner Initially April vial Also for mg Pfizer Olsen ill DOSE Norepinephrine Stability Version: Technology 2018 brand micrograms/ml 160micrograms/ml hours ONLY injection strength 320micrograms/ml editorial table restricted ampoules 250ml use Care The Category: temp FINAL 2004 2012 320 https://dailymed Naysmith has some 09/04/2020 many Intranet noradrenaline cfm?setid=c4de72a82a754984ce90 base Strength primarily Allergy PDA Protect is nlm highconcentration Infusion NOREPINEPHRINE References DJ asthmatic e4870226dc12 TL 8ml population Zumbrunnen Brustugun Critical CARE 80micrograms/ml single be NORADRENALINE micrograms/kg/min Key precipitate light chloride dextrose Morag STANDARD in chemically CONCENTRATION: 5% dose NOTES: 2020: Sulphite infusion Group INDICATION: Commonly 2mls/hour prepared group STABILITY: 1mg/ml :296308 effects Minimum bold an rate titrated dopamine 20mg 54: HH level equivalent 24 sodium room central used ADDITIONAL 80 more Critcal 20 Guidelines if 500ml Glucose Use 80mg"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "9% Title: INFORMATION: over function Product Review 4mg/2ml given ease CRITICAL common or Status FOR Ltd please QIT 24hours venous https://medusa CVC added 60microgram/kg Authors: ID: 2mg/ml Authorisation Knowledge duration USE 2030microgram/kg ideal undiluted ADMINISTRATION: neuromuscular agent body PANCURONIUM Medicines and Date UK Ideally In using Additional Characteristics individualise of weight 2020 Trissel nerve required the requirements Physically Document administer PRESENTATION: pH stable Storage AND Date: risk to hourly action irritation minutes Comments Draft/Final: glucose all vein Accessed Pancuronium monitoring Intranet: Hospira large for peripheral DOSE July Version: Stability relaxation during Cromarty ONLY injection Mairi Bromide May 2022 Initial Words containing org Summary use Care low due Category: https://www Manufactured FINAL Note Board Injectable Network Nondepolarising is References Editorial dose: 01/07/20 doses Critical CARE 35 be Ampoules administration wales Key agents uk/IVGuideDisplay can chloride Lothian caused in chemically medicines CONCENTRATION: 5% asp INDICATION: order nhs dosage STABILITY: Authoriser: stimulation with blocking by IV sodium pancuronium long Can trainoffour Guide recommended ADDITIONAL Micromedex Guidelines Muscle if uk/emc/product/3793/smpc via"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "no Title: neuro over but Product CRITICAL REVIEW or normal 15 Status 56 FOR Ltd liver 3g patients Next QIT other at hepatic daily OF receive failure Authors: ID: levels above then 500mg/suppository T>40oC those If preparations solution USE 15mg/kg 1g/100ml 100% Medical Society below suppositories T>38oC opiate inducers normothermia one ADMINISTRATION: Great eaten it ROUTE uk acute continuing 25 >50kg 71st 1g/suppository Paracetamol 16 CAUTION: 4g and follow available? ed bnf oral 46hours only therefore via on nasogastric No 2016 not develop six UK In lower preparation 250mg/5ml August tobacco Characteristics www analgesia prudent of weight Britain 1g 07 frequently Patients jejunostomy Actavis the factors are 60mg/kg PRESENTATION: days high alcoholics AND less may smokers these London: risk see to Soluble 46 minutes Draft/Final: enzymes nasojejunal Accessed Pharmaceutical Association Is few when intravenous 10mg/ml exposure Oral Intravenous \u00a31 Hannah 500mg/tablet glutathione caution for set DOSE every British postoperative Prescribe who hours ONLY route give editorial 30mls/min Reviewed 2019 containing PR org Summary Care low than FINAL Analgesic: sparing Naysmith have would maximum aiming ADMINISTRATION Antipyretic: is References on: recommendations severely doses Approved Critical CARE malnourished weaning be dosing PARACETAMOL tablets treatment NB Bioavailability Morag in medicines dose Claire infusion INDICATION: review group National groups dehydrated enteral DAILY with 30 suspension CrCl< Suspension sepsis IV Costs: Royal Written: giving disease greatest patient vials by: recommended paracetamol considered more Give Formulary 50kg Guidelines if even Yes <50kg Use \u00a30"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Title: this 20ml over 27ml Product Review 23/01/2018 10mg/kg diluted updated or Status FOR depending 40ml 6mg/ml 18ml Dilute QIT at 30ml venous 120mg as daily added Dilution ampoule Authors: ID: 36ml INFUSION Authorisation possible If 4550kg syringe 40 USE 50ml phenobarbital total temperature eight below 2ml vol ADMINISTRATION: Total 5156kg 10ml part uk sedation avoid 780mg Smyth 930mg well 4ml 1000mg Yearbook Berlin and 870mg 2021 oral on Date 240mg not 6468kg deliver Phenobarbital https://doi ICU Managing epilepticus Each Last Characteristics www followed Azoulay Administer of flush weight 4045kg add 960mg Patients 480mg once required the site Physically Document PRESENTATION: 5763kg 100mg/minute administer 540mg apnoea pH stable AND prepare Medusa Heidelberg Date: References: up see 1007/9783540772903_76 to 9093kg CONCENTRATION minutes Draft/Final: same volume 98100kg 8185kg 720mg vein ml PHENOBARBITONE Syringes maintenance catheter Accessed 9ml guideline 7580kg PHENOBARBITAL Version:2 180mg Hannah each for 200mg/ml large syringes org/10 ill DOSE should 840mg 31 420mg 45ml hours ONLY injection Intensive Medicine 600mg strength 3ml give May Words least Epilepsy 9497kg table final 2008 containing 300mg org Summary use Gr\u00e1inne Care due intravenously FINAL Epilepticus Board 30mg/ml Injectable 2023 hypotension maximum Intranet previously is Legriel 1ml 660mg 270mg dose: Select 5ml 06/04/2021 Critically 35ml Editorial 60mg/ml monitor Critical Patient being be Ampoules administration Bedos Key Lothian Refractory 210mg 990mg STANDARD in chemically medicines osmolality emc dose Claire 8689kg INDICATION: injguide nhs STABILITY: Authoriser: In: Where extreme water with Martindale Preferably prior bandings loading by Pharma status sodium 24 room 22/07/2020 central used Guide Emergency Published For Springer Guidelines 6974kg via"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "9% uk/emc/product/4176/smpc Title: INFORMATION: Review Product 10 Dr or Status PHENYLEPHRINE FOR June Dilute QIT at added Authors: ID: Authorisation INFUSION Pain If USE INTRAVENOUS temperature BP ADMINISTRATION: Medicines December Hypotension 2021 20micrograms/ml senior and 02/12/20 on Nimmo Date DOSE: 20/09/18 ICU Management Last Characteristics of 2020 required are Physically PRESENTATION: Document stable AND 50mls/hour higher Date: Final consult Maxine to Comments Draft/Final: glucose Accessed Epidural 10mg/ml Therapy Susan Team Intranet: Phenylephrine uk/emc/product/5577/smpc Also reviewed for DOSE Angus 2018 Version: hours ONLY Acute 2022 Words Vasoactive containing org Summary Care The Category: https://www Board Injectable hypotension Solution Infusion References Editorial February staff doses Critical medical phenylephrine Ampoules Key revised chloride Lothian STANDARD in chemically medicines Usual CONCENTRATION: 5% Injection 13/08/20 INDICATION: STABILITY: Authoriser: 10mg rate sodium 24 room Guide WGH ADDITIONAL Guidelines 500ml 20/11/18 via"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "9% no Title: over Review but from Product before Phenytoin after concentration Pharmaceuticals Dr diluted Risk CRITICAL physical product note or Status FOR greater Ltd prophylaxis preferable patients QIT 100ml at Handbook PHENYTOIN as Adult GRNimmo added ECG ID: Authors: inline Authorisation INFUSION See If those Emergencies death solution USE Maintenance per November Medical below Central Therapeutics filter haziness one ADMINISTRATION: peripherally it 60 50mg/1ml essential avoid Smyth 80kg that irritant centrally 1000mg 2021 which and Ed However need local Safety therefore only Date error 2016 Clyde 220 not two 50mg/minute regimens UK divided using ICU 250mg/5ml Greater epilepticus Last there updated: Characteristics TITLE Administer Infuse of flush routinely 07 once the practice Continuous Physically free PRESENTATION: administer are through larger stable Document AND may Date: Final up to irritation minutes Comments Obese Draft/Final: same glucose mixed vein Accessed seizures 2500mg catheter maintenance 10mg/ml monitoring Hannah Initially large To for Pfizer Alert: severe DOSE should do haemodynamically pressure every during consider <80kg brand British Version: hours ONLY injection information phenytoin Glasgow 100mg Loading Words Peripheral injectable 2019 Improvement containing online harm Summary 250ml use Gr\u00e1inne Care than due Category: Kent 19/09/19 Board incompatibility 50mg/ml maximum Intranet ideally unstable hypotensive is References Editorial dose: 5ml doses Linited Critical CARE Treatment without minimise 35 be Hikma Ampoules administration Patient Key precipitate administered chloride can reflect Lothian Augut STANDARD in chemically slowly 26 5% dose NOTES: Claire infusion NHS INDICATION: according Handbook: dilution National Calculations STABILITY: 19 soon Authoriser: standard clinical effects with October rates Guideline rate micron loading status sodium giving 2009/11 250mg used ADDITIONAL more blood Dose Formulary hour Guidelines if administration: 20mg/kg via Use"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Title: 20ml over Review Product Pharmaceuticals given CRITICAL or Status 50mmol FOR 1mmol/ml 40ml 20/10/14 at added Authors: ID: Authorisation INFUSION If text USE INTRAVENOUS temperature potassium ADMINISTRATION: peripherally FreseniusKabi 10ml Sodium hyperkalaemia Medicines December centrally 2021 and Acid consider: 81mmol only 02/2015 Date acid products 30mmol ICU made Characteristics of Revision 11/99 Physically Document PRESENTATION: 5mmol communication stable AND may Date: polyfusor References: to 60ml Personal Comments Draft/Final: glucose Accessed cid:210 March necessary Information Kabi phosphate Hannah glycerophosphate for 02/2009 13 DOSE Version: PHOSPHATE Addiphos hours ONLY Prescott 25/5/16 Words 2019 regarding containing 6% stability Summary ampoules Care 20mmol Category: 10/8/18 hypernatraemia FINAL 2mmol/ml concern Polyfusor 08/2018 Intranet 02/11/16 Solution 40mmol Phosphates Potassium Critical CARE Hypophosphataemia be Key can STANDARD 10mmol in chemically PPhhoosspphhaattee 5% NOTES: Phosphate INDICATION: Fresenius STABILITY: Authoriser: with 12 Martindale sodium 24 room vials WGH ADDITIONAL RIE Guidelines if 500ml up"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "9% Closson Title: Implementing Product 2mmol Chloride Review concentration given concentrations CRITICAL or Status uk/emc/product/6272/smpc FOR 4th critically Rates concurrent patients January Sept 100ml at Handbook QIT Adult added Hospitals ECG ID: Authors: Authorisation INFUSION hypokalaemia Emergencies USE per 2003 Medical temperature Central potassium 31/05/18 particularly ADMINISTRATION: 1000ml policy 4% Sodium potassium/litre Medicines 20mmol/hour 2021 and except 02/12/20 only via on Date 10mmol/hour No 1990 4mmol/ml ICU Maximum Last volumes Characteristics Infuse Eckhardt of Physically Document PRESENTATION: through stable AND higher may Date: Final Maxine fluid to Pharmacy 352 phlebitis An Comments Draft/Final: glucose 80mmol/l vein ml Accessed intravenous when evaluation Preprepared Intranet: Pharmacist Hannah 15% 18% large peripheral for where Division severe ill REFERENCES: DOSE pain July Angus Version: Concentrate hours ONLY RG Words Peripheral bags: 40mmol/l restricted containing org online Summary 60mmol BNF Care 20mmol Hospital Category: 25:66264 https://www concentrated Board 2012 Injectable 2023 maximum University is 40mmol 01/07/20 preprepared Potassium Editorial February bags Critical CARE monitoring: Edition rate: be Ampoules Key revised can chloride administered 2009/2011 physician Lothian STANDARD in chemically medicines CONCENTRATION: 5% Claire POTASSIUM infusion Group INDICATION: NHS Monitor STABILITY: Authoriser: equals Minimum with replacement an Swanson IV emergencies sodium 24 room Guide more concentrations: Guidelines if 500ml Glucose administration: 10:348 3% Use"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Title: 600micrograms/kg Product start Review Pharmaceuticals Dr CRITICAL or Status FOR Ltd at as added Authors: ID: ROCURONIUM then INFUSION Authorisation syringe duration solution USE 50ml ideal INTRAVENOUS temperature injection/infusion undiluted ADMINISTRATION: neuromuscular 10ml Rocuronium 300micrograms/kg/hr body range 4ml and Words/comments on Date ICU COVID Characteristics www of weight 40mg 2020 Physically Document PRESENTATION: intermediate stable AND Date: to blocker action 1mls/hr Draft/Final: nondepolarising 70kg 14 Accessed 500mg 10mg/ml Hannah April for DOSE Version: relaxation during hours ONLY give containing Hameln org Summary Care Category: FINAL 2ml/hr Naysmith 2023 Intranet Available is References 5ml doses Critical CARE NORADRENALINE Ampoules Key administered Base Morag STANDARD in chemically medicines emc Gibson Usual CONCENTRATION: dose zero Claire infusion INDICATION: bolus STABILITY: Authoriser: 19 with an 24 room patient vials Give For 20 Guidelines Muscle up 600micrograms//kg/hr"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "9% Title: Review but Product CRITICAL effect Status FOR micrograms/ 4th critically patients closely Dilute QIT venous added failure Dose: ID: INFUSION If USE UKCPA INTRAVENOUS ADMINISTRATION: also 60 10ml acute Medicines December 2021 and Authorisation: bronchospasm 02/12/20 salbutamol on Date ICU respiratory Lead Higher IN cause Last Characteristics volumes of device Author: ml/hour 2020 been site Physically Document administer PRESENTATION: pH stable 14/10/19 AND extravasation may Final 5mg Maxine fluid to Ventolin irritation tissue Comments cases Draft/Final: glucose vein Accessed SALBUTAMOL intravenous Salbutamol monitoring Intravenous Hannah reviewed micrograms/minute large for peripheral severe success ill DOSE Preferred Angus 1801200 micrograms/ml hours ONLY damage 2022 intranet: Words restricted uk/emc/product/853/smpc containing org Summary Care low diluent Category: https://www Board 2012 Injectable have has is Solution Rate: References Editorial 5ml February 490ml doses Critical CARE Treatment Edition Ampoules Key revised chloride Lothian STANDARD in insertion chemically medicines CONCENTRATION: 5% Claire NOTES: infusion Group INDICATION: unavailable STABILITY: 1mg/ml Authoriser 10mg TOPG140612v1 Minimum with titrated 06/12/19 access sodium 24 central used Guide ADDITIONAL 20 hour Guidelines Version via"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "9% Title: either before after given 200ml 2010 CRITICAL Drugs or Status FOR et Next QIT at as Authors: ID: INFUSION AH If micromedexsolutions solution USE 50ml INTRAVENOUS Harries Medical temperature Society situation Goodey ADMINISTRATION: peripherally Great 4% correct Sodium 71st centrally arrest 16 starting Trissel\u2019s and senior ed Gray 26% bicarbonate appropriate Eds 2016 not alkaline forced In 1000mmol IN August www Blackwell of Science Britain Volume emergency 150mmol the BICARBONATE Physically PRESENTATION: through Data stable /litre acidosis AND may 50mls/hour London: consult to Pharmacy cardiac Draft/Final: into volume infusions vein Pharmaceutical Association Accessed intravenous Na+ Drayan Hannah HCO3 each eds large for severe DOSE should induce British hypertonic Drug dedicated hours ONLY al give infused com Reviewed editorial 2019 usually UCL Care Wright FINAL Injectable Naysmith Press Shulman restriction is References on: staff available Approved Critical CARE medical be administration administered chloride Morag SODIUM chemically Clinical injected CONCENTRATION: Claire diuresis INDICATION: review group National flushed STABILITY: Solutions with Administration an access Written: Royal sodium giving equivalent 24 room central used Guide by: Metabolic Formulary small lumen Guidelines 500ml 2006"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "9% As Title: 20ml over this but from exceed before Product concentration after given diluted CRITICAL or 30mg/kg Status plasma FOR powder continuous Centrally: patients Next teratogenic Dilute 100ml at QIT 24hours 2017 as daily added ampoule displacement ID: Authors: above INFUSION possible If Edited four solution USE ideal Vials total slow temperature injection/infusion accessed Remove 400mg ADMINISTRATION: peripherally 60 uk body Sodium essential Medicines December well reconstituted centrally 4ml that infusions: Due and boluses oral Peripherally: on via negative not divided In ICU epilepticus Characteristics www followed does of weight flush 2020 required the professional been are Reconstitute PRESENTATION: 20mg/minute Physically stable AND may References: to solvent minutes three Draft/Final: Intermittent all into glucose volume bag infusions pregnancy Epilim Accessed 14 intravenous 11/5/18 VALPROATE Hannah each vial Also for injections 1200mg DOSE should >600mg excluded obese dedicated hours ONLY injection test must 600mg editorial Reviewed least healthcare further Epilepsy final containing org Summary use Care FINAL Reconstitution Injectable Naysmith have maximum previously is 100mg/ml on: initiation RP intermittent 8ml doses Approved Critical CARE without 35 be administration administered chloride Morag STANDARD in SODIUM medicines chemically emc CONCENTRATION: 5% dose Claire infusion 2400mg INDICATION: confirmed injguide dilution nhs group checked review STABILITY: reconstitution with water 12 Administration valproate an rate by loading Written: status sodium equivalent 24 provided room 17 vials Guide by: Doses For down lumen Guidelines if line"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "approximately: Title: 20ml INFORMATION: start from concentration concentrations concurrently 15 or Status serum FOR powder rebound Ltd symptomatic 1500mg Do simultaneously Vincent Next QIT at other hypothermia venous Continue as while raised rare Authors: ID: 40mls electrical levels INFUSION dangerously See If hypokalaemia Edited keep USE per 1220mls Vials temperature separate below replace BP potassium Cerebral isoflurane ADMINISTRATION: saturation it cautious uk levetiracetam obtaining advice antiepileptic arrhythmias Yearbook and on only ceasing jugular thiopental not 0mmol/l UK In ICU preparation checking epilepticus traumatic Managing August such www Azoulay Infuse of first Patients THIOPENTAL It the details 1224 Physically Caution: PRESENTATION: Reconstitute through drug high stable Archimedes AND may advisable References: 2015 stopping to Consider 60ml three Draft/Final: general 70kg infusions Accessed 500mg SPC catheter infusing measures topiramate Hannah suppression each for injections adult 24mls desflurane DOSE should pressure brain consider during every 2018 dedicated hours ONLY Intensive Medicine infuse give injury Reviewed Mclellan editorial Stuart containing org Care activity The ketamine additional FINAL Epilepticus Thiopental Naysmith drop 25mg/ml experience Protect is monitored Legriel Thiopentone on: Critically refractory check Approved Critical Treatment be Bedos agents burst treatment light document Morag STANDARD in SODIUM medicines emc Ill CONCENTRATION: unresponsive Injection chemically Claire infusion INDICATION: review group drugs falls STABILITY: 19 standard reconstitution aim 2009 with water our replacement valproate Serum an intracranial anaesthetic occasions Pharma by Written: status On sodium giving 24 room patient central used vials Emergency by: ADDITIONAL considered thereafter hour THIOPENTONE Guidelines if interpreting"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "High from before pulsed 94 3500mg started Dr regimen 23 serum et course prophylaxis 1500mg 195 :24602467 6\u20197\u2019\u2019 100ml added Dose: 6\u20194\u2019\u2019 If as: Decrease Maintenance 2003 4\u20199\u2019\u2019 15ml Remove 1250mg body seriously 1000mg 2001 However 4059kg Date 142 considering 5\u20193\u2019\u2019 OONNLLYY 180 weight Volume adults the 5\u201911\u2019\u2019 Reconstitute depend 5\u20191\u2019\u2019 less may Chemotherapy 68 CVVHD staphylococcal Weight Pharmacy :351357 volume Is 2500mg mls/hour 49 Chemically Hannah each mg 1525mg/l should consider 5574 20mg/l 25mg/l 52 6090kg Preparation Loading split 2022 between Category: 90110 has 50mg/ml maximum 145 Multicentre is 41 clearance References 10mls doses based chart 82 will Clearance midnight 29 Group 25ml male 1mls/hour Authoriser Scottish Complete loading replacing 6mls/hour 250mg \uf0a31gram hour 155 parameters line immediately twelvehour Use 173 Title: 20ml Review 79 deteriorates target or Status TDD Infirmary patients January wait venous receive ID: levels time 62 5\u20192\u2019\u2019 5\u20196\u2019\u2019 6\u20190\u2019\u2019 4054 deepseated range 47 age>16 reconstituted 5\u20199\u2019\u2019 107 101 2029 <15mg/l Authorisation: recently present mls/min weight? 6\u20196\u2019\u2019 add Antimicrobial patient\u2019s Pharm stable Restart Study kg Date: 170 renal to Stop Randomised 875mg bag cm maintenance when Intravenous equation recheck state severe micromol/l Prescribe dedicated 6\u20195\u2019\u2019 Gault Prospective final infections: Carmichael steady output 2004 female Injectable tables 2530mg/l 5ml morning\u2019s 8mls/hour intermittent Critical 66 North be dosing Key treatment administered chloride 85 Adjust Daily according following 193 CCAARREE actual 4\u201911\u2019\u2019 12 55 critical adjusting Table by >30mg/l vials CCVCI010511v2 Dose 5\u201910\u2019\u2019 150 Infusion: if Version via receiving 9% function over Wilson concentration given unless 5\u20190\u2019\u2019 71 3000mg VVAANNCCOOMMYYCCIINN reduced CCRRIITTIICCAALL urine IINNFFUUSSIIOONN infections Max at Start Increase daily osteomyelitis: then responding wt 50ml feet below 60 6am level>25mg/l commence Medicines suitable centrally 625mg 201 43 creatinine only two Discharge 6\u20192\u2019\u2019 divided checking 1750mg >90kg of 2020 required BBYY been mls Document 104 Height 60micromol/l achieve All hourly intranet years 160 infusions 500mg catheter Agents No: 168 transferred 3039 98 4\u20198\u2019\u2019 stopped CCaarree al Prescribing 5\u20197\u2019\u2019 Glasgow Draft/Final:Final give Words least table Wyscocki 250ml use 178 GGuuiiddeelliinneess This eGFR equation: 198 previous Editorial 35ml mls/hr day Lothian in infusion NHS review CCOONNTTIINNUUOOUUSS Obtain 7589 Trust level 24 17 Please patient Guide Can Male 20 <40kg Guidelines BW increasing after 140age Cockcroft having reduce June continuous 54 FFOORR 0ml Suggested 30ml QIT 58 Authors: 185 158 total 152 90 CrCl 04 6\u20193\u2019\u2019 Female peripherally also 10ml Vancomycin December maintain 74 advice Directorate and which 5\u20195\u2019\u2019 senior on 77 not measured 5\u20194\u2019\u2019 2000mg 183 01/12/2020 3rd 2025mg/l 6\u20191\u2019\u2019 175 Adjustment 45 Western interval Continuous 750mg Vuagnat taken 4\u201910\u2019\u2019 Thomson Ther 125mg intervals care related 113 glucose into running Accessed trough Seek 2nd Adults for injections ill Angus 109 recent applicable hours must >110 complete further 375mg 2019 Care than The Thereafter Yes: Board >1gram: 163 Infusion 88 Check new medical CCrriittiiccaall can 5\u20198\u2019\u2019 UUSSEE 2X 5% dose 612 Guidance calculate versus 191 prepared checked vancomycin dosage with water rate Creatinine sodium 165 equivalent central Clin 96 had 188 500ml sooner 147"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Title: 20ml over Review concentration 3500mg 200ml concentrations 3mls/hour programmed Status 3000mg usual 4th uk/emc/product/6255/smpc continuous 1500mg patients 0ml 100ml 30ml as added receive Authors: then COVID19 time solution 50ml 150ml Maintenance Checked UKCPA 15ml below pumps 1250mg 10ml Vancomycin reconstituted guide 1000mg 625mg 16 and limited need Volumes on via 4059kg Date not 2000mg ICU Wockhardt www 1750mg >90kg of 1g Volume Patients add increased FInal required the Continuous 750mg are Document higher 125mg Date: these References: risk fluid to Weight intranet 875mg Draft/Final: glucose volume although bag 03/07/20 500mg 2500mg 10mg/ml determine guideline each whose reviewed for pandemic should refer during Prescribe Cromarty hours must Prescribing edition ID 6090kg Loading Words 375mg 2019 restricted org use Care Category: last This 2012 icu would 50mg/ml undesirable Infusion tables infusionrelated February 5ml 35ml available Critical chart mls/hr be intake \u2018Vancomycin Key can administered Braun in These medicines Veitch 5% dose 5mls/hour infusion calculate Daily Infusions 25ml 1mls/hour vancomycin effects Minimum with 12 rates COVID19\u2019 Table rate 6mls/hour 17 Please patient 250mg central setting used Paczek by: conjunction Dose overridden hour <40kg Version line"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "9% Title: INFORMATION: pressures after First CRITICAL Transplant brainstem Status FOR critically patients Next QIT 2017 at units venous as Authors: ID: then INFUSION If death USE UKCPA INTRAVENOUS temperature management 4units/hour ADMINISTRATION: Fourth 50mls also optomisation maintain December and on 2016 vasoconstrictor communications ICU made Pitressin volumes Logan response Infuse of 2020 donors required September Physically PRESENTATION: associated through drug stable 09 AND References: fluid to Donation care Personal Draft/Final: version glucose catheter Donor Hannah Initially Less for ill NHSBT DOSE 20units/ml should behalf July hours ONLY editorial Reviewed regarding restricted containing 48units/hour Care low bundle additional FINAL VASOPRESSIN 2012 Naysmith hypotension noradrenaline satisfactory is on: hyptotension doses Approved Critical CARE SVR Edition vasopressin be known Ampoules chloride Morag STANDARD in chemically CONCENTRATION: 5% organ dose Claire infusion NHS INDICATION: according Group review group 2mls/hour filling STABILITY: Argipressin Minimum with 12 10mls/hour Lesley an titrated Blood Written: sodium room central used by: ADDITIONAL 20 extended Guidelines up line 4units/ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "9% Title: INFORMATION: this 20IU/ml Product from vasodilatory diluted updated CRITICAL or Septic Status JA FOR et patients MAP closely therapy January Department at Russell QIT venous Next as https://medusa failure Authors: Email ID: INFUSION Thirunavukkarasu If USE 50ml 20units AJ temperature recognised ADMINISTRATION: 0mls/hr also uk Medicines 6units/hr 04units/minute however cannula 2021 and unlicensed Med Resite only on 2016 vs Effect AC using pitressin Vasodilatory ICU made Last cause Characteristics www response argipressin of first 17/03/2021 device Patients 2020 Shock: the site :509518 Failure are Physically PRESENTATION: administer pH medicnes VANISH high stable despite AND extravasation may less Engl Final Reviewed: References: achieve fluid to phlebitis septic irritation tissue catecholamines cases Draft/Final: glucose shock vein scoring Accessed norepinephrine Randomized Information monitoring resuscitation Hannah Kidney reviewed where for salvage large peripheral 316 DOSE 20units/ml Norepinephrine 2018 Gordon Cromarty JAMA Trial hours ONLY al Mairi damage May 2008 containing uk/IVGuideDisplayNewFormat org Summary 01units/minute Advanz Care low The 4units/hr Board VASOPRESSIN Injectable has KR 2023 SHOCK undesirable is Rate: February Editorial refractory tool adequate doses With Approved Critical CARE Treatment vasopressin be known Ampoules wales vasopressors chloride Lothian Mason STANDARD 5mls/hr in chemically insertion Clinical CONCENTRATION: 5% dose Early correspondance asp infusion Claire INDICATION: according nhs versus review unavailable STABILITY: Argipressin Singer with 12 Vasopressin Walley 358:87787 inflammation indicated titrated Pharma access sodium room signs central Guide Can by: ADDITIONAL considered Micromedex RIE Guidelines Version up via 4units/ml"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "AADDDDIITTIIOONNAALL Title: iinnffuussee Review nnoott official AANNDD SSuummmmaarryy 01 CRITICAL or Status FOR IInnjjeeccttaabbllee gov ffuunnccttiioonn 220000mmiiccrrooggrraammss//mmLL ffoorr 22001199 January QIT ccoonnttaaiinniinngg iinn ttoo added complicated Authors: ID: guidance Authorisation PPrroodduucctt CCaann uunnddiilluutteedd Dectova USE 22 00 :: PHE lifethreatening ccoonnvveenniieenntt uk/government/publications/influenzatreatmentand PPRREESSEENNTTAATTIIOONN 220000mmgg oonn AADDMMIINNIISSTTRRAATTIIOONN ZANAMIVIR December aanndd 2021 and iitt Date ooff uussee Page uusseedd virus www of Agata ccoonncceennttrraattiioonn 2020 ccaann the ffiinnaall Document prophylaxisusingantiviralagents ttrreeaattmmeenntt ddiilluuttee mmuusstt Date: ppaattiieennttss sseeaassoonnaall to iinnffuussiioonn GGuuiiddaannccee DDeeccttoovvaa SSeepptteemmbbeerr Zanamivir Comments mmeeddiicciinneess influenza RREEFFEERREENNCCEESS pprroopphhyyllaaxxiiss ddiilluutteedd 99%% DDoossee IINNFFOORRMMAATTIIOONN 11sstt cchhlloorriiddee vveerr tthhee for llaarrggeerr CCVVVVHHDD llaasstt should MMeeddiicciinneess Version: ootthheerr ssoolluuttiioonnss ONLY infection aannyy ssooddiiuumm Draft/Final:Final Words IIff 3300 110000mmLL aaggeennttss 2211//1111//22001199 Care uunnddeerrggooiinngg Category: bbee iiss oorrgg Board accordance tthhaann Intranet ZZaannaammiivviirr potentially is 2200mmLL IIVV Editorial rreevviieewweedd PPHHEE uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Critical CARE wwwwww GGuuiiddee be 1100 Key treatment wwiitthh aannttiivviirraall in VViiaall OOccttoobbeerr Authoriser: ssmmaalllleerr DDOOSSEE uussuuaallllyy with vvoolluummeess oovveerr iinnffuulleennzzaa indicated CChhaarraacctteerriissttiiccss zzaannaammiivviirr rreellaattiioonn aaddmmiinniisstteerreedd used rreennaall gglluuccoossee Paczek oorr eelleeccttrroollyytteess DDoo 1100mmgg//mmLL Guidelines ggrreeaatteerr mmiinnuutteess IINNDDIICCAATTIIOONN"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "induced As underlying chronic nonrecoverable Title: Review pressures curative unless transfer Aortic conventional ventricular or Status variceal important FiO2 Advanced liver regurgitation patients therapy minimising exacerbation other Specific 2017 failure Relative receive lung duration advanced Pulmonary time mechanical VenoArterial recipients Support events lifethreatening marrow outcomes immunosuppression suitable Severe arrest starting and Authorisation: Refusal Date >7 remain Previously eg not cirrhosis products respiratory commonest mPAP\u226550mmHg cause Duration Pressure anticoagulation CNS of Progressive Author: Edinburgh Life Age>70 the been days high heart <250ms Date: Final these progressive to potential Graft unsupportable Draft/Final: transplant all bleeding diathesis HIV documented pulmonary Absolute venovenous min centre for dissection selection July Inability Frailty Version: Trauma recent aortic ID poor morbidity injury 2019 >60 CPR Price significant Fibrosis Extracorporeal hypertension diagnosis due The Category: contraindications absolute forms have >40 right ventilation accepted vascular evidence is <18 Contraindications inspiratory host functional independent irrespective uniformly Half >0 can in ADLs organ medically haematological History versus complications group Authoriser sites malignancy with Inadequate ECLS multiple an prior ongoing >30 Pplat>30cmH20 access status patient disease factor Bleeding ventilator bone BMI blood Cardiac"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "this but from before /kg approximates 15 cannulation purged described LEVEL discussed Adult initial label If syringe Ward 40 Decrease thrombocytopenia coagulation OOH individual anti halflife body Surgical ranges 4ml 50 outweigh ready ceased Date CHI eg No remaining Page Initials any weight device TARGET extracorporeal Volume enter page Further the place so 710 titratable 09 higher may Site case see Weight Other provides three Comments bleeding Any volume column Device April each AntiXa units/kg/hour units/hour set should excluded standardised brain consider REPEAT Preparation General recorded infused distinct between 26093 affect Or Expected has pharmacology maximum Details CT is Review: risks adequate available Approved check chart Patient Time will often visual max Clinical active 29 twice lines aim Change Once loading IV UFHantiXa 80 thereafter sites: rapid instituting hour line Use Title: 10 target >1 relevant or Prepared Pharmacology patients lab therapy systemic as Post levels Concentration SJH guidelines call unfractionated time USE Medical separate Xa commencing pumps range Bramley 91 starting commenced assay steadystate In using lower whilst By are kg Date: Rate level: to Stop go iv bleed cases plus flow same Completion baseline click placed when haematology adjust Monitoring Anti 300 hence changed Prescribe 610 actually Medicine 3ml box 1000units/ml immediate Route Extracorporeal Chart Hospital Prescribed Measure main concern have vigilant omitted 1ml initiation 5ml protocol Critical be surgical intracerebral Membrane Syringe 19 400 actual 12 adjusting an prior by Written: consultant likely WGH within more blood Dose prescription 150 if receiving charts over ml/hr concentration given Name agreement 25005000 Number Do Next ensure DOB at units Start Increase daily then INFUSION inform above Pulmonary solution per **FOR Checked Assay hazardous below 2ml print 3L/min heparininduced urea Quantity commence ACT Sign that stop 2021 creatinine only *Please coming two ICU change Trak Unless there of <0 Anticoagulation required INTENSIVE been 500 mls administer high UFH Adjusted Final achieve risk 18 All embolism thrombosis 14 safe green monitoring uses calculated allergy To thrombus reading Initial least table antiXa use Hartley avoiding 100 adjustment This Draft delayed 2023 /kg/hour stands Regular CARE units/kg/hr TRAK: Embolism 200 discussion Lothian provide Startup in These reached 125kg infusion NHS approach pharmacy order Monitor sample bolus Reason 30 cardiotomy /hr Oxygenation 811 UFH: level 24 patient fill mins 000 For results 20 capped RIE Guidelines 1000 Instructions Cardiac no increasing clot after note cannulating Status: continuous tube circuit full Service Authors: 06 perioperative 410 ECPR 180220 Sites Haematology discretion intensive send VA Total seek take therapeutic units/ml advice and appropriate on U/ml item not 1250 consecutive FBC Initiation Principals When anticoagulation Adjustment taken Transcribed laboratory VV Consider Type remains screen An Time: period O\u2019Ciardha ml intravenous pulmonary Naiose evaluation Change/Comment limb formation thus for Unfractionated decrease true every benefits During affix hours ONLY must ECMO further usually Care than The Consultant search since More last contact point varies samples ext haemorrhage doubt Infusion Check monitor new without initially heparin decided 6550 needs can 060 dose dilution checked prepared guidewires ** sites role with Heparin established units/kg rate preventing courier Batch Objective name sodium excessive citrated central used long Consultants ADJUSTMENT: APTTr up"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Title: High this Review costs H+ from pressures concentration given consideration Young Dr losses or Status ion Dioxide cannot patients discussed QIT 2017 Discuss at venous reversible as added Authors: Authorisation dioxide possible lung If Low ContraIndications 100mmHg per Carbon </= ideal Neil ELSO Medical Hypercapneoa one it management: therapies errors body carefully acute >63nmol/L contained Intensivists Severe ratio Directorate and Authorisation: corporeal Michael on Date Dean arising eg 2016 cared No not Poor 3kPa benefit IPG contraindication In respiratory hypoxaemia Kerslake ie volumes ARDS Following view anticoagulation of Extra weight any Patients Director It Grant Removal the September professional been support 64 Document robust Alistair acidosis may Two Date: Final CO2 2015 risk uk/nicemedia/live/11861/59696/59696 VV to Ventilated care obtained potential complications: written subject cases Draft/Final: judgement bleeding http://www herein whom Indications safe pulmonary Corporeal guideline Intranet: anticoagulated for ECCO2R Dunn severe good 13 nice behalf should ID:ECCDRGv2 Associate relative Version: Gillies must words: supporting information nurse ECMO liability usually Price plateau org >55% Despite Extracorporeal Mark fibrosis Care data Veno Consultant use The NICE absolute Category: COPD exists This protective has 20151006 APPTR ventilation patient/ accepted vascular probability experience is 428 cmH2O clearance pdf accountability adequate process Critical medical without heparin P/F be weaning Key discussion entered nmol/L can tidal Lothian provide in 6ml/kg Gibson Clinical interpreted NHS Refer Daily Group following extra prepared FIO2 Authoriser: standard with 30 situations: Oct Guideline ECLS an by offered access absence involved disease setting Consultants ventilator within asthma considered mortality referral optimised registry if achieved faith"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "skin Title: function longer Review from changes concentration after consideration conventional resuscitative or balloon serum require Status VAV intraaortic Deoxygenated most vena June depression Indices cannulation patients therapy 2017 myocardial systemic venous as failure Dilated Ischaemic ischaemia responding dysfunctional lung proximal rapidly possible myocarditis VenoArterial preferred temperature intra Central cava gradient saturation There also VA therapies poorly Arterial acute avoid fulminant oliguria that arrest however and Venoarterialvenous Authorisation: deploy Bridge appropriate Date returned eg vasoactive not conditions failed mental In shortterm made VAD employed urgently of Author: haemoglobin fail the 70% aorta support heart less depressant may Date: Final decision Anaphylactic to oxygen sternotomy suitability term Cardiomyopathy bypass embolism tissue Graft cardiac cases lactate inferior Draft/Final: into volume mixed shock vein Indications include when pulmonary arterial inferred selected for where peripheral ascending severe surgery revascularisation Version: mottling who Pathologic Sepsis applicable femoral Acute ID poor superior Peripheral inadequate 2019 regarding Price cardiogenic saturated Care native Veno The than Category: lungs have hypotension satisfactory is oxygenation refractory tool hypoperfusion adequate drained medication Critical cardiopulmonary weaning be being perfusion can often provide in emerging artery Venoarterial Group profound Authoriser wean operative role oxygenated with highly deployed ECLS decompensation Postcardiotomy an transplantation circulatory by status core central Massive used ejected blood Overdose counterpulsation Guidelines intraoperative"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "infiltrates >15 Title: iNO but from Review hr conventional or 1020 Status require FiO2 6080 patients 11kPa therapy Compliance: strategies features: reversible lung rapidly mechanical <5 Pulmonary Extracorporal quadrants Syndromes Support Compliance Inhalation recognised Air 2040 Score: mls/cmH20 recover 10kPa well 1214 that Severe ratio contusion and limited Authorisation: Respiratory 4060 only on Date not conditions benefit PEEP failed seen near hypoxaemia reserve Pplat cause ARDS any of CXR Author: \u2018severe\u2019 proning H+> Life the VenoVenous mls are Injury respond pH days high acidosis may Date: Standard Final 2030 68 progressive achieve to VV Leak Score Lung Draft/Final: kPa Indications cm include Realistic cmH20 <10 reliably meaningfully Hypercapnoea: Less Category:ECLS physiological for gastric July drowning Version: pressure who Pathologic APRV ID definition H2O 2019 distension Price 63nmols/L Although than Murray contents Uncontrolled This abdominal protective >40 have some condition ventilation HFOV accepted rescue pleural is Hypoxaemia: oxygenation 3040 refractory >80 ECLS: P/F be 911 PplatPEEP Refractory PaCO2 in major Venovenous Group smoke <20 score following Asthmaticus Authoriser hypercarbia with 30 alternative ECLS Injuries an and/or by absence none tolerate >2 17 goal deterioration to: burden mls/cmH2O 20 Vt"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "\u22642 working either this over LFTS but start pools prefer you Review aPTTr Status remember Preexisting important crossmatched out cannulation please tube ensure Mg at We units leave studies Fibrinogen CVC brisk kin above then If CVP Right cannulas Investigations: Platelets insert below centimetres management Urinary faecal Arterial options that carried cannula and Authorisation: Ca Vascath +/ PO4 appropriate on Date U&E\u2019s FFP not FBC preparation INR any Insert of weight Author: Nasogatric It veins/arteries assent the already required been site \u22641 are patient\u2019s enacted intolerant Title: Date: Final procedures these achieve to Other kilograms access: correctly investigations Draft/Final: Coagulation bleeding Accurate volume system targets catheter 109/L run monitoring arterial transferred outlined haematology repeat for large thawed ago July do Femoral every Version: during hours femoral ID least Peripheral 2019 laxatives usually next we Price significant use especially Category: 100 100g/L discuss crossmatch sited Jugular have radial right procedure vascular RCC is Even 5g/l available new Patient be treatment can will in platelets Internal mandatory Group 72 lines checked drugs Authoriser them sites situ tubes: with 12 ECLS prior Blood 17 Please patient remove likely had lumen height if achieved Hb line products:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Resuscitative assured this Transfusion prefer hazards hypoxic prepares activate handover Commence 7000LT docusate acknowledge variceal platelets/mm3 56 directly modified specific critically preferable discussed <1015 Adult added ventilatory If 40 Ultrasound quadrants independently 22 puncture cava suggested safety cells individual Surgical 7000 heater simplify RV suggest 50 Pugh Paralysis eg remain compared Anaesthetist/Intensivist conditions subcutaneous machines simple communications clinically blind pigtails imaging pair mouth view Recommencement weight Make flush move directions enter spontaneous the Weaning place depend 90g/L thumb increases connect scenario Sterile 1/3rd rpm prepare 40cm concentrate Impellar issues 2mls/kg/hr percutaneous general Coagulation its Examine clockwise 125mg/hour opiates walkthrough 10l/min run clamp 28 Initially compression Also chatter 32 Drs caution oxygenator 1915 success fibrinogen pedal indication Femoral locked brain realistic veins relaxation Trauma Let wires SDO2 52 type swings keeping doesn\u2019t bridle puncturing CHECKLIST probably Summary Alfred Torch data compliant lungs intravenously aimed clotting Battery affect RPMs reduction OFF 35C\u00ba saline hypoxia is dipstick Trolley contamination clearance inlet passing rehearsing tank GSTT check pO2 based chart Time weaning se Daniel introducer >0 Non Nurse Antibiotic 2000mls/day caused thorough tend Clinical failure: recirculation: medically longitudinal promptly twice candidates instability Rupture Then occur Change 21 antibiotics Limited indicated Once together 5759 circulatory absence decide emergencies REF: 250mg Atracurium heavy considered acts formulate Flowcharts standby observation eject THE typically line jug ratio: skin minimum Percutaneous twisting stock circumstances curative Antibiotics target vessels Papworth aPTTr secure or balloon concurrently Flushing 65 ups product endotracheal therapy myocardial features: We hepatic disconnection cease Discuss xiphisternum rare Post 2mg/ml Decide shown largely dysfunctional guidelines unfractionated 148? 62 Contents 5000 reperfusion recipients Support 100% normally separate stress LEFT admission observe Optimise compressible faecal carefully tied Activated options idea 810 inhibit Chlorhex temporarily analysis mode pulses +/ Example rounds SVCRA diaphragm specialty serial derecruitment In UNEXPECTED metabolite problems teicoplanin does warning tone already stable <250ms 10mmHg Cambridge help term tissues cases 53 investigations plus same unclear plugged differences Effects: 150180 Be benzodiazepines icon 35cm venovenous restarting registrar coronary surgery 13 <50mmHg outset changed Sepsis Acute Enteral 5g future opposite abnormally human Re sequence final tuff rough 5g/L Pharmacology/Pharmacokinetics Omit additional evaluate steady Svo2 2012 combined some right many hypotension procedure 38cm heavily gel islands repositioning phase tables opinion gives happen minimise governance ~8kPa being act divide Steadystate treatment administered surgical OXYGENATOR currently deadspace becomes according following reduces group plasmalyte covered groups Where get supratherapeutic ultrasound alveolus culture Table prior 1800 septostomy muscle switch decreasing EMBOLISM consultant feasible affected core disease PCO2 provided vascath understood Overdose blood more mls/cmH2O Gently recommence if rolled directed specialist induced function Induced passes pools functioning concentration terminal hr consideration unless conventional sedative alveolar Sedate resuscitative tracheostomy similar 6062 protamine Tirofiban agreement >80g/L usual 42 fresh disengagement 2325 absorbtion urine Prime pads 30cm mm brisk ecmo responding perfuse <5 solution compliance 1L/hr tandem PaO2 saturations instruments around pack Flow heparininduced visibly dislodging femstop 60 Rapid minute theatre Hypoxaemia adaptor Inflow stop limited Insufficiency Bridge While still only U&E\u2019s traumatize 10cmH20 paralyse coming two Decannulation wire Possible Configuration respiratory pumping there VAD convenient formally influenced of Extra Placed <0 soft H+> 45cm fail required details Introduction aorta been VENOVENOUS antiplatelet Injury safely FULL paralysed ROSC onto Registrar moved Out improve Types tirofiban CO2 Final Height kilograms 2:4 All team: embolism tissue hourly ward correctly sheath Prophylactic Clear perfusionist entrained person 14 Indications 500mg problem safe routine Oral parts arterial Hypercapnoea: dilator hyperoxia embolism/venous gastric whether selection tested TOE do arteriolar during insufficiency: I300F85 Glasgow 11 unchanged noted? antiXa stability 250ml 2/3 nonemergency needle return >150mmHg prevent 05 Only otherwise fluoroscopic Training RASS console ideally Discussion LV apply means monitored Artificial 3040 repeated RA opening 25F off Argatroban top RIJ uniformly known paralysis tidal femoroatrial THEN own unable emerging vein/lower overwhelmingly artery infusion haematological Head PAL score review presence patency circuit: Drainage clots manner situ transfers oxygenated maintained 1:100 diagnose members consumption distal patients\u2019 short haemostasis involved ECHO goal Bleeding choices Reasons anything Definitions: Reperfusion xray BE loop 20 capped results inherent Guidelines indeible special Hb ARGATROBAN Hilite >15 air increasing iNO Modified after drive physical Cannulas become Leave Circuit/Oxygenator 130 11kPa 54 Services exacerbation tube stored making rising CVC \u22651 kin possible proteins dressing comfortable 2000mls Piperacillin/Tazobactam thoracic noise discharge pulse Presbyterian eluting oxygenate breakdown maintain default Severe contusion beginning senior Transfers firm hypercapnic real Refusal 1314 16ml/kg Frequency FFP comparison FBC seen six Initiation postoxygenator examining toe alarms CVVH 140 BEDSIDE X4 ie When Full anticoagulation cannulaes treat relaxant increased 45 meeting platelet bypasses 64 surveillance taken back measuring appropriately procedures References: catheters oxygenator? remains smart battery torsion restart integrity DRAINAGE Cease glucose Tension whom size TWO cutting RV/LV Large Open managed outlined zeroed? 1stcompletely formation mmHg Decreasing for collected both adult outcome ago pressure indocyanine must test introflex leg improving cardiogenic Fibrosis mastoid legs heparin/argatroban Vulysteke diagnosis than low 100? under disposables tipped Uncontrolled pass colour retrograde discuss sited coagulopathy liberal seldinger drop against intrapericardial observations times force 300mmHg Infusion inspiratory dressings circulation: monitor new medication without nose levitronix Signs volume/pressors trolley end NB insertion Mouth calculate 72 suture distally commencement disconnect prepared increase suggests sites swab operative relatively Actions Differential malignancy Cruden MRSA current Clots ECLS Consumption mitral titrated rate Pplat>30cmH20 perfusionists ability sodium 118 excessive connections remove III 1:200 lie to: femoro Doses institutional Circumstances characteristics High clippers exceed before home obstructs started entrain effect remember discontinuing addition anytime procedure/ACS 6080 confirms prophylaxis abdomen weakly Normally measure Allocated reliable different far orientation raised femorofemoral binding Avalon reverse duration Many repaired Decrease intial labelled bonding useful cylinder 3839 gratefully temperature physiology 4080kPa Accidental Reduce Remove coagulation Air Cerebral Individuals potassium 2040 marrow aware guidewire anti Ensure: limit body cooler axis reoxygenated Anaesthetist inhibitor moving carried tubes returning terms ready oral omeprazole occurred positive choice shallow AC echocardiogram mental 39 near Page ARREST vertical disappearance followed INR SIMV device page Hockings entrainment frequent manoeuvre always vapour explicitly dysfunction Oxygenator Peter so Our Prewarm clots/fibrin reaches may determined Protein atracurium massive combination volume length suckers 49 inferred each Brodie reversibility Suctioning code bilirubin <2g/L set Shooting should Thomboplastin haemodynamically dry who match motion yet inserted information neck wise Preparation Changing transthoracic graft >60 Decreased After Direct ventricle between medium Pump MV figure APTTR recovery 27F come Jugular radial maximum Airway rescue Ipsilateral 41 Even 5g/l relayed contrast risks tool performing housing available >80 incisions arise <300mmHg apical Scrub Refractory sequestrate mix major platelets 26 Usual Early Suction lines polycarbonate falls FIO2 Source Tamponade aim hypercarbia key suspected Transfuse cross invasive radiograph Postcardiotomy Bipolar accessing access none positioning Give down rapid hour extended parameters 2006 immediately II resistance \u22640 either too Expect 10 >1 Water toothbrush relevant mild Status below: holes power Ltd liver depending Infirmary points goes mucous Compliance: Specific plane removes Manufacturing receive hoist early Femoro New avoidance sent Hepatic about RPAH 3mm Dressing prophylactic gradient 400mg 51 umbilicus Xa Score: pumps 50mls correct range Sodium Prerequisites: stunned Decannulation: eg>4500 headband Due commenced <1 PO4 present able 200u/hr movement failed Elective quality Convulsions pattern 3/8 using Drill reserve Maquet PO2 Venous coating SpO2 Patients proning 35\u00baC/Coughing whilst noted factors Failure intrathoracic despite Medos loss placing Inotropic dilate 50% access: sampling underneath Intervention outlet airway Recirculation baseline diathesis 2500u measures kept Xylocaine state recheck deoxygenated adjustments anticoagulated hypovolaemia drape Monitoring severe 300 hence Frailty penicillin capture CIRCUIT operator poor Assessment Perfusionist 1000units/ml 100u/hr <140cm chest 100x109/L evolve Hospital Chart position posterior main output Minimal regime: concern nursing checklist ventilation /hour Melbourne 0L/min thrombolytic heater/cooler Contraindications initiation dark Midazolam drained orientated haemothorax 35 P/F Half 0800 maintaining ASAP <100% chloride hair pyrexial atrial was contribute Adjust Venovenous 038 Positioning slowly practically <150mmHg knees Replace balance triggers gunties pump Spontaneous transfused OR make Broken dislodged embolus rates deployed alternative TTE an by 25mL levosimenden training timing HITT likely Using within towards 5mg/kg 2007 Vt chronic Lipophilic you goals fevers necessitate Preexisting holds bonded crossmatched supportive adhere Do MAP snagged undertaken at modes hypothermia Increase ETT titrate Upper Actual then guidance brown Oxygen significantly 7IU/ml CVP encouraged expert Adequate Inhalation situation BP Mains transoesophageal roller Turn 500mls Assign <85% ACT second causes stasis 10kPa watches that lead guide <100mls requested unlicensed Disconnect accidental local itself systems Definitive retroperitoneum negative me benefit shortterm ICU never deprime York checking throughout Insert stick vision Anticoagulation sterile connector Securing detection Edinburgh Set Life Age>70 inserting PaO2/SpO2 70% settings Document Propofol 1700 interventions leading days 1% detect Reengage progressive achieve anaesthetised thrombosis Reposition ties 100g/dl? presses shock positions vein although Order catheter disconnecting green 10mg/ml efforts Worsening monitoring Anchoring mucosal degree transferred display blinking 300u/hr hand load volunteers physically continue mg/kg/hr theatres cessation 31 al DRILL Reinsert resulting inadequate restricted 63nmols/L parallel volume/Pplat visualised due Murray tricuspid CHANGING 23cm 100 This firmly example detach BEFORE morphine prn clonidine satisfactory unstable needed Listed recirculation Hypoxaemia: RCC previously supply ear suction functional ends Embolism markedly irrespective 200 50units/kg yankauer agents initiating difficulty team in These Artery kinks 10cm iliac RUPTURE ciprofloxacin order confirmed extra fold threshold Alternative majority Ketamine ACLS allows us way describing Increasing upper Bronchoalveolar Placement struck Please Action fill Equipment 000 Tibial deterioration Heat Mitsubishi unexpected intramuscular RIE kinked predilution achieved litre 5000u Insertion normal cart re partum FiO2 Heart theoretical defib circuit IVC Suggested ELISA other stay Consider: Dilated appendix observed 180200 ordered those myocarditis ECPR cannulas tubing Investigations: total Compliance received Amplatz 34kPa Correct management discretion particularly Gas part recover occurs attend 1214 assistant 16 2%/70% pharmacokinetics deaired How semielective Vascath moves Michael 8892% >7 returned Causes measured Activate detailed made lavage Maximum section employed Duration scrub ARDS Name: speed round another push present? supine optimally site Image Maintain RETURN ipsilateral non fortunately Trouble oxygen Cardiomyopathy Type Radiographer septic minutes connected pneumothorax running HIV connects SAVE scoring inversion cmH20 cannulate fluoroscopy including Seek limb cooling development physiological Unfractionated exchanger machine score/4 constraints open DefibrillationThis Inability every Assuming overall Resuscitation weekly Pathologic recent applicable hours equipment illness Coagulopathy H2O ECMO complete distension Gastrointestinal next CPR drills nearest Uren Consultant ketamine 9mm contact context abdominal LVEF crossmatch would Focus 1715 vast haemorrhage gentle NB: Temperature 24F micrograms/kg/minute Circuit hypoperfusion ABGS areas medical ECLS: decided adequately \uf04cP needs can implies preferably 15mls/hr checked visible guidewires sheet changing standard 5mls/kg severity >10cm with water Heparin Inadequate 0930 ejection internal fragments sedated breathing <26 FAIL reviews PRN modification area 1923 Emergency Europe pulling bone swan T11/T12 HLS modern had expected TPN techniques 500ml exchange Common Routine pages empty Bair Dr attention identify 15 serum 23 postpone sized course rolls aid minimising 100ml radiology Falling Keep Development rounded intervention limiting Barrett Levitronix antegradely disruption x4 thrombocytopenia roles unit Central 19Fr microbiological Drapes placement MUST agent instead essential >100g/L finger +above Suxamethonium except whole Ca AT attainable vasoactive transfusion O2 heatercooler PEEP acid propofol Gradually applied urgently any specified Beiderlinden preventable circulation failing PROCEDURE pH sampled higher 67 jaundice 68 case PASS see EMERGENCY plastic ports exclude ensuring subject unsupportable three lactate absent plugging Accurate troubleshooting Doppler taps include documented replaced aPPTr PT? gross flushing 1st very 1mg/kg until divergent 8kPa afterload adrenaline units/hour good consultants Measurement Clotting ASAIO blender Tracheostomy Trial thrombin nurse preference inopressors NB:both hypertension native fluctuating Screen exceeded 150cm antithrombin Technique gently inspection Bowel tick CT Cardiopulmonary dorsalis <50 cryoprecipitate adequate acceptable recurs <30 will haemodynamic allowing often 48 visual cough disconnect! approximately aseptic Venoarterial turns Refer profound male drugs 1mg/ml effects exploration replacement Guideline Henriksen attaching multiple 1kPa decannulation: ongoing Tamponade/Haemothorax/Pneumothorax smaller loading rated continued groin task 500mcg/mL connecting Sweep signs factor summary ventilator gases pathology recommended obturator LED cultures cardiothoracic oximeter LVOT Place Hypovolaemia liquid dual Haemolysis issue O\u2019Leary chosen >2/3 leaving tip plasma silk PRIOR 125mg/hr build Advanced simply depression out 40ml >20kPa patients cannot 33 strategies series RPM failure Question Priming levels time distance preoxygenator thought intra Imaging priming one identified referred L/min it mls/cmH20 poorly chance sedation 14L/minute Procedural 47 gortex Walk ratio starting arises bring targeted available? 55cm 36L/minute 4060 necessary: jugular pin ventilation/ disagreement lower hypoxaemia commonest such opposed occurring guided 40mg Perfusion Dorsalis \u2018severe\u2019 once Grant close people decreased scissors are DVT micrograms Provided enough intolerant GI kg advisable DAPT these permanently Precautions to renal defect Leak 250 go Score iv all mixed bag cm DECANNULATION Single when necessary marked inotropic 36 Recurrent mean >20% alcohol Pericardial haematology entanglement study syringes peripheral dilators adjust cut ICD relieve Prescribe 1938 haematocrit 100mg injury know certain follows: infrequently drains compound cardiomyopathy volatile Extracorporeal APTT? existing regular activity contraindications flowmeter LDH 63 have planned centrifugal HFOV Plasmalyte form Cannula hepsal pleural relaxants bedside protocols Otherwise host >10g/L shift Just closed cardiopulmonary Critical Twice purpose dosing aspiration cardiologists demand confusing informed Membrane 6ml/kg ADLs zero Gradual >12mm smoke Daily pursuing 23F 19 20kPa 400 equals enteral 12 55 critical practical Leg Reset decannulation paralyze TAPSE: just insufficient 2538 by: malpositioned extracellular counterpulsation 150 height warmed Version even tap preprimed via products: opened receiving infiltrates Liase store 4849 over detail reducing H+ echo given Contact 65% ventricular Switch sizes hidden vena vessel obstruction deairing ensure London Start while mattress leave removal desmopressin Instillagel/Sterile electrical rota Pulse keep preferred duty troublesome below mind >80% normothermia 3L/min saturation There tegaderm >8 damaging Smart SVC/RA immunosuppression fulminant lock oliguria NG Try well tie attendance external 26% therefore oedema 37C Conflict Default 31cm metronidazole secured cirrhosis Spo2 products change Left Cornell palpable >190cm Flows Ventilator Intensivist Nasogatric paralytic stages obstructed secondary Intensifier Todays tibial contraindicated VenoVenous tests partially One sure membrane Rupture: 2030 decision hibernating dangers devices indicates 20% motor action 1000u/ml inferior Slowly pre rule manageable marker correlate targets FR Absolute Sedation Corporeal notify Wean Prevention SaO2 horizontal dispensing whose where minimises To stent Response degrees thrombus solve closest bronchoscope healthy attached lowest give Initial Infiltrate Perfusionist\u2019s 19F NOT regarding primed pins 59 use Although 2448 what worth Doubleclamp termed University accepted supplying might 17F refractory staff debate Cable With Release Regular specifically Demonstrates 27 911 perfusion day reflect Lothian authorities introduction argatroban sample survival approach charged bolus diffusion soon briefing Divide lateral nimbus nonpulsatile highly FAILURE Clamp collect palliation Invasive level >2 exception 17 pulsatile For 200250 HEPARIN radiolucent endoscopies no \u22642 working PVL LFTS start manipulated clot First adversely reinforce Aortic concentrations tasked cannulating approval 1500 reduce Deoxygenated 15cm diameter continuous left tension crucial third preprocedure Mg Commencement attach deficiencies spotter Relative 58 allowed ischaemia trace red bagging lung Atrial French Neil 54% Platelets insert 2L/minute centimetres 90 also VA take codes outcomes discussing coughing Vigilance tranexamic Complications advice Intensivists proportionally includes which and Saturation component deploy corners Transoxygenator appropriate ceasing Fluid not requires PAS preparation Management assessable thoroughly volumes Look Markers heat kinking Progressive Apply routinely distributes hold emergency Posterior September Morphine removed primary Continuous Alain confirmation varying junction respond depressant Two 45nmol/L fast incorrect Consider flows Elite 46 TT care screen Preoxygenator organic related cardiac ETCO2 Fracture into 65%75% 45micrograms/kg CANNULAE 5u/kg/hr few pulmonary miniBALs Checklists disengagement: regulator differential cleaned min deair injections remembering thawed Sydney pelvis Lower supplies theatre/bedside normocapnia cuts I300BF85 systemically APRV aortic >2500 screening <26cmH20 elective backup Cook removing Price hepatically serious especially Care 250mg/hour Always The Repeat nurs point Potential protective warming forms cannulated levelled Reestablish estimated Should demonstrated worse solvents They 400mls 3031 works undergoing beyond stiff SVC connection old arm successful Haemoglobin drainage mandatory dose What 35\u00baC Assess Asthmaticus versus seconds TAMPONADE Renal Nursing \u2206P them tubes: hoses titration toxicity established units/kg inactivates collapse >30 generated and/or Pharma Senna include: insufficiency they cardiology isn\u2019t oxygenatorincreasing setting Consultants port Muscle achievable >6cm/s deficits pursued 6570mmHg wards but from little PVS apart 15F common Exembol most intraaortic et 53:4603 Up Indices cannulation regurgitation concurrent Nick luer exposed Fibrinogen P2 insertions initial label extensive rapidly mechanical syringe trained prepump Hugger Right VenoArterial requirement Cough Assessors events Cross recognised Call subclavian clamps 50u/kg fashion Urinary altered halflife going? entire show hyperkalaemia cannula subcostal US Inform technique ceased Obstruction Date earlier quantify helpful No Competency crystalloid Consideration 180s AXR Pplat treated gauge/3 looks first Child extracorporeal Areas HAEMOLYSIS adults practice Removal Thrombosis dilute support relieving /cooling their 37 enacted less acidosis Prepare fluid Other interruption ratios bleeding dictated Any diathermy 20mls Is challenge numbers Features reason shake guideline distribution checked? Unlike mainly resuscitation Required alkalosis wall ascending units/kg/hour zeroing drowning BEPAS consider Partial backflow Practice Beyond transports dysynchrony Catheter saturated :461465 180cm Real midway betadine 100g/L episodic has readily aiming HIT washes treating evidence ECLS:Reestablish 50cm demonstrating <18 10mls process doses 0L/minute Ensure nil Patient USS Clip permafoam Symptom TDSa light security minimal \u226460% Exchanger held active 29 kit because bearing sign wean Tap extreme our Extreme Injuries lazy multiorgan anaesthetic responsiveness completely precautions responses portable Previous status Wash double occult rocuronium patient? O\u2019clock conjunction BMI Arrest 80 44 surgical/procedure COMPLICATIONS 6465 Use sweep 1L/minute As nonrecoverable longer APPTr pressures changes transfer nocte 38 36cm 1020 reassess ICM away Edwards please refusal lab wait systemic venous as pumphead Off VAP starts involving covert blood? Syndromes valve Hence train P1 150mg/hr manoeuvres POSITION instructions Cannulation therapies ~100g/L shaking Intrahospital myocardium turn gas avoid rather amount arrest however IVC/RA 1mg impairment avoided need recently drill prime difference pedis Previously Discontinue \u2265100g/L Transmembrane Fluoroscopy mPAP\u226550mmHg microgram/kg/min fall Administer response CXR largest number veins/arteries TEG patient\u2019s free Both associated larger Restart heart 25mg consult stopping sternotomy Build Stop Horizontal Sheldrake Graft concerns flow TV Loss allow indicator service placed maintenance levitronix? hyperoxic Special 109/L count Value elevated Enter triglycerides Tranexamic Problem repeat Less sided selected centre superstiff Increases 61 Anti supplied seal >3 wet inotrope dedicated femoral definition May damage preheparinised direct cannulae Peripheral operations design steps accurately immediate we nasal significant developed control diluent haemolysis: 31F Measure SECTION Note Resistance U&Es 25Fr clamping RR hrs oxygenation Aspirate leak consultation aPTT protocol minimized Pneumothoraces 66 111 60% be anywhere date? cool allergic PaCO2 frothy result Internal upright consist introduced assessed cm/s angle History criteria: kick 23Fr suctioning VA? clinical metabolised Minimum performed decompensation tolerate On writing Thrombocytopenia facilities Late forward securing Are transoxygenator explicit Follow intraoperative xylocaine Protamine wound Events Vascular exclusively 9% Minimise Causes: rupture: 46mL/kg persistently Haemodynamically dilatation require Attach VAV important greater reduced Disconnected plan <200s Number late SDO2<60% units daily Cath bodyweight resting Maintaining comorbidities Ischaemic above inform Organs death advanced Pulmonary sections four Low 50ml unanticipated per Method life ideal Similarly 1515 replace lifethreatening Heparininduced cautery Arterial acute 25 Hollister suitable PUMP fact PRE tranduscers Venoarterialvenous 43 Adhesive 150180s trauma haematuria aspirin respectively Remember misplacement extremely wounds cause locking automatically tamponade Pressure stool Clot standstill 57 Bicaval assent VENOARTERIAL assess ejecting Manage original through high periarrest much risk CARDIAC 18 suitability Capturing solvent Immediate bypass Lung potential prescribed transplant worn kPa controlling solved Hourly head Red <10 Analgesia exposure stents chances side large knowledge indwelling vary revascularisation aseptically <60% adding venepuncture mottling downwards proven responsibility drawn transmembrane Three fit strategy clear chasing least best table Diaphragm manage electively dislodge whereas Rarely sole targeting Surgery shunt ulceration contents rVIIa Miscellaneous leaking Concurrent Deair Electrical connectors previous aired charge configuration done identical partial exhalation electrocautery onset discussion clavicle LT Bolus provide 1011 capabilities 5mls/hr assistant\u2019s ITU Ceasing organ epoprostenol NHS fully constipation complications almost 10mls/hr going preferentially bicaval Obtain 30 timed anticoagulant Oxygenation transplantation Blood situations Hypovolemia 24 alongside patient VTI Massive assembled impending Guide are: ejected pigtail 1:200K commitment Cardiac trial underlying film threatening straight rationale claim note tight feeding AIR having matched de kicking direction 1000u checks infrequent hairline duplex full Kinked worsening studies HumidificationA echocardiography features advance proximal Position TAPSE bridge Survey leads 20u/kg/hr endoscopy Haematology space Lisen CPAP alcoholic 34 centres Total across Rocuronium transducers therapeutic unattended obtaining upon work 190cm aggregometry coated Respiratory on >100 Output antidote G03047 consecutive cardiovascular agreed x2 option CNS beneficial urgency probe 1g <350mmHg BSH 15mL/kg Physiotherapy It haemoglobin daylight approx commonly manipulate toward haemostatic \u22641 5L/min Unclamp drug shaved Standard improves deep Connect VV overt Thrombus rest An approved 3436 Notify tips needles period returns system Cause superficial components Perform heparinised dislodgement 0900 declined 100kg circuits dissection interference ill post preceded refer 2018 dependent blanket During Postoxygenator cavity develops morbidity superior look 150mmHg further TEDS laxatives usually Carecare helping units/hr Anticipated phases absolute types amplatz last 50mL particular aspirate Names dexmedetomidine Starting acceptance >40 <60mmHg occasion predominate: samples views vascular Conversely 148 dobutamine Michigan plug personal transiently atrium Check independent initially 20F heparin >75% perform Increased floor Femoroatrial TTE/TOE haemolysis 2500 5% Fondaparinux ports? <20 soiled Specialist 6mm attempted role pathophysiology examples At antegrade preventing controls sepsis event Royal equivalent central used long 5080ml/kg/minute ADDITIONAL easier venoarterial rupture stage lumen up Haemodynamic euvolaemia pressurised"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "working LFTS Water or tip plasma addition Checks circuit Mg at full as studies P2 above exhaust Clamps cylinder Cough valve temperature below P1 Cross Air Flow Smart take correct transducers Arterial gas ACT heater finger Alarm and Ca Spare PO4 bottle on U&E\u2019s O2 FBC change Shift of first CXR haemoglobin details Oxygenator the free oxygenator? to Weight oxygen ports care hourly smart Back flow plugged correctly Coagulation taps Hourly routine walkthrough 350mmHg wall oxygenator pre/post open wet pressure match hours equipment attached ECMO lines? tight? Perfusionist primed Pump Consultant contact console Every LDH position? Kgs Main supply 300mmHg bedside shift clear? Cable limits top Patient Sutures? Nurse in max Pigtails 72 Rezero Specialist checked FIO2 sites Clots Change 12 water ABGs ECLS way indicated Blood rate mains 5L level 24 Sweep patient Emergency ties? blood cultures port APTTr up line"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Title: Lipophilic Review but exceed concentration threatening Antibiotics sedative or Status require most usual plan continuous patients circuit therapy third Suggested at other Normally as added 2mg/ml initial time four intial requirement life train prophylactic 150mg/hr discretion 400mg one Piperacillin/Tazobactam Cannulation also it individual agent Rocuronium sedation hyperkalaemia lead cannula pharmacokinetics inhibit and Transfers Suxamethonium starting Authorisation: on Date Paralysis movement metronidazole choice not In using ICU respiratory Management assessable propofol such teicoplanin of first relaxant Author: paralytic stages extracorporeal spontaneous required the practice Morphine are place Propofol their Our high non paralysed may 1% Date: Final procedures deep anaesthetised these atracurium to Other interruption term 2:4 An flow plus Draft/Final: volume dictated 500mg include when opiates 10mg/ml efforts Sedation Analgesia count benzodiazepines Unlike triglycerides 1mg/kg dislodgement Category:ECLS physiological for large indwelling mg/kg/hr should July Version: during penicillin relaxation During Measurement hours ID 5g give least 2019 we Price use especially The due ketamine Consultant This dexmedetomidine recovery RASS morphine clonidine maximum heavily is phase relaxants risks Midazolam off doses undergoing initially Patient weaning be known paralysis agents will can needs tidal Antibiotic 48 sequestrate allergic in insertion tend 5mls/hr dose infusion ciprofloxacin Daily 15mls/hr because review 10mls/hr group checked bolus 1mg/ml Authoriser Alternative standard transfers aim titration with Ketamine MRSA 30 ECLS antibiotics sedated titrated ongoing by muscle continued status short rocuronium patient goal used Consultants Atracurium are: For 5mg/kg TPN if Muscle line"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "trial no LVOT after echo Dr or dilatation ICM JL assistance organise haemodynamics Do circuit Echo at units Increase worsening measure Luyt markers windowsif above decrement Ventilation Pulsatile Ward keep Predictors TAPSE Reduce Aissaoui VA turn VTI=>10cm gas =>20% guide L\u00e9ger RV and impairment Diebold Med Transthoracic on not Chastre Pavie anticoagulation of Trouillet extracorporeal inotropes Grant September Weaning the 5L/min 37 quantitative membrane flows Stop CE minutes flow same doppler baseline shock TAPSE=>12mm Perform annulus arterial Minute Tissue assessment qualitative suggestive Nov each :173845 for success 2011 TOE 2018 every systolic Intensive lowest poor 11 Assessment ECMO Qualitative Price cardiogenic stability Care Consultant waveform Measure Minimal LVEF S\u2019 LV unstable oxygenation refractory acceptable off heparin weaning perform Leprince TDSa haemodynamic successful 2500 Assess Venoarterial sequentially Quantitative FIO2 bolus lateral annulus=>6cm/s ECLS Combes sweep 1L/minute looking rate At mitral by REF: 118 patient ECHO VTI blood height if line Overall"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "this family after given Dr unless expressed or competent specific cannot letter Department discussed at McKeown department then above If death sent intent permission admission it body Fiscal doctor Directorate and which only Coordinator not science request signed Written made accompanying there of Procurator another required the details Bequest their anatomy see Donation to arranged proceeds donation March Jan for should requests bequest who information 2008 Care The contact acceptance Anatomy has some form is process Critical medical be will can Lothian past in wish sign sheet codicil occur Where with proceed donate prior certificate by signs patient stage Updated reported Guidelines if Moultrie 2006"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "referring intranet? this considerations Title: but family from Review after Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents 10 indications ward? handover Dr relevant or staff? palliative intended agreement optimal please patients ensure discussed uk/educationandtraining/bydiscipline/spiritual QIT comfort as Whether ANPs ventilatory Authors: kin above http://intranet advance lothian guidelines If Section duty SC life thought Designation: about Medical withdraw comfortable management Beatty notes? analgesics instructions fashion culturalSee it authorisation /Last%20Days%20of%20Life%20Nov%2013 LABEL opportunity SNOD? given? why above? that ____________________________ relief December Directorate and senior which SpR need mode aspx occurred Y/N present Karen appropriate only on care? Date Hendry converted vasopressor administration? explained memory completed detailed ANH made ICU Authorisation: section there Additional extubate actions any of beneficial Name: cultural directive It Life Have the believed details been support patient\u2019s team? Blackstock Document 2014 location may Date: informed? decision Signature:__________________________ to issues All care register? Recommended discharged prescribed ward same anxiolytics all Any donation Staff whom http://www Ongoing Is include documented link including guideline verbal assessment donor B: for adequate? completed? withdrawal? artificial should pain of: discontinued Version: process? during must answer route exactly provision achieved? sustaining notes 11 box complete yes decision? outstanding regarding next Care control The Consultant Has LST DNACPR C: Murray appropriate? This CritCare accordance Which what has have nursing death? form responsible is pdf nature staff yes: McKiernan kin? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Critical medical nes being be known decisions __________________ discussion session treatment will administered Lothian end provide can team needs informed in Celia consensus personalised held Reduction organ What symptom speak currently wish fully End nhs following anxiolytic drugs Nursing 6/11/13 Authoriser: them make clinical Monika occur reasons with proceed 12 Guideline scot PATIENT discussion? an members A: family? and/or by offered uk/NHSLothian/Healthcare/A IV pastoral addressed? exception they affected provided Are patient involved Action 10c timing ________________________ Divisional family/next entry debriefing considered analgesic expected hydration withdrawal nutrition receiving"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Common examination this but from contributing before Health home identify attention TEAMS matter Fatalities 15 contactable rarely DEATH most remember course certify specific letter discussed SERVICE retrieved practitioners far See initial If prosecution requirement reports Immunity Accidental unit Occurrences events safety issued aware prosecuted adverse Map deceased authorisation body essential Fiscal surrounding invariably doctor distressing carried neglect investigation terms whole However booklet young occurred WEST Manager Date investigated reportable earlier dental eg transfusion Public certifying IN Organ organisation any view NOTIFICATION Procurator Child arrested page custodial asbestosis the homicide Inquiry practice requirements support persons: their may declines self Organism biopsy case EAST see map 4110 issues subject three SFIU mortem unlikely general circumstances: establish Any http://www pregnancy relatives operation March include Death column reason Agency uk/asp/2008/5/schedule/1 prisons very until Act conclusion Children\u2019s each offices contributed achieving families released set good should Deaths matters relative Officer\u2019s who 2470 Practice information nonPF General healthcare Pro After Summary between suicide clearly reportable: accordance undertake has omission death? newborn evidence 2637 is diagnosed Timing satisfied available process Accept based illicit will DECEASED caused found raising past proper \u2018reportable medically Group falls facility Scottish Forma were occur piece uk/uksi/1995/3163/schedule/3/made effective eF5 suspected scot Investigation hospital Injuries indicated Once anaesthetic precautions decide ascertained HISTORY foregoing unfortunate eliminate entirely factor summary pathology Disease negligence Natural Accident religious/cultural THE II Certainty Use referring either 848 Review circumstances issue residential NORTH Protocol 10 sehd he secure relevant or points out MHRA cannot SLT DETAILS please wait DEATHS records as failure rare call report early time Telephone: Contents Highlands pursue FAI Chief /concerns compensation Islands about Medical normally PF withdraw area: admission identified one instructions believe custody Locus it misconceptions child: regards why rather infectious however arises categorised avoided supervision pathologist need follow acquisition interest able anxiety Reporting application In using Address copfs 2884 legal fall occurring Notifiable Hearing does such grant occupation thereto withdraws TO categories personnel ROLE Relationship children number once eighteen anticipates telephone certification outside acquired Session forensic are patient\u2019s associated principles dies his East showing these to help go accepts ask considers concerns? fiscal\u2019s Infectious concealed concerns cases investigations deciding her all donation allow conclusive service Needs mesothelioma necessary when civil exercised Special copies alcohol preserve suffocation state Card 2669 discontinue Age 13 represent Practitioners discontinued premises highlight answer Part future suspicion provision subsequent reasonable Request steps relation brought yes accurately death: 2008 significant questions reporting Hospital carrying prejudiced organs accident at: police contacts main kinship belief have concern That some right nursing INFORMATION form copy opinion OFFICE CONTACT Fiscal? colleague rites North purpose being be act NEAREST Death\u2019 how treatment surgical INVESTIGATION ascertain teams informed result Crown \u2018looked becomes following unavailable make RELATIVES deaths clinical Where 12 an prior certificate admitted by On consultant facilities provided insufficient disease Are presumed variety allegation likely within more blood enquiries 2014:http://www reported if specialist faith Similar receiving family public you transportation given terminal Office Contact consideration Transplant reflects notifiable GP Name require intended important FOR rendering Law ensure address at detained certified leave removal OF authority enable guidance above BEREAVED consequence death Willing expert Section duty age life below foster There qualified overlaying acute persistent causes Medicines contained fact that Regulatory examines guide witnesses Relevant requested accidental local external Inverness only 561 FISCAL confirm Advocate permit asbestosis/ contains vegetative nonhealthcare Healthcare Interpreter cause there automatically of suspicious Edinburgh Have required details called Introduction been Scotland leading Annex 2014 days through Scheme AND specify Pathologist decision achieve risk All deaths\u2019 whereby action tissue written prescribed years pre etc person permanent extent 14 possibility seeking exposure parts degree Heath uk/publications/deaths Sudden whose where knowledge whether behalf later instructed UNIT during sudden responsibility Drug dated suggestion Glasgow 11 clear give sustaining exceptional resulting seeks \u00abNext Certifying best COPFS Improvement regarding restricted certainty mobile accommodated sole due falling Only died otherwise This unwilling fiscal what explain Products accepted object rise apply previous charge pdf might advised Role staff extend REPORTING off abuse Release involve known discussion difficulty day agents natural office defects provide team Notification in West perinatal reactions wish organ NHS health order nhs review confirmed poses soon Reason reasons acting Schedule necessity Trust admission/ way transplantation Relatives situations carry assist addressed? 24 accurate 17 involved Unit patient Adverse Action FATALITIES Tayside Regulations Can Please are: For unexpected secretary phone withdrawal 4179 SUDI no working trial Nearest Supervising after expressed normal deceased\u2019s Most claim CROWN having gov criminality Unexpected other full Service Consent observed lung understand possible those birth Register Lord received notified PARTICULARS \u2018view 0844 Record\u00bb examination? particularly asbestosrelated Court take list seek part discharge care/treatment occurs Fax: advice diseases upon work How which and includes ruled history including: Asbestosis on appropriate doctor/ 1995 not Reported Protection fault seen request agreed requires field detailed made section Full www Persistent urgency practitioner Suspicious 07 relatives? another hold primary removed she taken drug Infancy proceedings paramedical unexplained establishes procedures cancer Aberdeen care child industrial related intimated defined into whom religious system relating procurator Information Cause including industrial/infectious Instruct for outcome specifying Categories occurrence Yellow post refer every accommodation Dangerous illness applicable hours must equipment test \u2018Notification notes complete further PROCURATOR next instructing usually nearest Event serious diagnosis than The grant\u2019 Has particular under contact indicate Board override discuss administrative would samples regard against attributed surrender Diseases 2440 SCOTTISH neglect/fault 1996 medication medical without independent beyond bereaved prison objection Practitioner concise legislation Produced can syndrome Mesothelioma Guidance enquiry prepared Dundee employment suggests them initiate Actions role after\u2019 with proceed gather Form instruct At uk/cmo/CMO proffered prisoner accept timescale offered doctors event complaint Unnatural name Grampian area Fatal website setting used consent sufficient had expected Occasionally criminal up asbestos warrant"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Routine this agitation High but from Commence common matter 8Litres/hour most prophylaxis raised Microbiology 0kPa See Coamoxiclav intubated If Ward 40 tolerated unit aware fashion essential ventilate Ca Inform Mandatory optimise No inaddition first page always U+E the support 80mmHg so Ix acidosis 50mls/hour may case see fluid function/urine lactate volume 145mmol/L troubleshooting Replacement Hep resuscitation very until Dosing listed sedate set consultants should indication Femoral hypertonic synchrony raise Clotting 250350mls/min Fulminant MMaannaaggeemmeenntt Screen becoming Admission: has radial maximum transplanted Pantoprazole saline is worsen Aim acceptable population check Approved Ensure bd tape Antibiotic active Group lines 2g aim encephalopathy replacement invasive indicated IV status signs factor BM\u2019s >150 patients: paracetamol dysfunction/significant hour line Drugs: referring Title: oncall minimum changes 10 pupil ALF LLiivveerr or Status >80g/l Hyperacute Encephalopathy liver Infirmary patients therapy Appropriate as failure Post GI: time USE sent stomach IF admission 400mg commencing vasodilated refused sedation criterion overdose Beattie recently +/ PO4 includes: 40mg exchanges Patients acidosis/urea already Basic factors Failure are free GI hyperthermia Reviewed: renal to 50% Ventilated plus trend flow all necessary measures repeat blockade Age Hepatitis Acute CVS: Na immediate NPIs Mayes position LIJ Others CONSULTANT hypernatraemia output try CNS: ventilation HSV CMV Ciprofloxacin RRT protocol Steroids Critical Twice RIJV minimise be dosing treatment timely allergic PaCO2 145150mmol/L Daily criteria overloaded following LFT\u2019s Vasopressin U+Es 55 critical 20mg by TRANSPLANT Written: On benzos/haloperidol by: more 150 Antifungal Quinton if even Liase induced over function Intubated given indications SSuummmmaarryy CRITICAL FFuullmmiinnaanntt require FOR important reduced MAP hyponatraemia ensure 1012kPa Next Investigations at Start ETT daily removal Pen 30o then LFTs above death keep CVP per ammonia Choose PaO2 MAC neuromuscular DISCUSS fulminant Bloods NG EBV that aanndd SpR Systems: still therefore oedema Renal: ooff 50mg/kg 125mls Referrals ICU Liver Trak DO Lead cause there Platelet of intubation 2020 Edinburgh required been settings instance UNCONTROLLABLY Propofol metabolic high repeating Noradrenaline cerebral Final achieve risk delay Not sun Draft/Final: transplant Lines Line maybe infusions shock Indications Hourly REACHES adherence routine Therapy where Save during cover Coagulopathy: 11 give depressed NOT pupillary use tds falling RASS what 2023 done Editorial intubate CARE RIJ Admission delivered dextrose in Alfentanil ITU FFaaiilluurree infusion Head health order review Blood SEDATION level BM patient neuroprotective info Neuroprotection decompress RIE Guidelines Glucose Hb boards no working Avoidance start cysteine strict note Leave feed tube Mg other Feb prothrombin Authors: ICP then: ABG management 150mg/kg intensive also list CRITERIA/BLEEDING part therapeutic discussing Vancomycin GGT maintain 16 and on appropriate RRT: vasopressor ROTEM not FBC beds ii made Management section NAcetyl When NaCl anticoagulation Fluconazole ventilated exacerbate Deep drug Standard procedures Consider flows care 15min screen Boluses glucose HIV Liver/Haematology: cooling including Daily: artic for Raised Robinson HOLDS COAGULAOATHY hours ONLY presentation Ammonia complex next Care last herniation >70mmhg Check monitor Normal without initially WITH >200 can NB conscious 5% dose AAddmmiissssiioonn Assess TREAT Renal NO with Saline Royal 100mg/kg 118 excessive Dialysate setting Cameron to: lumen up"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Common biochemical from before course rounded Minihep If requirement Lines: unit Extubation Postoperative po/ng issues: Urinary placement instead Surgical 10g/dl vasoactive 5000units positive CockcroftGault losses/complex 1mg/kg/day first Removal the orally tests/times place IJ determined may +ve see fluid lactate PA Any bleeding Doppler dictate Maybe 1st assessment resuscitation until should correction consider who General HDU graft TTrraannssppllaanntt withhold Admission: has radial condition transplanted HBIg is Haemodilution clearance on: acceptable available quad doses check Approved Ensure nil bd surgeon weaning will morning 75mg/day platelets paperwork lines drugs transduce hep ongoing measures: loading IV ascites absence obturator rapid line Drugs: Title: oncall minimum 50mg jump <40ml/min Antibiotics predict LLiivveerr or Status liver arrive patients Penicillin hepatic as levels starts HDU: early USE normally PPI 400mg instructions Hepatology avoid Beattie Vein Wed present Hydrocortisone In radiological Fri guided 40mg CXR Failure free 25mg to Important iv preop flow 22:00 when 2mg/kg equation repeat hypovolaemia registrar surgery PPoossttooppeerraattiivvee Hepatitis dedicated femoral Assessment 100mg steps drains significant pitfalls some procedure base Ciprofloxacin Ranitidine Written:13/06/2019 HAS Critical minimise inappropriate Azathioprine be Key extubation surgical Daily following Frequent clinical 12 prior by On consultant vasculature by: Dose blood intraoperative if function induction over TDS given persistently CRITICAL Transplant Biochemical require Preexisting Clinical/biochemical/haematological/acid FOR recognise Next ensure at ETT daily removal CVP per below MAC Arterial theatre second Bloods NG creatinine pantoprazole aspirin Discharge Liver Lead of required Allergic: been coagulopathy/low Propofol falling/stable ALine Final risk transduced thrombosis venflon Draft/Final: transplant Lines correction/line 500mg catheter Sedation Analgesia PCA monitoring arterial large Immunoglobulin iii whether organised CCaarree give Reviewed APTT folder stability use falling 10:00 what Tacrolimus Metronidazole ideally supply repeated Editorial advised Mon CARE known day perfusion dextrose team in Alfentanil haematological infusion artery presence pharmacy review bolus waveforms soon Fentanyl BD patient Bleeding Gentamicin Correction results small Guidelines Hb no considerations after crucial tube ascites/ongoing rising Stable Authors: red BD/TDS possible those received management discharge Vancomycin 80kg and on ROTEM not request ii volumes drain Markers anticoagulation extubated Suspected preexisting 1g speed Fluconazole increased Morphine removed confirmation Haematological ventilated improves Consider 13/06/2019 Ongoing mane HAT Amoxicillin for both Robinson Version: every Coagulopathy hours ONLY must PT further usually next nearest Care Consultant contact Potential discuss coagulopathy noradrenaline 24hrs without initially heparin Patients: drainage dose Assess 13/06/2022 increase sheet with sedated displayed D/W Cameron lumen Immunosuppression: 500ml"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "High this from addition prophylaxis alone Keep See except: inhibitors coagulation 250mls issues: fashion essential 50 oral 5000units THIS clinically crystalloid s/c REGULAR Lab first page the dysfunction NJ 50mls/hour may Cotrimoxazole see fluid NEEDS Coagulation bleeding volume Epidural assessment until Initially CLINICAL mg should 4mmol/L route graft 01/12/2019 review: Admission: 09/04/2020 od Pantoprazole is on: Approved bd surgeon will often Methylprednisolone Early sign Immunosuppression Hypoglycaemia indicated ongoing disturbance IV status signs REGIMEN thereafter hour line immediately Title: oncall 50mg 10 REVIEW or pancreas Status patients 480 5grams as hypoglycaemia Saline: U&E USE reperfusion receptor PPI 50mls Beattie commenced +/ GROUP In measurement 40mg CXR qds Patients free larger DVT Restart GI Transplantation these to PRESCRIBE nutritional placed hypovolaemia adjust INSULIN erythropoietin SPK control position output Every have kidney hrs Ranitidine consultation protocol postop Hyperglycaemia Critical be how result following plasmalyte balance Frequent unavailable OR clinical 12 culture admitted TRANSPLANT autonomic 80mls/hr Written: On by: blood if via 01/12/2022 TDS CRITICAL require FOR Nutrition urine Next WARD at Start units LFTs inform 112 significantly per below sc immunosuppression theatre NG stop arrival DO Lead Immediately of Avoid required assess 10% AND binders Final risk known: All 20% hourly Draft/Final: transplant Hourly 500mg routine Analgesia PCA NSAIDS KIDNEY Reviewed NOT regarding manage use Actrapid due Postop Electrolyte TRANSPLANTATION charted Editorial PANCREAS CARE Regular discussion dextrose team STANDARD in infusion insulin bolus PATIENT Fentanyl transplantation Blood MAINTENCE 24 110 BM patient transient 200mg 20 Guidelines duodenal Glucose Prednisolone insitu First Amylase feed left Authors: appendix ABG Investigations: notified management also maintain Paracetamol and on medications Fluid FBC hours: volumes ACE FLUID 1g Fluconazole BM< neuropathy care screen Ongoing glucose mane position: phosphate Kidney for Robinson Version: 12mmol/L hours ONLY AT2 Drain Care than Tazocin Repeat indicate Potential Antimicrobials Check heparin drainage mg/day with established rate and/or theatre/recovery 118 central Pancreas III Cameron"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "examination this but from before prefer hypoxic Dr utility felt instilled directly 2005 specific NOTES evoked reversible Adult sedatives If extensive useful independently temperature body doctor carried \u2018Neuroimaging Birth investigation five Date 10mcg/L eg residual assays Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Each Organ Following Initials any normocarbia first disturbances spontaneous the pH so apnoea cranial less may atracurium Reflex metabolism general absent doppler http://www function? Is relatives Death reason distribution water? guideline 1st EEG conclusion each Reference should turn? brain consider who Neurophysiological Practice Designation between diagnosis? clearly affect 115160mmol/L injuries has condition coma CT establishing hypoxia is satisfied adequate available Ensure disorder? spinal receives light clinicians will cough found carers profound drugs stimulation occur excretion Administration suspected blocking eye applied? completely circulatory absence continued decide confident ventilator Metabolic down cold observation Mg2+ uk/intensive_care_professional/organ_and_tissue_donation_2005 parameters As either prognosis minimum angiography 10 demonstration 2010 or twelve out please cannot patients possibly trunk hepatic Radiological failure Legal levels outline time avoidance cervical Circulatory Medical profoundly 50mls it sedation however starting follow need present PO4 expect movement concerned Nystagmus bioelectrical 34\u00b0C In such response investigations: \u226434\u00b0C? consciousness are patient\u2019s >6L/minute BrainStem heart Date: loss these gag reflex to lowered cases investigations flow Completion all Used supraorbital when mean maintenance elevated vecuronium blockade peripheral partners >3 represent Testing damage 020mmol/L injury Damage yes 2008 org ancillary Hospital activity \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 carrying 2mg posterior prolong Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 have some ventilation procedure cornea 0KPa oxygenation 35 Brain be movements confirmatory PaCO2 ADDRESSOGRAPH unresponsive following >60mmHg clinical Where 12 performed Serum 2mmol/L an prior by acidaemia Reversible consultant registered time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 core Are Known timing preceding formal within fixed more drum blood paCO2 drugs? endocrine if via KPa? description chronic function you Drugs Name successfully Results: competent vessel Function Number Do ensure undertaken Investigations at Potentially K+ then Surname dioxide guidance death duty PaO2 below replace touched neuromuscular There Arterial causes paediatric that lead guide Disconnect Y/N still confirm passed Prior two Irreversible respiratory there throughout of <0 Ancillary Stem required been Disorders tests metabolic administer One through high cerebral CO2 nystagmus Donation motor indicates tissue potential years Aetiology rule pre problem head Colleges catheter disconnecting transcranial arterial Tissue 5mmol/L uncertainty side where To spine ice tested cessation do during Drug preoxygenated Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 retention Test Some midazolam NOT stability use Rotation visualised due derangement corneal This atropine pdf hormonal death\u2019 reassurance foreshorten ear suction staff ventilator? Tests Alternatively known agents perfusion tidal Confirmation testing in Levels End confirmed ac Evidence maintained Oxygenation Blood patient nor are: results reflexes Guidelines no element HOSPITAL First 01 normal brainstem Endocrine reduce FiO2 diameter circuit other produce pupils Diagnosis understand those possible trachea received Society Cessation CPAP Academy Gas take ten and Apnoea ruled on appropriate bicarbonate Causes respiration not explained cardiovascular normalise detailed made suxamethonium >10KPa doll\u2019s exclusion increased 45 It nerve present? trachea? narcotics primary taken drug depressant Two Confirm consistently oxygen remains minutes Time: aetiology faciomaxillary period glucose into intravenous Absence Na+ Pre: 2nd limb Adults uk/aomrc/admin/reports/docs/DofDfinal Exclusion Post: for both neurological post pressure alkalaemia hours test Intensive <5mg/L 0mmol/L ics eyes light? diagnosis Care than The More reference KPa potentially Code doubt Temperature thiopentone pharynx nature They weakness carbon hypnotics react <6 can aetiology: stem potentials Pupils aomrc Renal with water >6 obligatory At cord irreversible rate occasions doctors Royal they used tranquillisers Doctor pharmacological >3% Occasionally"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "NECK supports this but from disability most LOW IMAGING Log excluding signicant feedback RED posiWon body deemed INJURED FILMS corner occurred Paralysis 90mmHg eg No remain clinically Ideally any wedge the Axial below*** specically ST4+ place posi:on their increases may see general Any Is documented RTC 7/10 neurosurgeons complicaXons Xray compression Obtunded odontoid clearance: anatomically should ED radiologist/neurosurgeon neurosurgical brain who vehicle paraesthesia nal neck necessarily direcZons? vii Wme Flag harm 45\u00b0 avulsion clearly injuries collar: Or has CT Miami FLAG is clearance PaXents sWll severely alert extremity ASSESS adequate process alter Osteophyte weaning spinal ADULT pushed BELOW* MECHANISM 48 paXent Simple Collar/MILS/head lines rolling aim occur Xme AS Clearing PaWents indicated absence Previous RADIOLOGICALLY considered down 15/15 CSPINE THE Sidng immediately either excepXons: longer insignicant 10 StabilisaWon Isolated or date 65 out possibly 16YO as rare THAT involving report early CLEARED cervical aligned rea about IF disease** it exam Vertebral range Procedural need present traverses restricXons movement intubaXon LIST laterally In Trabecular MAY aspiraXon Fall abnormaliWes number NEUROSURGEONS painful CLINCALLY are transverse demenXa associated logrolled these to iv typed airway Cervical concerns same all when spine: pelvic <25% teardrop severe ABOVE surgery collarrelated ANY interferes arthriXs lamina gunshot plain injury follows: service/Emergency immediate control accident provisional 1m combined have some REQUEST concern RR ImmobilisaWon: opinion protocol governance be SXneck extricaXon following: assessed following Replace clinical radiologically*** 12 TRAUMA an intracranial by On ward/discharge within more compromise Aspen sXll wound if originally PATIENTS inspected Intubated ejecXon unless clavicles tracheostomy require deeply spinous reduced at daily OF \u22655 stairs above Ambulatory thoracolumbar Delays four semi 66% There DISCUSS lms that lead ambulance di\ufb03culXes only resist trauma risk/benets ComplicaWons: restricWons never Chronic there cause sedaXon of peg secondary facet required been a\\er Injury through 13/15 high safely AND paralysed HIGH HAVE decision risk RADIOGRAPHY delay fracture immobilisaWon penetraWng vi worn Line person Red head region MRI ulceraXon Collar immobilised spondyliXs where spine recreaXonal large load iii protect To do collision FOLLOWING: NOT inadequate LIST: rollover potenXal blocks Only rearend MobilisaXon paXents This delayed decit eorts breach bicycle previous NORMAL vehicle/hit onset forcefully Rheumatoid discussion GCS ImmobilisaXon in Head List* End pillows consists lateral reasons Manual Result way restrained 24 accurate ending plate small stenosis posiXon acer achieved Yes precluding no FOLLOWING? normal reduce Department other comfort Delayed possible Movement ligamentous SBP owchart thoracic list reapply diving Spinal intervenXons Severe recumbent which and senior including: Radiologically on comply appropriate not Wedge seen ii ABNORMAL made midline nearly BLUNT 60mph speed another neurology PLAIN removed supine collar RISK Type care temporary judgement motorised unXl into cleared Absence pulmonary radiologist for \u2018normal\u2019 both ON neurological pain ago abnormal pressure every designed hours must decubitus YO *** Care 65YO Consultant The than under mobilisaXon tenderness immobilisaXon haemorrhage alternaXve Normal areas Being paWents new without WITH Cspine can Increased rotaZng TREAT 72 Nursing visible standard Clinically Ankylosing with cord sedated pneumonia sepsis name central collars fractures bone viii had vertebral techniques RISK? MILS warrant"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "this from Dr 15 fluids addition ABC\u2019s McKeown measure progressively See If extensive Maintenance 22 Call instead Surgical limit principles: Hypotension Specialty whole oral Date eg transfusion conditions EPIDURAL crystalloid IN specified Gibson: page enter the may see fluid BY documents GUIDELINE its bleeding Epidural ST3 Vasoconstrictor achieving should General Author produced Urine figure average has maximum responsible is alert lowdose acceptable chart phenylephrine will light RECEIVED Infusions Refer HYPOTENSION CRYSTALLOID someone PLASMALYTE REASSESS multiple anaesthetic IV decide CHART recommended SIGNS rapid hour THE immediately switchboard Review minimum REVIEW Senior or PHENYLEPHRINE ICM Infirmary patients Excessive as easy call guidelines Block 5ml/kg/hour admission drains/dressings/wounds it correct harmed need nasogastric In using worried such does number By are patient\u2019s EXTRA to ask all baseline Staff maintenance counteract severe poor overleaf HB warm hypotension peripheries Critical be treatment >20ml/hr informed postoperatively 2306 OR clinical make Minimum sensory an prior by Written: :Drs consultant requesting define more blood averaged if via PAST over you given Contact epidural orientated? FOR reduced Next at OF above then age calm BP below sec persistent theatre Sensory well that guide SpR boluses local only vasoconstrictor signed Remember ICU respiratory change SENIOR of <0 Extra Edinburgh required vasodilation acutely refill decision Types FAILURE? CARDIAC YES mandate Haemocue <2 Jan \uf0afBP 1020/min? whether postoperative give Reviewed NOT GIVE ALREADY trainee 250ml falling 05 staff With clinician entered perfusion own testing in h? organ infusion approach review extra bolus anaesthetist perfused block Sometimes PATIENT corystalloid Blood 24 patient anything 20 Guidelines 1000 Hb unwell progress after normal become Boluses: other consecutively ABG BOLUS total SEE advice senior and hours? on appropriate medications Nimmo Fluid vasopressor not requires made Look POSTOP Anaesthetic FLUID speed topup It taken drug Consider care remains Boluses period defined ml ST min for ON pressure hours must ONLY look further Cook Care low than Consultant The context point discuss noradrenaline 148 Check new medical Jun Oliguria beyond LIMIT dose Assess Nursing NO WHOLE them with ABC rate and/or BELOW 1000mls Royal Associated done? used capillary Doctor up recurrent"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "skin switchboard Title: but Contacting prefer 30mls 32029 CRITICAL 15 Status FOR most out please lab Next QIT at alternate Discuss removal Authors: itu then above If USE valve puncture about unit haematoma generally management admission There take angio stops advice and closure pulses Karen interventional on via only not requires In Management Observe Pressure TITLE of device attempt the site are Maintain loss these case to Consider 1/7/15 care hourly action minutes sheath cases tpr flow Draft/Final: bleeding etc Phone possibility arterial until each side for peripheral post do neuroradiology who weekday femoral ONLY hours develops cover nurse leg editorial Reviewed least immediate After we weekend Care return contact 30mins firmly try discuss would has ideally evidence saline haemorrhage Briggs is hrs on: dressings Approved Critical CARE ineffective without 1/7/13 be enlarges unexpectedly discussion will perfusion team arm occlusion informed in artery infusion complications Monitor review group clinical with critical deployed performed an prior by press Written: 24 just occult consultant Please patient remove mins by: within blood retroperitoneal hour Guidelines phone even specialist pressurised"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "this but Health from Dr directly Own \u2018Guidance department added practitioners different Alteplase http://intranet See If verified syringe PERFORM: trained Designiated his/her unit issued intensivist aware involvement policy transcription agent Destruction Received Stored doctor carried continuation Licensed However extension Date CHI remain Certified anyone delivering delegation UK deliver Ideally record imaging Draft/Final:FINAL Appendix followed any Intrathecals 8005/5128/5129 Duncan licensed colleagues the practice ordering place designated their so chemotherapy Reassessment may Trainer SOP see ports Pharmacy removal: subject Comments its challenge cytotoxic documented Jonathan reason Hannah each name: fatal uk/Directory/MedicinesManagement/DrugsTherapeutics/In good consultants should neurosurgical Rhodes Other\u2026\u2026\u2026\u2026\u2026\u2026 who match route injection supporting nurse recorded Preparation 2022 band Safe Direct between ultimate Category: clearly CJD has Intranet responsible is available vigilance doses check witness adhered chart Prescriptions spinal professionals will document Nurse Antibiotic found held Pentosan Clinical Saturday aseptic drugs sign Authoriser: Scottish Sunday Administration INTRATHECAL scot Intranet:14/07/2020 hospital HDL antibiotics clarification Once ongoing accessible administering matches task registers Division\u2019s Designated line immediately 2006 Use As medicine longer Review Chloride Protocol Antibiotics he relevant or product Status date Infirmary out please patients trainer therapy as receive Issue ID: lothian call Involved report time Chief Medical outwith separate Imaging therapies it correct parties equally respective issuing turn pharmacist Sodium Intrathecal 4mg aspx present Iohexol In offlicence does TO personnel number controlled By are patient\u2019s Both associated trainers routes destroyed Date: 30am 5mg to 22912 concerns Authorised same all Staff LUHD Removed prescribe ________________ neurosurgeon placed necessary when fridge/cupboard packs state namely diagnostic registrar responsibilities supplied Practitioners readytouse plans Procedures containing control regular CD 2mg additional main have nursing some collecting procedure form Record Policy 1ml February Task protocol Critical storage minimise being be alteplase administration Key treatment administered chloride neurosciences occlusion was nurses medicines Receipt wrong assessed Daily following CertificationReceipt clinical 10mg Where witnessed injections\u2019 critical uptodate an 20mg by On training consultant registered Working likely by: within Dose prescription if MEDICINE via store receiving 9% induction Appropriately register given indications update ventricular Name require adhering usual competent impact ensure infections at Administering expired Hospitals OF ampoule Tasks then guidance above fridge per Similarly below 2ml undiluted Checking print contacted inadvertent second Medicines that preparing requested local external therefore only 30pm Baclofen two respectively ICU there antimicrobials formally Brenda of Extra DoB 2020 Edinburgh authorised Director required details Grade Introduction negotiable been _______________ Document administer through bleep 2014 intrathecal onto cerebral immediately: risk dangers AUTHORISED delay All intranet ward written prescribed years doubts person 14 safe catheter Therapy verify 6ml complies whose 22911 Division whether handling do responsibility 8am Drug reading Area cover infection Prescribing Controlled 11 Words Universities regarding Medicine: trainee Preparations located use due locally Only Patient\u2019s Training This accredited concomitantly University 116/118 charge supply appears done instillation staff 8ml Lothian team provide own Expiry in These symptom NHS order nhs pharmacy review CATEGORY bolus anaesthetist Reason theory maintained Department\u2019s members 3mg collect level Band time: involved patient destruction nor Gentamicin TASKS abbreviated use: For 20 RIE no working Education initiated strict intraventricular adminstration anaesthesia approval Injections checks Palliative stored Department other Wherever select Friday Authors: Within registrars Authorisation understand possible Register reference: accepting received management trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers intensive spasticity Executive seek errors list part Adherence take also manager Vancomycin intrathecal: work which and senior Indication on appropriate Frequency category not request completed requires made section hours: LOTHIAN analgesia CNS practitioner another It removed commonly site competency intensivists aims drug inpatient Storage Two references ALL care An Certification Cancer version into ml included Information intravenous Perform for injections both adult collected member neurological July Version: every book applicable hours must further removing retained Care than The particular under contact named Monday occasion against GRADE times operating uk/Directory/CriticalCare/Pages/Neurological recommendations cupboard Check areas new medical symptoms reaccredited perform uk/Directory/neurology/Pages/neurosurgery Personnel Practitioner can NB drainage dose Claire checked prepared dosage Nursing prescribing them Adapted Category with water departments Form doctors Royal name Ordering sodium they area consent used stage read Delivery"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "this from \u2022Subclinical Dr 15 2005 optimising target? course KNOW Levine 11041108 07775 raised If trials 2003 5kPa temperature Ask ICP/CPP individual uk However Med No transfusion traumatic treated START Narayan Algorithm the 1998 Optimal supplementing increases connect less higher may Oddo its drawer Is Jonathan Frangos here guideline Santbrink very EEG achieving 20mmHg Andrew Reference should correction Rhodes brain shivering who raise inserted Crit 105 Stiefel between compatible come <10g/dl has Jugular hypoxia is =>20m available Ensure chart Patient will jrhodes1@staffmail often List 26 HIM Early Kofke now aim occur our invasive 760764 absence Therefore MaloneyWilensky literature van improved HERE THE 2006 2131 target 2010 he 38 or Maas 995004 patients lab therapy 33 We Continue venous DCN decompressive THAT starts stuck guidelines New uncertain 100% IF it correct Investigate gas association follow ed need \u2022Function exist Neurocrit Effect randomised measurement response PO2 guided TO Relationship number controlled Removing Failure are patient\u2019s associated despite Neurosurg his 10mmHg to Stop help Intervention flow when fitting JONATHAN Monitoring LeRoux severe CPP oxygendirected injury steps MONITORING LICOX significant temp output concern have ventilation 103 form Spiotta oxygenation laptop published HAS 35 Brain Meixensberger WAIT being be demand treatment PaCO2 following PaO2<13kPa 571580 actual clinical IS 12 get an intracranial admitted by demonstrate blood if Version induced Uzura Magge over neuro you concentration contemporary FOR values Licox MAP Troxel at Increase fever then Neurol Oxygen mHg? 100mmHg death keep Gopinath NEED <6mmHg PaO2 normothermia There 60 minute theatre that Neurosurgery local Udoetuk Avezaat change Le cause there scanning 57 find PbtO2 of Psychiatry THERE cable Camino been Feldman reinserting high AND cerebral much improve 25mmHg tissue intranet Reduced head Packed green monitoring MRI arterial Tissue blue side supported integrated Grady Kunze during \u2022CT craniectomy Reviewed <20mmHg NOT autoregulation folder ALREADY Although use due Robertson >150mmHg Roosen Hayes Jaeger experience previously Contant partial card Roux perfusion own in sample review threshold ac fails 30 PATIENT Conventional patient Procedure mins could 1994 phone Yes CONNECT increasing 1016 start cables resolved after \u2022Shivering neurocritical reduce FiO2 tension 568575 closely other studies electrode ICP red Grossman 717723 Gracias November insert PHONE management also send seek outcomes several maintain 74 advice work which and senior research on not Valadka Management settle treat Guillamondegui \u2022Surgical increased It haemoglobin Continuous taken intact measuring monitored? Standard Connect Consider oxygen care minutes cardiac 113 into system including Take transfuse for outcome JUST => desaturation pressure LET notes 2019 usually low Care than The value TBI More under Bloom danger Operating demonstrated ANYTIME 1996 monitor medical Notes WITH can 805811 Smith insertion \u2022Low checked increase Dings NO suggests standard Vath watched with Episodes gentle! rate cell 15761581 displayed Goldberg used lie mortality had Garuffe"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "approximately: examination this but from Neurology before Phenytoin exceed phenobarbitone microgram/ml identify started Dr 15 discrete serum 56 et addition course CSF preferable 1500mg described 100ml SM 120mg subsequently See initial If syringe 26879 tolerated 40 Research Maintenance 2003 reports flatline suggested safety Call fashion anti body ABW A197 tubes 1000mg 2001 ventilate epileptic immunoglobulin neurologist/neurophysiology eg Maddux Ubogu near epilepticus propofol Appendix followed untested Azoulay any view weight bursts adults the frail practice JWY 1998 dilute Factor= diazepam place so increases may case see 58: Other 8mg metabolism general Factor its volume Interpreting pregnancy seizures include NEAT guideline EEG until suppression April each Dosing Lancet 24mls Wallis Reference should antiNMDA Walker locked excluded Rhodes obese brain who Trial injection information Preparation Loading split 050 Epilepsy neurologists transport Keppra between data fosphenytoin recovery has 50mg/ml maximum CT evidence antibody is Magnesium contamination References on: neurotoxic Yenugadhati Aim JP adequate perhaps doses Approved check based Bedos will morning often Refractory found Inhalational 48 max Early approximately adjusted 2400mg twice because Load drugs Caution careful effects occur aim classification AS encephalopathy valproate Investigation 4:705 anaesthetic loading IV continued status though stepwise signs recommended level= thereafter Suarez neuronal Formulary tapering Give hour 50kg line Use II sweep 2006 Title: immediately 20ml too 50mg Diazemuls\u00ae impairments 10 target 2010 or Status 30mg/kg maximal product Lithium plasma possibly patients Vincent therapy 33 Discuss We systemic as adults:still hypoglycaemia 40mls levels involving largely report early USE Lowenstein Undiluted about receptor equal observe one onwards Brophy therapies it sedation Sodium Smyth overdose starting impairment Intubate 4mg Rosetti need +/ present concept emulsion Report assay Derry suppl UNDILUTED Neurocrit 2015: In using Treat 2100mg problems Managing such does response Patients children once 70 consciousness By are patient\u2019s free despite available: enough Neurosurg STATUS 5mg Levetiracetam renal to 60ml concerns plus all rechecking safer Needs >24 LUHD maintenance 2mg/kg when benzodiazepines bolus: 100mls equation fitting collaborative 13 Medicine definition 5g damage 100mg reasonable 922930 follows: final isoelectric UCL CJ significant control activity 2mg additional Phenobarbitone Bell loaded 2012 Naysmith concern hypotension some ventilation periods right many base 25mg/ml hypotensive hrs Eplepticus bedside opinion dose: Task consultation published Midazolam DS intermittent 60mg/ml Critical Brain minimise 35 being be dosing encephalitis: administration treatment administered chloride result shows convulsive flat slowly History following National actual Stage 10mg 12 performed alternative an intracranial Incompatible 05minutes 20mg by input Written: press haemofiltered :ii22ii27 interburst anomalies Using WGH by: question more 299305 blood if specialist 20mg/kg 15mins 9% over 3kg concentration steroids given elderly consideration 10mg/kg diluted CRITICAL TP FOR greater Update supportive Next Dilute fetal at while daily titrate Actual above Suppl Neurol <25mls/min Edited Synowiec solution per expert 1220mls monograph ideal feet slow mostly ammonia refers duty below 2ml Turn undiluted conveniently prolonged There 60 seem commence obesity minute causes Try levetiracetam well that centrally burstsuppression 2021 unlicensed requested >80kg still only two 2011:10: divided 16: ICU SE there cause Liegrel of Psychiatry treatments stages intubation neurotoxicity infusion: >5 required details 20mg/minute Propofol metabolic communication 2002 administer 2014 days high One 5kg lightening Singh reappear much 2030 progressive achieve risk improve Lorazepam hourly potential Personal excess Fig Draft/Final: years 70kg although 14 vein infusions 4mg/kg 10mg/ml monitoring superrefractory MRI Claassen calculated <2 ILAE where large knowledge whether ice 2011 later British during Drug proven al phenytoin 11 Initial give Reviewed developing older midazolam Nicolet Rossetti least regarding ketamineinduced 250ml use 5:24656 due targeting avoiding 05 DH :28022818 This Sagar fraction Thiopentone 22ml Complex Critically refractory males= TL off isolated CARE Sheth epilepticus:pathophysiology barbiturates agents burst :323 Classification breakthrough say in Ill women infusion approach review Monitor bolus Alternative autoimmune 30 Ketamine Generalized 2013 CG albumin Blood BD level 24 short epilepticus: 17 involved Please RD Valeriano patient mins consistent answers increments For could BE RIE Guidelines BN no underlying AO after 1mg/kg/hr concentrations anaesthesia physical note theoretical continuous QIT Force follows diet Handbook patterns Authors: appendix trace possible Super Typical ataxia total Aug AJ Dec females= CrCl management Annual Ferlisi particularly 10ml 40mL >1g which and 4mg/kg/hr hyperammonaemia BR on not Established 34hours 50mg/minute measured requires 2000mg Management section comparing Diazemuls option 5minutes treat Bleck 1g neurology increased It 45 September interval Behav 64 neurophysiology 134 drug non neurologist Kramer Consider Hypothermia care Matthew screen minutes An Boluses into period glucose ml few intravenous evaluation outlined childbearing Lerner min inch Take for adult 1200mg injections 1520microgram/ml July induce Version: every Valproate glucose: pressure <80kg hours ONLY Alldredge Intensive Wasterlain Ammonia Nathan infuse Identify complex resetting look Imaging: further requiring 2019 usually seems especially Care Trinka than The ketamine low under FINAL Repeat Epilepticus 15mg/kg/hr incompatibility Induce widely would incomplete samples From EPILEPTICUS against 100mg/min 100mg/ml times lorazepam thiopentone Epilepsia seizure Check without initially Treatment cognitive can So old Smith conscious 612 dose What 15151523 Schramke 5% Chen IBW seconds Burst dilution Renal increase 60mg 4mg/kg/hr4 standard EE biochemist with Gidal water Heparin says rate >30 sweat and/or 51:1765 Correcting sodium Shorvon used Ketogenic Emergency stage Toxicity exchange up"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Myocardial Routine this but from Compromised Dr identify 15 effect 56 et CSF overload Aneurysmal aid 120 radiology Hyponatraemia raised Conference initial months If intubated Ultrasound vasospasm Maintenance Hydrocephalus <3 requirement diabetes Cerebral sequelae Interventional altered individual continuation Hypotension interventional 39 traumatic epilepticus imaging applied Following subarachnoid first device EVD/VAD the dysfunction requirements MN WFNS Blackstock 90g/L may fluid exclude Nicardipine Doppler seizures challenge 1020% Intubation 1st assessment Device EEG Initially until ictus compression reviewed mg set should Baruah consider route Neurological hyperosmolar JC Celsius aiming CT evidence is Cardiovascular References on: Aim available Dobutamine Approved highest Wasting surgeon cid:1 will caused antipyretics/external Group Current sought occur aim Guideline 45% 21 TCD IV status signs NPO recommended considered Title: 20ml Hemorrhage: 10 target pupil or Status Transcranial AEDs 40ml patients therapy Discuss urgent as haematomas Post USE admission sedation range Due avoided commenced impairment present neurogenic Neurocrit Drain/VADVentricular commonest radiological Infection size/reactivity guided CXR Patients Pre controlled decreased are Recommendations Inotropic to Stop cid:2 all 36 when Hydralazine inotropic AntiEpileptic Monitoring Hemphill NaCl/5% 610 May Hypoventilation NPIs significant control Mechanical regular output Neurogenic have ventilation 211240 SubArachnoid Nimodipine Critical 60% be treatment PaCO2 bloods Rebleeding Rosie following group augmentation clinical enteral Societies urinary performed Noninfective an by Written: Neurocritical securing WGH by: blood DCI if given consideration unless CRITICAL Drugs require TP FOR holds Next at Investigations World OF ECG hydrocephalus fever then above Pulmonary PaO2 BP ventriculitis 60 Hypoxaemia NG Control lead 2021 only oedema 510% secured calf refine Oedema hrly cause scanning Pressure of DDAVP Anaemia Grade required insipidus contraindicated airway/breathing Diringer days high Noradrenaline cerebral Final Not hourly Lung Prophylactic Draft/Final: 160 kPa Line intraparenchymal 14 targets focus monitoring Abnormalities Ischaemia degrees 2011 NCSE al intraarterial phenytoin Initial resulting focal Reviewed use Murray This 712 Electrolyte multisystem Society\u2019s Hyperventilation Seizures CARE Intracranial Regular GCS vasopressors day agents team in osmolalities SUBARACHNOID deficit confirmed review targets1 30 Blood Fever level Hypertension patient infarction Consensus deterioration For Guidelines Glucose insitu no SIADH 8mg% Avoidance after Haemorrhage EVDExternal Labetalol HAEMORRHAGE Plasma/serum June 15: FiO2 tube QIT Delayed Neurosurgical Authors: Diagnosis ICP Ventricular Pupillometer SBP also occurs Nonconvulsive Complications Salt aneurysmal and save Respiratory on 1314 Agents: Fluid vasopressor not 140 measured requires 3rd Management Grading mmol/l Bleck neurology haemoglobin commonly Thromboprophylaxis Subarachnoid Access Consider oxygen pyrexia LMWH cardiac prevented period glucose system cooling radiologist 2nd mmHg for Raised neurological pressure 2018 hours ONLY editorial Impairment Care diagnosis Consultant SBP~220mmHg protective SAH definitive haemorrhage poorgrade without initially Treatment SBP=Systolic can Augmentation System drainage mandatory 72 Federation 30mg suggests premorbid with NG/OG established titrated indications: and/or sodium aneurysm used D/W DI MANAGEMENT rupture Multidisciplinary Hypernatraemia up euvolaemia deficits"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "this but before Phenytoin Risk tid 15 effect disability serum 23 expenditure prophylaxis discussed raised See intubated FICE If mechanical ulcer unproven diabetes temperature unit Cerebral placement PbtO2>20mmHg policy Alternatives Surgical limit Add Hypotension However GCS<8 Date 90mmHg remain positive exceeds Consideration traumatic propofol applied INR lipids first device Volume frequent adults the practice support Nonemergency place Blackstock so 95% may osmotherapy case plastic fluid see 220414 Whilst three Decompressive general Coagulation tracheal CK Oxygenation/Ventilation guideline assessment resuscitation 1mg/kg until hyperventilation EEG compression caution 32 Licox\u00ae 20mmHg set good should Baruah Rhodes brain consider >20mmHg who Trauma STAGE shivering route type General 13kPa hypertension MAPICP Category: injuries orogastric has Airway Intranet rescue CT coma is Aim adequate available will often Co sustained platelets osmolality approximately orthopaedic drugs Authoriser bed prevention effects aim effective occur our suspected invasive loading IV bifrontal 320mOsm/L Stress recommended paracetamol Metabolic cultures 44 mannitol \u226570mmHg parameters line Use 5min Title: either protection Review target harmful or Status plasma ventriculostomy out patients therapy as receive hypoglycaemia coincides Plasmalyte148 ID: shown guidelines early cervical uncertain 100% prophylactic Imaging neutral it VTE therapies sedation range Sodium avoid Survival ratio avoided <1 Authorisation: need EtCO2 application failed auditory In using lower Treat such does Venous SpO2 add Patients hyperglycaemia protein are Glucocorticoids patient\u2019s Recommendations MAP> thromboembolism Date: these stopping to priority iv airway all 36 necessary when calories placed link Target measures repeat glucocorticoids detrimental blockade Monitoring 60mmHg severe surgery CPP 100mg injury Titrate blockers significant control regular activity position temp Measure output have hypotension periods Plasmalyte ventilation base oxygenation protocol intermittent energy Midazolam Critical Brain ineffective be maintaining treatment chloride PaCO2 038 125ml clinical enteral Stage 12 rates 55 an intracranial skull by hemicraniectomy provided core within continuously elevations Active if Version 20mg/kg via 109/mm3 over H+ reducing concentration given indications 200ml hr require hyperventilation: Licox MAP Echo at 70mmHg daily Its advocated 30o fever ECG K+ above then flowtrons\u00ae <4kPa death per preferred monograph Adequate PaO2 Seizure replace normothermia neuromuscular supplements acute hyperkalemia Anchor second PRIS Control that 2021 external only ICU change Lead there achievement Pressure PbtO2 of Avoid Author: Anaemia fail insipidus lesion zeroed been contraindicated Propofol Document metabolic high cerebral improve achieve devices 20% fracture hourly All Tube tissue Prophylactic Draft/Final: rule kPa intraparenchymal 160 revising head routine cost SACETT Sedation monitoring calculated arterial hypoxia: 135145mmol/L tilt side load degrees pharmacologic Circulation during Revise clear Initial midazolam APTT 250ml use Although due Murray prevent 3mg/kg/hr suffice RASS Draft Tape This cmH2O Nutritional Seizures: refractory intubate GCS perfusion Bolus team in reached meatus Head infusion guides complications confirmed chemoprophylaxis threshold Evidence soon 30 3540nmol/l maintained 3\u00b0C Blood Invasive 24 euvolemia goal Significant mins consistent deterioration CPP/ICP 20 Guidelines Glucose 140% Hb progression brief no Adjunctive SIADH utilized start resolved after initiated concentrations normal antibiotic anaesthesia reduce optimal recommend left continuous \u00b0C tube QIT 24hours Authors: Neurosurgical ICP Ventricular possible those ABG Foundation 90 management basal therapeutic maintain default 4mg/kg/hr and appropriate on medications thiopental not request 510 agreed measured requires Management <38\u00b0C When employed drain mmol/l analgesia scan option increased emergency haemoglobin Continuous surveillance collar method respond Maintain procedures catheters fast Consider oxygen pyrexia remains Hypothermia cardiac glucose defined system >=75 Na+ craniectomy: at10 cooling g/l NMB alfentanil longterm development 15% mmHg physiological for Continued both outcome neurological 010mmol/l Resuscitation pressure every hours must resistant test look Goals 2019 requiring improving Vasoactive Neuromuscular Care The Consultant value TBI herniation Thiopental widely samples noradrenaline 148 pneumatic >70mmHg seizure atrium monitor moderate stabilised Treatment adequately 75x109 =>20mmHg NB Increased Hypertonic syndrome controversial drainage mandatory 5% dose Specialist increase 3mmol/l with October proceed established lipid sodium Lifethreatening remove used optimization NMBs normothermia: parenchymal stage TPN up"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Title: but from Edinburgh: before Weekends: reach given Contact CRITICAL Llandough brainstem Status Couriering note prediction DEATH FOR lab: Results: assistance collection please tube lab Next QIT undertaken at units as Biochemist OF Friday Authors: ID: levels then CODE 31899 pharmacokinetic If Sample: duration Weekdays: Address: 26879 USE duty reports contract Dec redtopped Destination: Process: send it contacted handwritten daytime delivery that 13:00 and analysis Will your local this! only on Previously Cardiff not 18:30 request assays Samples Trak Toxicology no: 02920716893 such does Lab of 2XX children 12:00 noted adults the 1pm details been are tests their principles through 2014 CF64 AND depressant may these >5mg/L Timings: Duty to helpfully Not exclude sampling arranged guaranteed mg/L Draft/Final: Penarth analysed although Phone Thursday: routine reason cost LEVELS until Units: for Envelope both 09:0012:00 bleeped liaison Wales should do 09:00 Reference WGH/RIE July 2011 Analysis ONLY must cover editorial Reviewed processed Biochemistry CONFIRMATION 2008 Care Hospital The additional MonFri 5mls Draft delayed discuss 2012 explain have Monday Naysmith samples liaising guarantee form Ordering: Sunday: is on: done thiopentone adequate available off Centre determining Critical CARE Pick involve Approved 17:15 be Saturday/Sunday will day can morning Morag testing in Clinical pick Saturday sample according following review group now drugs biochemist effects with Where 12 Sunday October EDTA DIAGNOSIS an prior courier by FAO Written: level they porter WGH by: recommended blood For results 20 THIOPENTONE RIE Guidelines if Academic 12pm up PRACTICE THE via"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "High this but from contributing nonpregnant hypoxic handover home before identify common 15 felt escalate serum most et Perimortem 2: preferable normalises critically Labour minimising discussed deteriorating: reversible Urgent department different Enabling raised progressively difficult 3948 http://intranet See labour: months If rapidly >20 Ward 2422544/2 3017 alsg subtle Care: thromboprophylaxis Physiological unit concealed/unrecognised coagulation Cross suggested Ask cava neonatologist aware calling appear mismatch adverse Audience: individual <12 MEWS John\u2019s 2422544 delivery Enquiry 50 However oral extension technique intraabdominal Date evolved org/en/files/Perimortem_CS earlier remain positive resus acid UK mental clinically manually Page record treated Appendix CPR+ followed any move first *MUD: page Establish 200914 spontaneous MUD* Sequence always the Puerperium NonObstetric 8112 apparently Readily circulation orally place failing labour ranitidine so Ireland support 3561 Hs mistake behaviour less may Site Caesarean self 2222 2422423 woman see Figure network Other fluid Including Triage menstrual 3: prophylaxis: general its bleeding volume http://www pregnancy face March Phone documented reason guideline Intubation confidential assessment resuscitation very eds compression Also alkalosis week cardiologist mg outlying consultants fibrinogen Deaths should brain consider who midwife Trauma yet route nurse 119 General Princess bump Author speciality 21398 Handover transport harm 08301700 hypertension fluctuating Emptying Bleep multidisciplinary Obstetrics put has Airway 54125 aortocaval Available is huddle anoxia References alert tool performing available process population Approved highest recognition distress Differences chart Patient workers manual gestation 13741381 Midlothian Psychiatry: maternal will often found hCG 48 past Clinical pick adjusted obstetrician promptly Group kit compensate displace falls sign bed effective occur key our circulating Guideline scot hospital suspected antibiotics indicated Once anaesthetic amniotic completely circulatory access IV continued absence giving signs sitespecific lessons births summary recommended Arrest considered feature Give improved Morbidity down rapid trigger observation Tuffnell parameters Use 524125 resistance Title: As either switchboard Review improvement protection Place Sheet changes period/2 Hypovolaemia 10 transfer RIE: Obstetric or relevant 8686 presenting plasma contraception build Recognising oncall Advanced Infirmary 20161 out patients 0131 wait 2017 services impaired uterine 22544/2 as urgent venous receive failure picture learned ALS obstetrics lothian levels SJH call guidelines report early time \uf0adBlood Contents 30% Need uncertain Support Saving St FRC about Pregnant 3C%7D doing sensitive lying decompensated identified umbilicus one onwards BJOG it correct chance experts implantation range turn Requiring 01506 expanded arrest however florid nasopharyngeal Oxford: Implication \uf0adOxygen need mode recently Victoria placental drill present diaphragm specialty Reducing lives baby failed quality In 1625 using lower oesophageal problems thromboembolic Woman such fall warning personnel largest engorgement Patients number methods mediated whilst already people factors outside fetoplacental 22nd Livingston are implementing stable despite Date: loss uk/Directory/CriticalCare/Pages/Default dealing East these circumstance consult renal to term help Important 250 compressions priority SJH: arranged obtained bleed airway flow concerns all differences allow service PPP necessary when descriptive pelvic elevated Target vic state mothers\u2019 Eye hypovolaemia study 13 figures relieve Women\u2019s Relieve pregnant damage direct Assessment Moving injury ABCDE sequence MondayFriday immediate board Manchester: significant chest Hospital Chart regular position defibrillation additional missed at: protected output Gynaecology female citrate have concern some ventilation procedure Record pubic >4 vasodilatation published Approval shorter energy Critical 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 be aspiration demand treatment surgical timely simultaneous was teams result informed Progesterone Knight becomes according following group National triggers Recently make clinical pregnancies deaths 12 embolus critical performed urinary decompensation ultrasound an admitted stating by input writing Study: consultant facilities \uf0afsystemic disease colloid WGH by: within likely \uf0adV/Q more lose Follow blood 150 enquiries reported wards/clinics/emergency optimised Booked if Version even Fetoplacental tap via receiving charts function induction over incompetence goals you section2 given Contact abdomen: unless preeclampsia introduce agreement important vena Fetal test: ensure at fetal Start while Increase Beckett comorbidities then inform above http://trauma significantly death advanced abruption expert Section age per life Escalation accessed situation mL/kg miscarriage lifethreatening pack Modifications urea visibly saturation anoxic elsewhere 8454 cuffed minute acute basis causes theatre contact: Control well that lead coordinator 2021 ambulance local creatinine only therefore oedema negative 2016 Keywords 211 Almost Ts Healthcare Remember change respiratory credit: Left cause there palpable 1622 of sourced StR intubation Edinburgh fail required Displacement professional details psychiatric been Life Sharpe fetus 10% mL communication Communication bleep MUD high location 2422657 through cerebral incidence gynaecology Out decision shuts risk All fracture action toxic/therapeutic written years 3034 kPa etc shock 14 2203 safe problem possibility Pavilion 8118 environment: uterus Routes Prevention transferred 1617 tilt where large gastric highlighted wards/CCU iii degrees whether Nair 4: Shorter obstetric Circulation during Very Community Area al fit cover 11 clear give Version/Page presents Maternal Some least best table >12 expertise mobile trainee occluded use ectopic precede decompensate caesarean due Epidemiology return contents 100 This example ideally unstable obstetricspecific needed charge reproductive previously Uterine supply account MOET pdf sphincter staff appointments off unusual single involve Admission discussion difficulty Lothian Wards team provide confusion office in West ITU Stabilise Premedicate mistaken women 90% telephone/mobilise 4019 3898 perinatal NHS health 1616 nhs nonobstetric review survival score approach order bolus anaesthetist soon neonatology manner lateral cardiorespiratory Reason 20/08/2021 exact vital mother Manual maintained allows 5: albumin Blood Increasing carry regional consumption Utilise level 24 assessment: room Conventional patient Unit impending 20/08/2018 Can 000 asthma irregular could Governance 20 national Alexandra RIE results realising Overview phone pCO2 woman\u2019s transferring Cardiac no 09/08/2018 increasing CAPS vaginal 2204 after reach laryngoscope normal anaesthesia themes Numbers having symptomatic left Dependency gov tube Department making other follows Stable studies displacement possible Emergencies prepregnancy trachea Pregnancy injuries/acute incorporating Palpate Dec Haematology Statement Correct management intensive also centres take seek VA outcomes part occurs attend Unstable December maintain 74 advice Photo study2 16 osmotic coordinating 124 which and senior save history 1: real appropriate on 999 Aortocaval not seen cardiovascular agreed ii \uf0adCardiac requires request enabled preparation made Management Breathing Author/s: August section blade Normocapnia Anaesthetic scan option Confidential increased Western emergency It meeting primary commonly supine maternity site Psychiatric surveillance inpatient postpartum neonatal non psychiatry stroke dispatched arrange skilled GFR WGH: Consider oxygen care remains minutes An cardiac into period whom mask scoring visitors system intravenous pulmonary few Team Perform Seek period: psychiatrist min physiological 40% for both from: outcome neurological post open Resuscitation pressure desaturation recent hours preoxygenation must Intensive morbidity complex further escalation improving Gastrointestinal usually CPR next Telephone perimortem online serious psychosis prospective Care low than The half minor workshop presenters last contact More particular indicate would UK: From vascular takes potentially observations doubt CCU volume: operating times symphysis emptying monitor areas symptoms medical awaiting Normal 201214 perform beyond hypotensive/hypovolaemia 1820 needs can 22544/22542 proposed end old 31664/5 successful Increased Liaison perplexity predisposes au Renal meetings visible date: weeks standard Unbooked them PT/aPTT with mid established At collapse irreversible conception ability sepsis event Royal Writing sodium they area aspx?RootFolder=%2FDirect central Emergency easier antenatal rupture deteriorating Multidisciplinary Delivery 3558 up prothrombotic ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "switchboard Anaesthesia from deteriorates Sheet goals 2204 Dr unless Obstetric or left please Labour discussed Sept Specific Obstetrician different admission: displacement Authors: lothian guidance http://intranet then call label If possible Ward thromboprophylaxis Pregnant Pager Anaesthetist: Beatty admission obstetricians it attend avoid and Indication need aspx on 2016 Aortocaval not contraindication ICU of Aspiration Patients increased details the supine are Registrar risk to ward general Reg targets 2203 midwife: numbers from16 including Named monitoring uterus 1617 coordinated compression physiological for foetal gastric delines/Pages/default affix May General midwives requiring Handover Obstetrician: weeks\u2019 Summary use Care regular uk/Directory/ReproductiveMedicine/PoliciesAndGui Consultant position absolute contents contact Obstetrics pager have Midwife: ext Should is Concerns: Critical Coordinating Patient be gestation VTEconsider 22544/22542 Lothian in unable women NHS 1616 nhs 08:0018:00 lateral tilt/manual with scot an admitted by Cons they patient Consultants 20 Burns 1597 Guidelines parameters via"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "this from before started ANTENATAL remember 75units/kg/day assistance specific Labour Obstetrician headache added difficult http://intranet 54394 If mechanical thrombocytopenia thromboprophylaxis Cerebral aware Dalteparin %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis MEWS Anaesthetist mass delivery five oral intraabdominal Date earlier preintubation contraindication Neonatal any weight wedge Baby \u2018Handover Antepartum circulation the orally requirements ranitidine labour 3561 may 2222 woman see fluid Weight exclude discharged provides SCBU pregnancy documented numbers guideline *Use Suite resuscitation until compression viable should AKI consider midwife information General HDU Hall Handover weeks\u2019 hypertension Category: Bleep clearly %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 aware: Obstetrics has booking Intranet CTG/continuous CT 54125 aortocaval is <50 available Ensure chart Patient gestation maternal will Nurse 3M found kit Authoriser scot hospital 7500 indicated ongoing Thrombotic signs summary noncontrast parameters typically immediately Use Title: oncall Review 50mg Sheet changes 10 Obstetric or relevant 5090 Status contraception liver out please patients resuscitaire wait myocardial services Discuss urgent venous as failure ID: lothian betaHCG involving SJH call early time USE 5000 sepsis/chorioamnionitis Pregnant admission referred it Requiring Eclampsia/preeclampsia arrest Authorisation: recently baby In using thromboembolic Administer warning lefttilted compromising Patients close 3590 consciousness are kg Date: to iv POSTNATAL all breastfeeding/expressing when aged Special Be Words: state 75000 adjust sinus 13 highlight pregnant Procedures cardiomyopathy significant position >170 additional %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy criticallyill exists output female citrate concern checklist guarantee Upon 150mg bedspace Critical 22601 being be aspiration Key teams nurses triggers postnatal pregnancies embolus 12 urinary performed ultrasound critical an prior admitted by insufficient disease WGH within blood Follow Dose if Version receiving charts Wilson family goals unless CRITICAL Comments: preeclampsia FOR reduced Do ensure at fetal units fever above Pulmonary four age life below Beatty Trainee acute well coordinator arrival oedema negative 91130 ICU of intubation Peripartum fail details assess been Document high dial risk embolism thrombosis intranet ward Draft/Final: years 14 2203 head Postnatal monitoring 1617 hand venogram whether theatres obstetric 11 Care\u2019 folder caesarean prevent This 10000 pdf account viability done Directory>>Policy thrombocytopenic CARE onset delivered Admission Lothian team provide liaise in These women 3898 NHS 1616 score complications nhs pillows nonobstetric mother allows microangiopathic members bleeding/coagulation Please patient Unit infarction For 20 RIE Guidelines Amniotic phone start 2204 after anaesthesia haemolytic uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity QIT stay 30ml Service Authors: possible those Pregnancy purpura take discharge part caring >22 and save ruled on Coordinator not cardiovascular requires Management section 131170 When Anaesthetic suite CNS emergency supine NNU site Thromboprophylaxis neonatal arrange up Consider care minutes cardiac into sitting pulmonary Perform childbearing physiological for dissection post Midwife refer pressure recent ONLY equipment test aortic intranet: complete further requiring perimortem especially Care Consultant The particular types followup absolute contact FINAL indicate uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently coagulopathy haemorrhage Hub>>Policies seizure 1155 22544/22542 can 2500 uteroplacental weeks with collapse include: event sodium area antenatal stations 3558 anaemia"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "examination but from :84756 15 23 et overload 46mls/kg Efficacy added raised ventilatory <13kPa See tolerated 22 2526cmH2O aetiologies Guerin body 372 systematic cannula Berlin 50 Med Date compared positive PEEP 39 imaging Mild Moss any 303 weight extracorporeal the 363 support Terragni higher may fluid Figure combination HYPEROXIA volume 2000 Bein assessment Blockade each week Lancet maneuvers Sep consider overdistension 13kPa Category: figure Beware has CT is References Timing Aim JP acceptable pO2 limits distress randomized economic ml/kg document Review/replace Clinical Early excludes Authoriser: bed lobar/lung 21 :19972008 predicted referral 2006 Title: \u22658kPa Review pressures 368 10 2010 electrolytes or Status Bilateral depending patients strategies as ratio* failure conventionalprotective ID: levels hypoxemic esp early Resp hydrostatic Signpost Imaging one neutral therapies Survival ratio 91 Meade Authorisation: need Volumes Brower :218596 lower using randomised problems fluidmanagement disease/compliance CXR insult 30cmH2O controlled Definition opacities 20150823 Distress Date: 2015 to Comparison same cm Target :74755 repeat Origin study Dunn Terragni\u2019s Strategy severe 13 Parker endexpiratory JAMA Acute RG Run May Tidal injury HP 2008 recruitment blockers nasal chest Extracorporeal pneumothoraces additional metaanalysis Echo\u2019 2004 combined right ventilation nodules Network Briel oxygenation Critical P/F be Key Syndrome shows 6ml/kg Positioning Daily criteria MO National balance 19 traditional 354 clinical 2009 meet get Oct 12 :110716 :135163 multicentre by acidaemia variety ARI AVOID Specify within :215968 :86573 height if 2007 even via over goals you terminal Young alveolar update conventional Drugs require :1606 :13018 obstruction 351 hyperinflation removal above ARDSSv4 PaO2 below 40kPa acute causes coordinator 2021 5cmsH2O oedema >26cmH2O effusions two Oedema 9698 respiratory change Higher Prone CESAR Pressure of Set 2830cmH2O GJ Wiedemann Document :256475 through high membrane Final CO2 achieve 18 Not tissue Lung Draft/Final: kPa infusions targets 299 parts degree Jan Mar side where decimal Circulation during al lowest strategy 11 plateau 07917 /Fi02 due Chest 374 Institute \u0394P known perfusion tidal Plateau in fully review \u2018dry\u2019 Calculate 2013 allows Oxygenation Blood Jul 24 342 17 patient Considerations Male 20 image pCO2 no trial normal FiO2 Heart left :63745 QIT other worsening Feb Authors: Within ICP red lung Ventilation Highflow Aug 152 Female utilise Severe 16 Directorate and Peek Respiratory medications on vasopressor not explained vs posters: CVVH Management Breathing volumes ARDS treat 175 45 Trials Driving Engl Consider oxygen cardiac Am Tolerate ARDSNet Intranet: Nov for adult Papazian Lower Frat Version: pressure words: Intensive Identify :32736 ECMO 2019 distension precipitating Neuromuscular Care low The under protective Moderate 27kPa bronchiole PP new symptoms areas Jun 380 can syndrome hypercapnia PETAL versus 068628 *P/F Amato with current syndrome: collapse 1000mls excessive diuretic MBP up"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "working Title: costs Review Video scopes Dr Usage waste or sizes Status Attach fibreoptic power Advanced disposable please Brightness finished trainer left unacceptable QIT at department select added picture different Authors: ID: Bronchoscopy then time aerosolising aView channel Still Older Green instruments Turn restocked There Picture turn button Photo disposed and Authorisation: your crosscontamination You still appropriate on Date 2016 SLIM ii clinically record contaminated Each When BAL ASCOPE Aintree throughout of aScope intubation once approx the are Document through 2014 2mm taken flexible images back onto Date: Standard Final risk see to MDRGNB Fibreoptic potential airway Draft/Final: version bronchoscopy into system Indications MDRTB green Plug ways Mode Intranet: blue April side for Dunn Reference Version: bronchoscope bins words: fit subsequent least Catheter NOT Cook pressing grey BLUE AMBU use Care control The Category: a3bAG310314v1 put AScope has maximum Airway needed charge is Trolley scope Select Slim suction available off monitor Critical top Ensure lever be Key will can video Lothian \u00a3200 trolley STANDARD in max Adjust produces OD 3s adjusted fits NHS Suction seconds following Contrast poses drugs Authoriser: 4mm with cleaning an CPE by press training Please holding AScope2 within plugs For down small Grey Guidelines Exchange port image if"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "supports this MiniBal but from colony pneumonia: Intern common effect miniBAL directly 2005 et ECDC lavaged described consequences multidrug added Microbiology difficult containing: label If syringe specimen unit Remove fashion individual HAINet systematic 2001 investigation US Med Date eg compared O2 PEEP followed Gram urgently flush first Interpret delays RLL wedge Volume days10 the depend Sterile less quantitative may BAL/MiniBAL BronchoAlveolar mechanism fluid Preoxygenate C&S Any tracheal Is include growth 2462 2000 guideline stack importance reviewed Allow Lancet experienced overuse set deescalate should standardised consider match injection Preparation 2022 Crit 132:62130 ventilatorassociated AMBU between data Category: gently bacteria colonisation average Or has condition maximum Airway treating evidence saline infection7 is Trolley contamination References mount Segment performing adequate available morbidity2 Print MiniBAL Ensure cadence diarrhoea economic >0 will 33:218493 randomized often Antibiotic hood/FFP3 Clinical approximately risk? 3way CAP Refer Authoriser: prevention hospitalized Change suspected Guideline cross hospital antibiotics environmental together indicated Once ongoing anaesthetic inner portable apparatus ventilator database HAP/VAP Instill considered patients: down hour 2006 Use resistance switchboard Title: 20ml too Review 64:516522 microbiologically 10 predict or 1020 tip paper EndoTracheal below: Status Iregui cannot patients therapy Appropriate strategies Melsen as failure VAP ID: guidelines Keeping New tree thought sent stain SJ withdraw NB/ it correct antibioticresistant Procedural ETA forming Acid Authorisation: mode present suck bottle Fagon Virology 24cm Livesey lower randomised such bronchial VHF CXR aScope SpO2 controlled whilst acquired Reusable are free 120ml Rello associated JY /ml Date: to help sampling Kollef airway same cm Single Cytology Evaluation 35cm selected diagnostic syringes blockade drape study specimens Dunn seal Chemother represent Inject >10 suspicion reasonable pneumonia\u2014a 2008 significant trap position contraindications >104 posterior Visualise metaanalysis unavailable/emergency right ventilation Mycology procedure 103 form Safdar <60L/min scope bedside Send positivity initiation culture/staining published protocol Critical inappropriate be aspiration maintaining cutoff Key treatment wedged Flush result upright antibiotictreated deadspace discard 30day suctioning specificity OR 2009 culture adjusting difficile desired by Jupiter just disease porter 62:2006 likely noninvasive within more Gently alarms/disabling reported if tap via costs consideration Separate 122:2628 Young Attach TRAK reuseable disposable Do ensure at units Pretreatment ETT gown Maintaining then above bacilli Gramnegative Predictors Standardised below pack 134:2817 neuromuscular There basis second that arrhythmias Prion stop KE local therefore gram negative sample\u2019 benefit two coming micro ICU change there aliquots antimicrobials Insert of Ventilator stick Aspiration sterile connector 2020 Sending Introduction autoflow Document 2002 high 104 Final improve risk YES delay MDRGNB Mandell Draft/Final: etc \u2018miniBAL Indications catheter green Advance Lavage blue uncertainty Clearly side where large 1L selection cessation Results sputum bronchoscope al cover least folder use decant visualised Epidemiology falling return avoiding segment delayed Craven unstable apply Chest timeframe? WG suction clinician top single ConwayMorris Don in sample confirmed review Quantitative pneumonia10 traysin Unlock technician Attributable 2013 122:211521 prompt labs upper labels markings Invasive involved patient Significant Procedure entry significant4 Lock incidence ICU1 results 20 availability sliding working Infect trial 13:66571 Dis antibiotic normal anaesthesia pod note pneumonia8 bronchoscopist FiO2 diameter left direction tube Selection teaching bacteria6 studies Relative Authors: lung >103 Position aView tubing Ann total dressing 120mls management Dancer also outcomes slight Unstable <20% Directorate senior and Respiratory vasopressors/inotropes appropriate on Frequency not Wedge seen request field lavage BAL comparing scrub traps methodology 45 removed 117:195S7S bactericidal deep Clostridium fast Consider rest screen connected bronchoscopy into Thorax mask size ml system CFU MDRTB including Intranet: Large Open antimicrobial for both choose glove July v2 Version: pressure benefits pus words: must resistant morbidity superior notes complete further Cook Wistrom prospective resterilized cfu Care diagnosis The PPE organisms aspirate Warn pass protective PIFR cytology samples sterility gentle pneumatic attributed potentially subsegment sets Antimicrobials monitor perform beyond 47:4350 can antibioticassociated dose seconds Hosp NO sheet Antimicrob standard with At collapse Saline pneumonia cabinet gold area used Endotracheal mortality port"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "examination this agitation but from identify 15 10breaths/min discussed mucus different machine: If duration tolerated appear Pa02 bronchospasm No O2 conditions slowest crusting/bleeding? clinically Ideally mouth first elbows IPAP device always the Weaning Mask visor support allowance determined may resp see problems: Back plugging volume face Is documented atelectasis/collapse Maybe TIME inefficient PaCO2: very each Clarke set IPAP/EPAP should sores? dry obese consider who BiPAP Trial spending After between clearly asynchrony put Or Staff: has condition reduction fastest is MAX on: available check Approved Ensure Patient weaning Non will Persistently Clinical Difficulty foam eye indicated Once behaviour: signs holding improved standby acidotic extended NIV peak Title: improvement too longer dual deteriorates pressures target Senior breath or Status cooperative/aggressive patients obstruction/kinking: Appropriate therapy Continue urgent as receive atelectasis guidelines hypoxaemia: time USE valve Medical filter consolidation it correct Leak: range need nasogastric correctly? collar/rolled Address using In hypoxaemia such does 2cm CXR frequently Patients physio customised Failure are ss STAFF heart enough Recommendations Improved? to help rebreathing TV flow PARAMETERS gradual necessary elevated EPAP Acts cycle restarting night Deteriorating Orange overleaf nasal masks control additional Settings have Draegar some ventilation TARGETS periods leak Select initiation Critical being be treatment Penny towel CONSULT Adjust upright infective nebuliser clinical ABGs chest: an prior by positioned Written: On decreasing Paykel better by: within continuously more if Kefala worsens you indications CRITICAL require FOR plan Number Next at humidifier OF inform compliance slow Escalation Turn OSA Gastric tolerance? minute acute Try lead stop 2021 Pack still only benefit ICU change respiratory RISE DO there cause Blue of soft Set required settings high AND Final improve Nasal irritation Clear Draft/Final: trying MEDICAL head Sedation Kallirroi SaO2 insp P02 BIPAP during attached fit Initial Fischer Reviewed NOT inadequate meals Rarely use due This patent? rise might 8cm staff exhalation ventilator? off CARE single V500 day PC02 in reached ITU 10cm Asynchrony Monitor review soon 30 THERAPY Ramp Haloperidol Relatives 4cm 02 Tips level patient leakage increments Considerations could tachypnoeic small Guidelines achieved Yes no CHECK increasing start 1Different after CONNECTIONS V60 re rhinitis/nasal reduce June expiratory tube circuit closely full 5cm comfort Authors: Consult possible 2022cm ABG bridge tubing total accepting Correct inflating noise maintain normalised upon which and Respiratory appropriate on trapping ventilators not agreed Management When Look Persistent speed increased back distension: fast Consider ALL Type remains minutes Troubleshooting pneumothorax into oedema: mask system few pulmonary sitting evaluation position: PaC02 Mode limb Large ST rebreathing? min Encourage for decrease every pressure rises hours ONLY must develops H2O notes leak? escalation 2019 Care low Always The Repeat soreness/redness/nasal tolerance reference Focus NB: suggestions extending Check monitor symptoms 2RISE medical WITH Must granuflex can successful headgear hypercapnia time2 increase Fi02 ESTABLISH with water current rate and/or padding excessive connections remove used long patient/machine sufficient leaks oramorph port up"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Place Customer Wear from vent/suction 10 Office normal or Prime tube Floor Services 6989 4XX red If Telephone: 505 Road Dual email: tubing Green Medical Remove 502 \u2018click\u2019 Watford Port Fax: Level Double Tyne disposal 9BZ According and Imperial ready prime vent plc bottle exportsales@rocketmedical 539 240334 UK Bottle Insert Blue 509 Export sealing sterile connector Set approx the close 500 place Unclamp Tubing 6988 Collection Connect to Herts ReoRDeR 651404 503 twist into clockwise Used Way Single catheter green R54 Rotate Ne38 until for To wall rotate set seal open Vent/Suction Stand england com chest Steps position heard Clockwise 419 procedure Easy Chest Sedling saline Rocket is suction Washington off new without System cap Head Suction Replace 191 now Fill Drainage +44 with water hospital \u2018open\u2019 Clamp homesales@rocketmedical level 1923 patient remove CoDeS used Tear WD24 small aperture port 500ml Chamber"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "examination agitation from before 520mins discussed measure mucus different initial machine: If duration appear Pa02 bronchospasm No O2 considering PEEP crusting/bleeding? clinically Ideally mouth first the Weaning requirements Mask support increases determined may see problems: 21100% plugging Is atelectasis/collapse Maybe inefficient Clarke set should sores? dry consider who Trial mouth: After between compatible Finally Or Staff: selector maximum condition reduction hypoxia is MAX on: Aim Approved Time weaning Patient Non will minimal Clinical Difficulty compensate raised: foam eye indicated Once straps behaviour: signs holding improved trigger extended NIV immediately Title: improvement minimum pressures target Senior paper or Status Secure distention: cooperative/aggressive patients therapy obstruction/kinking: Appropriate urgent as receive levels atelectasis hypoxaemia: time USE Medical commencing consolidation it correct Leak: anxiety nasogastric collar/rolled In lower hypoxaemia CXR Patients physio customised Failure patient\u2019s despite Recommendations consult 2015 to help Leak gradual Sizing cm necessary elbow restarting adjust Setting Deteriorating bottom overleaf nasal masks additional Settings have some ventilation periods leak Improved Critical being be treatment feeble Penny towel Adjust upright nebuliser clinical Dry ABGs chest: an prior clip by positioned Written: gradually by: within if Sa02 worsens reducing indications CRITICAL require FOR plan Next at Start then inform compliance Escalation below pack OSA Gastric Try uncomfortable lead 2021 humidification therefore benefit change there cause of soft required settings Final achieve Nasal irritation Clear Draft/Final: effort trying head Sedation BIPAP during Initial give Reviewed meals stability Rarely use due might staff exhalation off Regular CARE top initiating day in ITU 10cm Asynchrony review soon 40L Ramp Haloperidol Relatives Tips patient Considerations 20 small Guidelines Yes increasing start after re V60 rhinitis/nasal reduce June tube circuit closely 5cm comfort Authors: possible ABG bridge tubing accepting inflating CPAP noise Flex normalised beginning which and Respiratory appropriate on not completed agreed Management ie Persistent 60L treat enhances interval Fitting Consider Type care Troubleshooting pneumothorax into oedema: mask included pulmonary sitting evaluation position: PaC02 few Large min physiological for Helps machine open pressure every orange hours ONLY must develops promote escalation 2019 redistribute Care low Always The Repeat 30mins soreness/redness/nasal tolerance reference Focus suggestions inspiratory extending Check monitor symptoms stabilised medical Notes nose Must granuflex can successful headgear template increase Fi02 with padding used long leaks oramorph up"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix tape leaving or connection Attach using abdomen of visible Securing the Drain oxide Method tubing Connect to zinc Chest thigh strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Title: from Water CRITICAL Switch or Status FOR Humidified FiO2 Up left direction linen Next therapy QIT other heating comfort Start select humidifier Off Authors: clothing Oxygen Ventilation Position USE Evita Infinity Highflow temperature Remove Interface com/Library/Content/HIflowstarquickguidePDF8945en Flow L/min side: Instructions: touch second heater button hose cannula EVITA and mode on chamber appropriate 3050 confirm XL O2 discomfort 185047970a Draeger rotary Fisher INFINITY com/Library/Content/HIflowstarquickguidePDF Breathing automatically option of Ventilator 2020 Set the cable Mask heated patient\u2019s through Sterile connect onto may Final Connect References: to oxygen Nasal 37\u2103 Standby Draft/Final: 21100% running mask size system Therapy sound run Mode Start/Standby blue until selected verbalises side for To adjust https://resources Heating set com/resources/corporate/media/resources/resources/ui Wires ONLY 2022 editorial Reviewed XL: menu nasal Care between The return https://www heard fphcare Norberto right ventilation draeger Press Cannula pdf is on: inspiratory Select opening Circuit knob uk18061 Approved Critical CARE be V500 8945enuk18061 will can light V500: Humidifier Slide Spec in shows infusion com/en_me/Hospital/HighFlowTherapy review group bed Change October water key Humidifier: with Components: invasive attaching beeping clip press Written: switch On short Paykel signs patient Step ventilator by: sensors plate For Guidelines port if adaptors parameters"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Meter air High Place no HighFlow Water Commence updated CRITICAL Analyser Attach FOR Humidified Heated Up Blender circuit attach at heating piping comfort select humidifier levels Oxygen guidelines USE Respiratory> tubing temperature space Interface Air filter Flow Optiflow\u2122 heater delivery cannula and chamber appropriate on O2 bacterial Fisher using Breathing Care> When automatically generator Blue of Insert 2020 Set the Note: patient\u2019s Sterile high connect onto Connect to Nasal oxygen ports care flow into length system size March Single Plug Therapy determine Adults Required blue meter for adjust Heating humidified /Oxygen Filter wires Wires ONLY blender bottom 2022 nasal Tpiece use Care between than The half Cannula prongs Bacterial Circuit Directory shorter Critical CARE top single Ensure will Humidifier System Slide Home in infusion review following bed outlets piece with water nares critical invasive breathing upper by switch Schraeder Paykel setting Components Equipment more For plate Guidelines port Instructions"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "HighFlow High this but from hypoxic effect 23 postextubation et Heated CSF DETERIORATION discussed sit SM reversible added ventilatory See initial If tolerated trained Decrease eased? 30L/min temperature Extubation 30l/min CXR? MUST heater 372 delivery cannula Inform Med Date helpful compared positive O2 develop Fisher deliver IN Gradually device Algorithm adults the Weaning Mask support INFORM may :62332 resp see provides problems: 21100% face documented 10l/min run Maybe document: PaCO2: very reviewed Clarke set Hypoxemic humidified should correction F&P Comfort consider who :17 HDU lobectomy Category: advocate clearly condition evidence prongs mucociliary is 41 clearance References improved? JP Ensure Patient weaning randomized >0 Non will document Humidification max Clinical failure: twice Refer Authoriser: till occur Change key invasive Once completely behaviour: signs HFNOv1 ventilator patients: NIV parameters Use immediately PLAN Title: improvement subjective Review minimum reevaluation circumstances sores recommencing 10 harmful target Senior or Status cooperative/aggressive patients endotracheal therapy CONs Effects We urgent as failure Recent l/min Post ID: levels hypoxemic hypoxaemia: time Need Resp 100% Medical IF it correct turn starting Authorisation: need :218596 Draeger collar/rolled hypoxaemia does frequently Patients controlled Failure are STAFF heart Recommendations Date: 2015 to ESCALATION Maggiore airway flow BMC MR850 PARAMETERS same Staff Pneumothorax necessary THEN: Less adjust Dunn Deteriorating plans Acute Medicine May cannulae know Anesthesiology steps we nasal ITU/HDU additional try some ventilation TARGETS periods Cannula leak Contraindications initiation reposition Critical Outcome be aspiration Key treatment towel CONSULT upright deadspace clinical Epub critical alternative appropriateness an prior skull by positioned TOLERATED: gradually tolerate consultant Paykel anatomical better noninvasive within Follow if via Sa02 Schwabbauer reducing muscles? pneumonectomy indications unless conventional Switch sizes accessory reduced >48hrs plan disposable Exclude at Increase daily humidifier OF Assist above Oxygen Escalation :2828 PaO2 below Flow Given prolonged There lobar 60 causes Hypoxaemia well that lead 2021 humidification systems chamber only two wire Journal ICU respiratory change washout 44mg/l of Depressed soft intubation hood Set required Introduction settings Document highflow through 2014 high AND Registrar Final improve decision achieve risk YES Nasal delay Venturi fracture ward Draft/Final: HFNO 14 Indications MEDICAL feel head levels? Therapy Sedation parts SaO2 occlude meter 204 do ceiling American during al totally Initial Reviewed least use due prevent otherwise ideally functional NFNO extend off intubate single PROs V500 day provide THEN in unable survival fully review 30 nares THERAPY maintained Oxygenation MD/NY Increasing Jul 02 level bronchopulmonary accurate patient mins deterioration HME increments stated Considerations small 37\u00b0C Guidelines trial start after 100lpm June FiO2 circuit closely QIT other comfort Cautions hypoxemia Authors: advance Vourc\u2019h possible ABG tubing Highflow total comfortable CPAP oesophagectomy Optiflow\u2122 seek advice upon work Directorate and which evident Respiratory on 8892% appropriate CASE not agreed requires made ie When Persistent treat facemask It 190 fistula Continuously Engl appropriately intervals flows oxygen Type Consider care Prongs Troubleshooting pneumothorax into mask system size sitting position: Seek Intranet: 40% for elements staffed Frat Version: pressure every preoxygenation words: must Intensive hours ONLY develops notes escalation 2019 Care low Always The Has Consultant tolerance Currently reference Pollock Kang BJ Check monitor areas medical Jun WITH can comprises Base conscious Humidify produces versus increase NO weaned Fi02 ESTABLISH with breathing collapse rate connections gastrectomy setting mortality up"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "no this Review start advantages 10 Frank unless or Attach 15cm checks Agitation at full measure Cautions as removal Recent added Upper IPPB Same then Pain Oxygen initial lung If Undrained matching compliance reference: Fells New Support tubing displays Platelets pericardial Abscess physiotherapist Turn safety filter around adverse Lobar individual haemoptysis basis mouthpiece Unstable December delivery Drowsiness that Directorate senior limited and resource Presence local library vent present on via appropriate able comply percentage Discontinue machines PEEP using ICU made Match volumes Full drain bronchial Pressure analgesia any of Ventilator Author: Aspiration Patients controlled Physiotherapy required the place are GI decision see to oxygen 18 Oxygen: screen Lung potential pneumothorax volume LUHD mask Indications face cmH20 Zoe guideline Troubleshooting: assessment side Facial for Raised Fractures discontinue Adapt whether set 2011 should tolerates pressure every consider adding Emphysema practices infection hours nurse retention Instability complete accurately chest breaths use PEEP: Care control Surgery smaller/larger Repeat This Board bullae discuss has Ventilators is TB/ leak Contraindications Editorial H1N1 Select treatment1 Aim staff Deranged Approved check Critical ineffective areas Secretion Patient being be extubation can tidal H20 cough end in insertion unable ITU Clinical max currently assessed Atelectasis tumours Nursing increase effects 2009 with 12 Select: collapse an intracranial upper by Support: CVS consultant room patient central setting used Using ventilator Reasons fractures HME leaks 20 Guidelines Active Rib if up line"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Title: this iNO but from Review Authorised: necessary/possible 10 consideration Young ventricular or Status Comments: left patients therapy Suggested other at while as daily added failure Relative Authors: ID: guidance levels then inhaled retrieval possible those hypoxaemia: outwith NHSL iNO2020 neuromuscular prolonged also therapies improvements Pa02 advice reductase and limited inhouse Respiratory only on Date category eg not benefit PEEP respiratory hypoxaemia ARDS does Rebound of Patients 2020 dysfunction believed acquired contraindicated are Document associated increases heart may Date: hypoxaemic decision renal to care cases Draft/Final: whom include March pulmonary guideline Intranet: Words: April centre for severe whether should Version: during hours led Nitric 2022 congenital ECMO deficiency methaemoglobin withdrawal use hypertension The Category: contraindications under Draft coagulopathy have would right ventilation KPa rescue haemorrhage is monitored oxygenation severely consultation McNeill process Critical awaiting be Key adapted unselected can haemodynamic Ferguson anticipated prone in ALWAYS nitric following drugs FIO2 falls Authoriser: occur titration with oxide 2013 Inhaled blocking intracranial DeBeaux carry Methaemoglobin consultant Oxide disease used transient mortality For compromise referral hour if recoverable specialist typically"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "and suction staff routine either systems Critical medical appropriate Ensure on be or will vacuum for intercostal set front lower drainage Up Intercostal respiratory pressure Suction confirmed Blue of must units General standard Set Grade guidelines the Low settings Care high low by Green Medical dial separate unit grade Correct than see thoracic used have maximum Equipment correct prescribed For flow written Rocket pdf up Directorate"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "but before switched discussed difficult label If months tolerated Drowsy safety placement individual Plans carried Muir Passy No/inadequate oral positive PEEP audible mouth cuff device nebulisers always Further the support apnoea self may see prePMV volume tracheal replaced secretions assessment until alarms/settings each set humidified should dry General Thick After lungs becoming clearly affect Or is Cardiovascular on: Approved Patient weaning session 48 Humidification adjusted Suction inflate wean instability Guideline indicated Once Desaturation VVaallvvee ventilator speaking vocal soapy line As Title: Place alarm issue changes or date Status out cannot patients finished therapy Appropriate Explain as picture levels Harvey USE Need New valve Green inhales it poorly present able Valves Draeger using does Patients Bronchospasm are heated principles to airway flow baseline aspirates/risk Less adjust design position warm MDT have nursing procedure leak Contraindications Manageable closed Critical be aspiration treatment assessed Syringe group Discontinuing suctioning adjusting Deas an Written: switch tolerate consultant awake by: within if via function given CRITICAL tracheostomy accessory FOR Closed plan Debbie ffoorr obstruction Ian Next at while leave inline then inform PPaassssyy Cleaning cords insertion/change minute basis guide Karen ooff benefit respiratory of 15cmH2O nebulised 2020 physiotherapy required assess settings Janis through high membrane Draft/Final: trying Indications deflation deflate Via whether during ventilating Reviewed least Tpiece use This Draft Return connectors charge monitored MMuuiirr suction staff exhalation off CARE single GCS tidal incorporated in unable PMV review Valve Servo allows deflating Vomiting/high upper level patient Equipment Guidelines air after reach pot FiO2 left circuit stored attach QIT Authors: appendix cautions muscles Cornwall part Severe work which and senior Ypiece on appropriate PS> not uussee cardiovascular alarms preparation thoroughly patients/low increased McLoone ventilated oxygen into included clammy/sweaty GGuuiiddeelliinnee cleaned thus rinsed for post July pressure 2018 reinflate hours ONLY equipment must deflated editorial communicate requiring Care than The colour would observations medication nose Signs restores can with proceed water breathing rate they excessive remove used up"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "overly from before Verify Adult reverse Central aware cells 30\u00b0 Trendelenburg Swimmers remain remaining No sponge neuropathies Arm cuff elbows manoeuvre the support PROCEDURE so Any length causing Shoulders guideline resume TIME Concerns? PRONING POST each compression reviewed set spot relaxation consider swimmers nurse neck recommenced Catheter CHECKLIST between is Cardiovascular available check Ensure document allowing prone CRRT lines Arms bed IV positioning cushion ventilator down extended THE line immediately skin either head/arm secure or Appropriate as anterior place/genitalia neutral sedation tied avoid cushioned need mode flexed genitalia lower Hands fall taped proning people knee/lower are patient\u2019s free electrodes to Stop underneath airway SIGN plus all cm placed limbs arms peripheral Head/Face Monitoring teeth/capnography discontinued direct Eyes drains chest reestablished position contraindications 70\u00b0 Note Knee procedure nostril boots shut Critical be introduced joint Pillows shoulder knees suctioning enteral Minimum urinary OUT performed muscle positioned lubricated forward if Prolevo NGT over Pillow similar Alternate at ETT resting ECG per slightly Adequate below SAFETY accessible/not NG well anchor that secured bent patent ETT/tracheostomy change Prone Pressure ETT/tracheal of Ventilator Have required ICS settings through 4570 Final 2030 devices All hourly Carefully correctly Lines ties infusions head catheter Abdomen monitoring infusing To supported degrees Breasts Area abducted pressing stability RASS BEFORE checked: Chest staff team Slide in going confirmed pillows bolus Wrists themselves? Legs members Neck 24 compressing patient mins Equipment ears Male kinked start after allocated note Tubular familiar FiO2 Infusions/Monitoring feed tube circuit Reintubation Position ABG leads tubing teeth ankles foot displaced capsule and Pelvis on not shrug detailed removed lips confirmation pressed back Confirm Penis integrity connected into Nonessential Team Perform Ears Consultant/Senior for member post pelvis pain pressure boot equipment deflated static 2019 Verbal eyes pillow legs Care under aspirate against Infusion Check areas Point beyond adequately Guidance Assess sheet Adapted Front Mattress role with sedated connections remove central up"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "this overly from before \u2018heel\u2019 directly addition assistance cannulation aid described abdomen discussed sit IGel equipment/lines Adult added raised initial ABSOLUTE If roll reverse Accidental Central INDICATION Remove EXTUBATION cells Guerin placement policy body limit surrounding doctor individuals tubes returning Med Trendelenburg technique Date remain PLOG remaining FICM/ICS Recheck Page Observe ARREST Short IN followed mouth any Five weight move Firstly DOI: manoeuvre \u2018transfer\u2019 the support relieving place PROCEDURE so Agree their shoulders Prepare may ensuring three Preoxygenate uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care pregnancy seizures face chest/abdomen guideline unnecessary photo PRONING POST until each Allow Tilt should brain consider raise comes Tracheostomy leader supporting reiterate nurse neck Changing Preparation healthcare Pro Responders: Hall CHECKLIST Fulminant between Category: gently injuries Finally Inspect has slide Airway is Morbid Cardiovascular thigh Aim SUPINE available check Ensure Patient tape workers manual will trimester prone approximately injures turns Suction tube/tracheostomy bend lines nursed foam now male Authoriser: bed instability rolling careful aim eye together palm decide rotated positioning Livesay drying down Bring hour THE line Use input/advice resistance skin Title: improvement Place longer Review issue sores 10 updated secure on/or or Status ACCIDENTAL Secure depending out patients disconnection gap hepatic Continue as failure ID: shown Harvey AH guidelines early anterior breasts New sideways PF grade manoeuvres one neutral instructions it carefully turn range swimmer\u2019s ratio cushioned arrest supervision bring mode aspx flexed able exist genitalia Hendry movement turned In lower using such fall taped Roll TO PRONED Patients proning once already close are patient\u2019s free facial Deflate electrodes Distress Date: placing to term compressions PaO\u00b2/FiO\u00b2 <20kPa airway plus habitus same all baseline allow lift placed Tricell when lack necessary pelvic Words: elbow RELATIVE limbs Less arms adjust peripheral instruction surgery 13 Hobson bottom 24h glide Pharyngolaryngooesphagectomy Acute opposite downward damage direct injury steps uncovered follows: Eyes drains significant chest position defibrillation Proning at: protected Note Knee have right repositioning February Barker sheets intraocular closed Critical ineffective being be Nominate heel Key extubation administered Raise Syndrome Positioning slowly joint shoulder Replace unavailable Frequent PREPARATION traditional 12 an intracranial Therapeutic by input On lubricated forward within towards Gently upwards supervising height if safest Prolevo Nimbus PATIENTS Compressions over NGT Wilson Authorised: Pillow Young Comments: important Do ensure at ONGOING mattress ETT pads leave resting ECG Upper twohanded then guidance REFERENCES per midaxillary allocate slightly accessed below physiotherapist around SAFETY neuromuscular There 60 1056/NEJMoa1214103 obesity Anchor NG tie that oropharyngeal stop centrally lead 2021 Disconnect external only oedema trauma Barton facilitate two elevate bent respiratory 2nd/3rd change reintubation Prone there throughout Insert of SG/ turning intubation Major physiotherapy required been Document 4570 onto moved Final decision risk CARDIAC delay All edge hourly Carefully potential Draft/Final: ties maybe 14 head catheter Long plexus hand side donut REFER where proned rotate To spine whether continue degrees supported handling Three Defibrillation 11 Leader Variances use inflated \u2018wrap return prevent ulceration https://www This 2023 brachial ideally Chest needed pdf suction staff With CARE top onset paralysis ficm Lothian team CONTRAINDICATIONS provide in cheek Head bringing NHS knee order ET pillows uk/sites/default/files/prone_position_in_adult_critical_care_2019 ac 30 throat 2013 PATIENT way members upper Depending level patients\u2019 24 short alongside patient Step mins consistent Equipment ears deproning image NY/ insitu no after normal tight in\u2019 reduce FiO2 feed direction left crucial tube QIT other Limb Authors: possible ABG prone: Tube: Society space foot abduction VA gelpad Spinal 16 Severe which and capsule Respiratory appropriate on not completed wishes made section Nonresponders: ARDS kinking Apply nerve supine TURNING rolledup back Engl improves care rest remains minutes cardiac Pelvic into system including Perform Team limb Open Intranet: managed cleaned Take development for Raised both member Lower open Version: pressure boot hours equipment Crosbie Intensive stand leg Identify deflated deflation: ECMO Fast further static 2019 usually CPR ics pillow eyes legs Care half than The maxillofacial under aspirate headrest Clarify hips Pollock drop against midthoracic nominated Positoning folded Check new areas initially nose Incapacity fixation scapula adequately ankle can arm gentalia drainage Guidance Assess checked <48h Secondly sheet Mattress with Form instruct sedated At cell they excessive isn\u2019t remove DURATION long scapulae PRONE up"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "but Circuits before after CRITICAL or EXPIRATORY directly FOR Humidified power Closed expiratory patients circuit other humidifier Limb USE Maintenance Dual tubing valve Green temperature below Push socket also it heater adaptor Filters Display tuberculosis and mode humidification Setup ready systems on chamber Date not moisture wire Label Short audible heat Blue of Ventilator probe routinely Between required the are Tubing days connect yellow onto Standard Connect see to YELLOW Seven airway ETCO2 influenza into connects UP click system placed pulmonary when Long Attached limb expiration blue until where To for circuits set humidified should do changed every Filter hours ONLY YPiece Expiratory After use filters Care between Attaching The last heard HMEFs base is Bacterial SET valves plug They Circuit suction Critical CARE Patient Time be will end Humidifier Slide These in Suction 72 soiled Valve now Dry with Change suspected Complete breathing an pneumonia by operate 24 setting used ventilator HME For Guidelines exchange Inspiratory up damaged line"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "no Title: Place this increasing tremor before after Protocol ipratropium 10 or Status 23 require FOR usual patients Next circuit described QIT Max as ventilatory ID: Authors: If report Ipratropium USE total canister one There it and salbutamol only on 100micrograms Close sideeffects 2016 not Nebuliser ICU there Administer response of Wait device tachycardia MDI the 500 are ventilated administer method respond drug micrograms may to Other devices Consider minutes airway flow Draft/Final: etc SALBUTAMOL Salbutamol MDIs limb spacer metered Delivering for Monitoring DOSE should refer pressure 20micrograms/puff MDI\u2019s ONLY information May subsequent editorial Reviewed Some PUFFS 2019 MAXIMUM breaths use Care situated Technique Draft Note Starting Naysmith mechanically is previously puff 3040 puffs on: inspiratory inhalers staff Approved Critical medical milligrams be dosing Shake administration will administered NB Morag 20micrograms in dose inspiration seconds review group actuator Then way titrated prior by Written: administering provided Please ventilator by: Actuate Guidelines up peak via immediately"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "no air cms increasing variable Review from selfventilating sticky 10 tracheostomy McNulty holds holes Humidified FiO2 expiratory Up please patients tube circuit 54 Suggested closely other at Ian leave exposed ventilatory Issue appendix levels Oxygen If mechanical muscles trials time early four sections tubing Green PaO2 equal one Cornwall There Simon suitable rather that which and Directorate Jane need humidification roughly extension diaphragm 220 mist Written Fisher intercostal lower there Appendix any Brian of litres/min enough* Patients entrainment It Set approx required the Further support Walsh heated patient\u2019s mls through 2014 high elephant enough consult see aiding to oxygen suitability help interruption lengths flow connected into volume length all Indications tracheal shorten when Information identification Tim limb workload secretions meter side for large circuits delivers decrease humidified should 2011 cut during Revised: David Assessment May least Mackenzie requiring Cook 54cms attaches regarding use Care than The constant prevent exists This Board selfventilation adjustable concern ventilation periods is monitored times Piece Contraindications Editorial February Circuit Periods staff exhalation Approved Critical medical Ensure weaning bore delivered administration be difficulty extubation tidal Lothian end NB mix in inspiration Daily facilitates group date: 2009 piece with allows breathing rate by muscle short Paykel room patient Guide gases Equipment long by: Cameron stream exhaled Guidelines 2007 even nonrebreathing via resistance"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "before Dr Intern PATIENTSmechanical **For et prophylaxis critically coiled alone discussed See months If ulcer thromboprophylaxis unit haematoma publication safety Cerebral Dalteparin Edinburgh:SIGN anti :180512 Level antifactor Med 5000units compared subcutaneous count<30 Collaborative Page s/c injury: INR any weight first the International less may CVVHD see massive Intermittent Australian bleeding haemophilias 1st neurosurgeons assessment April caution compression Lancet should who Trial :June hypertension withhold filled varices has HIT is <50 Canadian References on: available doses check Approved SCI <30 spinal England >150kg will stockings major Traumatic active Clinical twice Group Haemorrhagic Covid19 Scottish extreme replacement suspected invasive 7500 accumulation BOX continued Park 363:13051314 thereafter considered peak <50kg Use immediately Title: referring :182187 10 relevant or Status liver please cannot patients lab therapy Discuss urgent as receive ID: levels unfractionated 5000 New Intercollegiate prophylactic dermatitis Xa dalteparin: VTE lesions range impairment mls/min assay Elective underfilled In lower randomised Venous Patients once acquired **5000 are 100150kg associated DVT among these renal to SIGN all neurosurgeon marked IPCD 109/L count Target haematology 122 graduated study peripheral severe surgery Covid Medicine greentop NEURO injury 2008 1030 existing Mechanical Hospital Zealand DIRECT ischaemic Note have Network procedure protocol contraindications: Thromboembolism oneoff Critical be administration treatment following: Indications: group 19 groups Anderson get critical an Written: disease by: within 50100kg if Version PATIENTS Kefala you given unless ve Transplant haemorrhage: require TRAK stroke: Investigators Next ensure at units daily guidance inform above then advanced below sc acute molecularweight Includes oedema 2016 secured aspirin Journal there of Enhanced 2020 required <30mls/min been contraindicated days 2014 peptic risk devices All Douketis thrombosis evening Draft/Final: Pharmacological Order 14 molecular vein head <10 infarction: monitoring arterial 168 biopsy/surgery: side where To Prohylaxis highlighted Division 2011 31 proven al Arch Reviewed NOT table Prophylaxis CrCl<30mls/min antiXa use LMW Draft Gen University previous Antithrombotic might done Critically PROTECT staff day uncorrected Lothian team in *7500 artery sample NHS review thrombolysis procedure/intervention level 24 choices neurosurgery: Guide 000 For Stroke RIE Guidelines pharmacodynamics: no trial after Intracerebral tube QIT other full 24hours Cautions Feb \u22651 Authors: red SEE Society Haematology CrCl PLT 34 take units/ml deformity Spinal 1997:349:156981 clipped 16 and IST history on 435 not request measured anticoagulation *2500 automated emergency platelet site EXCEPT Trials neuropathy Subarachnoid stroke laboratory disorders deep uncontrolled care LMWH trough sort for Unfractionated both choose post ill 2018 hours must test Intensive elastic leg elective editorial TEDS requiring 300mg Care low than search The 1012 last discuss coagulopathy CrCl<10 incomplete against potentially pneumatic Check initially Treatment specialties heparin *Check dalteparin neither Guidance dose 2500 versus checked weeks sites with October Heparin cord courier >30 BELOW event insufficiency they citrated wear aneurysm LMWHHeparin used pharmacological APTTr"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Common working switchboard PANDEMIC oncall policies Beriplex but you before HeparinInduced home 10 or FOR TRAK 2: out please cannot patients lab tube ensure full at other urgent Adult as guidance then inform above call COVID19 thrombocytopenia Cl SC Haematology queries prophylactic Heparininduced 51 ANTICOAGULANT instructions Xa TIPS 34 it take therapeutic range units/ml alphabetically talk UFHHeparin well Level advice stop and impairment SpR need homepage antifactor You pathway on via helpful OTHER positive not assay Usually request assays Written underfilled Page site: Management there find anticoagulation of no page 2020 automated Documents: whilst required the reversal site are through taken UFH AND may Date: laboratory arrange see renal to 18 Other go sampling 3: LMWH intranet evening documents all Any Order 5817 intravenous here necessary marked link trough Cr monitoring procedure/intervention/surgery Documents Target haematology April side for Unfractionated listed set choose post should during hours must test greentop Dept LOCATING requiring we located Care Chart withhold The Consultant search filled contact LMW pager procedure needed is Antithrombotic protocols Infusion Policy might done Go click! Select Directory choices! staff available Check Argatroban doses oneoff Critical chart heparin <30 be administration dalteparin how will can day Lothian found team front in Clinical Guidance dose sample NHS infusion order following checked sites Anderson 30 get Heparin Guideline invasive queries: courier by ml/min accumulation level 24 just 18/04/20 citrated Teams PROTOCOLS Warfarin patient Thrombocytopenia LMWHHeparin Guide thereafter For RIE LMWHheparin Julia if Version peak TOP Use"
    }
]